data_2hlw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hlw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.406 ' HD3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 111.747 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -52.53 -35.63 53.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.491 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -55.37 -53.54 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.288 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 22.4 tpp180 -57.53 -40.16 78.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.42 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 78.8 mt -60.67 -51.46 69.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.05 -52.75 62.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.447 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.43 -43.13 99.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 80.6 mm-40 -72.41 -28.47 63.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.706 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 44.7 tp -61.35 -42.49 98.79 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.53 -49.26 56.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.791 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.27 78.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.216 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.27 -51.31 18.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.649 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.18 -44.28 92.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -58.4 -56.21 25.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.19 170.01 15.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.677 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.95 -177.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.61 108.95 1.36 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.663 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 16.08 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.578 0.228 . . . . 0.0 111.272 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.42 50.72 17.39 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.981 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -70.52 -23.34 62.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -155.01 173.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -160.86 112.0 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.977 0.418 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 141' ' ' LYS . 25.2 p90 -101.14 81.66 2.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.84 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.77 179.01 35.39 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.995 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 mt -90.38 144.58 25.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.977 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.0 m -97.72 -66.8 0.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.38 93.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 81.6 m95 -90.87 169.27 11.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.056 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.22 124.69 24.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.64 115.95 3.07 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.804 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -91.1 157.17 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 25.6 mt -152.86 141.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.819 0.342 . . . . 0.0 111.748 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.47 149.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.731 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -79.43 139.57 21.83 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.865 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 72.0 Cg_endo -87.69 127.42 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.973 2.449 . . . . 0.0 112.109 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 81.7 Cg_exo -47.52 139.9 16.98 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.552 2.168 . . . . 0.0 112.99 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 9.6 mtt85 79.7 40.47 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 31.0 p -159.09 151.75 21.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.78 -39.63 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 151' ' ' MET . 49.8 m-85 -80.27 -21.57 42.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.114 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.2 pt-20 -38.36 138.01 0.51 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 55.03 45.94 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.711 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -143.69 112.76 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.511 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 5.4 mp -70.45 160.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.425 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 15.3 m-85 -151.9 126.76 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.41 . . . . 0.0 111.208 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.2 t -94.94 151.83 18.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.0 mp -150.96 160.37 43.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.14 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.63 114.81 10.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.5 mp -106.36 120.75 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.214 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -93.95 120.54 34.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -128.63 105.19 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.53 -110.64 2.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.387 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.1 118.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.153 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 4.8 mtpp 61.81 87.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.506 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -105.27 -66.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.896 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 55.4 Cg_endo -69.63 2.91 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.439 1.426 . . . . 0.0 112.952 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 16.4 pt-20 -112.06 -9.34 13.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.663 0.268 . . . . 0.0 111.041 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.56 19.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.01 123.29 13.49 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.694 2.263 . . . . 0.0 112.382 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . 93.2 Cg_endo -80.07 167.81 19.52 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.726 2.284 . . . . 0.0 112.317 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.19 89.11 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.24 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.126 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 129.71 12.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.953 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.502 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.5 m-85 -75.2 130.93 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.31 -45.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.301 0.572 . . . . 0.0 109.647 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 9.9 t -69.0 -179.38 1.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.689 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 8.5 mmtt -88.95 105.23 17.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.502 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -132.25 153.15 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.771 -178.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -125.98 102.6 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.565 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 18.4 ttm -124.3 144.71 49.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.17 -32.71 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.288 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.78 -10.65 39.87 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.09 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.445 HG22 HG21 ' A' ' 123' ' ' VAL . 46.1 t -111.75 126.36 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.399 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.18 165.64 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -111.77 30.25 7.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.66 -58.16 1.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.808 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -104.9 -34.16 8.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.08 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.3 32.14 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.89 110.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.445 HG21 HG22 ' A' ' 116' ' ' VAL . 2.8 t -76.81 104.74 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.356 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.83 123.34 83.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.92 -13.15 31.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.386 2.057 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -72.31 -35.11 68.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.795 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.4 -46.56 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 22.8 mm -65.9 129.91 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.74 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 88.5 p -67.48 -59.16 3.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.595 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.79 -30.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.864 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 2.2 mp -83.18 -43.66 15.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.731 0.3 . . . . 0.0 110.644 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.84 -54.86 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -105.92 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -48.5 139.86 8.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.434 ' HG2' ' CD1' ' A' ' 138' ' ' TYR . 14.8 pt20 -127.37 -170.71 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -86.39 -25.58 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -12.17 59.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 135' ' ' GLN . 12.3 m-30 -73.92 155.43 38.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.43 . . . . 0.0 111.302 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.2 p -155.9 -176.4 5.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.4 mt -57.95 -44.45 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . 1.3 pttt -61.03 -34.88 75.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.657 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.3 t -68.34 -40.62 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.477 0.656 . . . . 0.0 109.446 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 37.4 t -61.22 -53.03 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.966 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.967 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.14 -42.57 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.028 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -68.99 -53.09 22.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 148' ' ' ARG . 3.5 pp -57.17 -42.63 81.49 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.945 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -67.03 -33.3 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 0.0 110.078 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -59.16 -41.8 89.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.054 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mt -66.7 -38.15 86.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.912 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.7 mtp -58.25 -30.56 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' MET . . . . . 0.413 ' CE ' ' CZ ' ' A' ' 148' ' ' ARG . 2.4 mtt -76.84 -26.3 54.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.677 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.1 m -65.42 162.66 17.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 12.1 ttmm -63.58 -27.78 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.85 -53.73 51.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.923 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 151' ' ' MET . 51.4 m-20 -91.4 -22.96 20.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.449 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -80.72 19.64 0.82 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -118.34 -31.87 4.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.85 0.357 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.47 150.54 23.83 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.66 125.9 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.282 1.988 . . . . 0.0 112.458 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -83.71 154.86 65.27 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.798 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 122.473 2.115 . . . . 0.0 112.21 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 14.7 pt20 . . . . . 0 N--CA 1.459 -0.02 0 CA-C-O 120.725 0.297 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 18.6 m -76.9 -168.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.914 0.388 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -60.94 -35.0 75.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.54 -54.02 49.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.2 mmt180 -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.477 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.1 mt -61.29 -39.43 90.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.6 mt -72.11 -52.82 14.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.37 -42.08 98.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 6.9 mm-40 -69.62 -29.6 67.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.491 HD11 ' HG ' ' A' ' 60' ' ' LEU . 31.7 tp -63.35 -45.18 92.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.893 0.378 . . . . 0.0 110.667 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.69 -43.31 89.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.018 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -52.81 63.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.26 -31.61 81.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.625 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.16 -41.82 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.031 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.878 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.57 173.58 43.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.576 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -154.49 -177.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 111.231 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.02 103.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.625 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.36 19.29 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.602 0.239 . . . . 0.0 111.307 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 49.35 43.98 35.08 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.779 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -70.18 -19.51 63.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.1 m -155.03 172.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 111.46 1.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.742 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.478 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 31.9 p90 -102.9 97.02 7.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.686 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.13 21.55 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.108 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.491 ' HG ' HD11 ' A' ' 44' ' ' LEU . 1.8 mt -105.64 143.69 33.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.788 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -82.95 -44.01 15.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.447 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -77.45 139.84 39.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.303 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.474 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 71.2 m95 -135.31 144.37 46.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.1 120.48 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -113.8 108.88 2.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.675 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -95.15 150.92 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 44.1 mt -152.25 138.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.917 0.389 . . . . 0.0 111.743 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 76' ' ' ILE . 15.1 mt -109.31 149.28 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.169 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -91.64 120.34 6.0 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.114 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.24 141.15 95.24 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.547 2.165 . . . . 0.0 111.925 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 21.1 Cg_endo -60.37 145.81 97.91 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.877 2.385 . . . . 0.0 113.278 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.53 43.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.818 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 4.4 p -162.75 158.72 23.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.06 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -40.2 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.0 110.95 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 30.1 m-85 -79.69 -18.69 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.913 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.8 pt-20 -40.74 148.27 0.1 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 41.4 57.08 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.298 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.5 mmt85 -155.86 111.38 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 5.2 mp -66.55 165.07 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 13.4 m-85 -149.43 133.31 17.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.083 0.468 . . . . 0.0 111.439 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 68.0 m -94.96 148.0 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.3 mp -151.3 160.07 43.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 14.8 mtpp -142.22 113.26 7.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 110.25 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.32 148.92 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.268 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 69' ' ' THR . 12.5 mt-10 -131.53 130.59 42.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.332 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.74 -169.16 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.59 -133.2 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.427 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 113.12 2.26 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.452 2.101 . . . . 0.0 112.146 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 60.05 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.646 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.3 t80 -83.23 -63.71 0.25 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.371 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 58.7 Cg_endo -70.91 1.83 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.666 1.578 . . . . 0.0 112.688 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -111.62 -13.77 13.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.674 0.273 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.83 61.07 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 111.312 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.49 122.43 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.614 2.209 . . . . 0.0 112.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -82.37 175.24 9.16 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.744 2.296 . . . . 0.0 112.739 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CZ ' ' HD2' ' A' ' 106' ' ' ARG . 17.3 t80 -94.84 121.41 36.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.802 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.04 138.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.239 0.543 . . . . 0.0 111.596 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -150.28 128.72 12.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.49 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.7 m-85 -71.55 131.93 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.97 -39.35 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.23 0.538 . . . . 0.0 109.634 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 5.0 t -68.59 -173.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.692 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 166' ' ' GLN . 3.0 mmtt -99.51 69.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.439 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.478 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 153.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.8 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.11 101.91 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpp -124.89 153.52 42.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -54.89 -44.06 73.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.328 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.13 -6.54 55.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.277 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 123' ' ' VAL . 47.2 t -108.78 131.75 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.1 165.21 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m -113.05 -12.57 13.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 t -109.33 -33.3 6.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.32 . . . . 0.0 111.001 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -104.43 -39.61 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.03 0.443 . . . . 0.0 110.427 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.55 -1.58 69.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.053 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.9 t -58.84 112.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 116' ' ' VAL . 10.9 t -77.47 109.73 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.633 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.58 110.31 3.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.98 -19.24 62.0 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.547 2.164 . . . . 0.0 112.432 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -49.77 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.976 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.59 -40.93 80.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.71 129.22 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.005 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -67.56 -54.56 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 138' ' ' TYR . 6.7 p -50.08 -36.61 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.496 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -83.03 -44.5 15.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.8 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.88 45.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.66 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -48.83 136.89 13.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.368 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.68 -170.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.04 -36.85 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -0.53 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.552 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD2' HG22 ' A' ' 130' ' ' VAL . 4.3 m-30 -72.56 154.49 40.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 111.099 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.0 p -156.07 -176.27 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 44.1 mt -54.7 -37.86 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 20.2 ttpp -61.44 -39.74 91.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.202 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.52 -33.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.932 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.16 -53.43 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.321 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 26.8 mt -64.77 -48.32 74.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.066 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -59.45 -49.73 76.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.758 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 4.2 tp10 -60.15 -53.06 62.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 148' ' ' ARG . 4.5 pp -58.33 -41.59 84.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 8.4 tmm_? -62.61 -34.07 76.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.28 86.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.826 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 6.0 mt -60.83 -48.1 83.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.871 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 30.0 mtt -51.58 -35.74 42.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.776 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.6 ttm -74.04 -14.59 61.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.71 164.44 14.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.0 tttt -65.32 -48.85 71.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.25 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.06 -31.17 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.025 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.07 -25.16 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.442 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 24.4 ptm -88.1 42.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.815 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -141.19 -35.15 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.3 mt -52.88 151.11 8.88 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.317 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.77 122.58 8.98 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.144 1.896 . . . . 0.0 112.73 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -86.91 152.86 54.27 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.9 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.343 0.285 0 C-N-CA 122.462 2.108 . . . . 0.0 111.972 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.445 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.655 0.264 . . . . 0.0 111.025 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.0 m -79.7 175.82 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.647 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 109' ' ' THR . 14.9 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -53.41 -36.91 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -52.56 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -58.19 -39.08 78.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -63.56 -53.88 44.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.765 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.5 mt -58.94 -51.48 69.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 0.0 111.226 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.75 -49.79 73.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.15 -28.61 68.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.6 tp -62.31 -42.55 99.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -30.47 65.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -74.21 -64.77 2.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.64 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.62 -44.06 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -59.35 -25.92 64.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.92 161.82 26.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG21 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.68 -178.0 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.972 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.09 -63.63 5.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.818 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.58 -6.52 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 51' ' ' VAL . . . 51.85 31.98 32.68 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.443 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 p -72.52 -17.01 61.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 144' ' ' LEU . 35.5 m -152.14 175.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.945 0.403 . . . . 0.0 111.161 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.05 110.78 1.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.335 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.469 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 28.5 p90 -100.0 105.36 17.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.59 148.47 18.07 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.9 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -54.66 130.22 39.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.956 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.148 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.8 m -80.8 -27.47 36.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.754 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -99.64 147.79 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 111.168 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 70.4 m95 -134.84 160.99 36.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -130.4 118.09 20.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.36 118.41 4.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.244 -0.979 . . . . 0.0 114.178 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -92.9 150.3 20.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 47.5 mt -150.02 138.0 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 111.759 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -95.34 148.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -73.21 116.01 5.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 8.4 Cg_endo -50.68 128.33 23.64 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.463 2.108 . . . . 0.0 111.873 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 33.0 Cg_exo -61.16 172.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.376 2.051 . . . . 0.0 112.598 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 3.9 mpp_? 44.42 41.78 4.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.737 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -162.14 161.66 28.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.688 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.91 -29.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.02 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' C ' ' A' ' 84' ' ' GLU . 68.2 m-85 -80.03 -21.01 44.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 80' ' ' ARG . 1.7 tt0 -23.9 124.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 t30 49.21 69.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.904 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.1 mmt180 -154.24 106.26 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 50.3 mt -69.69 165.37 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 29.9 m-85 -153.2 128.19 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.033 0.444 . . . . 0.0 111.441 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 33.3 t -94.01 149.29 21.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.1 mp -151.56 160.63 43.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 0.0 111.323 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -136.21 115.34 12.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.3 mp -107.05 126.47 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.348 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 51.3 mt-10 -95.38 126.13 40.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.87 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 p -114.29 -178.32 3.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.98 -164.16 13.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.4 -40.58 62.14 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.661 2.241 . . . . 0.0 112.457 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 73.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.462 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 1.3 t80 -76.52 -58.48 1.15 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.432 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 59.6 Cg_endo -71.09 0.42 6.65 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.882 1.722 . . . . 0.0 112.836 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -120.09 9.72 11.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.448 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.64 20.61 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 111.551 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.0 119.78 7.27 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 0.0 112.361 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 50.9 Cg_endo -84.07 164.26 13.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.869 2.379 . . . . 0.0 112.531 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 28.7 t80 -97.94 98.58 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.491 . . . . 0.0 110.28 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.8 t -95.12 138.51 20.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.024 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.89 120.46 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.565 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 4.1 m-85 -65.87 155.53 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.743 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' ' CD2' ' A' ' 168' ' ' TYR . 25.0 t -110.04 -51.47 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.105 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 t -67.35 -175.81 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.942 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 11.1 mmtm -88.57 110.76 21.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.565 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 1.4 tt -138.79 150.35 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.715 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.463 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.401 ' CE ' HD13 ' A' ' 150' ' ' LEU . 1.8 tpp -124.56 152.9 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -34.97 62.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -118.2 25.12 8.42 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.126 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG2' HG11 ' A' ' 123' ' ' VAL . 48.5 t -130.83 126.0 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.797 0.332 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.89 151.69 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 p -112.78 28.37 8.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -131.08 -55.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -105.25 -34.31 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.18 1.0 33.52 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.956 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.95 111.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 116' ' ' VAL . 5.2 t -77.34 117.69 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.682 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.86 112.92 9.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.519 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 -17.23 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.311 2.007 . . . . 0.0 112.333 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -37.92 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.756 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.76 -38.29 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.8 mm -76.41 121.75 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.836 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.8 p -67.23 -55.2 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.372 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.97 -32.45 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.521 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.4 mp -83.57 -50.51 8.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.71 32.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.16 52.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.442 ' CD2' ' HD3' ' A' ' 103' ' ' PRO . 63.2 t-105 -49.92 140.11 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 2.1 mm100 -117.67 -172.22 2.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.75 -32.81 15.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 m -78.97 -12.22 60.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 135' ' ' GLN . 10.9 m-30 -72.75 152.17 41.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 111.032 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -155.98 -176.36 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 HD13 ' CE2' ' A' ' 71' ' ' TRP . 50.1 mt -53.96 -40.08 43.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.447 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 2.0 ptpt -60.59 -39.75 89.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -69.27 -38.39 77.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.922 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.53 -53.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.055 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HB3' HG11 ' A' ' 56' ' ' VAL . 22.7 mt -63.86 -43.7 95.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.535 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -57.66 -39.95 78.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -51.49 69.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.579 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 107' ' ' PHE . 11.6 mt -49.5 -46.07 47.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.961 0.41 . . . . 0.0 110.588 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.4 77.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.746 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -61.13 -42.76 99.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -64.64 -48.21 75.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 35.7 mtt -54.56 -27.62 40.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 25.7 mtm -76.27 -19.95 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.3 t -65.07 157.32 28.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -65.15 -46.14 82.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.35 -28.77 69.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -87.77 -27.71 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 22.92 2.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -124.31 -33.46 3.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.65 145.07 41.93 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.8 125.02 13.54 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.26 1.973 . . . . 0.0 112.215 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -84.07 124.67 74.11 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 122.175 1.917 . . . . 0.0 111.999 179.837 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.2 pt20 . . . . . 0 CA--C 1.524 -0.053 0 CA-C-O 120.949 0.404 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.4 p -78.15 145.31 35.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.148 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 2.9 m-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.738 0.304 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.6 p30 -66.09 -29.01 69.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -50.24 70.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.196 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.6 mmt85 -66.41 -36.74 83.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.479 HD21 ' CZ2' ' A' ' 71' ' ' TRP . 43.4 mt -60.01 -41.18 91.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.2 mt -72.13 -52.73 15.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.537 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -41.34 98.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 74.4 mm-40 -70.51 -29.3 65.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.75 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 51.1 tp -61.89 -46.82 87.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.258 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.52 -49.65 74.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.876 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.93 -29.72 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -78.45 -44.14 11.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.724 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -76.8 -43.75 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.671 0.272 . . . . 0.0 111.097 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -52.86 -28.12 21.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.99 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.91 179.08 18.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.11 -177.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.83 -86.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.608 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.59 -16.42 61.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.569 0.224 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.35 31.43 65.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.2 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -73.0 -9.52 58.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 m -156.19 165.22 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.998 0.428 . . . . 0.0 111.172 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -162.0 111.04 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.406 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.47 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 27.2 p90 -101.57 130.82 47.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.36 -160.16 8.66 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.576 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.54 127.67 54.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.821 0.343 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -179.78 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.904 0.383 . . . . 0.0 110.661 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 -63.66 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -72.24 98.31 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.702 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.504 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 50.9 m95 -90.2 158.52 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.78 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.57 148.58 25.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 90' ' ' LEU . . . -141.62 102.13 0.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.761 -1.209 . . . . 0.0 113.754 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtp -93.96 146.15 24.13 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 52.7 mt -150.74 126.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.771 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 76' ' ' ILE . 16.2 mt -102.74 149.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.126 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -90.49 140.81 15.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.952 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.97 136.38 6.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.792 2.328 . . . . 0.0 112.093 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 77.0 Cg_exo -48.65 144.49 14.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.641 2.228 . . . . 0.0 113.127 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 75.45 43.72 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.795 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 49.8 p -161.16 147.01 14.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.378 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.61 -36.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.052 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 151' ' ' MET . 49.1 m-85 -80.91 -22.36 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.963 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -39.41 148.41 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 84' ' ' GLU . 26.0 p30 41.08 47.8 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.418 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.4 mmt85 -148.39 109.86 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.692 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 43.1 mt -68.52 166.15 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 28.0 m-85 -150.25 132.33 15.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 46.8 t -93.46 147.4 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.2 mp -152.58 160.15 43.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.102 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 4.1 mtpp -143.44 115.56 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.5 mp -106.43 120.68 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.17 124.05 37.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.1 p -113.02 -169.5 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.27 -136.97 5.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.556 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.69 130.49 26.47 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.594 2.196 . . . . 0.0 112.124 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.48 59.61 3.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.576 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.9 t80 -84.63 -55.51 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.635 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.0 Cg_endo -78.13 5.6 5.27 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.961 1.774 . . . . 0.0 112.568 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -123.74 -4.48 8.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.23 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.32 18.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.986 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.26 110.97 3.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.723 2.282 . . . . 0.0 112.009 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 97.8 Cg_endo -76.78 -99.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.358 2.038 . . . . 0.0 112.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -149.9 131.45 14.84 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.731 0.3 . . . . 0.0 111.49 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.54 139.51 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.332 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 8.3 ptt180 -150.25 141.66 23.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.524 ' CD2' HG23 ' A' ' 111' ' ' ILE . 22.8 m-85 -83.97 139.92 32.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.837 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.1 t -93.66 -40.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.444 HG22 ' CD2' ' A' ' 88' ' ' TYR . 4.9 t -68.52 -173.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.879 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 5.4 mmtt -97.23 76.77 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 110.166 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG23 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -103.76 149.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.476 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -126.09 102.32 7.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.743 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.421 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -124.74 150.37 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -26.73 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -116.8 16.24 13.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.09 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 107' ' ' PHE . 76.6 t -137.61 122.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.71 165.84 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 96.4 p -117.01 21.75 13.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -51.5 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 110.586 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -103.11 -32.17 9.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.937 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 94.29 5.92 61.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.049 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.84 112.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.964 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 116' ' ' VAL . 11.9 t -78.16 106.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' GLY . 8.6 t0 -65.86 116.56 33.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 41.1 Cg_endo -66.74 -14.89 45.65 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.403 2.069 . . . . 0.0 112.388 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -72.39 -36.11 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.782 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.54 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 131' ' ' LEU . 19.9 mm -74.42 128.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 t -67.77 -54.74 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.736 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.403 ' HB ' ' CG ' ' A' ' 146' ' ' GLU . 12.6 p -49.9 -33.01 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.413 ' CD2' ' HB3' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -85.25 -45.59 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.86 55.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -135.53 42.59 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.411 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 73.3 t-105 -49.42 125.2 10.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 2.9 tt0 -81.93 175.83 10.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -96.45 31.45 2.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.08 9.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.812 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.435 ' CG ' HG13 ' A' ' 142' ' ' VAL . 10.2 m-30 -75.09 177.56 6.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.734 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -156.85 -176.56 6.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.776 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 62.4 mt -57.91 -37.03 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 24.7 ttpt -62.83 -37.03 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.435 HG13 ' CG ' ' A' ' 138' ' ' TYR . 42.7 t -68.83 -34.8 66.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.005 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.43 -53.24 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.5 mt -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.998 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.31 -44.82 95.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.403 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 2.6 tp10 -61.95 -53.3 57.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.867 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.3 pp -60.61 -37.97 83.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.399 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -64.44 -36.2 83.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 109.932 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.1 mtt-85 -59.04 -40.5 85.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.701 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.13 -41.14 97.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.778 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.458 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 60.7 mtt -55.9 -34.98 66.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.469 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 10.8 mtm -75.57 -14.21 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 154.22 38.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -62.24 -50.79 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -35.41 76.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.396 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -86.78 -20.74 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.813 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.7 24.45 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 111.227 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -117.75 -32.02 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.501 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.3 mt -54.72 138.52 62.2 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.471 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.36 121.54 8.51 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.224 1.95 . . . . 0.0 112.729 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -87.67 113.68 55.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.133 1.889 . . . . 0.0 112.055 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.0 pt20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.9 p -76.39 -170.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.606 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 6.3 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.978 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -67.74 -35.38 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.92 26.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 tpp180 -57.61 -41.68 81.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.468 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 22.5 mt -62.71 -36.07 81.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 mt -72.03 -52.68 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.02 -47.44 77.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 73.1 mm-40 -63.33 -32.88 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.025 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 57.8 tp -63.01 -45.46 92.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.13 -47.57 85.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -32.67 67.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.432 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -84.03 -40.64 8.54 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.688 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -69.52 -47.98 62.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.999 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -61.65 -28.6 69.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.717 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.4 174.62 15.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.593 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.421 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -127.48 138.58 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.082 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.61 -70.6 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.535 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.53 11.27 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' HB ' ' A' ' 51' ' ' VAL . . . -75.32 110.1 2.96 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.631 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -72.66 -17.42 61.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 144' ' ' LEU . 33.1 m -93.72 176.45 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.459 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.36 112.79 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.344 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.446 ' CZ2' ' HB3' ' A' ' 141' ' ' LYS . 32.7 p90 -105.47 102.27 11.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.72 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.63 147.82 16.88 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.0 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HG ' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -55.18 155.51 4.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -93.88 -60.72 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -69.99 91.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CD2' HD13 ' A' ' 140' ' ' ILE . 88.2 m95 -89.11 160.29 17.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.713 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.65 123.39 22.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.691 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.17 171.06 13.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.789 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.4 mtp -142.58 151.15 41.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.211 -0.495 . . . . 0.0 109.815 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 48.2 mt -150.27 120.91 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 111.847 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 76' ' ' ILE . 27.0 mt -93.37 149.1 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.253 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -88.67 143.13 17.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.65 130.36 3.75 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.984 2.456 . . . . 0.0 112.097 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.569 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 74.3 Cg_exo -48.47 141.05 20.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 113.039 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER 80.46 40.67 0.07 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 51.7 p -160.64 150.28 17.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.743 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.81 -37.53 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 111.157 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 25.3 m-85 -79.85 -22.85 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.841 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -38.52 145.65 0.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 43.18 54.72 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.123 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 64.8 mmt-85 -154.18 107.21 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.734 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 mp -66.2 167.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 20.7 m-85 -150.26 128.3 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 0.0 111.018 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.566 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 17.0 t -90.05 149.7 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.332 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.0 mp -152.52 160.34 43.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.035 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.0 OUTLIER -142.9 116.65 9.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.0 mp -106.6 124.11 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.441 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.98 105.77 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.6 m -105.5 120.97 42.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -122.59 -145.29 6.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.524 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.89 116.55 2.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 62.32 76.71 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -81.66 -62.72 0.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 47.8 Cg_endo -68.53 -1.64 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.651 1.567 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -114.67 8.88 16.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.036 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.48 143.38 3.42 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.317 . . . . 0.0 111.289 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.32 118.37 5.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.763 2.309 . . . . 0.0 112.239 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 91.5 Cg_endo -80.8 -179.61 5.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 61.3 t80 -97.04 100.09 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.51 137.78 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -150.28 118.58 6.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.249 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.501 ' CG ' HG21 ' A' ' 111' ' ' ILE . 15.8 m-85 -62.31 149.27 42.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.507 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.59 -42.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.144 0.497 . . . . 0.0 110.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.404 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.5 t -68.62 -176.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.009 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 21.9 mttm -92.79 76.52 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.501 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -104.99 150.1 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.868 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -125.99 102.68 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 10.5 ttm -124.45 153.97 41.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.235 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -38.22 66.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.74 23.96 18.32 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.466 ' CG2' HG11 ' A' ' 123' ' ' VAL . 58.7 t -132.72 128.33 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.683 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.67 157.38 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -116.88 28.47 8.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.5 t -135.05 -52.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -105.35 -33.07 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.083 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.13 0.82 44.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.988 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.427 HG12 ' CZ ' ' A' ' 104' ' ' PHE . 54.8 t -58.91 110.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.466 HG11 ' CG2' ' A' ' 116' ' ' VAL . 19.5 t -77.06 115.11 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.685 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.19 115.06 17.98 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.15 -12.15 34.93 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.305 2.004 . . . . 0.0 112.605 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -33.71 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.02 -33.86 17.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mm -73.99 122.15 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -67.49 -54.55 19.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.364 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 138' ' ' TYR . 11.4 p -49.94 -32.39 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.532 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.94 -51.76 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.28 -34.21 60.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -123.11 51.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -49.02 155.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.245 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -132.81 179.6 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -37.64 18.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -79.81 -1.51 39.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.444 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 135' ' ' GLN . 5.4 m-30 -73.11 160.56 31.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.1 m -156.52 -176.55 6.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 71' ' ' TRP . 72.6 mt -59.36 -38.84 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -64.68 -34.56 78.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.37 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -67.76 -37.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 109.409 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.2 t -66.94 -53.1 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.942 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.416 ' HB3' HG11 ' A' ' 56' ' ' VAL . 20.7 mt -61.64 -44.29 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.976 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -57.54 -41.94 81.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.11 -48.65 80.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.457 HD12 ' CZ ' ' A' ' 107' ' ' PHE . 12.7 mt -52.41 -45.99 66.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -42.44 86.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.215 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -61.96 -46.84 87.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.438 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.1 mt -61.01 -32.27 71.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.428 ' HE3' ' CZ ' ' A' ' 107' ' ' PHE . 3.4 mtt -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.4 mtp -76.42 -12.7 60.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.425 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.2 m -65.22 154.59 37.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -51.08 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -28.78 69.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.375 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 2.7 m-80 -88.16 -28.76 21.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -88.78 22.38 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -121.76 -30.37 4.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.85 143.17 52.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.73 125.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.452 2.102 . . . . 0.0 112.779 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -84.97 157.47 59.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.324 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo . . . . . 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.055 179.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.854 0.359 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 41.8 m -77.53 -176.23 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' A' ' 109' ' ' THR . 11.4 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 3.4 ppt_? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.417 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 26.3 m120 -59.38 -34.82 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.637 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -52.52 63.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.733 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -60.83 -34.16 74.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.524 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 79.8 mt -63.14 -48.87 76.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.805 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.0 mt -69.64 -46.28 66.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -62.71 -50.34 71.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.602 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -64.99 -28.5 69.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.774 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 60.9 tp -61.99 -44.27 97.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 110.503 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.67 -44.05 87.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -59.51 5.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 58' ' ' TRP . . . -59.35 -47.25 91.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.706 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -57.0 -47.26 81.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -53.96 44.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.993 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.19 -176.25 40.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -155.67 -178.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.06 106.64 1.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.67 13.65 9.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.56 0.219 . . . . 0.0 111.318 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.65 43.85 22.36 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.876 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -71.39 -16.95 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.189 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 m -155.74 172.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.511 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.25 113.31 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.901 0.381 . . . . 0.0 111.197 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CH2' HG12 ' A' ' 51' ' ' VAL . 35.9 p90 -108.11 114.85 29.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.08 -158.38 10.0 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -114.26 144.87 42.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.004 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.809 0.337 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -65.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.071 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 99.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.509 ' CE2' HD12 ' A' ' 140' ' ' ILE . 49.3 m95 -90.13 155.39 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.642 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -102.04 158.65 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.18 153.3 24.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.203 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 31.6 mtp -145.66 147.62 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.764 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 50.3 mt -151.38 120.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 111.796 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -93.77 149.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.392 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.57 140.43 16.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.825 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 93.0 Cg_endo -78.62 136.74 13.94 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.5 Cg_endo -53.52 142.6 58.95 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 112.829 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.61 42.75 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.535 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 68.9 p -160.4 154.5 23.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.846 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.59 -37.65 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 111.141 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CE1' ' OE1' ' A' ' 161' ' ' GLN . 51.4 m-85 -80.09 -22.28 42.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.907 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -40.37 136.44 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.173 0.511 . . . . 0.0 112.362 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 56.58 49.14 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.467 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -148.71 108.21 3.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.038 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.443 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 mp -69.08 165.4 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.571 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 23.5 m-85 -152.2 121.22 6.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 43.0 m -88.91 151.24 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.9 mp -153.99 160.29 41.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.106 0.479 . . . . 0.0 111.511 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 2.9 mmtp -137.75 116.23 12.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.257 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.6 mp -106.59 120.71 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.492 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 58.2 mt-10 -94.08 117.64 30.39 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.722 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.64 -169.14 1.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.767 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.21 -147.76 8.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.08 -70.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.546 2.164 . . . . 0.0 112.378 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.85 68.36 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.894 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -87.94 -61.36 0.24 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.589 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 60.8 Cg_endo -71.97 2.25 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.619 1.546 . . . . 0.0 112.764 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -119.66 7.64 11.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.659 0.266 . . . . 0.0 111.079 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.52 151.35 12.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.11 123.1 11.8 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.25 167.0 22.06 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 54.0 t80 -95.55 89.44 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.294 0.568 . . . . 0.0 110.445 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 106' ' ' ARG . 22.3 t -92.32 143.39 11.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' N ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -149.97 118.72 6.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.035 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.535 ' CG ' HG23 ' A' ' 111' ' ' ILE . 7.9 m-85 -65.15 127.95 33.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' ' CD2' ' A' ' 168' ' ' TYR . 27.1 t -84.44 -46.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.251 0.548 . . . . 0.0 110.182 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 88' ' ' TYR . 8.2 t -69.21 -175.76 0.82 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 162' ' ' PRO . 5.9 mmtt -90.52 102.79 15.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.813 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.535 HG23 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -129.7 146.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 111.63 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -125.94 102.26 7.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.656 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.407 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 3.6 ttm -125.1 159.05 32.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -55.84 -27.91 53.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.159 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.64 30.01 4.32 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.265 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 123' ' ' VAL . 59.9 t -137.86 127.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -59.43 151.23 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.271 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.0 25.92 10.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.49 -46.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -102.36 -34.77 9.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.492 . . . . 0.0 109.815 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 99.16 -1.76 57.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.5 t -58.83 110.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 116' ' ' VAL . 4.7 t -76.17 110.8 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.75 113.27 10.24 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.944 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.406 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 39.3 Cg_endo -66.49 -15.7 48.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.381 2.054 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -36.16 67.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.1 -28.63 21.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.297 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.41 ' CG2' HG11 ' A' ' 130' ' ' VAL . 44.8 mm -80.44 132.18 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -55.34 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.534 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 131' ' ' LEU . 7.2 p -49.88 -37.43 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.11 -46.61 10.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.11 -29.37 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -135.44 48.29 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -49.59 132.11 21.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -165.69 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -96.68 -39.01 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 t -80.76 2.51 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.688 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.414 ' CD2' HG21 ' A' ' 130' ' ' VAL . 5.0 m-30 -72.8 156.79 38.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 111.158 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 -176.37 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.509 HD12 ' CE2' ' A' ' 71' ' ' TRP . 74.0 mt -55.25 -44.97 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.064 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.415 ' HG3' ' CH2' ' A' ' 58' ' ' TRP . 19.4 ttpp -56.72 -37.85 71.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.04 -35.95 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.71 -53.84 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.37 -45.88 85.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.888 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.34 -31.35 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.22 -52.24 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' A' ' 107' ' ' PHE . 9.6 mt -49.61 -46.08 48.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -64.26 -37.92 89.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.984 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.498 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 20.2 mtt180 -63.01 -44.28 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.991 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 1.4 mt -65.43 -32.68 74.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.341 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 32.0 mtt -68.41 -29.11 67.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 30.2 mtm -76.23 -10.96 59.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.324 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.1 t -64.88 151.36 45.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -54.8 29.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -61.19 -24.78 66.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.47 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -86.88 -34.31 19.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.411 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.1 ptm -87.08 43.01 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.043 0.449 . . . . 0.0 110.84 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -144.23 -39.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.375 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.7 mt -52.97 145.67 22.16 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.29 124.95 14.72 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.197 1.932 . . . . 0.0 112.067 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' CE1' ' A' ' 83' ' ' TYR . 74.0 mm-40 -85.26 119.08 72.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.549 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 110' ' ' LYS . 56.6 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.622 2.215 . . . . 0.0 112.03 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.436 ' CG ' ' CG ' ' A' ' 110' ' ' LYS . 29.6 pt20 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.822 0.344 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.24 174.02 11.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.802 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.59 -50.8 69.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -57.86 -45.36 86.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 97.3 mt -63.87 -34.11 77.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.756 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -72.12 -52.89 14.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 110.976 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.51 -49.64 68.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.6 mt-10 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.716 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 25.3 tp -63.44 -49.17 74.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.907 0.385 . . . . 0.0 110.588 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -54.98 -56.63 17.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.15 -25.69 59.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -72.36 -55.42 6.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.722 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -69.19 -47.87 63.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.301 . . . . 0.0 111.333 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -39.67 68.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.884 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.44 170.84 12.5 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG22 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -122.23 -177.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.77 -93.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -23.12 66.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 51' ' ' VAL . . . 83.49 27.75 38.26 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.395 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -72.24 -10.32 59.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 74' ' ' MET . 35.1 m -154.24 171.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.69 111.69 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.759 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.457 ' NE1' ' HA3' ' A' ' 47' ' ' GLY . 35.3 p90 -103.48 157.5 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.547 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.83 174.0 30.23 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.323 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.83 11.99 12.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.403 -0.399 . . . . 0.0 112.024 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 111.037 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.77 -55.72 3.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.57 138.84 40.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.491 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 77.3 m95 -135.36 164.73 27.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.89 -179.84 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.285 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 58' ' ' TRP . . . -164.53 159.08 31.98 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.402 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.9 mtp -144.88 148.68 34.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 56.6 mt -152.3 121.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.76 149.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -98.95 148.01 18.68 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.131 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 90.6 Cg_endo -82.24 144.22 13.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.783 2.322 . . . . 0.0 112.112 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.1 Cg_endo -53.17 142.35 55.81 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.74 2.293 . . . . 0.0 112.673 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.4 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.82 41.28 0.1 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.52 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 43.7 p -159.93 150.0 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -47.22 -37.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 111.192 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' HG21 ' A' ' 82' ' ' ILE . 65.9 m-85 -79.95 -21.66 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.72 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -42.33 137.7 1.94 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 112.165 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.5 42.06 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.645 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 79.1 mmt-85 -144.61 107.06 4.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.431 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 4.6 mp -67.39 167.34 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.184 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 26.7 m-85 -147.98 125.96 12.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.567 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 38.1 t -88.84 148.7 23.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.434 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 89' ' ' SER . 2.9 mp -151.4 160.16 43.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.183 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -142.77 114.78 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.518 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.34 149.16 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.858 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.31 125.69 29.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.568 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.35 -179.18 3.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.307 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.8 -144.57 8.18 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.64 113.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.121 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 70.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.938 0.399 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.1 t80 -83.51 -60.12 0.35 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 61.0 Cg_endo -72.31 3.35 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.869 1.712 . . . . 0.0 112.993 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.41 -6.23 10.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 111.228 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.49 151.84 44.28 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.37 123.25 12.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.65 2.234 . . . . 0.0 112.339 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 96.6 Cg_endo -80.53 173.16 12.61 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.689 2.259 . . . . 0.0 112.438 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.89 89.13 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.202 0.525 . . . . 0.0 110.455 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.1 t -95.77 138.74 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -150.15 126.52 10.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.884 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.52 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 9.9 m-85 -73.77 135.66 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.14 -41.59 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -69.24 -178.51 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.082 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 40.6 mttt -93.43 91.02 6.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.744 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.52 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -121.48 144.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -122.7 102.99 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 5.0 ttm -124.34 157.35 35.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -54.22 -38.67 65.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -112.36 25.98 11.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.958 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.403 ' CG2' HG13 ' A' ' 123' ' ' VAL . 81.1 t -137.72 126.62 33.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -59.81 149.32 31.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.07 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -110.9 28.43 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.792 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.64 -46.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.79 -33.68 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 0.0 110.027 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.7 -4.45 56.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.753 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.83 115.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.417 ' CG1' HG13 ' A' ' 128' ' ' ILE . 11.8 t -76.74 108.13 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.619 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 115' ' ' GLY . 3.5 t0 -64.95 110.73 4.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.409 ' HA ' ' CD1' ' A' ' 131' ' ' LEU . 43.2 Cg_endo -67.61 -13.12 37.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.992 . . . . 0.0 112.433 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -30.51 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -93.09 -48.08 6.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.417 HG13 ' CG1' ' A' ' 123' ' ' VAL . 24.5 mm -61.02 131.51 26.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.7 p -67.49 -54.47 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.454 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 131' ' ' LEU . 7.2 p -49.87 -32.79 8.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.552 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 130' ' ' VAL . 61.9 mt -84.24 -53.03 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.722 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.45 -24.06 18.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.512 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -136.73 45.12 2.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 111.016 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 70.5 t-105 -50.38 138.5 16.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.053 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -108.36 -170.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.925 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.57 -40.52 12.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.46 1.92 27.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.552 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.433 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 4.0 m-30 -72.75 151.76 41.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.3 p -155.43 -176.33 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.805 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.491 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 65.6 mt -51.19 -48.08 32.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.26 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -55.37 -39.48 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.659 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 45.7 t -69.03 -37.61 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.289 0.566 . . . . 0.0 110.017 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -63.38 -53.77 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.093 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.7 mt -64.98 -45.06 87.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.878 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -61.34 -51.08 70.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.075 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.413 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -59.76 -53.47 57.6 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.3 pp -57.59 -37.7 73.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.056 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.49 -33.8 76.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.695 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.35 89.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.899 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.63 -40.45 97.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.449 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 22.9 mtt -55.22 -34.7 64.16 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.615 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.3 mtm -75.43 -13.96 60.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.103 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 t -65.56 158.31 27.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -65.41 -49.87 67.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.14 -30.07 70.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.321 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.91 -26.17 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.653 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.74 46.66 1.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -143.17 -39.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.35 155.62 9.37 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.589 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.11 142.16 60.28 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.288 1.992 . . . . 0.0 111.8 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.45 ' HG3' HG23 ' A' ' 82' ' ' ILE . 6.3 mm-40 -146.63 98.67 4.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.477 2.118 . . . . 0.0 112.199 179.889 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.4 m -157.64 169.72 24.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 110' ' ' LYS . 16.2 m-85 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.96 -35.61 64.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.36 -51.91 65.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.664 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 12.9 mmt-85 -57.95 -40.32 80.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.5 mt -61.82 -50.67 71.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.81 -51.59 66.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.97 -47.97 82.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.097 0.475 . . . . 0.0 110.303 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 51.0 mt-10 -67.93 -26.66 66.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.464 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 43.1 tp -60.7 -45.35 94.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.12 -37.08 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.43 -42.59 78.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.476 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -77.01 -40.64 24.63 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.676 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -66.1 -40.58 90.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -59.28 -76.16 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.12 165.68 36.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG12 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -148.51 -177.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.365 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.12 104.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.933 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 56.53 22.28 6.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.595 0.236 . . . . 0.0 111.497 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' HA2' HG21 ' A' ' 51' ' ' VAL . . . 51.07 46.35 50.66 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.794 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.6 p -71.4 -22.5 61.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.273 . . . . 0.0 111.206 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.93 173.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.78 110.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.341 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.476 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 26.5 p90 -99.92 96.26 7.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -105.66 -152.95 20.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.585 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -121.81 147.61 45.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 111.148 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.954 -179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.883 0.373 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.85 -56.28 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.59 105.35 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.431 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 30.4 m95 -89.5 150.86 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.669 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -101.99 113.29 26.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.75 106.54 2.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.913 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtp -90.63 147.32 23.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 56.8 mt -149.61 150.14 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.872 0.368 . . . . 0.0 111.447 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mt -105.89 148.83 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.231 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.09 117.22 5.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.256 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 142.56 18.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.425 2.083 . . . . 0.0 112.0 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 61.0 Cg_endo -73.01 175.97 9.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.418 2.079 . . . . 0.0 112.753 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 40.92 41.8 1.33 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.592 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 6.8 p -162.0 160.97 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -43.65 -28.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.883 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 84' ' ' GLU . 72.0 m-85 -79.58 -22.09 44.2 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 80' ' ' ARG . 1.7 tt0 -24.16 125.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 45.55 72.9 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 22.5 mmt180 -157.43 104.66 2.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 88' ' ' TYR . 5.0 mp -66.02 167.64 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.497 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 60.1 m-85 -153.4 128.67 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.546 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.465 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -93.17 145.87 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.82 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.5 mp -149.43 160.44 43.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.282 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.9 OUTLIER -138.61 111.49 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.188 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.33 120.15 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.85 133.16 37.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.739 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.522 ' HB2' ' CG ' ' A' ' 98' ' ' TYR . 21.5 p -115.35 -169.3 1.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.14 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.85 -147.04 15.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.234 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.6 119.03 4.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.478 2.119 . . . . 0.0 111.999 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp 59.46 75.19 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.852 0.358 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.656 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 6.1 t80 -86.52 -54.49 0.39 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.84 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.6 Cg_endo -82.57 8.76 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.991 1.794 . . . . 0.0 112.236 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.92 3.87 7.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.81 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.21 143.34 3.57 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.61 110.95 2.48 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.847 2.365 . . . . 0.0 112.632 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 73.0 Cg_endo -76.9 -96.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.505 2.137 . . . . 0.0 112.416 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 59.8 t80 -148.17 136.02 20.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.894 0.378 . . . . 0.0 111.651 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.75 140.28 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -150.5 139.43 20.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.965 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.549 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 8.8 m-85 -77.44 114.83 16.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.868 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.65 -46.68 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.164 0.507 . . . . 0.0 110.273 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.403 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -68.6 -179.83 1.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.06 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -88.68 120.22 29.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.549 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -157.84 153.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -125.94 102.03 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.43 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.466 ' O ' ' N ' ' A' ' 115' ' ' GLY . 7.6 ttm -125.24 143.49 50.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 113' ' ' MET . 2.4 m-80 -58.03 79.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.008 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 113' ' ' MET . . . 145.94 -35.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.284 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 123' ' ' VAL . 58.5 t -89.16 139.3 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -59.71 138.45 57.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.0 p -96.14 48.88 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 p -178.07 -38.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -102.45 -37.73 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.095 0.474 . . . . 0.0 109.991 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.16 -5.58 61.24 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.126 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 104' ' ' PHE . 24.4 t -58.54 111.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.089 0.444 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 116' ' ' VAL . 7.4 t -77.08 110.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.477 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.59 110.28 3.84 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.2 -17.71 58.3 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.353 2.035 . . . . 0.0 112.326 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -72.43 -43.79 63.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.6 63.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 44.4 mm -81.91 130.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -59.88 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.5 m -49.7 -30.82 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.662 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 mp -84.39 -45.22 12.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.21 -63.38 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 58.89 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -49.15 164.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -152.98 173.92 14.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.49 -27.24 63.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.194 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.52 -24.76 41.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -73.56 144.72 45.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.81 -176.32 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.364 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' OH ' ' A' ' 98' ' ' TYR . 62.5 mt -50.09 -39.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.715 0.293 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 14.6 ttpp -61.7 -45.73 92.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.328 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.45 -35.6 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.884 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.9 t -62.99 -53.81 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.917 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.6 mt -64.36 -44.6 90.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.556 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -57.66 -40.62 79.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.985 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.97 -53.03 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.766 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 7.5 mt -50.25 -45.9 54.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -62.94 -38.15 89.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.755 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -46.52 88.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.206 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 147' ' ' LEU . 1.6 mt -59.43 -46.28 89.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.34 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 2.5 mtt -61.13 -25.41 66.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -20.4 58.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -65.26 154.57 37.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 11.6 mttm -65.13 -45.79 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -27.38 68.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.41 -27.67 22.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.348 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -89.72 45.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.098 0.475 . . . . 0.0 110.698 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -138.82 -38.56 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.1 mt -53.18 147.3 18.22 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.461 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.83 125.89 12.05 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.285 1.99 . . . . 0.0 112.535 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -83.7 157.39 64.07 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo . . . . . 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 112.207 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 29.4 p -78.74 -168.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 2.2 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.852 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -32.9 51.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -54.93 37.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.3 mmt-85 -57.52 -37.74 73.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 110.196 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 91.9 mt -61.87 -38.35 87.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.25 -52.74 15.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.396 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -63.51 -50.02 71.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 91.5 mt-10 -60.34 -32.34 71.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 25.8 tp -62.66 -43.7 98.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.941 0.401 . . . . 0.0 110.38 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.73 -56.13 26.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.25 -45.02 84.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.441 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.08 -44.31 94.41 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.768 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -67.8 -48.04 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.185 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -22.84 64.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.83 167.18 27.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.265 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG22 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -115.62 -176.96 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 0.0 111.163 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -47.14 -86.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.195 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.91 -14.42 61.05 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA2' HG22 ' A' ' 51' ' ' VAL . . . 72.92 37.73 56.54 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.26 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -72.35 -17.1 61.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.59 0.233 . . . . 0.0 111.53 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -154.26 174.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.942 0.401 . . . . 0.0 111.336 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.78 111.07 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.272 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CH2' ' HD3' ' A' ' 141' ' ' LYS . 34.8 p90 -103.01 73.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.042 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.41 -170.29 46.36 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.773 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.72 141.7 36.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.845 0.355 . . . . 0.0 111.035 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.796 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -58.17 -65.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 146.28 52.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 63.8 m95 -134.9 146.68 49.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -102.04 121.44 42.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -118.44 109.8 1.83 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.679 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mtp -94.33 152.47 18.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 37.4 mt -152.31 129.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 111.697 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 76' ' ' ILE . 18.8 mt -102.85 149.26 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -85.09 143.42 20.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.02 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.2 Cg_endo -84.2 134.02 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.826 2.351 . . . . 0.0 111.942 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 71.0 Cg_exo -48.79 143.22 17.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.502 2.135 . . . . 0.0 112.987 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER 74.17 43.97 0.27 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.504 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 30.7 p -160.06 149.45 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.623 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -36.82 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.065 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 94.4 m-85 -80.27 -22.27 41.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.1 pt-20 -42.54 133.09 3.47 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.79 11.91 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.622 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -115.28 104.17 11.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 87' ' ' ILE . 40.5 mt -61.79 169.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.282 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.493 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 25.4 m-85 -152.42 129.73 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.389 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.6 m -93.84 146.41 23.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.83 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.2 mp -151.06 160.19 44.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.5 mtpt -141.68 114.53 8.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.72 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.13 120.79 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.182 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.08 126.78 40.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.8 p -113.53 -172.02 1.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.19 -140.08 7.77 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.589 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.72 120.46 5.94 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.205 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mttt 51.44 70.3 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.56 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -88.58 -63.0 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 70.5 Cg_endo -73.47 3.7 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.605 1.536 . . . . 0.0 112.478 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.54 -4.43 12.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.33 161.26 29.81 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.59 123.88 14.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.655 2.237 . . . . 0.0 112.474 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.17 171.76 15.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.641 2.228 . . . . 0.0 112.31 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -96.39 89.37 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.473 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.71 139.3 18.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.221 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -150.42 120.22 7.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.525 ' CD2' HG21 ' A' ' 111' ' ' ILE . 20.5 m-85 -65.56 139.44 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -91.45 -42.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.865 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.409 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -69.05 -178.63 1.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.803 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HE2' ' CE1' ' A' ' 168' ' ' TYR . 0.3 OUTLIER -93.36 76.44 4.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.525 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -99.6 152.0 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.475 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.73 102.48 7.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.676 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.42 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 12.4 ttm -124.69 148.01 48.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.236 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -55.02 -28.36 51.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -120.07 28.01 6.52 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.012 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 107' ' ' PHE . 94.1 t -136.25 131.99 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 110.726 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -59.49 132.34 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.993 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 m -97.81 31.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.987 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -141.38 -48.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.28 -34.73 7.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 106.08 -4.12 38.45 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 113.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.796 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.424 HG12 ' CG2' ' A' ' 116' ' ' VAL . 10.2 t -76.76 119.41 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.726 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER -65.33 110.72 4.69 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.49 -20.8 71.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.383 2.056 . . . . 0.0 112.407 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -45.04 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.806 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.48 -52.41 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mm -58.1 128.1 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.0 t -67.39 -56.32 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.453 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 138' ' ' TYR . 9.2 p -49.95 -30.84 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.352 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.06 -55.06 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.06 -25.08 19.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.272 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -134.2 51.04 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CZ3' ' CD ' ' A' ' 103' ' ' PRO . 57.0 t-105 -49.44 160.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.246 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.425 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 3.1 tt0 -140.62 177.16 8.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -77.32 -39.74 46.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 m -80.0 0.36 31.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-30 -72.78 149.66 43.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.962 0.411 . . . . 0.0 111.151 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -155.7 -176.45 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.36 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 31.7 mt -58.17 -37.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.721 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 6.5 ttpm? -62.04 -40.17 94.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 22.0 t -67.88 -40.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.678 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.2 t -61.13 -53.22 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.328 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 27.0 mt -64.14 -44.8 91.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.847 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.31 -48.85 79.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.641 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 142' ' ' VAL . 1.5 tp10 -60.0 -53.26 59.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.6 pp -57.77 -41.0 81.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.814 0.34 . . . . 0.0 110.45 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.407 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 3.3 tmm_? -63.83 -33.09 74.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.168 0.509 . . . . 0.0 109.876 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -58.5 -44.85 89.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.101 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.82 -41.97 98.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.887 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.417 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 14.7 mtt -56.44 -29.43 61.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' MET . . . . . 0.412 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 9.7 mtm -74.21 -22.69 59.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.3 t -65.96 158.09 29.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.054 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.455 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 6.2 mttt -65.41 -36.03 82.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.151 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.6 -44.33 97.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.008 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -87.7 -20.8 25.74 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.455 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -88.74 23.43 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.81 -30.99 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.276 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.0 mt -54.71 145.5 40.4 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.83 124.69 10.87 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.263 1.976 . . . . 0.0 112.673 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.441 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 7.1 mm-40 -85.06 158.04 59.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.832 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 40.6 Cg_endo . . . . . 0 C--N 1.344 0.328 0 C-N-CA 122.333 2.022 . . . . 0.0 111.932 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.412 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 7.2 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.0 m -160.0 135.57 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.413 ' CE1' ' HE2' ' A' ' 110' ' ' LYS . 24.6 m-85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.422 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 36' ' ' ARG . 5.0 m120 -71.26 -44.85 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -58.16 -44.39 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 0.0 110.455 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -60.59 -40.48 91.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.365 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD22 ' CD2' ' A' ' 98' ' ' TYR . 80.4 mt -60.58 -53.65 54.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.888 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.55 -50.82 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.7 -43.98 97.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 89.6 mt-10 -71.71 -27.79 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.32 -46.01 91.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.84 0.352 . . . . 0.0 110.586 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 13.6 mt-10 -68.47 -44.06 75.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -27.72 43.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.484 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -88.13 -30.44 17.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -83.47 -43.7 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 10.0 mmtt -58.45 -62.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.898 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 174.71 45.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG13 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.04 -177.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.85 105.09 1.37 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.49 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 66.89 14.09 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.556 0.217 . . . . 0.0 111.33 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 49.05 41.33 29.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 p -71.43 -18.91 62.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 111.13 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 144' ' ' LEU . 21.1 m -155.1 169.8 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 m -161.73 110.99 1.54 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.675 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.497 ' CH2' ' CB ' ' A' ' 141' ' ' LYS . 32.4 p90 -103.81 143.45 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -151.82 -136.09 2.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.039 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mt -132.61 133.04 43.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.743 0.306 . . . . 0.0 110.905 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.038 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.78 -61.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.199 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.2 93.62 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 40.5 m95 -90.06 152.63 21.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.01 152.08 21.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.724 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -143.71 102.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.629 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.4 mtp -94.17 147.06 23.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 45.5 mt -151.78 138.06 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.74 0.305 . . . . 0.0 111.588 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mt -99.26 148.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.118 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.69 117.97 4.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.266 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 146.86 49.61 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.163 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 13.4 Cg_exo -69.3 173.64 10.26 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.635 2.224 . . . . 0.0 112.73 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.499 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 41.48 43.14 2.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.792 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 19.9 p -161.3 158.17 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.42 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -44.32 -27.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 53.6 m-85 -78.79 -24.56 44.54 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.553 ' CG ' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -22.01 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.21 65.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.753 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 9.4 mmt180 -152.87 102.9 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.429 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 11.0 mt -67.56 168.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.208 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 25.9 m-85 -150.34 132.91 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 0.0 110.992 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 48.7 m -94.18 146.7 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.296 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 89' ' ' SER . 3.8 mp -151.7 159.89 43.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.96 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 28.1 mttt -144.54 117.91 9.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.519 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.0 mp -106.2 123.65 61.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -93.82 108.67 20.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 57.4 m -113.54 152.55 30.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.65 -149.36 4.95 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.592 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.78 -48.63 18.54 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.665 2.243 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 77.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -101.79 -66.68 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.2 Cg_endo -69.76 -0.94 7.63 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.346 1.364 . . . . 0.0 112.312 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.22 -4.69 16.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.986 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.61 144.22 8.01 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 120.836 0.351 . . . . 0.0 111.308 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.01 110.07 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.868 2.378 . . . . 0.0 112.042 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 41.6 Cg_endo -67.56 -176.17 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.444 2.096 . . . . 0.0 112.244 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -94.76 94.63 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 111.197 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.6 t -96.32 138.54 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.781 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -150.22 126.12 10.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 111' ' ' ILE . 25.1 m-85 -68.1 126.78 30.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.35 -41.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.262 0.553 . . . . 0.0 109.948 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.4 t -68.41 -175.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.828 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -98.83 68.02 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.512 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.343 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.47 101.89 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.1 ttm -125.2 157.5 36.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -54.67 -52.86 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.19 -11.64 64.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.109 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.411 ' CG2' HG11 ' A' ' 123' ' ' VAL . 43.7 t -107.19 121.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.42 143.75 52.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.925 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -98.25 29.15 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 p -140.0 -43.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.23 -32.74 9.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 110.033 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -3.16 81.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.874 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.96 110.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 116' ' ' VAL . 3.4 t -77.69 107.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -63.77 109.99 3.25 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.849 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.41 -23.28 74.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.323 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -41.33 66.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -74.65 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.427 ' CG2' HG11 ' A' ' 130' ' ' VAL . 35.5 mm -75.46 133.25 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.734 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.5 -58.84 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.016 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG11 ' CG2' ' A' ' 128' ' ' ILE . 14.9 p -49.85 -33.91 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.795 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.91 -41.85 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.84 69.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.86 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 47.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -48.03 157.22 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.28 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 179.28 7.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 -31.98 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -79.13 -12.77 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.226 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.2 m-30 -72.87 153.74 40.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -156.16 -176.39 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.44 HD11 ' CE3' ' A' ' 71' ' ' TRP . 2.9 mt -54.92 -35.14 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.497 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -67.39 -38.93 85.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.63 -37.67 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.5 -52.9 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.551 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 42.6 mt -62.48 -43.68 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.956 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -61.96 -51.11 69.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.054 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.408 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -59.8 -53.36 58.82 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.6 pp -56.08 -40.76 74.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.987 0.422 . . . . 0.0 110.134 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 1.4 ttt-85 -62.6 -34.16 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.73 -38.47 78.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.538 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mt -64.08 -41.48 97.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.492 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 34.7 mtt -55.7 -32.36 63.24 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.283 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -19.82 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.949 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -65.12 159.83 22.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 157' ' ' MET . 4.6 mtpm? -65.21 -36.01 82.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.301 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.78 -35.86 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -89.57 -11.63 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 14.1 ptm -90.61 24.57 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 111.187 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.07 -37.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.823 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.7 mt -54.37 157.66 4.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.414 ' C ' ' HG2' ' A' ' 161' ' ' GLN . 44.0 Cg_endo -66.11 146.59 82.31 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.326 2.017 . . . . 0.0 112.116 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HG3' HG22 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -146.26 103.04 4.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.586 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.374 2.049 . . . . 0.0 112.204 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.737 0.303 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 83.8 m -155.99 154.3 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.609 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 109' ' ' THR . 24.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.835 0.35 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -65.02 -34.81 79.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -55.72 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -58.47 -39.26 79.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 84.1 mt -61.72 -40.31 94.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.16 -52.57 15.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.64 -43.18 99.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.921 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -68.63 -29.72 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.797 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 64.0 tp -62.85 -47.13 84.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.6 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -58.11 -41.63 83.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -66.45 -62.81 4.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.586 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -52.28 -39.7 60.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.987 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -72.74 -27.48 62.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.57 170.01 22.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.515 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -177.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.9 -76.72 0.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -14.27 61.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.222 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.6 28.65 73.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -71.88 -12.32 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.585 0.231 . . . . 0.0 111.426 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.9 m -154.21 161.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.776 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.01 124.83 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.795 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.473 ' CZ2' ' HB3' ' A' ' 141' ' ' LYS . 4.4 p90 -114.87 -179.12 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.28 44.12 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.057 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.46 120.79 40.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.981 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 m -75.01 -68.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.31 142.68 50.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.752 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 92.0 m95 -135.17 144.16 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.293 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 159.9 14.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 156.81 26.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.885 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 24.5 mtp -145.48 147.25 31.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.712 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 41.3 mt -150.57 120.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.823 0.344 . . . . 0.0 111.759 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 76' ' ' ILE . 21.0 mt -86.66 149.21 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.429 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -74.69 134.0 16.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.844 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 84.1 Cg_endo -78.39 127.61 8.32 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.192 . . . . 0.0 111.737 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.8 Cg_endo -50.04 141.21 30.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.628 2.219 . . . . 0.0 112.727 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 75.4 44.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.235 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 17.6 p -159.4 154.55 25.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.426 HG21 ' CD2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -50.11 -38.51 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.989 0.424 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.441 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 42.3 m-85 -80.35 -20.62 43.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.026 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.4 pt-20 -41.85 133.06 2.93 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 66.99 41.38 2.7 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.553 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 84' ' ' GLU . 2.4 mpt_? -149.59 115.7 5.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.718 0.294 . . . . 0.0 111.362 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 87' ' ' ILE . 37.1 mt -65.57 168.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.021 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 22.5 m-85 -153.32 119.53 5.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.8 m -88.77 153.17 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.632 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.0 mp -153.75 160.28 42.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.369 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -137.87 114.16 10.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.452 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.19 121.45 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.494 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -94.25 127.6 40.21 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.787 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 83.8 m -132.19 121.46 23.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.69 -153.02 25.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.94 -36.34 43.51 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.644 2.229 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 118.21 32.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.542 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.6 t80 -135.93 -67.35 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.22 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.6 Cg_endo -69.37 0.92 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.439 1.426 . . . . 0.0 112.5 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -107.41 -20.59 13.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.313 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.25 161.03 28.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 0.0 111.469 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.58 119.17 6.21 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.659 2.239 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -86.49 -123.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.873 2.382 . . . . 0.0 111.675 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' H ' ' HB2' ' A' ' 103' ' ' PRO . 12.4 t80 -145.93 129.49 16.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.677 0.275 . . . . 0.0 110.693 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -135.36 140.55 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.1 ptt85 -150.3 122.51 8.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.167 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.524 ' CG ' HG21 ' A' ' 111' ' ' ILE . 10.2 m-85 -60.03 141.21 56.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.446 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.27 -44.05 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 110.327 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.426 HG21 ' CD2' ' A' ' 88' ' ' TYR . 7.2 t -68.22 -175.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -91.25 86.97 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.977 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.524 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -119.46 151.47 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.481 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -126.07 102.33 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.649 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 27.9 ttm -124.45 143.97 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.36 -25.75 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -111.58 15.3 27.04 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.5 ' CG2' HG11 ' A' ' 123' ' ' VAL . 86.9 t -137.74 127.69 36.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.797 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.7 165.89 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.055 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' CZ ' ' A' ' 168' ' ' TYR . 15.6 m -106.22 -16.86 14.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.198 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.1 m -77.39 -61.45 1.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.62 -38.04 6.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.7 21.18 8.01 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.56 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.09 111.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 116' ' ' VAL . 3.3 t -77.49 100.91 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.3 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.9 OUTLIER -64.74 119.75 60.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.01 -14.99 40.59 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.505 2.137 . . . . 0.0 112.638 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -28.83 63.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.38 -28.22 15.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.256 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.9 mm -77.18 128.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -67.52 -60.03 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.356 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.9 m -49.98 -32.53 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.553 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.67 -43.01 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.18 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 54.79 1.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -47.85 158.09 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.545 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -142.64 178.12 7.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.37 -30.57 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.017 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.8 p -79.31 -9.82 59.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.395 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -73.3 155.15 39.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.6 m -156.17 -176.52 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.3 mt -58.5 -41.57 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 pttt -62.36 -36.62 82.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 0.0 110.273 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.47 -37.94 78.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.436 0.636 . . . . 0.0 109.59 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.65 -53.34 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.941 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.5 -46.02 91.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.689 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.02 -30.04 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.071 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.83 -48.54 36.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.01 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.447 HD12 ' CD2' ' A' ' 90' ' ' LEU . 8.9 mt -54.74 -45.94 74.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.69 -38.88 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.819 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.405 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 5.7 ttm180 -61.62 -43.99 97.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.051 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -62.02 -41.88 98.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.421 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 12.0 mtm -62.04 -27.66 69.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.2 mtm -75.95 -16.9 59.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.95 154.52 37.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -60.53 -43.25 97.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.12 -32.9 73.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.909 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -86.76 -36.66 18.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 6.9 ptm -78.92 48.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 110.987 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -146.6 -39.57 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.316 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.9 mt -52.3 148.16 12.37 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.497 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.95 121.95 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.258 1.972 . . . . 0.0 112.659 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.404 ' OE1' ' CE1' ' A' ' 83' ' ' TYR . 87.4 mm-40 -87.54 122.59 70.48 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.046 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.221 1.947 . . . . 0.0 111.864 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.829 0.347 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 35.5 m -75.81 -179.36 4.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.524 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.408 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 4.6 m120 -66.54 -41.92 87.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.11 -44.57 94.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 13.2 mmm-85 -58.57 -43.41 89.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.3 mt -61.29 -39.38 90.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.986 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -72.11 -52.66 15.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.265 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -42.19 99.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.919 0.39 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 9.3 mm-40 -69.02 -29.4 67.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.491 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 55.7 tp -61.77 -47.24 86.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.981 0.419 . . . . 0.0 110.36 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.27 -41.42 99.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.59 -48.82 78.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -63.93 -50.86 58.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.12 -47.97 81.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -62.55 -26.54 68.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.794 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.41 163.41 24.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.403 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG21 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.74 -177.19 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.12 -68.98 1.35 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.047 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -84.52 -3.91 58.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 51' ' ' VAL . . . 53.21 35.53 50.01 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.373 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 p -71.37 -15.66 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.648 0.261 . . . . 0.0 111.603 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 m -154.13 175.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.386 . . . . 0.0 111.115 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -161.38 110.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.538 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CH2' ' CB ' ' A' ' 141' ' ' LYS . 27.6 p90 -98.96 132.12 44.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.692 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.82 175.31 19.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.122 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.39 14.41 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.217 -0.491 . . . . 0.0 112.03 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.081 179.897 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.784 0.326 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -81.47 -57.09 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 135.9 45.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.456 ' CE3' HD12 ' A' ' 140' ' ' ILE . 75.0 m95 -135.31 171.72 14.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 0.0 111.354 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.6 165.71 25.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.346 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.437 ' HA3' HD22 ' A' ' 144' ' ' LEU . . . -157.39 110.41 0.44 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.074 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtp -90.09 153.09 20.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 88' ' ' TYR . 29.8 mt -151.71 139.22 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.1 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 76' ' ' ILE . 17.5 mt -114.35 149.13 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.29 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.75 138.79 14.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.955 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.29 146.88 25.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 112.12 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 13.2 Cg_endo -56.22 147.62 65.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.833 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 77.35 44.75 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.481 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 76.7 p -161.87 152.94 18.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.428 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -52.71 -37.02 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.572 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.448 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 82.0 m-85 -81.84 -14.04 56.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.042 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -46.85 140.3 4.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.208 0.528 . . . . 0.0 112.191 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m120 45.96 42.2 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.012 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.7 mmt-85 -139.72 86.17 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 88' ' ' TYR . 4.1 mp -47.25 164.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 75' ' ' ILE . 43.5 m-85 -154.34 128.02 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 111.242 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 m -92.87 154.66 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.467 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.1 mp -152.38 160.63 43.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 116.03 12.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.73 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.6 149.01 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.684 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.7 134.83 39.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 110.904 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 98' ' ' TYR . 1.4 p -120.23 -178.33 3.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.175 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.39 -157.71 8.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.51 -25.29 14.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.618 2.212 . . . . 0.0 112.604 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 95.63 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.861 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 2.3 t80 -97.19 -65.11 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.59 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 42.8 Cg_endo -67.44 -1.68 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.655 1.57 . . . . 0.0 112.651 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -109.51 -6.06 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.363 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.03 157.95 33.98 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.69 125.98 20.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.678 2.252 . . . . 0.0 112.074 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 90.9 Cg_endo -81.55 163.69 18.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.553 2.169 . . . . 0.0 112.708 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -95.22 90.26 5.8 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.554 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.85 138.71 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.246 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -150.2 125.21 9.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.581 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 3.4 m-85 -70.52 153.66 42.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.19 -40.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.28 0.562 . . . . 0.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t -68.31 -176.39 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 50.5 mmtt -87.68 94.62 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.779 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.581 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 1.2 tt -130.68 145.69 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.865 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -126.37 102.32 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.89 157.39 36.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.009 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -54.5 -58.89 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.238 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.405 ' CA ' ' CB ' ' A' ' 127' ' ' ALA . . . -79.77 -16.7 76.8 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.425 ' CG2' HG12 ' A' ' 123' ' ' VAL . 62.8 t -94.92 136.61 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.925 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.91 179.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.8 m -133.09 34.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.986 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -152.57 -47.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.39 -37.25 6.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.125 0.488 . . . . 0.0 110.296 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.31 2.36 41.29 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.011 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 t -58.89 110.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.425 HG12 ' CG2' ' A' ' 116' ' ' VAL . 3.7 t -76.94 112.77 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.408 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -64.19 110.91 4.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.25 -18.53 37.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.496 2.131 . . . . 0.0 112.403 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -47.82 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.7 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.405 ' CB ' ' CA ' ' A' ' 115' ' ' GLY . . . -67.91 -42.7 80.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.1 mm -69.01 123.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.5 t -66.06 -55.86 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.457 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 138' ' ' TYR . 8.6 p -49.97 -32.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.479 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.49 -49.51 8.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.769 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.52 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.306 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -134.81 43.87 2.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.912 0.387 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -49.55 148.64 2.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 138' ' ' TYR . 1.5 mt-30 -130.54 -171.93 2.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 37.8 t30 -104.25 58.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -160.52 -27.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.716 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 22.6 m-85 -70.78 172.03 9.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.465 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.2 m -156.07 -176.42 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.368 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.456 HD12 ' CE3' ' A' ' 71' ' ' TRP . 33.4 mt -53.87 -44.43 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.247 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 21.8 pttt -58.57 -37.48 75.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 138' ' ' TYR . 41.3 t -68.36 -39.23 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 109.627 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.1 t -61.82 -53.39 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.835 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.437 HD22 ' HA3' ' A' ' 73' ' ' GLY . 20.9 mt -61.4 -43.78 98.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.64 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.89 -40.21 79.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -53.04 62.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.65 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 16.2 mt -50.56 -46.21 57.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 110.658 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -62.15 -34.4 76.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.941 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -61.44 -43.04 99.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.958 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 3.6 mt -63.56 -44.75 93.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 15.1 mtt -58.32 -29.77 66.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.928 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.6 mtm -76.9 -15.95 59.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.3 m -64.94 141.23 58.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 10.8 tptt -51.28 -53.24 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.07 -23.1 65.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.747 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.12 -25.91 23.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.722 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 14.5 ptm -86.64 19.23 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.089 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.86 -30.72 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.282 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.8 mt -54.72 144.23 46.39 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.554 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.38 150.3 68.56 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.238 1.958 . . . . 0.0 112.04 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.428 ' HG3' HG23 ' A' ' 82' ' ' ILE . 25.0 mm-40 -146.49 116.59 4.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 110' ' ' LYS . 80.9 Cg_exo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 122.509 2.139 . . . . 0.0 112.141 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 28.2 pt20 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.865 0.364 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 51.8 m -77.39 176.27 9.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.416 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 1.7 t30 -60.57 -32.78 71.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.744 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -54.58 41.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 6.0 mmt180 -57.68 -38.73 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.083 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 69.9 mt -61.86 -52.26 64.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.23 -50.49 70.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -61.67 -46.36 90.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.4 mt-10 -70.56 -29.33 65.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.399 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 54.5 tp -62.12 -35.21 78.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.358 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 -34.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.2 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.17 -34.28 70.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.511 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.493 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -85.02 -34.39 15.09 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.41 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -51.98 -43.77 63.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.872 0.368 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -62.47 -29.45 70.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.505 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . 87.77 35.13 9.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.613 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER 40.41 -170.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.13 -83.35 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.734 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.96 -23.84 48.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.73 32.35 59.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -72.52 -13.31 61.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 m -154.77 171.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.747 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -161.76 111.02 1.53 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 34.7 p90 -103.86 130.08 51.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -142.35 -139.05 3.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.066 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -125.17 145.68 49.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.905 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.89 0.376 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -66.5 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 98.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.791 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.426 ' CE3' HD12 ' A' ' 140' ' ' ILE . 62.0 m95 -88.78 152.09 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 147.39 26.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -140.31 99.53 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.996 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -92.45 149.29 21.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 44.6 mt -150.85 144.99 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 111.607 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 76' ' ' ILE . 18.5 mt -120.11 149.23 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.4 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.14 123.26 7.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.023 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.47 142.28 71.18 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.488 2.125 . . . . 0.0 111.996 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 42.6 Cg_exo -57.07 146.14 82.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.699 2.266 . . . . 0.0 112.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 81.61 42.46 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.825 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 15.7 p -162.52 155.83 20.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.863 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.23 -40.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.937 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 67.2 m-85 -79.43 -18.0 53.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.841 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.6 pt-20 -41.28 143.87 0.39 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.279 0.561 . . . . 0.0 112.474 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.5 t30 45.65 54.35 7.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.822 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 4.8 mmt85 -152.72 107.27 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.492 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 5.1 mp -67.16 165.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.481 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 27.5 m-85 -150.75 130.72 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.983 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.513 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 28.2 t -93.12 148.28 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.141 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.1 mp -152.27 160.02 43.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.046 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.8 mtmt -143.56 117.23 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.28 127.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.99 117.14 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.7 m -126.3 159.46 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.63 -126.53 0.82 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.02 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.378 2.052 . . . . 0.0 112.401 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 69.46 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.546 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.2 t80 -90.26 -64.5 0.18 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.042 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 72.9 Cg_endo -74.98 3.99 5.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.391 1.394 . . . . 0.0 112.307 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -113.13 -11.02 13.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.757 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.53 146.81 18.0 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.4 110.17 0.57 Allowed 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 122.825 2.35 . . . . 0.0 112.188 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 45.7 Cg_endo -67.89 -176.2 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -94.93 95.37 8.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.42 138.15 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.645 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -150.2 138.31 20.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.192 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 111' ' ' ILE . 14.3 m-85 -83.85 137.98 33.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.879 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.0 t -93.63 -39.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.224 0.535 . . . . 0.0 109.867 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.0 t -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.924 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -94.11 82.8 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.523 HG23 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -112.57 149.09 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.53 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -126.23 102.95 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.9 ttm -124.37 155.39 38.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.953 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -54.54 -52.88 60.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.18 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.21 -14.47 66.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.037 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 123' ' ' VAL . 48.6 t -98.95 132.21 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.15 167.84 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.7 m -123.68 31.05 6.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.2 p -142.69 -47.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -104.69 -37.16 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.131 0.491 . . . . 0.0 110.119 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.32 43.61 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.998 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 116' ' ' VAL . 8.8 t -77.21 111.93 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.685 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.79 125.2 89.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 -15.85 24.62 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.421 2.08 . . . . 0.0 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -72.43 -42.46 65.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.938 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.6 -46.73 21.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.407 HG13 HG12 ' A' ' 123' ' ' VAL . 21.3 mm -62.46 132.29 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.3 p -67.36 -56.0 11.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.408 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.406 ' CG2' ' CG2' ' A' ' 128' ' ' ILE . 3.2 m -49.93 -36.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.618 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.71 -43.71 19.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.652 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.74 62.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -139.08 55.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -49.67 157.87 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 138' ' ' TYR . 9.0 mm100 -131.32 -166.65 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.34 -40.42 9.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 t -79.3 -3.89 48.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.394 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 135' ' ' GLN . 5.2 m-30 -72.46 151.8 42.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.845 0.355 . . . . 0.0 111.045 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 p -156.34 -176.5 6.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.426 HD12 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mp -53.12 -29.96 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.28 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.478 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 8.6 pttt -71.04 -40.27 71.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.406 ' N ' ' HG3' ' A' ' 141' ' ' LYS . 66.4 t -68.88 -35.53 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.503 0.668 . . . . 0.0 109.453 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.85 -52.81 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.002 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 22.4 mt -62.72 -47.75 82.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.916 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -60.32 -48.86 79.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.529 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.98 -53.23 60.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.826 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.3 pp -60.63 -41.05 94.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.952 0.405 . . . . 0.0 110.301 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.68 -31.63 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.061 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -59.37 -44.6 92.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 1.0 OUTLIER -63.37 -46.81 84.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.228 179.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 11.7 mtp -48.67 -39.11 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttp -77.33 -27.68 52.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.8 147.97 52.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.481 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 1.7 mmmp? -51.16 -25.58 5.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.58 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -54.86 36.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.012 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 150' ' ' LEU . 12.8 m-80 -88.2 -30.96 19.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.481 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 2.7 ptm -72.91 52.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.112 0.482 . . . . 0.0 111.297 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.15 -42.68 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.024 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt -53.79 150.55 13.66 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.595 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.93 126.0 14.55 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.373 2.049 . . . . 0.0 112.43 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.416 ' OE1' ' CE2' ' A' ' 83' ' ' TYR . 35.8 mm-40 -84.38 120.4 74.33 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.224 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.259 1.973 . . . . 0.0 111.896 179.574 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.5 m -77.3 -167.48 0.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 109' ' ' THR . 1.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -65.77 -36.4 83.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -55.32 -53.86 50.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.716 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 8.1 tpp180 -57.51 -42.89 83.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 73.5 mt -59.44 -40.81 88.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.982 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.22 -52.72 15.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.641 0.258 . . . . 0.0 111.366 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.76 -36.87 82.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 32.4 mt-10 -76.56 -28.91 56.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.0 tp -62.29 -35.08 77.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.137 0.494 . . . . 0.0 110.033 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -41.8 45.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.371 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -38.39 76.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.918 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.66 -58.29 5.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.693 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -58.0 -36.02 72.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -76.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.68 168.21 39.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG12 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.43 -176.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 111.166 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.05 97.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.682 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.61 22.18 12.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.718 0.294 . . . . 0.0 111.274 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.4 46.95 44.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.698 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.676 0.274 . . . . 0.0 111.297 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -154.41 175.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.91 110.65 1.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.463 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.466 ' CH2' ' CB ' ' A' ' 141' ' ' LYS . 28.6 p90 -100.12 87.45 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -143.49 12.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.767 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -120.4 140.65 51.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.775 0.322 . . . . 0.0 111.024 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -51.86 12.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -78.86 95.97 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.713 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 40.8 m95 -89.06 165.36 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -127.08 118.5 24.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.617 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.64 119.12 4.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.662 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mtp -93.73 154.39 17.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 30.4 mt -152.27 138.06 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.846 0.355 . . . . 0.0 111.761 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 76' ' ' ILE . 17.9 mt -116.79 149.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.415 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.83 146.8 18.34 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.11 141.18 11.56 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.827 2.351 . . . . 0.0 112.25 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 58.0 Cg_exo -51.81 141.77 43.99 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.546 2.164 . . . . 0.0 112.798 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER 79.06 41.18 0.09 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.529 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 43.4 p -159.68 152.42 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -47.77 -39.14 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 111.316 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' CE ' ' A' ' 151' ' ' MET . 89.9 m-85 -78.8 -22.61 46.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.909 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -41.52 135.25 2.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 56.22 20.48 4.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.925 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.13 105.45 11.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.797 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 47.1 mt -70.65 165.05 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 35.6 m-85 -150.25 130.22 13.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.02 0.438 . . . . 0.0 111.197 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 30.9 t -93.76 151.29 19.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.4 mp -151.29 160.31 43.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.0 ttmt -139.01 114.51 9.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.6 mp -106.42 120.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.355 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -94.25 122.23 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.801 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.72 -169.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.98 -153.42 15.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.01 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.304 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -96.65 74.22 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.587 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.7 t80 -96.71 -52.8 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 2.3 Cg_endo -80.25 3.95 7.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.776 1.651 . . . . 0.0 112.224 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -114.5 -18.57 11.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.14 73.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.88 124.43 16.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.578 2.185 . . . . 0.0 112.325 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 89.0 Cg_endo -77.91 167.83 23.09 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.64 2.227 . . . . 0.0 112.223 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -96.45 89.23 4.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.239 0.543 . . . . 0.0 110.351 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.56 141.15 15.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.051 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -150.25 128.84 12.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.091 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.568 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 8.4 m-85 -75.23 123.15 24.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.7 t -75.72 -40.74 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.337 0.589 . . . . 0.0 109.499 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.415 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 7.4 t -69.75 -177.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.864 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 14.0 mttt -97.99 97.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.756 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.568 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -126.55 151.14 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.835 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -126.21 102.77 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.423 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 31.3 ttm -124.42 153.08 42.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -52.53 -26.16 12.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -123.15 22.49 7.11 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.041 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.406 ' CG2' HG11 ' A' ' 123' ' ' VAL . 57.6 t -136.09 126.54 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.661 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 138.01 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 t -101.89 54.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.2 p -176.79 -39.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -102.81 -34.47 8.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 109.974 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.96 64.75 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.983 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.77 115.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 107' ' ' PHE . 15.0 t -77.51 115.18 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.8 OUTLIER -65.13 113.2 10.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.531 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.21 -12.3 34.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.52 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.23 -49.95 31.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.97 -51.71 30.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 31.7 mm -57.81 132.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -60.33 2.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.202 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.414 HG22 ' CG2' ' A' ' 128' ' ' ILE . 10.4 m -49.99 -30.15 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.717 0.294 . . . . 0.0 111.739 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 4.0 mm? -83.85 -47.63 10.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.6 -31.65 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.474 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -135.83 42.46 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -50.55 117.46 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.226 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -99.9 -176.79 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.03 56.07 2.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.9 p -159.45 -18.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 135' ' ' GLN . 19.2 m-85 -71.85 169.84 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.08 0.467 . . . . 0.0 111.416 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.74 -176.38 5.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.475 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.445 HD11 ' CE2' ' A' ' 71' ' ' TRP . 66.8 mt -56.22 -47.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 111.32 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.466 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 11.5 ptpt -60.69 -34.86 74.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.768 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.54 -37.62 77.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.452 0.644 . . . . 0.0 109.392 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.6 t -63.58 -52.88 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.843 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 21.1 mt -62.55 -48.75 78.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.698 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -60.36 -46.08 91.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.565 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.09 -53.47 56.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.735 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.423 HD23 ' CZ ' ' A' ' 107' ' ' PHE . 3.5 pp -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 73.4 ttt-85 -65.13 -33.42 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.741 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -43.68 90.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.961 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 1.1 mt -66.3 -38.19 87.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.106 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.453 ' CE ' ' CE1' ' A' ' 83' ' ' TYR . 8.7 mtt -54.97 -35.57 64.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.729 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 53.2 mtm -75.74 -12.55 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.226 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.85 26.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.6 mtpp -59.13 -44.07 92.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.19 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.38 -33.25 73.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.757 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.81 -39.2 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.534 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -72.44 1.5 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 111.574 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -111.91 -32.42 6.61 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 110.154 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.81 147.19 43.57 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.13 141.13 75.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.383 2.055 . . . . 0.0 111.811 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -146.57 117.66 4.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.464 2.109 . . . . 0.0 112.249 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.3 m -160.74 148.2 15.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.679 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 109' ' ' THR . 23.1 m-85 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.896 0.379 . . . . 0.0 111.034 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 34.7 m120 -68.27 -36.97 80.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.27 -57.62 11.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.013 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -57.6 -43.29 84.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.555 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 53.7 mt -62.8 -38.3 90.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 12.8 mt -72.13 -52.72 15.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.24 -43.25 98.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 98.2 mt-10 -68.01 -32.1 72.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 59.1 tp -61.44 -42.64 99.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.311 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.34 -50.78 68.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.799 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.95 -40.45 80.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -69.26 -58.55 6.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.66 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.76 -39.86 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 111.111 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -58.12 -72.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.36 158.02 9.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.576 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -175.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.36 104.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.471 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.94 20.25 11.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.834 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.81 47.97 30.51 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.805 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.9 p -71.73 -18.04 62.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 111.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.7 m -156.85 169.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.735 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -160.93 111.18 1.73 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.571 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.496 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 30.7 p90 -102.21 96.42 6.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -109.83 -144.4 10.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.912 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -121.17 131.96 54.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.255 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.8 0.333 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.36 -55.34 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -77.99 97.07 5.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 27.2 m95 -91.79 152.02 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.804 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 1.9 m -102.23 144.95 30.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -136.06 103.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.73 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtp -92.59 151.66 20.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 30.8 mt -151.82 142.72 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.765 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.23 149.42 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.323 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.29 148.92 17.75 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.004 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HG3' ' HG2' ' A' ' 152' ' ' MET . 92.0 Cg_endo -79.77 132.36 9.69 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.909 2.406 . . . . 0.0 111.975 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 15.8 Cg_endo -56.86 83.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.709 2.273 . . . . 0.0 112.583 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 81' ' ' THR . 5.2 ptt180 161.32 30.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.715 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 74.9 p -162.08 163.65 28.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.93 -37.97 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 97.0 m-85 -79.44 -11.61 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.153 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 5.1 pt-20 -51.71 146.41 7.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 t30 44.62 29.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.611 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 1.6 mmt180 -131.29 99.64 4.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 5.0 mp -62.7 166.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.796 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 33.8 m-85 -150.82 130.21 12.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.032 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.503 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 40.5 m -92.97 151.19 20.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.187 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.2 mp -152.41 160.17 43.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.7 OUTLIER -141.15 114.37 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.83 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.35 120.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.481 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 130.04 40.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.428 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.49 ' CB ' ' CD2' ' A' ' 98' ' ' TYR . 4.0 p -127.88 -179.03 4.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.18 -149.0 5.75 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.077 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.07 -78.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.466 2.11 . . . . 0.0 111.819 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 25.9 mtmt -82.76 77.32 9.52 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.667 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -91.26 -52.37 0.29 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 3.4 Cg_exo -79.31 5.0 6.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.984 1.789 . . . . 0.0 112.516 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -120.2 -8.14 9.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.343 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.46 62.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.667 0.27 . . . . 0.0 111.252 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 122.37 11.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.6 Cg_endo -82.29 175.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.721 2.28 . . . . 0.0 112.432 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -97.54 90.19 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.88 138.9 18.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.058 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.19 130.18 13.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.026 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.553 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 10.6 m-85 -76.01 126.7 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.1 t -78.95 -39.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.354 0.597 . . . . 0.0 109.634 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.7 t -69.07 -176.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.067 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 30.1 mttt -99.14 87.52 3.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.553 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -116.87 153.52 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.95 -178.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.35 102.78 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.736 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.427 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 1.9 tpp -123.98 156.48 36.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.227 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -53.61 -43.37 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.164 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.05 28.41 11.17 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.944 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.404 ' CG2' HG13 ' A' ' 123' ' ' VAL . 76.9 t -135.4 130.17 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.824 0.345 . . . . 0.0 110.689 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.55 158.26 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -118.67 26.71 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.48 -51.42 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.5 -34.13 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.007 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.65 0.63 34.59 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.919 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.86 113.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.404 HG13 ' CG2' ' A' ' 116' ' ' VAL . 13.1 t -76.67 115.17 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.471 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 110.14 3.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.918 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.38 -15.76 47.22 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.446 2.097 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -46.72 58.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.5 -42.65 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.699 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.03 103.78 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -53.96 -55.64 25.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 138' ' ' TYR . 7.2 p -49.97 -31.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.15 -48.69 9.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.11 69.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.09 34.44 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.404 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 54.8 t-105 -49.37 132.22 20.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -121.26 -178.34 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -86.11 61.06 6.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.9 m -160.85 -28.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.433 ' CD1' HG13 ' A' ' 142' ' ' VAL . 19.3 m-85 -70.96 168.16 17.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.425 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.09 -176.43 5.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.246 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.436 ' CG1' ' OH ' ' A' ' 98' ' ' TYR . 10.7 mt -55.94 -51.34 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.282 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 ptpt -53.16 -35.06 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 138' ' ' TYR . 40.9 t -69.04 -41.19 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.47 0.652 . . . . 0.0 109.547 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.61 -53.13 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.342 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 28.5 mt -63.09 -48.54 78.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.741 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.86 -46.53 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -60.0 -53.16 61.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.568 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 148' ' ' ARG . 4.4 pp -62.0 -38.39 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 5.7 ttt-85 -69.59 -30.71 68.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.803 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -43.68 90.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.837 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.33 -42.43 92.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.848 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.445 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 21.3 mtt -50.97 -35.26 32.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.81 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' MET . . . . . 0.413 ' HG2' ' HG3' ' A' ' 78' ' ' PRO . 69.8 mtm -74.44 -22.21 59.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.94 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.6 m -65.79 158.3 28.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 28.7 mttp -65.19 -32.19 73.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -46.94 85.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.128 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -87.15 -21.76 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.471 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -82.56 13.64 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -116.52 -30.38 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.194 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.7 mt -55.41 148.85 30.93 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.829 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.63 149.57 89.61 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.156 . . . . 0.0 112.047 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.413 ' HG3' HG21 ' A' ' 82' ' ' ILE . 20.0 mm-40 -146.31 133.71 10.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.87 0.367 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.6 p -80.3 -170.69 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.977 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 110' ' ' LYS . 10.7 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.99 131.2 20.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.603 2.202 . . . . 0.0 112.299 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.87 -146.91 4.9 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -152.77 30.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.71 136.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -49.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.3 -66.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.173 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -179.34 3.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.13 -167.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.51 152.47 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 60.09 104.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.23 106.98 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -103.43 -59.59 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.0 p -95.73 113.66 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -105.63 30.69 5.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mp -141.7 -48.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -69.71 157.71 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -53.74 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.6 -67.91 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.99 95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -135.53 138.4 43.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 tt -142.18 83.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.36 140.0 45.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.13 105.84 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.522 2.148 . . . . 0.0 112.304 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.62 153.02 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -164.12 -65.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.55 163.39 14.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -143.59 31.43 1.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.33 139.11 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -92.92 165.49 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.0 99.92 1.25 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.528 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.6 134.5 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.05 158.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' CG2' ' HD2' ' A' ' 35' ' ' PRO . 14.1 p -80.22 141.01 53.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.816 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 73.9 Cg_exo -49.54 142.38 23.92 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.362 2.042 . . . . 0.0 112.344 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.406 ' HD3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.58 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.747 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -52.53 -35.63 53.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.491 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . 8.0 t80 -55.37 -53.54 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.288 . . . . 0.0 111.045 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 22.4 tpp180 -57.53 -40.16 78.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.42 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 78.8 mt -60.67 -51.46 69.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.05 -52.75 62.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.447 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.43 -43.13 99.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 80.6 mm-40 -72.41 -28.47 63.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.706 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 44.7 tp -61.35 -42.49 98.79 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.53 -49.26 56.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.791 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.27 78.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.216 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.27 -51.31 18.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.649 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.18 -44.28 92.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -58.4 -56.21 25.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.19 170.01 15.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.677 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.95 -177.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 111.076 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.61 108.95 1.36 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.663 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 16.08 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.578 0.228 . . . . 0.0 111.272 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.42 50.72 17.39 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.981 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -70.52 -23.34 62.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.7 m -155.01 173.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.556 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -160.86 112.0 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.977 0.418 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.456 ' CZ3' ' HB2' ' A' ' 141' ' ' LYS . 25.2 p90 -101.14 81.66 2.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.84 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.77 179.01 35.39 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.995 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 mt -90.38 144.58 25.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.977 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -76.93 -56.63 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.05 106.4 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 3.6 m-20 -68.17 46.38 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 39.0 mp0 -157.38 27.03 0.29 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.45 -169.81 2.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.353 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.8 mmt -130.6 -60.49 0.99 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.582 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.4 t -86.68 -8.28 57.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.416 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 55.94 81.99 0.11 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.0 m -97.72 -66.8 0.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.38 93.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.454 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 81.6 m95 -90.87 169.27 11.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.056 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.22 124.69 24.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.64 115.95 3.07 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.804 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -91.1 157.17 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 25.6 mt -152.86 141.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.819 0.342 . . . . 0.0 111.748 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.47 149.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.731 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -79.43 139.57 21.83 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.865 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 72.0 Cg_endo -87.69 127.42 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.973 2.449 . . . . 0.0 112.109 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 81.7 Cg_exo -47.52 139.9 16.98 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.552 2.168 . . . . 0.0 112.99 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 9.6 mtt85 79.7 40.47 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 31.0 p -159.09 151.75 21.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.78 -39.63 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CZ ' ' HG2' ' A' ' 151' ' ' MET . 49.8 m-85 -80.27 -21.57 42.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.114 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.2 pt-20 -38.36 138.01 0.51 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 55.03 45.94 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.711 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -143.69 112.76 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.511 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 5.4 mp -70.45 160.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.425 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 15.3 m-85 -151.9 126.76 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.41 . . . . 0.0 111.208 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.2 t -94.94 151.83 18.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.0 mp -150.96 160.37 43.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.14 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.63 114.81 10.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.5 mp -106.36 120.75 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.214 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -93.95 120.54 34.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -128.63 105.19 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.53 -110.64 2.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.387 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.1 118.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.153 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 4.8 mtpp 61.81 87.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.506 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -105.27 -66.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.896 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 55.4 Cg_endo -69.63 2.91 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.439 1.426 . . . . 0.0 112.952 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 16.4 pt-20 -112.06 -9.34 13.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.663 0.268 . . . . 0.0 111.041 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.56 19.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.01 123.29 13.49 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.694 2.263 . . . . 0.0 112.382 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . 93.2 Cg_endo -80.07 167.81 19.52 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.726 2.284 . . . . 0.0 112.317 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.19 89.11 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.5 t -94.24 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.126 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 129.71 12.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.953 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.502 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.5 m-85 -75.2 130.93 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.31 -45.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.301 0.572 . . . . 0.0 109.647 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 9.9 t -69.0 -179.38 1.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.689 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 8.5 mmtt -88.95 105.23 17.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.502 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -132.25 153.15 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.771 -178.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -125.98 102.6 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.565 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 18.4 ttm -124.3 144.71 49.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.17 -32.71 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.288 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.78 -10.65 39.87 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.09 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.445 HG22 HG21 ' A' ' 123' ' ' VAL . 46.1 t -111.75 126.36 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.399 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.18 165.64 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -111.77 30.25 7.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.66 -58.16 1.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.808 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -104.9 -34.16 8.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.08 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.3 32.14 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.7 t -58.89 110.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.445 HG21 HG22 ' A' ' 116' ' ' VAL . 2.8 t -76.81 104.74 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.356 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.83 123.34 83.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.92 -13.15 31.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.386 2.057 . . . . 0.0 112.491 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -72.31 -35.11 68.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.795 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -85.4 -46.56 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.887 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 22.8 mm -65.9 129.91 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.74 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 88.5 p -67.48 -59.16 3.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.595 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.79 -30.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.864 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 2.2 mp -83.18 -43.66 15.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.731 0.3 . . . . 0.0 110.644 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.84 -54.86 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -105.92 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -48.5 139.86 8.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.434 ' HG2' ' CD1' ' A' ' 138' ' ' TYR . 14.8 pt20 -127.37 -170.71 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -86.39 -25.58 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -12.17 59.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 135' ' ' GLN . 12.3 m-30 -73.92 155.43 38.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.43 . . . . 0.0 111.302 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.2 p -155.9 -176.4 5.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.4 mt -57.95 -44.45 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . 1.3 pttt -61.03 -34.88 75.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.657 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.3 t -68.34 -40.62 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.477 0.656 . . . . 0.0 109.446 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 37.4 t -61.22 -53.03 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.966 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 25.0 mt -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.967 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.14 -42.57 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.028 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -68.99 -53.09 22.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 148' ' ' ARG . 3.5 pp -57.17 -42.63 81.49 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.945 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.446 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -67.03 -33.3 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 0.0 110.078 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -59.16 -41.8 89.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.054 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mt -66.7 -38.15 86.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.912 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.7 mtp -58.25 -30.56 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' MET . . . . . 0.413 ' CE ' ' CZ ' ' A' ' 148' ' ' ARG . 2.4 mtt -76.84 -26.3 54.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.677 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.1 m -65.42 162.66 17.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 12.1 ttmm -63.58 -27.78 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.85 -53.73 51.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.923 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 151' ' ' MET . 51.4 m-20 -91.4 -22.96 20.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.449 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -80.72 19.64 0.82 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -118.34 -31.87 4.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.85 0.357 . . . . 0.0 110.33 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.47 150.54 23.83 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.66 125.9 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.282 1.988 . . . . 0.0 112.458 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -83.71 154.86 65.27 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.798 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.9 160.51 47.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.473 2.115 . . . . 0.0 112.21 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -87.32 34.93 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.144 2.563 . . . . 0.0 112.902 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 169.2 163.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.009 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.29 32.98 6.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.413 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 14.7 pt20 -69.59 158.62 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.297 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 18.6 m -76.9 -168.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -99.91 -31.35 11.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 155.25 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.945 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.748 0.309 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.64 166.21 26.77 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.514 2.143 . . . . 0.0 112.338 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.77 -120.27 1.02 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.477 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.4 31.02 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -78.18 140.25 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 60.56 82.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -98.48 108.84 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.37 162.95 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.943 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.8 mt -113.74 -178.34 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -44.44 4.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.69 111.19 23.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -123.15 21.95 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m 59.97 64.93 1.18 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.894 0.378 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.24 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.85 142.95 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.31 95.53 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.11 126.39 53.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.06 179.97 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.63 120.06 0.71 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -167.65 33.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.61 -31.8 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -59.27 126.61 82.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.83 133.08 16.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.72 -37.42 4.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -73.4 106.35 5.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.58 -169.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.14 152.36 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.5 p -164.46 167.91 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -66.55 -75.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.08 178.66 43.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.58 -27.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 111.199 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 62.87 122.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -80.06 144.7 59.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.79 148.68 44.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -61.01 -38.47 86.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -60.94 -35.0 75.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.54 -54.02 49.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.2 mmt180 -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.477 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.1 mt -61.29 -39.43 90.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.6 mt -72.11 -52.82 14.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.37 -42.08 98.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 6.9 mm-40 -69.62 -29.6 67.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.491 HD11 ' HG ' ' A' ' 60' ' ' LEU . 31.7 tp -63.35 -45.18 92.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.893 0.378 . . . . 0.0 110.667 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.69 -43.31 89.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.018 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -52.81 63.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.26 -31.61 81.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.625 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.16 -41.82 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.031 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.878 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.57 173.58 43.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.576 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG13 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -154.49 -177.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 111.231 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.02 103.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.625 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.36 19.29 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.602 0.239 . . . . 0.0 111.307 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 49.35 43.98 35.08 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.779 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -70.18 -19.51 63.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.1 m -155.03 172.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 111.46 1.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.742 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.478 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 31.9 p90 -102.9 97.02 7.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.686 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.13 21.55 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.108 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.491 ' HG ' HD11 ' A' ' 44' ' ' LEU . 1.8 mt -105.64 143.69 33.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.788 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.38 -46.25 73.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -94.8 -49.97 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.695 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 9.9 t0 97.49 -6.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -155.68 28.49 0.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.17 162.61 14.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.289 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.1 mtp -78.92 -54.0 6.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.428 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -86.99 88.73 7.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.359 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.15 56.56 2.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -82.95 -44.01 15.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.447 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -77.45 139.84 39.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.303 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.474 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 71.2 m95 -135.31 144.37 46.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.1 120.48 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -113.8 108.88 2.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.675 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -95.15 150.92 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 44.1 mt -152.25 138.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.917 0.389 . . . . 0.0 111.743 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 76' ' ' ILE . 15.1 mt -109.31 149.28 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.169 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -91.64 120.34 6.0 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.114 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.24 141.15 95.24 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.547 2.165 . . . . 0.0 111.925 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.591 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 21.1 Cg_endo -60.37 145.81 97.91 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.877 2.385 . . . . 0.0 113.278 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 80.53 43.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.818 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 4.4 p -162.75 158.72 23.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.06 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -40.2 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.0 110.95 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 30.1 m-85 -79.69 -18.69 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.913 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.8 pt-20 -40.74 148.27 0.1 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 41.4 57.08 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.298 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.5 mmt85 -155.86 111.38 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 5.2 mp -66.55 165.07 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 13.4 m-85 -149.43 133.31 17.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.083 0.468 . . . . 0.0 111.439 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 68.0 m -94.96 148.0 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.3 mp -151.3 160.07 43.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 14.8 mtpp -142.22 113.26 7.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 110.25 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.32 148.92 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.268 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 69' ' ' THR . 12.5 mt-10 -131.53 130.59 42.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.332 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.74 -169.16 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.59 -133.2 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.427 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 113.12 2.26 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.452 2.101 . . . . 0.0 112.146 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 60.05 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.646 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.3 t80 -83.23 -63.71 0.25 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.371 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 58.7 Cg_endo -70.91 1.83 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.666 1.578 . . . . 0.0 112.688 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -111.62 -13.77 13.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.674 0.273 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.83 61.07 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 111.312 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.49 122.43 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.614 2.209 . . . . 0.0 112.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -82.37 175.24 9.16 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.744 2.296 . . . . 0.0 112.739 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CZ ' ' HD2' ' A' ' 106' ' ' ARG . 17.3 t80 -94.84 121.41 36.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.802 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.04 138.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.239 0.543 . . . . 0.0 111.596 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -150.28 128.72 12.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.49 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.7 m-85 -71.55 131.93 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.97 -39.35 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.23 0.538 . . . . 0.0 109.634 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 5.0 t -68.59 -173.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.692 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 166' ' ' GLN . 3.0 mmtt -99.51 69.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.439 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.478 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 153.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.8 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.11 101.91 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpp -124.89 153.52 42.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -54.89 -44.06 73.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.328 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -99.13 -6.54 55.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.277 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 123' ' ' VAL . 47.2 t -108.78 131.75 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.1 165.21 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m -113.05 -12.57 13.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 t -109.33 -33.3 6.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.32 . . . . 0.0 111.001 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -104.43 -39.61 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.03 0.443 . . . . 0.0 110.427 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.55 -1.58 69.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.053 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.9 t -58.84 112.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 116' ' ' VAL . 10.9 t -77.47 109.73 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.633 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.58 110.31 3.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.98 -19.24 62.0 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.547 2.164 . . . . 0.0 112.432 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -49.77 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.976 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.59 -40.93 80.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.6 mm -67.71 129.22 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.005 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -67.56 -54.56 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 138' ' ' TYR . 6.7 p -50.08 -36.61 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.496 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 130' ' ' VAL . 0.3 OUTLIER -83.03 -44.5 15.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.8 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.88 45.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.66 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -48.83 136.89 13.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.368 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.68 -170.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.04 -36.85 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -0.53 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.552 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD2' HG22 ' A' ' 130' ' ' VAL . 4.3 m-30 -72.56 154.49 40.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 111.099 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.0 p -156.07 -176.27 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 44.1 mt -54.7 -37.86 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 20.2 ttpp -61.44 -39.74 91.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.202 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.9 t -68.52 -33.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.932 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.16 -53.43 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.321 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 26.8 mt -64.77 -48.32 74.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.066 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -59.45 -49.73 76.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.758 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 4.2 tp10 -60.15 -53.06 62.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 148' ' ' ARG . 4.5 pp -58.33 -41.59 84.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.456 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 8.4 tmm_? -62.61 -34.07 76.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.28 86.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.826 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 6.0 mt -60.83 -48.1 83.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.871 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 30.0 mtt -51.58 -35.74 42.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.776 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.6 ttm -74.04 -14.59 61.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.71 164.44 14.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.0 tttt -65.32 -48.85 71.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.25 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.06 -31.17 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.025 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.07 -25.16 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.442 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 24.4 ptm -88.1 42.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.815 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -141.19 -35.15 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.3 mt -52.88 151.11 8.88 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.317 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.77 122.58 8.98 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.144 1.896 . . . . 0.0 112.73 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -86.91 152.86 54.27 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.9 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.81 118.22 5.53 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.462 2.108 . . . . 0.0 111.972 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 164' ' ' GLU . 72.4 Cg_endo -76.91 72.94 5.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.464 2.11 . . . . 0.0 112.599 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 0.2 OUTLIER 165.97 -59.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.768 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.35 18.09 10.71 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.41 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.445 ' O ' ' CG ' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -70.3 144.56 51.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.025 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.0 m -79.7 175.82 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.647 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 109' ' ' THR . 14.9 m-85 -69.14 136.18 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.969 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.18 156.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.601 0.238 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.46 -44.48 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.455 2.104 . . . . 0.0 112.334 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.83 -161.18 24.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.561 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -132.48 141.92 49.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.62 60.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -87.73 -63.73 1.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.982 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -142.25 165.35 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mt -136.46 127.76 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.45 39.55 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -104.82 -51.58 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.102 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -94.36 -51.44 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t 61.71 167.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 127.43 17.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 125.93 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 t -136.12 106.1 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -108.25 31.44 5.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -155.18 76.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.66 83.1 0.35 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.548 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtm105 -67.41 152.65 45.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.808 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.69 170.96 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.37 149.94 97.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 149.46 21.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.613 2.209 . . . . 0.0 112.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -64.42 130.92 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -128.67 36.27 4.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -116.87 88.23 2.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -80.8 132.65 35.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 95.6 m -68.29 166.79 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.41 134.88 34.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.34 83.78 0.39 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.83 164.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -97.79 148.64 23.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.21 154.46 74.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.41 161.85 5.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.672 2.248 . . . . 0.0 112.066 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -54.13 -52.34 61.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.264 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -53.41 -36.91 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -52.56 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -58.19 -39.08 78.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -63.56 -53.88 44.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.765 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.5 mt -58.94 -51.48 69.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 0.0 111.226 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.75 -49.79 73.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.15 -28.61 68.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.6 tp -62.31 -42.55 99.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -30.47 65.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -74.21 -64.77 2.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.64 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.62 -44.06 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -59.35 -25.92 64.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.92 161.82 26.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG21 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.68 -178.0 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.972 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.09 -63.63 5.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.818 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.58 -6.52 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 51' ' ' VAL . . . 51.85 31.98 32.68 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.443 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 p -72.52 -17.01 61.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 144' ' ' LEU . 35.5 m -152.14 175.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.945 0.403 . . . . 0.0 111.161 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.05 110.78 1.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.335 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.469 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 28.5 p90 -100.0 105.36 17.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.59 148.47 18.07 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.9 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 mt -54.66 130.22 39.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.956 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.97 -62.07 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.148 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 5.2 t0 -76.44 -53.6 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 5.2 t70 96.04 -3.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.041 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -158.17 29.86 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -80.44 -164.77 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.432 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.28 118.84 37.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.384 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p 62.95 12.74 6.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.856 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.524 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER 46.41 63.3 1.93 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.8 m -80.8 -27.47 36.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.754 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -99.64 147.79 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 111.168 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.502 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 70.4 m95 -134.84 160.99 36.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -130.4 118.09 20.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.36 118.41 4.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.244 -0.979 . . . . 0.0 114.178 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -92.9 150.3 20.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 47.5 mt -150.02 138.0 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 111.759 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -95.34 148.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.421 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -73.21 116.01 5.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 8.4 Cg_endo -50.68 128.33 23.64 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.463 2.108 . . . . 0.0 111.873 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.511 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 33.0 Cg_exo -61.16 172.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.376 2.051 . . . . 0.0 112.598 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 3.9 mpp_? 44.42 41.78 4.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.737 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -162.14 161.66 28.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.688 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -43.91 -29.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.02 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' C ' ' A' ' 84' ' ' GLU . 68.2 m-85 -80.03 -21.01 44.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 80' ' ' ARG . 1.7 tt0 -23.9 124.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 t30 49.21 69.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.904 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.1 mmt180 -154.24 106.26 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 50.3 mt -69.69 165.37 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 29.9 m-85 -153.2 128.19 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.033 0.444 . . . . 0.0 111.441 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 33.3 t -94.01 149.29 21.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.1 mp -151.56 160.63 43.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 0.0 111.323 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -136.21 115.34 12.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.3 mp -107.05 126.47 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.348 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 51.3 mt-10 -95.38 126.13 40.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.87 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 p -114.29 -178.32 3.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.98 -164.16 13.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.4 -40.58 62.14 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.661 2.241 . . . . 0.0 112.457 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 73.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.462 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 1.3 t80 -76.52 -58.48 1.15 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.432 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 59.6 Cg_endo -71.09 0.42 6.65 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.882 1.722 . . . . 0.0 112.836 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -120.09 9.72 11.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.448 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.64 20.61 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 111.551 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.0 119.78 7.27 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 0.0 112.361 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 50.9 Cg_endo -84.07 164.26 13.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.869 2.379 . . . . 0.0 112.531 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 28.7 t80 -97.94 98.58 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.491 . . . . 0.0 110.28 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.8 t -95.12 138.51 20.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.024 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.89 120.46 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.565 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 4.1 m-85 -65.87 155.53 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.743 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' ' CD2' ' A' ' 168' ' ' TYR . 25.0 t -110.04 -51.47 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.105 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 t -67.35 -175.81 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.942 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 11.1 mmtm -88.57 110.76 21.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.565 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 1.4 tt -138.79 150.35 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.715 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.463 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.401 ' CE ' HD13 ' A' ' 150' ' ' LEU . 1.8 tpp -124.56 152.9 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -34.97 62.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -118.2 25.12 8.42 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.126 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG2' HG11 ' A' ' 123' ' ' VAL . 48.5 t -130.83 126.0 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.797 0.332 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.89 151.69 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 p -112.78 28.37 8.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -131.08 -55.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -105.25 -34.31 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.18 1.0 33.52 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.956 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.95 111.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 116' ' ' VAL . 5.2 t -77.34 117.69 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.682 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.86 112.92 9.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.519 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.43 -17.23 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.311 2.007 . . . . 0.0 112.333 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -37.92 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.756 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -80.76 -38.29 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 48.8 mm -76.41 121.75 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.836 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.8 p -67.23 -55.2 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.372 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -49.97 -32.45 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.521 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.4 mp -83.57 -50.51 8.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.899 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.71 32.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.16 52.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.442 ' CD2' ' HD3' ' A' ' 103' ' ' PRO . 63.2 t-105 -49.92 140.11 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 2.1 mm100 -117.67 -172.22 2.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.75 -32.81 15.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 m -78.97 -12.22 60.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 135' ' ' GLN . 10.9 m-30 -72.75 152.17 41.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 111.032 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -155.98 -176.36 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 HD13 ' CE2' ' A' ' 71' ' ' TRP . 50.1 mt -53.96 -40.08 43.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.447 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 2.0 ptpt -60.59 -39.75 89.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -69.27 -38.39 77.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.922 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.53 -53.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.055 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.419 ' HB3' HG11 ' A' ' 56' ' ' VAL . 22.7 mt -63.86 -43.7 95.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.535 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -57.66 -39.95 78.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -51.49 69.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.579 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.463 HD13 ' CE1' ' A' ' 107' ' ' PHE . 11.6 mt -49.5 -46.07 47.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.961 0.41 . . . . 0.0 110.588 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.4 77.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.746 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -61.13 -42.76 99.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -64.64 -48.21 75.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 35.7 mtt -54.56 -27.62 40.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 25.7 mtm -76.27 -19.95 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.3 t -65.07 157.32 28.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -65.15 -46.14 82.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.35 -28.77 69.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -87.77 -27.71 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 22.92 2.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -124.31 -33.46 3.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.65 145.07 41.93 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.8 125.02 13.54 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.26 1.973 . . . . 0.0 112.215 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -84.07 124.67 74.11 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.25 118.16 4.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.175 1.917 . . . . 0.0 111.999 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.75 87.55 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.0 112.467 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 167.91 -35.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 57.62 21.86 44.15 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.351 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.2 pt20 -70.67 158.23 36.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.4 p -78.15 145.31 35.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.148 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 2.9 m-85 -58.64 112.63 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 t -111.11 100.57 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.925 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mmm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.666 0.27 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 178.27 5.55 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.585 2.19 . . . . 0.0 112.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 123.04 139.8 5.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -108.81 165.63 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.82 127.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.31 -47.03 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.76 -46.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -160.44 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -75.38 173.54 10.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -114.0 70.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.73 109.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.09 108.78 17.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -23.2 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.26 148.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -64.37 162.47 14.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 110.87 11.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.11 100.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -114.15 99.14 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.76 165.86 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.44 22.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.523 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -90.46 129.5 36.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.745 0.307 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.75 117.87 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -67.22 151.39 97.19 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.5 -64.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.467 2.111 . . . . 0.0 112.261 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.3 -80.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.52 -70.93 0.11 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 49.28 94.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -85.25 167.86 15.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.08 92.05 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.32 107.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.09 -118.18 2.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.409 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -68.12 148.35 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.001 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -46.06 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -80.58 126.75 77.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.0 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.7 161.67 2.01 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.381 2.054 . . . . 0.0 112.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? -76.45 -41.81 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.6 p30 -66.09 -29.01 69.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -50.24 70.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.196 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.6 mmt85 -66.41 -36.74 83.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.479 HD21 ' CZ2' ' A' ' 71' ' ' TRP . 43.4 mt -60.01 -41.18 91.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.2 mt -72.13 -52.73 15.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.537 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -41.34 98.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 74.4 mm-40 -70.51 -29.3 65.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.75 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 51.1 tp -61.89 -46.82 87.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.258 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.52 -49.65 74.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.876 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.93 -29.72 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -78.45 -44.14 11.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.724 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -76.8 -43.75 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.671 0.272 . . . . 0.0 111.097 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -52.86 -28.12 21.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.99 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.91 179.08 18.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.11 -177.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.83 -86.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.608 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.59 -16.42 61.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.569 0.224 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.35 31.43 65.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.2 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.4 p -73.0 -9.52 58.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 m -156.19 165.22 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.998 0.428 . . . . 0.0 111.172 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -162.0 111.04 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.406 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.47 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 27.2 p90 -101.57 130.82 47.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.36 -160.16 8.66 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.576 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.54 127.67 54.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.821 0.343 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -51.65 -64.56 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -79.64 -64.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.961 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 3.1 t70 96.1 2.23 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.148 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -157.22 29.54 0.29 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.69 -165.34 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.278 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.84 -40.42 88.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 68' ' ' LEU . 1.5 t -154.6 -117.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER -153.88 58.61 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.904 0.383 . . . . 0.0 110.661 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 -63.66 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -72.24 98.31 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.702 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.504 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 50.9 m95 -90.2 158.52 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.78 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.57 148.58 25.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 90' ' ' LEU . . . -141.62 102.13 0.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.761 -1.209 . . . . 0.0 113.754 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtp -93.96 146.15 24.13 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 52.7 mt -150.74 126.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.771 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 76' ' ' ILE . 16.2 mt -102.74 149.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.126 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -90.49 140.81 15.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.952 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.97 136.38 6.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.792 2.328 . . . . 0.0 112.093 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 77.0 Cg_exo -48.65 144.49 14.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.641 2.228 . . . . 0.0 113.127 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 75.45 43.72 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.795 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 49.8 p -161.16 147.01 14.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.378 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.61 -36.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.052 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 151' ' ' MET . 49.1 m-85 -80.91 -22.36 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.963 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -39.41 148.41 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 84' ' ' GLU . 26.0 p30 41.08 47.8 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.418 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.4 mmt85 -148.39 109.86 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.692 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 43.1 mt -68.52 166.15 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 28.0 m-85 -150.25 132.33 15.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 46.8 t -93.46 147.4 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.2 mp -152.58 160.15 43.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.102 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 4.1 mtpp -143.44 115.56 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.5 mp -106.43 120.68 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -94.17 124.05 37.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.1 p -113.02 -169.5 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.27 -136.97 5.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.556 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.69 130.49 26.47 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.594 2.196 . . . . 0.0 112.124 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.48 59.61 3.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.576 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.9 t80 -84.63 -55.51 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.635 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.0 Cg_endo -78.13 5.6 5.27 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.961 1.774 . . . . 0.0 112.568 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -123.74 -4.48 8.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.23 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.32 18.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.986 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.26 110.97 3.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.723 2.282 . . . . 0.0 112.009 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 97.8 Cg_endo -76.78 -99.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.358 2.038 . . . . 0.0 112.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -149.9 131.45 14.84 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.731 0.3 . . . . 0.0 111.49 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.54 139.51 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.332 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 121' ' ' GLY . 8.3 ptt180 -150.25 141.66 23.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.524 ' CD2' HG23 ' A' ' 111' ' ' ILE . 22.8 m-85 -83.97 139.92 32.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.837 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.1 t -93.66 -40.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.444 HG22 ' CD2' ' A' ' 88' ' ' TYR . 4.9 t -68.52 -173.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.879 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 5.4 mmtt -97.23 76.77 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 110.166 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG23 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -103.76 149.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.476 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -126.09 102.32 7.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.743 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.421 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -124.74 150.37 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -26.73 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -116.8 16.24 13.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.09 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 107' ' ' PHE . 76.6 t -137.61 122.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.71 165.84 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 96.4 p -117.01 21.75 13.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -51.5 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 110.586 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -103.11 -32.17 9.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.937 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 94.29 5.92 61.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.049 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.7 t -58.84 112.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.964 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.431 HG13 ' CG2' ' A' ' 116' ' ' VAL . 11.9 t -78.16 106.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' GLY . 8.6 t0 -65.86 116.56 33.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 41.1 Cg_endo -66.74 -14.89 45.65 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.403 2.069 . . . . 0.0 112.388 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -72.39 -36.11 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.782 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -84.91 -36.54 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 131' ' ' LEU . 19.9 mm -74.42 128.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 t -67.77 -54.74 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.736 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.403 ' HB ' ' CG ' ' A' ' 146' ' ' GLU . 12.6 p -49.9 -33.01 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.413 ' CD2' ' HB3' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -85.25 -45.59 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.86 55.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -135.53 42.59 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.411 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 73.3 t-105 -49.42 125.2 10.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 2.9 tt0 -81.93 175.83 10.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -96.45 31.45 2.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.08 9.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.812 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' CG ' HG13 ' A' ' 142' ' ' VAL . 10.2 m-30 -75.09 177.56 6.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.734 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -156.85 -176.56 6.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.776 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 62.4 mt -57.91 -37.03 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 24.7 ttpt -62.83 -37.03 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.435 HG13 ' CG ' ' A' ' 138' ' ' TYR . 42.7 t -68.83 -34.8 66.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.005 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.43 -53.24 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.5 mt -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.998 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.31 -44.82 95.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.403 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 2.6 tp10 -61.95 -53.3 57.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.867 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.3 pp -60.61 -37.97 83.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.399 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -64.44 -36.2 83.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 109.932 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 45.1 mtt-85 -59.04 -40.5 85.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.701 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.13 -41.14 97.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.778 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.458 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 60.7 mtt -55.9 -34.98 66.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.469 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 10.8 mtm -75.57 -14.21 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 154.22 38.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -62.24 -50.79 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -35.41 76.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.396 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -86.78 -20.74 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.813 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.7 24.45 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 111.227 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -117.75 -32.02 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.501 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.3 mt -54.72 138.52 62.2 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.471 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.36 121.54 8.51 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.224 1.95 . . . . 0.0 112.729 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -87.67 113.68 55.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.33 117.8 3.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.133 1.889 . . . . 0.0 112.055 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.69 105.12 1.94 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.712 2.275 . . . . 0.0 112.336 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 167.33 -40.79 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.35 11.99 82.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.0 pt20 -70.31 158.56 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.9 p -76.39 -170.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.606 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 6.3 m-85 -90.77 -43.91 9.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.978 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -172.66 81.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.903 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.632 0.253 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.82 -43.05 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.451 2.101 . . . . 0.0 112.304 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.52 112.71 0.36 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.417 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.77 159.41 42.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -80.61 114.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.86 92.97 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -110.07 -26.22 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.224 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -58.83 99.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 11.3 p90 -176.92 143.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.8 mt 60.96 92.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 -75.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -145.96 -47.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.77 -44.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m 62.42 168.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 171.08 10.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.07 -179.02 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -83.83 75.53 10.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -100.5 31.54 3.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.14 87.6 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 139.44 14.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.497 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 114.66 26.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mt -108.12 -63.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.66 130.24 22.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.43 169.64 22.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.478 2.119 . . . . 0.0 112.325 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.1 mtm105 -102.52 36.82 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.28 -41.31 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 60.94 -175.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -86.23 115.26 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -134.83 31.46 3.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.84 -178.55 17.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 p -164.7 -44.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.173 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 mttt 59.61 174.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 m -150.61 135.23 9.66 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.16 144.11 48.86 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.353 2.035 . . . . 0.0 112.17 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -38.56 79.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -67.74 -35.38 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.92 26.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 tpp180 -57.61 -41.68 81.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.468 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 22.5 mt -62.71 -36.07 81.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 mt -72.03 -52.68 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.02 -47.44 77.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 73.1 mm-40 -63.33 -32.88 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.025 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 57.8 tp -63.01 -45.46 92.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.13 -47.57 85.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -32.67 67.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.432 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -84.03 -40.64 8.54 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.688 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -69.52 -47.98 62.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.999 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -61.65 -28.6 69.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.717 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.4 174.62 15.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.593 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.421 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -127.48 138.58 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.082 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.61 -70.6 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.535 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.53 11.27 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' HB ' ' A' ' 51' ' ' VAL . . . -75.32 110.1 2.96 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.631 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -72.66 -17.42 61.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 144' ' ' LEU . 33.1 m -93.72 176.45 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.459 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.36 112.79 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.344 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.446 ' CZ2' ' HB3' ' A' ' 141' ' ' LYS . 32.7 p90 -105.47 102.27 11.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.72 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.63 147.82 16.88 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.0 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' HG ' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -55.18 155.51 4.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -31.28 42.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.849 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 64' ' ' GLU . 4.2 t0 -149.92 102.94 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -68.25 42.71 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 62' ' ' ASP . 5.5 mm-40 -159.74 31.69 0.19 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.36 -173.66 2.39 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.61 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.2 mtm -122.6 1.05 9.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.213 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -154.21 118.64 4.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.817 0.342 . . . . 0.0 110.538 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.66 61.47 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 m -93.88 -60.72 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -69.99 91.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.427 ' CD2' HD13 ' A' ' 140' ' ' ILE . 88.2 m95 -89.11 160.29 17.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.713 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.65 123.39 22.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.691 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.17 171.06 13.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.789 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.4 mtp -142.58 151.15 41.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.211 -0.495 . . . . 0.0 109.815 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 48.2 mt -150.27 120.91 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 111.847 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 76' ' ' ILE . 27.0 mt -93.37 149.1 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.253 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -88.67 143.13 17.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.65 130.36 3.75 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.984 2.456 . . . . 0.0 112.097 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.569 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 74.3 Cg_exo -48.47 141.05 20.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 113.039 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER 80.46 40.67 0.07 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 51.7 p -160.64 150.28 17.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.743 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -47.81 -37.53 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 111.157 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 25.3 m-85 -79.85 -22.85 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.841 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -38.52 145.65 0.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 43.18 54.72 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.123 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 64.8 mmt-85 -154.18 107.21 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.734 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 mp -66.2 167.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 20.7 m-85 -150.26 128.3 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 0.0 111.018 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.566 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 17.0 t -90.05 149.7 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.332 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.0 mp -152.52 160.34 43.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.035 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.0 OUTLIER -142.9 116.65 9.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.0 mp -106.6 124.11 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.441 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.98 105.77 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 81.6 m -105.5 120.97 42.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -122.59 -145.29 6.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.524 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.89 116.55 2.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 62.32 76.71 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.485 ' C ' ' CD1' ' A' ' 98' ' ' TYR . 0.6 OUTLIER -81.66 -62.72 0.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 47.8 Cg_endo -68.53 -1.64 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.651 1.567 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -114.67 8.88 16.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.036 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.48 143.38 3.42 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.317 . . . . 0.0 111.289 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.32 118.37 5.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.763 2.309 . . . . 0.0 112.239 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 91.5 Cg_endo -80.8 -179.61 5.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 61.3 t80 -97.04 100.09 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.51 137.78 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -150.28 118.58 6.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.249 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.501 ' CG ' HG21 ' A' ' 111' ' ' ILE . 15.8 m-85 -62.31 149.27 42.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.507 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.59 -42.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.144 0.497 . . . . 0.0 110.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.404 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.5 t -68.62 -176.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.009 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 21.9 mttm -92.79 76.52 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.501 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -104.99 150.1 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.868 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -125.99 102.68 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.436 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 10.5 ttm -124.45 153.97 41.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.235 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -38.22 66.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.74 23.96 18.32 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.466 ' CG2' HG11 ' A' ' 123' ' ' VAL . 58.7 t -132.72 128.33 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.683 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.67 157.38 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -116.88 28.47 8.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.5 t -135.05 -52.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -105.35 -33.07 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.083 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.13 0.82 44.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.988 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.427 HG12 ' CZ ' ' A' ' 104' ' ' PHE . 54.8 t -58.91 110.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.466 HG11 ' CG2' ' A' ' 116' ' ' VAL . 19.5 t -77.06 115.11 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.685 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.19 115.06 17.98 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.15 -12.15 34.93 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.305 2.004 . . . . 0.0 112.605 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -33.71 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -89.02 -33.86 17.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.0 mm -73.99 122.15 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -67.49 -54.55 19.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.364 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 138' ' ' TYR . 11.4 p -49.94 -32.39 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.532 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.94 -51.76 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.28 -34.21 60.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -123.11 51.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -49.02 155.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.245 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.428 ' HB3' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -132.81 179.6 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -37.64 18.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -79.81 -1.51 39.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.444 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 135' ' ' GLN . 5.4 m-30 -73.11 160.56 31.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.1 m -156.52 -176.55 6.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 71' ' ' TRP . 72.6 mt -59.36 -38.84 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -64.68 -34.56 78.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.37 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -67.76 -37.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 109.409 178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.2 t -66.94 -53.1 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.942 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.416 ' HB3' HG11 ' A' ' 56' ' ' VAL . 20.7 mt -61.64 -44.29 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.976 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -57.54 -41.94 81.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.11 -48.65 80.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.457 HD12 ' CZ ' ' A' ' 107' ' ' PHE . 12.7 mt -52.41 -45.99 66.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -42.44 86.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.215 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -61.96 -46.84 87.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.438 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.1 mt -61.01 -32.27 71.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.428 ' HE3' ' CZ ' ' A' ' 107' ' ' PHE . 3.4 mtt -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.4 mtp -76.42 -12.7 60.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.425 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.2 m -65.22 154.59 37.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -51.08 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -28.78 69.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.375 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 2.7 m-80 -88.16 -28.76 21.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -88.78 22.38 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.224 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -121.76 -30.37 4.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 45.5 mt -54.85 143.17 52.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.73 125.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.452 2.102 . . . . 0.0 112.779 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -84.97 157.47 59.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.324 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -50.0 164.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.055 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.79 24.72 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.842 2.361 . . . . 0.0 113.578 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 169.59 -33.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.03 24.3 4.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -68.97 158.38 34.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.83 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 41.8 m -77.53 -176.23 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' A' ' 109' ' ' THR . 11.4 m-85 -76.84 167.45 21.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 t -175.94 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 1' ' ' MET . 94.1 Cg_endo -82.15 -39.23 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.52 2.147 . . . . 0.0 112.407 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 62.05 88.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.37 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.95 101.09 10.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.98 127.73 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -55.72 -35.91 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.452 ' N ' ' HG2' ' A' ' 6' ' ' GLN . . . 52.22 22.64 2.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.481 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.8 t -174.45 106.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -132.04 -62.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 mt 54.84 -174.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.193 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -104.65 125.47 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.89 138.79 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -43.89 2.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -87.79 159.31 18.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -131.8 155.0 48.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -121.08 142.15 50.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.27 -61.79 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.4 148.93 22.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -139.89 -54.79 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.64 -145.42 7.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -158.84 168.13 27.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.92 173.58 11.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -142.83 118.02 6.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.42 143.59 58.35 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.431 2.088 . . . . 0.0 112.223 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.19 -178.84 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -160.76 -45.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.815 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -152.32 177.77 10.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -106.37 -42.25 5.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.77 -174.2 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 60.54 108.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.49 179.05 5.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.409 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 p -140.9 -45.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.158 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -163.41 159.96 22.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 m -150.53 94.15 3.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.5 155.53 46.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.558 2.172 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 3.4 ppt_? -55.32 -40.37 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.049 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.417 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 26.3 m120 -59.38 -34.82 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.637 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -52.52 63.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.733 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -60.83 -34.16 74.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.524 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 79.8 mt -63.14 -48.87 76.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.805 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.0 mt -69.64 -46.28 66.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -62.71 -50.34 71.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.602 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -64.99 -28.5 69.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.774 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 60.9 tp -61.99 -44.27 97.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 110.503 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.67 -44.05 87.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -59.51 5.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 58' ' ' TRP . . . -59.35 -47.25 91.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.706 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -57.0 -47.26 81.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -53.96 44.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.993 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.19 -176.25 40.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -155.67 -178.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.06 106.64 1.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.67 13.65 9.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.56 0.219 . . . . 0.0 111.318 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.65 43.85 22.36 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.876 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -71.39 -16.95 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.189 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 m -155.74 172.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.511 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.25 113.31 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.901 0.381 . . . . 0.0 111.197 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.433 ' CH2' HG12 ' A' ' 51' ' ' VAL . 35.9 p90 -108.11 114.85 29.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.08 -158.38 10.0 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 mt -114.26 144.87 42.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.004 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -70.64 -47.01 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -92.55 -46.34 7.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 17.4 m-20 93.46 -2.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.285 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -158.05 30.23 0.25 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 109.556 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -163.64 0.77 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.257 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 9.4 mtt -123.8 131.62 53.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 p 75.9 -11.25 1.15 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.971 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.26 57.41 5.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.809 0.337 . . . . 0.0 111.248 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -65.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.071 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 99.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.509 ' CE2' HD12 ' A' ' 140' ' ' ILE . 49.3 m95 -90.13 155.39 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.642 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -102.04 158.65 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.18 153.3 24.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.203 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 31.6 mtp -145.66 147.62 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.764 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 50.3 mt -151.38 120.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 111.796 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -93.77 149.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.392 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.57 140.43 16.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.825 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 93.0 Cg_endo -78.62 136.74 13.94 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.5 Cg_endo -53.52 142.6 58.95 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 112.829 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.61 42.75 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.535 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 68.9 p -160.4 154.5 23.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.846 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -50.59 -37.65 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 111.141 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CE1' ' OE1' ' A' ' 161' ' ' GLN . 51.4 m-85 -80.09 -22.28 42.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.907 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -40.37 136.44 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.173 0.511 . . . . 0.0 112.362 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 56.58 49.14 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.467 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -148.71 108.21 3.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.038 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.443 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 mp -69.08 165.4 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.571 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 23.5 m-85 -152.2 121.22 6.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 43.0 m -88.91 151.24 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.9 mp -153.99 160.29 41.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.106 0.479 . . . . 0.0 111.511 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 2.9 mmtp -137.75 116.23 12.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.257 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.6 mp -106.59 120.71 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.492 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 58.2 mt-10 -94.08 117.64 30.39 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.722 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.64 -169.14 1.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.767 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.21 -147.76 8.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.08 -70.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.546 2.164 . . . . 0.0 112.378 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.85 68.36 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.894 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.535 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -87.94 -61.36 0.24 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.589 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 60.8 Cg_endo -71.97 2.25 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.619 1.546 . . . . 0.0 112.764 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -119.66 7.64 11.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.659 0.266 . . . . 0.0 111.079 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.52 151.35 12.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.11 123.1 11.8 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.47 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.25 167.0 22.06 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 54.0 t80 -95.55 89.44 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.294 0.568 . . . . 0.0 110.445 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 106' ' ' ARG . 22.3 t -92.32 143.39 11.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' N ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -149.97 118.72 6.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.035 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.535 ' CG ' HG23 ' A' ' 111' ' ' ILE . 7.9 m-85 -65.15 127.95 33.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' ' CD2' ' A' ' 168' ' ' TYR . 27.1 t -84.44 -46.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.251 0.548 . . . . 0.0 110.182 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.444 HG23 ' CD2' ' A' ' 88' ' ' TYR . 8.2 t -69.21 -175.76 0.82 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 162' ' ' PRO . 5.9 mmtt -90.52 102.79 15.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.813 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.535 HG23 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -129.7 146.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 111.63 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -125.94 102.26 7.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.656 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.407 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 3.6 ttm -125.1 159.05 32.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -55.84 -27.91 53.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.159 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -126.64 30.01 4.32 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.265 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 123' ' ' VAL . 59.9 t -137.86 127.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -59.43 151.23 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.271 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.0 25.92 10.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.49 -46.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -102.36 -34.77 9.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.492 . . . . 0.0 109.815 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 99.16 -1.76 57.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 37.5 t -58.83 110.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.435 HG13 ' CG2' ' A' ' 116' ' ' VAL . 4.7 t -76.17 110.8 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.75 113.27 10.24 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.944 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.406 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 39.3 Cg_endo -66.49 -15.7 48.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.381 2.054 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -36.16 67.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -88.1 -28.63 21.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.297 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.41 ' CG2' HG11 ' A' ' 130' ' ' VAL . 44.8 mm -80.44 132.18 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -55.34 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.534 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 131' ' ' LEU . 7.2 p -49.88 -37.43 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' N ' HG13 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.11 -46.61 10.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.11 -29.37 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -135.44 48.29 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -49.59 132.11 21.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -165.69 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -96.68 -39.01 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 t -80.76 2.51 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.688 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.414 ' CD2' HG21 ' A' ' 130' ' ' VAL . 5.0 m-30 -72.8 156.79 38.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 111.158 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 -176.37 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.509 HD12 ' CE2' ' A' ' 71' ' ' TRP . 74.0 mt -55.25 -44.97 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.064 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.415 ' HG3' ' CH2' ' A' ' 58' ' ' TRP . 19.4 ttpp -56.72 -37.85 71.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.04 -35.95 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.71 -53.84 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.37 -45.88 85.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.888 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.34 -31.35 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.22 -52.24 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' A' ' 107' ' ' PHE . 9.6 mt -49.61 -46.08 48.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -64.26 -37.92 89.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.984 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.498 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 20.2 mtt180 -63.01 -44.28 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.991 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 1.4 mt -65.43 -32.68 74.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.341 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 32.0 mtt -68.41 -29.11 67.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 30.2 mtm -76.23 -10.96 59.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.324 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.1 t -64.88 151.36 45.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -54.8 29.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -61.19 -24.78 66.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.47 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -86.88 -34.31 19.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.411 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 27.1 ptm -87.08 43.01 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.043 0.449 . . . . 0.0 110.84 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -144.23 -39.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.375 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.7 mt -52.97 145.67 22.16 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.29 124.95 14.72 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.197 1.932 . . . . 0.0 112.067 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.408 ' OE1' ' CE1' ' A' ' 83' ' ' TYR . 74.0 mm-40 -85.26 119.08 72.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.549 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.455 ' HB2' ' HB2' ' A' ' 110' ' ' LYS . 56.6 Cg_exo -51.99 165.89 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.622 2.215 . . . . 0.0 112.03 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 165' ' ' GLY . 89.6 Cg_exo -43.09 175.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.03 2.487 . . . . 0.0 113.011 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 165' ' ' GLY . 4.4 mp0 -44.44 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.309 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 163' ' ' PRO . . . 20.86 50.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.795 -0.639 . . . . 0.0 114.537 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.436 ' CG ' ' CG ' ' A' ' 110' ' ' LYS . 29.6 pt20 -71.19 158.35 36.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.556 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.24 174.02 11.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -89.46 86.67 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 m -144.71 38.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.987 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.905 179.892 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.609 0.242 . . . . 0.0 111.46 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.38 -27.78 15.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.398 2.066 . . . . 0.0 112.32 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.99 -174.31 12.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.86 134.32 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.97 -44.77 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 63.0 145.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.64 -50.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p -90.81 110.45 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.54 -170.53 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.6 mt -52.54 -51.3 60.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.21 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tttt 67.79 27.42 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 55.27 -177.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -127.72 21.95 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t 57.8 -177.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.948 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -157.38 146.36 19.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 175.18 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 122.91 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.2 77.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -176.47 170.83 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.85 89.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.23 48.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.424 . . . . 0.0 110.903 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.58 -48.5 8.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -138.63 151.18 68.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.97 -167.69 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.525 2.15 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.86 164.21 14.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.44 39.96 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -132.1 34.31 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.03 37.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 90.26 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.03 98.88 10.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.53 88.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -109.01 143.22 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.54 110.09 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.61 130.79 6.89 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HD2' ' CD2' ' A' ' 38' ' ' PHE . 51.1 Cg_exo -53.7 161.87 4.07 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.436 2.091 . . . . 0.0 112.233 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.11 -38.21 76.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -55.59 -50.8 69.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -57.86 -45.36 86.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 97.3 mt -63.87 -34.11 77.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.756 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.3 mt -72.12 -52.89 14.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 110.976 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.51 -49.64 68.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.6 mt-10 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.716 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 25.3 tp -63.44 -49.17 74.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.907 0.385 . . . . 0.0 110.588 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -54.98 -56.63 17.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.15 -25.69 59.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -72.36 -55.42 6.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.722 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -69.19 -47.87 63.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.301 . . . . 0.0 111.333 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -39.67 68.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.884 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.44 170.84 12.5 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG22 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -122.23 -177.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.77 -93.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -23.12 66.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 51' ' ' VAL . . . 83.49 27.75 38.26 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.395 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -72.24 -10.32 59.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 74' ' ' MET . 35.1 m -154.24 171.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.69 111.69 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.759 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.457 ' NE1' ' HA3' ' A' ' 47' ' ' GLY . 35.3 p90 -103.48 157.5 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.547 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.83 174.0 30.23 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.323 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 62' ' ' ASP . 1.0 OUTLIER -86.83 11.99 12.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.403 -0.399 . . . . 0.0 112.024 -179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 66.88 -68.47 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' LEU . 4.0 m-20 -130.3 121.91 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.787 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.43 46.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.91 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -159.24 28.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -88.8 -172.75 3.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.361 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.0 mtt -131.26 130.21 42.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.047 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.5 p 59.12 18.79 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.32 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.03 65.77 1.16 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.239 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.77 -55.72 3.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.57 138.84 40.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.491 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 77.3 m95 -135.36 164.73 27.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.89 -179.84 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.285 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 58' ' ' TRP . . . -164.53 159.08 31.98 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.402 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.9 mtp -144.88 148.68 34.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 56.6 mt -152.3 121.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.76 149.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -98.95 148.01 18.68 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.131 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 90.6 Cg_endo -82.24 144.22 13.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.783 2.322 . . . . 0.0 112.112 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.1 Cg_endo -53.17 142.35 55.81 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.74 2.293 . . . . 0.0 112.673 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.4 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.82 41.28 0.1 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.52 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 43.7 p -159.93 150.0 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -47.22 -37.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 111.192 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.459 ' CD1' HG21 ' A' ' 82' ' ' ILE . 65.9 m-85 -79.95 -21.66 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.72 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -42.33 137.7 1.94 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 112.165 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.5 42.06 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.645 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 79.1 mmt-85 -144.61 107.06 4.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.431 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 4.6 mp -67.39 167.34 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.184 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 26.7 m-85 -147.98 125.96 12.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.567 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 38.1 t -88.84 148.7 23.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.434 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 89' ' ' SER . 2.9 mp -151.4 160.16 43.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.183 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -142.77 114.78 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.518 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.34 149.16 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.858 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.31 125.69 29.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.568 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.35 -179.18 3.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.307 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.8 -144.57 8.18 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.64 113.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.121 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 70.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.938 0.399 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.1 t80 -83.51 -60.12 0.35 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 61.0 Cg_endo -72.31 3.35 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.869 1.712 . . . . 0.0 112.993 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.41 -6.23 10.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 111.228 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.49 151.84 44.28 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.37 123.25 12.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.65 2.234 . . . . 0.0 112.339 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 96.6 Cg_endo -80.53 173.16 12.61 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.689 2.259 . . . . 0.0 112.438 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.89 89.13 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.202 0.525 . . . . 0.0 110.455 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.1 t -95.77 138.74 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -150.15 126.52 10.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.884 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.52 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 9.9 m-85 -73.77 135.66 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.14 -41.59 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -69.24 -178.51 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.082 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 40.6 mttt -93.43 91.02 6.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.744 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.52 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -121.48 144.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -122.7 102.99 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 5.0 ttm -124.34 157.35 35.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -54.22 -38.67 65.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -112.36 25.98 11.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.958 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.403 ' CG2' HG13 ' A' ' 123' ' ' VAL . 81.1 t -137.72 126.62 33.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -59.81 149.32 31.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.07 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -110.9 28.43 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.792 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.64 -46.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -103.79 -33.68 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 0.0 110.027 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.7 -4.45 56.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.753 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.83 115.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.417 ' CG1' HG13 ' A' ' 128' ' ' ILE . 11.8 t -76.74 108.13 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.619 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 115' ' ' GLY . 3.5 t0 -64.95 110.73 4.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.409 ' HA ' ' CD1' ' A' ' 131' ' ' LEU . 43.2 Cg_endo -67.61 -13.12 37.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.992 . . . . 0.0 112.433 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -30.51 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -93.09 -48.08 6.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.417 HG13 ' CG1' ' A' ' 123' ' ' VAL . 24.5 mm -61.02 131.51 26.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.7 p -67.49 -54.47 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.454 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 131' ' ' LEU . 7.2 p -49.87 -32.79 8.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.552 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 130' ' ' VAL . 61.9 mt -84.24 -53.03 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.722 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.45 -24.06 18.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.512 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -136.73 45.12 2.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 111.016 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 70.5 t-105 -50.38 138.5 16.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.053 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -108.36 -170.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.925 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.57 -40.52 12.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.46 1.92 27.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.552 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.433 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 4.0 m-30 -72.75 151.76 41.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.3 p -155.43 -176.33 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.805 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.491 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 65.6 mt -51.19 -48.08 32.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.26 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -55.37 -39.48 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.659 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 45.7 t -69.03 -37.61 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.289 0.566 . . . . 0.0 110.017 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.4 t -63.38 -53.77 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.093 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.7 mt -64.98 -45.06 87.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.878 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -61.34 -51.08 70.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.075 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.413 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -59.76 -53.47 57.6 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.3 pp -57.59 -37.7 73.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.056 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.49 -33.8 76.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.695 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.35 89.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.899 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.63 -40.45 97.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.449 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 22.9 mtt -55.22 -34.7 64.16 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.615 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.3 mtm -75.43 -13.96 60.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.103 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 t -65.56 158.31 27.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -65.41 -49.87 67.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.14 -30.07 70.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.321 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.91 -26.17 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.653 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.74 46.66 1.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -143.17 -39.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.35 155.62 9.37 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.589 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.11 142.16 60.28 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.288 1.992 . . . . 0.0 111.8 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.45 ' HG3' HG23 ' A' ' 82' ' ' ILE . 6.3 mm-40 -146.63 98.67 4.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.47 149.09 18.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.477 2.118 . . . . 0.0 112.199 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.84 158.68 55.19 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.565 2.177 . . . . 0.0 112.458 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.64 174.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.34 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.4 -66.84 1.72 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -69.72 158.48 35.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.4 m -157.64 169.72 24.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 110' ' ' LYS . 16.2 m-85 -74.39 84.15 1.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.2 m -120.09 166.12 13.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.865 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.87 -28.27 24.95 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.87 -156.14 20.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.409 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -80.48 76.48 7.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.73 118.59 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 66.34 -76.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -145.7 -50.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 1.8 p 84.13 -19.56 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.685 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.2 t80 66.89 -70.77 0.1 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.75 0.31 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.25 148.44 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -159.84 174.87 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 60.62 -179.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -71.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.3 p -120.69 29.98 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 62.52 123.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 pp -152.83 100.81 2.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -138.99 121.55 16.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.62 -34.55 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 61.31 -178.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.96 134.5 4.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.81 76.12 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -160.96 127.25 3.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.13 126.59 28.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.827 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.37 -62.47 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.405 2.07 . . . . 0.0 112.295 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -84.38 178.35 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -151.99 -57.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.96 178.2 4.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -151.32 -178.29 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -91.86 96.15 10.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -104.16 105.58 15.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.29 -107.31 3.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.428 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 p 43.67 36.25 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.649 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 155.94 34.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.14 114.38 46.29 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HG2' ' CD1' ' A' ' 38' ' ' PHE . 36.9 Cg_endo -65.88 161.95 37.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.423 2.082 . . . . 0.0 112.229 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -55.8 -51.31 67.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.032 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.96 -35.61 64.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -55.36 -51.91 65.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.664 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 12.9 mmt-85 -57.95 -40.32 80.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.5 mt -61.82 -50.67 71.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.81 -51.59 66.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.453 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.97 -47.97 82.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.097 0.475 . . . . 0.0 110.303 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 51.0 mt-10 -67.93 -26.66 66.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.464 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 43.1 tp -60.7 -45.35 94.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.12 -37.08 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.43 -42.59 78.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.476 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -77.01 -40.64 24.63 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.676 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -66.1 -40.58 90.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -59.28 -76.16 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.12 165.68 36.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG12 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -148.51 -177.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.365 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.12 104.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.933 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 56.53 22.28 6.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.595 0.236 . . . . 0.0 111.497 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' HA2' HG21 ' A' ' 51' ' ' VAL . . . 51.07 46.35 50.66 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.794 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.6 p -71.4 -22.5 61.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.273 . . . . 0.0 111.206 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.1 m -154.93 173.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.78 110.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.341 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.476 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 26.5 p90 -99.92 96.26 7.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -105.66 -152.95 20.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.585 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -121.81 147.61 45.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 111.148 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.69 -41.64 86.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.954 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 5.7 t0 -110.23 -49.75 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 11.0 t0 95.61 -2.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.278 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.93 30.03 0.26 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.55 166.29 16.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.276 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.1 mtm -83.37 1.36 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 p -154.55 103.1 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -82.99 58.46 4.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.723 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.85 -56.28 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.59 105.35 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.431 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.6 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 30.4 m95 -89.5 150.86 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.669 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -101.99 113.29 26.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -110.75 106.54 2.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.913 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtp -90.63 147.32 23.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 56.8 mt -149.61 150.14 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.872 0.368 . . . . 0.0 111.447 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mt -105.89 148.83 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.231 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.09 117.22 5.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.256 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.8 142.56 18.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.425 2.083 . . . . 0.0 112.0 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 61.0 Cg_endo -73.01 175.97 9.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.418 2.079 . . . . 0.0 112.753 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.518 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 40.92 41.8 1.33 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.592 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 6.8 p -162.0 160.97 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -43.65 -28.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.883 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 84' ' ' GLU . 72.0 m-85 -79.58 -22.09 44.2 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 80' ' ' ARG . 1.7 tt0 -24.16 125.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 45.55 72.9 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 22.5 mmt180 -157.43 104.66 2.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 88' ' ' TYR . 5.0 mp -66.02 167.64 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.497 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 60.1 m-85 -153.4 128.67 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.546 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.465 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -93.17 145.87 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.82 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.5 mp -149.43 160.44 43.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.282 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.9 OUTLIER -138.61 111.49 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.188 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.33 120.15 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.85 133.16 37.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.739 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.522 ' HB2' ' CG ' ' A' ' 98' ' ' TYR . 21.5 p -115.35 -169.3 1.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.14 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.85 -147.04 15.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.234 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.6 119.03 4.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.478 2.119 . . . . 0.0 111.999 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp 59.46 75.19 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.852 0.358 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.656 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 6.1 t80 -86.52 -54.49 0.39 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.84 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.6 Cg_endo -82.57 8.76 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.991 1.794 . . . . 0.0 112.236 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.92 3.87 7.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.81 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.21 143.34 3.57 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.61 110.95 2.48 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.847 2.365 . . . . 0.0 112.632 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 73.0 Cg_endo -76.9 -96.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.505 2.137 . . . . 0.0 112.416 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CZ ' HG12 ' A' ' 122' ' ' VAL . 59.8 t80 -148.17 136.02 20.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.894 0.378 . . . . 0.0 111.651 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.75 140.28 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.395 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -150.5 139.43 20.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.965 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.549 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 8.8 m-85 -77.44 114.83 16.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.868 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.65 -46.68 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.164 0.507 . . . . 0.0 110.273 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.403 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -68.6 -179.83 1.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.06 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -88.68 120.22 29.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.549 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -157.84 153.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -125.94 102.03 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.43 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.466 ' O ' ' N ' ' A' ' 115' ' ' GLY . 7.6 ttm -125.24 143.49 50.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.405 ' N ' ' HG2' ' A' ' 113' ' ' MET . 2.4 m-80 -58.03 79.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.008 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 113' ' ' MET . . . 145.94 -35.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.284 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.418 ' CG2' HG11 ' A' ' 123' ' ' VAL . 58.5 t -89.16 139.3 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -59.71 138.45 57.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.0 p -96.14 48.88 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 p -178.07 -38.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -102.45 -37.73 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.095 0.474 . . . . 0.0 109.991 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.16 -5.58 61.24 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.126 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 104' ' ' PHE . 24.4 t -58.54 111.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.089 0.444 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 116' ' ' VAL . 7.4 t -77.08 110.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.477 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.59 110.28 3.84 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.2 -17.71 58.3 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.353 2.035 . . . . 0.0 112.326 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -72.43 -43.79 63.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.6 63.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 44.4 mm -81.91 130.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -59.88 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.5 m -49.7 -30.82 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.662 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 mp -84.39 -45.22 12.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.21 -63.38 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 58.89 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -49.15 164.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -152.98 173.92 14.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.49 -27.24 63.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.194 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.52 -24.76 41.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -73.56 144.72 45.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.256 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.81 -176.32 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.364 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' OH ' ' A' ' 98' ' ' TYR . 62.5 mt -50.09 -39.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.715 0.293 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 14.6 ttpp -61.7 -45.73 92.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.328 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.4 t -67.45 -35.6 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.884 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.403 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.9 t -62.99 -53.81 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.917 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.6 mt -64.36 -44.6 90.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.556 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -57.66 -40.62 79.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.985 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -59.97 -53.03 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.766 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 7.5 mt -50.25 -45.9 54.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -62.94 -38.15 89.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.755 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -46.52 88.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.206 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.427 HD11 ' HA ' ' A' ' 147' ' ' LEU . 1.6 mt -59.43 -46.28 89.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.34 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 2.5 mtt -61.13 -25.41 66.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -75.76 -20.4 58.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -65.26 154.57 37.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 11.6 mttm -65.13 -45.79 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -27.38 68.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.41 -27.67 22.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.348 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -89.72 45.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.098 0.475 . . . . 0.0 110.698 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -138.82 -38.56 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.1 mt -53.18 147.3 18.22 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.461 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.83 125.89 12.05 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.285 1.99 . . . . 0.0 112.535 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -83.7 157.39 64.07 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -56.88 165.19 5.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 112.207 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.52 19.86 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.806 2.337 . . . . 0.0 112.967 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 168.44 -174.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.62 21.99 40.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.62 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.12 158.12 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 29.4 p -78.74 -168.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 2.2 m-85 -85.11 155.79 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.47 32.92 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.78 -46.42 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.598 2.199 . . . . 0.0 112.295 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.81 -90.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.32 74.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.11 -48.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 43.74 68.49 0.52 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.463 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.71 -44.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 m 61.62 159.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' N ' ' CD1' ' A' ' 9' ' ' TYR . 1.2 p90 -157.48 161.1 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.763 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HG ' ' CD2' ' A' ' 9' ' ' TYR . 8.2 mt 74.0 -59.56 0.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.58 79.68 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -158.35 133.95 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.55 -60.79 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -171.41 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 109.44 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.67 113.47 26.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 p -160.74 176.95 10.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -128.04 -44.22 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 69.0 -67.69 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.84 -106.76 0.55 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 174.44 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 pp -103.81 -38.13 7.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -158.19 102.24 1.72 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.66 58.54 6.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.599 2.199 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -69.78 -69.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.91 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.69 102.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -132.28 101.63 5.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.04 83.48 2.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.72 91.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.06 29.0 0.52 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.4 m -62.49 102.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.062 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -159.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -78.58 142.05 61.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.644 0.259 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.5 151.86 22.73 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -56.0 -48.95 74.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -32.9 51.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -54.93 37.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.3 mmt-85 -57.52 -37.74 73.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 110.196 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 91.9 mt -61.87 -38.35 87.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.25 -52.74 15.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.396 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -63.51 -50.02 71.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 91.5 mt-10 -60.34 -32.34 71.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 25.8 tp -62.66 -43.7 98.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.941 0.401 . . . . 0.0 110.38 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.73 -56.13 26.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.25 -45.02 84.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.441 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.08 -44.31 94.41 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.768 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -67.8 -48.04 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.185 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -22.84 64.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.83 167.18 27.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.265 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG22 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -115.62 -176.96 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 0.0 111.163 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -47.14 -86.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.195 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.91 -14.42 61.05 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA2' HG22 ' A' ' 51' ' ' VAL . . . 72.92 37.73 56.54 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.26 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -72.35 -17.1 61.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.59 0.233 . . . . 0.0 111.53 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.8 m -154.26 174.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.942 0.401 . . . . 0.0 111.336 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.78 111.07 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.272 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CH2' ' HD3' ' A' ' 141' ' ' LYS . 34.8 p90 -103.01 73.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.042 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.41 -170.29 46.36 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.773 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.72 141.7 36.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.845 0.355 . . . . 0.0 111.035 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.6 -32.64 73.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.6 t70 -169.4 129.98 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.64 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.76 33.38 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 62' ' ' ASP . 34.5 mm-40 -158.81 29.33 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.62 1.94 47.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.824 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.58 113.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.011 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p 62.35 15.56 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.601 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 44.71 47.15 8.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -58.17 -65.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 146.28 52.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.536 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 63.8 m95 -134.9 146.68 49.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -102.04 121.44 42.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -118.44 109.8 1.83 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.679 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mtp -94.33 152.47 18.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 37.4 mt -152.31 129.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 111.697 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 76' ' ' ILE . 18.8 mt -102.85 149.26 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -85.09 143.42 20.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.02 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.2 Cg_endo -84.2 134.02 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.826 2.351 . . . . 0.0 111.942 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 71.0 Cg_exo -48.79 143.22 17.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.502 2.135 . . . . 0.0 112.987 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER 74.17 43.97 0.27 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.504 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.419 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 30.7 p -160.06 149.45 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.623 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -36.82 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.065 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.496 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 94.4 m-85 -80.27 -22.27 41.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.1 pt-20 -42.54 133.09 3.47 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.79 11.91 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.622 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -115.28 104.17 11.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.456 HG21 HD13 ' A' ' 87' ' ' ILE . 40.5 mt -61.79 169.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.282 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.493 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 25.4 m-85 -152.42 129.73 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.389 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.501 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.6 m -93.84 146.41 23.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.83 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.2 mp -151.06 160.19 44.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.5 mtpt -141.68 114.53 8.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.72 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.13 120.79 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.182 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.08 126.78 40.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.8 p -113.53 -172.02 1.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.19 -140.08 7.77 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.589 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.72 120.46 5.94 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.205 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mttt 51.44 70.3 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.56 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -88.58 -63.0 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 70.5 Cg_endo -73.47 3.7 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.605 1.536 . . . . 0.0 112.478 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.54 -4.43 12.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.33 161.26 29.81 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.59 123.88 14.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.655 2.237 . . . . 0.0 112.474 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.17 171.76 15.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.641 2.228 . . . . 0.0 112.31 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -96.39 89.37 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.473 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -93.71 139.3 18.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.221 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -150.42 120.22 7.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.525 ' CD2' HG21 ' A' ' 111' ' ' ILE . 20.5 m-85 -65.56 139.44 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 t -91.45 -42.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.865 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.409 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -69.05 -178.63 1.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.803 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HE2' ' CE1' ' A' ' 168' ' ' TYR . 0.3 OUTLIER -93.36 76.44 4.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.525 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -99.6 152.0 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.475 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.73 102.48 7.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.676 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.42 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 12.4 ttm -124.69 148.01 48.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.236 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -55.02 -28.36 51.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -120.07 28.01 6.52 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.012 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 107' ' ' PHE . 94.1 t -136.25 131.99 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 110.726 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -59.49 132.34 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.993 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 m -97.81 31.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.987 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -141.38 -48.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.28 -34.73 7.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 106.08 -4.12 38.45 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 113.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.796 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.424 HG12 ' CG2' ' A' ' 116' ' ' VAL . 10.2 t -76.76 119.41 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.726 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER -65.33 110.72 4.69 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.49 -20.8 71.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.383 2.056 . . . . 0.0 112.407 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -45.04 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.806 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -71.48 -52.41 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.6 mm -58.1 128.1 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.0 t -67.39 -56.32 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.453 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 138' ' ' TYR . 9.2 p -49.95 -30.84 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.352 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.06 -55.06 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.06 -25.08 19.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.272 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -134.2 51.04 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CZ3' ' CD ' ' A' ' 103' ' ' PRO . 57.0 t-105 -49.44 160.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.246 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.425 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 3.1 tt0 -140.62 177.16 8.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -77.32 -39.74 46.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 m -80.0 0.36 31.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-30 -72.78 149.66 43.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.962 0.411 . . . . 0.0 111.151 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -155.7 -176.45 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.36 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 31.7 mt -58.17 -37.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.721 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 6.5 ttpm? -62.04 -40.17 94.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 22.0 t -67.88 -40.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.678 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.2 t -61.13 -53.22 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.328 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 27.0 mt -64.14 -44.8 91.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.847 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.31 -48.85 79.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.641 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 142' ' ' VAL . 1.5 tp10 -60.0 -53.26 59.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.6 pp -57.77 -41.0 81.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.814 0.34 . . . . 0.0 110.45 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.407 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 3.3 tmm_? -63.83 -33.09 74.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.168 0.509 . . . . 0.0 109.876 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -58.5 -44.85 89.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.101 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.82 -41.97 98.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.887 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.417 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 14.7 mtt -56.44 -29.43 61.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' MET . . . . . 0.412 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 9.7 mtm -74.21 -22.69 59.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.3 t -65.96 158.09 29.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.054 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.455 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 6.2 mttt -65.41 -36.03 82.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.151 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.6 -44.33 97.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.008 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -87.7 -20.8 25.74 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.455 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -88.74 23.43 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.81 -30.99 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.276 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.0 mt -54.71 145.5 40.4 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.83 124.69 10.87 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.263 1.976 . . . . 0.0 112.673 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.441 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 7.1 mm-40 -85.06 158.04 59.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.832 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 40.6 Cg_endo -66.76 118.25 5.4 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.333 2.022 . . . . 0.0 111.932 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.99 55.79 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.768 2.312 . . . . 0.0 112.882 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 165.12 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.823 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -93.9 45.67 2.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.131 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.412 ' CB ' ' HG3' ' A' ' 110' ' ' LYS . 7.2 mm-40 -69.72 159.06 34.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 0.0 111.436 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.0 m -160.0 135.57 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.413 ' CE1' ' HE2' ' A' ' 110' ' ' LYS . 24.6 m-85 -46.61 146.81 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.422 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.3 84.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.825 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.666 0.27 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.4 141.13 34.63 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.522 2.148 . . . . 0.0 112.271 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.04 -73.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.28 92.18 3.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -101.49 53.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 127.4 32.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.38 22.55 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.297 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m 62.04 108.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -69.9 147.51 50.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.4 mt 60.0 161.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -160.56 170.94 19.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -121.22 179.53 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -132.26 -50.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 p -168.73 153.9 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -82.8 -32.1 27.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -171.25 125.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 m -156.47 86.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.39 87.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -165.68 110.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.18 93.78 1.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.54 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.61 30.79 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.42 105.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.73 142.57 25.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 59.71 6.32 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 112.337 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.89 88.53 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -165.56 -44.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.78 95.68 7.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 150.77 20.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.07 -80.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttp 53.33 94.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.36 93.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.577 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 t -136.76 32.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -176.99 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.667 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 34' ' ' VAL . 17.7 m -79.47 112.62 30.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.407 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 22.5 Cg_exo -64.81 137.53 54.02 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 82.24 -48.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.755 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' ' 36' ' ' ARG . 5.0 m120 -71.26 -44.85 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -58.16 -44.39 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 0.0 110.455 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -60.59 -40.48 91.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.365 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD22 ' CD2' ' A' ' 98' ' ' TYR . 80.4 mt -60.58 -53.65 54.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.888 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.55 -50.82 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.7 -43.98 97.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 89.6 mt-10 -71.71 -27.79 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.32 -46.01 91.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.84 0.352 . . . . 0.0 110.586 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 13.6 mt-10 -68.47 -44.06 75.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -27.72 43.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.484 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -88.13 -30.44 17.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -83.47 -43.7 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 10.0 mmtt -58.45 -62.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.898 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 174.71 45.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG13 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.04 -177.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.85 105.09 1.37 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.49 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 66.89 14.09 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.556 0.217 . . . . 0.0 111.33 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 49.05 41.33 29.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 p -71.43 -18.91 62.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 111.13 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.412 HG13 ' HB3' ' A' ' 144' ' ' LEU . 21.1 m -155.1 169.8 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 m -161.73 110.99 1.54 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.675 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.497 ' CH2' ' CB ' ' A' ' 141' ' ' LYS . 32.4 p90 -103.81 143.45 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -151.82 -136.09 2.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.039 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 mt -132.61 133.04 43.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.743 0.306 . . . . 0.0 110.905 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.14 -53.56 56.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.038 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 9.0 t70 -110.05 -48.62 3.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.969 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 2.5 t70 95.96 21.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.968 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -157.17 29.53 0.3 Allowed 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.04 -166.03 1.42 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.205 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.418 ' O ' ' CG2' ' A' ' 67' ' ' THR . 0.0 OUTLIER -84.97 109.71 18.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 66' ' ' MET . 15.0 t 46.7 35.6 3.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 55.52 80.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.78 -61.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.199 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.2 93.62 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 40.5 m95 -90.06 152.63 21.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.01 152.08 21.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.724 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -143.71 102.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.629 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.4 mtp -94.17 147.06 23.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 45.5 mt -151.78 138.06 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.74 0.305 . . . . 0.0 111.588 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mt -99.26 148.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.118 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.69 117.97 4.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.266 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 146.86 49.61 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.163 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 84' ' ' GLU . 13.4 Cg_exo -69.3 173.64 10.26 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.635 2.224 . . . . 0.0 112.73 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.499 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER 41.48 43.14 2.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.792 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 19.9 p -161.3 158.17 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.42 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -44.32 -27.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 53.6 m-85 -78.79 -24.56 44.54 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.553 ' CG ' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -22.01 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.21 65.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.753 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 9.4 mmt180 -152.87 102.9 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.429 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 11.0 mt -67.56 168.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.208 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 25.9 m-85 -150.34 132.91 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 0.0 110.992 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.505 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 48.7 m -94.18 146.7 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.296 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 89' ' ' SER . 3.8 mp -151.7 159.89 43.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.96 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 28.1 mttt -144.54 117.91 9.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.519 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.0 mp -106.2 123.65 61.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -93.82 108.67 20.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 57.4 m -113.54 152.55 30.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.65 -149.36 4.95 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.592 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.78 -48.63 18.54 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.665 2.243 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 77.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -101.79 -66.68 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.2 Cg_endo -69.76 -0.94 7.63 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.346 1.364 . . . . 0.0 112.312 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.22 -4.69 16.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.986 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.61 144.22 8.01 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 120.836 0.351 . . . . 0.0 111.308 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.01 110.07 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.868 2.378 . . . . 0.0 112.042 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 41.6 Cg_endo -67.56 -176.17 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.444 2.096 . . . . 0.0 112.244 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -94.76 94.63 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 111.197 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 44.6 t -96.32 138.54 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.781 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -150.22 126.12 10.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.537 ' CD2' HG22 ' A' ' 111' ' ' ILE . 25.1 m-85 -68.1 126.78 30.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.35 -41.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.262 0.553 . . . . 0.0 109.948 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.4 t -68.41 -175.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.828 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -98.83 68.02 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.512 . . . . 0.0 110.274 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.537 HG22 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.343 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.47 101.89 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.1 ttm -125.2 157.5 36.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -54.67 -52.86 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.19 -11.64 64.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.109 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.411 ' CG2' HG11 ' A' ' 123' ' ' VAL . 43.7 t -107.19 121.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.42 143.75 52.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.925 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -98.25 29.15 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 p -140.0 -43.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -102.23 -32.74 9.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 110.033 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -3.16 81.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.874 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.96 110.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.411 HG11 ' CG2' ' A' ' 116' ' ' VAL . 3.4 t -77.69 107.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -63.77 109.99 3.25 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.849 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.41 -23.28 74.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.323 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -41.33 66.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -74.65 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.427 ' CG2' HG11 ' A' ' 130' ' ' VAL . 35.5 mm -75.46 133.25 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.734 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.5 -58.84 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.016 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG11 ' CG2' ' A' ' 128' ' ' ILE . 14.9 p -49.85 -33.91 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.795 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.91 -41.85 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.84 69.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.86 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 47.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -48.03 157.22 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.28 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 179.28 7.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 -31.98 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -79.13 -12.77 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.226 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.2 m-30 -72.87 153.74 40.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -156.16 -176.39 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.44 HD11 ' CE3' ' A' ' 71' ' ' TRP . 2.9 mt -54.92 -35.14 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.497 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -67.39 -38.93 85.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.1 t -68.63 -37.67 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.5 t -63.5 -52.9 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.551 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 42.6 mt -62.48 -43.68 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.956 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -61.96 -51.11 69.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.054 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.408 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -59.8 -53.36 58.82 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.6 pp -56.08 -40.76 74.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.987 0.422 . . . . 0.0 110.134 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 1.4 ttt-85 -62.6 -34.16 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.73 -38.47 78.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.538 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.6 mt -64.08 -41.48 97.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.492 178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 34.7 mtt -55.7 -32.36 63.24 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.283 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -19.82 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.949 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -65.12 159.83 22.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 157' ' ' MET . 4.6 mtpm? -65.21 -36.01 82.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.301 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.78 -35.86 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -89.57 -11.63 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 14.1 ptm -90.61 24.57 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 111.187 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.07 -37.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.823 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.7 mt -54.37 157.66 4.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.414 ' C ' ' HG2' ' A' ' 161' ' ' GLN . 44.0 Cg_endo -66.11 146.59 82.31 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.326 2.017 . . . . 0.0 112.116 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.437 ' HG3' HG22 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -146.26 103.04 4.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.586 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.74 117.96 4.66 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.374 2.049 . . . . 0.0 112.204 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.49 90.4 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.813 2.342 . . . . 0.0 112.321 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.54 -173.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.876 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.27 30.62 8.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.369 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.09 158.63 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 83.8 m -155.99 154.3 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.609 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 109' ' ' THR . 24.7 m-85 -54.64 111.08 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.1 m -142.37 30.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.917 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.653 0.263 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.17 128.51 22.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.547 2.164 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.03 -110.39 3.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.438 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.34 167.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.21 42.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.999 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.85 90.74 0.81 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.56 -37.32 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 m -85.66 125.72 33.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.97 158.66 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mt 60.31 176.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tttt 68.25 -69.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m 63.14 130.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.952 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -130.17 -72.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p 55.72 -171.27 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.45 120.05 6.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.19 138.2 31.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.01 -169.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.79 37.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.07 56.13 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -152.04 17.26 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 64.52 -78.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.7 139.97 47.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.64 127.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.22 -168.17 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.5 2.133 . . . . 0.0 112.232 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -126.52 36.44 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt 65.07 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.1 87.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -171.48 115.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.2 m -76.41 112.97 13.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.57 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.043 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.46 8.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -133.21 141.98 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -117.71 -66.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -80.03 128.03 75.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.53 152.09 17.04 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.35 2.033 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -40.94 91.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -65.02 -34.81 79.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -55.72 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -58.47 -39.26 79.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 84.1 mt -61.72 -40.31 94.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.16 -52.57 15.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.64 -43.18 99.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.921 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -68.63 -29.72 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.797 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 64.0 tp -62.85 -47.13 84.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.6 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -58.11 -41.63 83.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -66.45 -62.81 4.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.586 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -52.28 -39.7 60.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.987 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -72.74 -27.48 62.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.57 170.01 22.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.515 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -177.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.9 -76.72 0.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.95 -14.27 61.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.222 . . . . 0.0 111.288 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.6 28.65 73.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.44 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -71.88 -12.32 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.585 0.231 . . . . 0.0 111.426 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.9 m -154.21 161.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.776 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.01 124.83 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.795 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.473 ' CZ2' ' HB3' ' A' ' 141' ' ' LYS . 4.4 p90 -114.87 -179.12 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.28 44.12 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.057 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.46 120.79 40.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.981 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.41 -34.77 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -101.05 -53.89 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 9.6 t0 94.91 1.55 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -158.63 30.03 0.23 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.333 0.587 . . . . 0.0 109.598 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.62 -165.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.306 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mtt -111.74 122.14 46.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 p 61.1 17.18 7.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.522 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 47.35 70.74 0.38 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 m -75.01 -68.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.31 142.68 50.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.752 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.482 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 92.0 m95 -135.17 144.16 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.293 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 159.9 14.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 156.81 26.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.885 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 24.5 mtp -145.48 147.25 31.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.712 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 41.3 mt -150.57 120.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.823 0.344 . . . . 0.0 111.759 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 76' ' ' ILE . 21.0 mt -86.66 149.21 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.429 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -74.69 134.0 16.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.844 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 84.1 Cg_endo -78.39 127.61 8.32 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.192 . . . . 0.0 111.737 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.8 Cg_endo -50.04 141.21 30.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.628 2.219 . . . . 0.0 112.727 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 75.4 44.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.235 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 17.6 p -159.4 154.55 25.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.426 HG21 ' CD2' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -50.11 -38.51 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.989 0.424 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.441 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 42.3 m-85 -80.35 -20.62 43.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.026 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.4 pt-20 -41.85 133.06 2.93 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 66.99 41.38 2.7 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.553 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 84' ' ' GLU . 2.4 mpt_? -149.59 115.7 5.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.718 0.294 . . . . 0.0 111.362 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 87' ' ' ILE . 37.1 mt -65.57 168.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.021 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 22.5 m-85 -153.32 119.53 5.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.8 m -88.77 153.17 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.632 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.0 mp -153.75 160.28 42.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.369 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -137.87 114.16 10.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.452 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mp -106.19 121.45 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.494 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -94.25 127.6 40.21 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.787 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 83.8 m -132.19 121.46 23.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.69 -153.02 25.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.94 -36.34 43.51 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.644 2.229 . . . . 0.0 112.381 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 118.21 32.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.542 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.6 t80 -135.93 -67.35 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.22 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.6 Cg_endo -69.37 0.92 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.439 1.426 . . . . 0.0 112.5 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -107.41 -20.59 13.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.313 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.25 161.03 28.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 0.0 111.469 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.58 119.17 6.21 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.659 2.239 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -86.49 -123.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.873 2.382 . . . . 0.0 111.675 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' H ' ' HB2' ' A' ' 103' ' ' PRO . 12.4 t80 -145.93 129.49 16.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.677 0.275 . . . . 0.0 110.693 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.2 t -135.36 140.55 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.1 ptt85 -150.3 122.51 8.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.167 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.524 ' CG ' HG21 ' A' ' 111' ' ' ILE . 10.2 m-85 -60.03 141.21 56.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.446 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.27 -44.05 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 110.327 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.426 HG21 ' CD2' ' A' ' 88' ' ' TYR . 7.2 t -68.22 -175.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -91.25 86.97 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.977 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.524 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -119.46 151.47 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.481 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -126.07 102.33 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.649 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 27.9 ttm -124.45 143.97 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.36 -25.75 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -111.58 15.3 27.04 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.5 ' CG2' HG11 ' A' ' 123' ' ' VAL . 86.9 t -137.74 127.69 36.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.797 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.7 165.89 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.055 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' CZ ' ' A' ' 168' ' ' TYR . 15.6 m -106.22 -16.86 14.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.198 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.1 m -77.39 -61.45 1.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.62 -38.04 6.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.7 21.18 8.01 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.56 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.09 111.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 116' ' ' VAL . 3.3 t -77.49 100.91 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.3 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.9 OUTLIER -64.74 119.75 60.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.01 -14.99 40.59 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.505 2.137 . . . . 0.0 112.638 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -28.83 63.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -95.38 -28.22 15.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.256 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.9 mm -77.18 128.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.154 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -67.52 -60.03 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.356 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.9 m -49.98 -32.53 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.553 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.67 -43.01 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.617 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.18 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 54.79 1.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -47.85 158.09 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.545 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -142.64 178.12 7.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.37 -30.57 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.017 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.8 p -79.31 -9.82 59.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.395 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -73.3 155.15 39.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.6 m -156.17 -176.52 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.3 mt -58.5 -41.57 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 pttt -62.36 -36.62 82.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 0.0 110.273 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.47 -37.94 78.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.436 0.636 . . . . 0.0 109.59 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.65 -53.34 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.941 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.5 -46.02 91.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.689 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.02 -30.04 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.071 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -72.83 -48.54 36.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.01 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.447 HD12 ' CD2' ' A' ' 90' ' ' LEU . 8.9 mt -54.74 -45.94 74.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.69 -38.88 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.819 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.405 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 5.7 ttm180 -61.62 -43.99 97.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.051 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -62.02 -41.88 98.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.421 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 12.0 mtm -62.04 -27.66 69.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.2 mtm -75.95 -16.9 59.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.95 154.52 37.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -60.53 -43.25 97.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.12 -32.9 73.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.909 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -86.76 -36.66 18.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 6.9 ptm -78.92 48.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 110.987 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -146.6 -39.57 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.316 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.9 mt -52.3 148.16 12.37 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.497 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.95 121.95 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.258 1.972 . . . . 0.0 112.659 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.404 ' OE1' ' CE1' ' A' ' 83' ' ' TYR . 87.4 mm-40 -87.54 122.59 70.48 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.046 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.48 136.42 63.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.221 1.947 . . . . 0.0 111.864 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.623 ' O ' ' CB ' ' A' ' 164' ' ' GLU . 55.7 Cg_endo -70.09 97.28 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.42 2.08 . . . . 0.0 112.666 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.623 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 8.7 tt0 114.99 155.41 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.714 0.806 . . . . 0.0 110.889 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.04 35.12 4.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.304 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -69.33 158.48 34.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.956 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 35.5 m -75.81 -179.36 4.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.524 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -90.4 131.54 36.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.6 t 60.19 77.59 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.576 0.227 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.39 126.94 11.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.447 2.098 . . . . 0.0 112.308 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.13 93.65 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.586 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 62.05 114.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.92 -15.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.51 104.98 0.05 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.43 -28.24 9.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t 68.16 -70.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -177.51 -61.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.08 178.33 6.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -134.13 174.58 10.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.97 92.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 pt20 -119.22 -3.01 10.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.39 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER 85.44 -25.6 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.643 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.97 108.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.13 91.75 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.7 m -158.57 175.19 13.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.27 138.5 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -128.98 126.49 39.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.87 -68.14 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -147.83 110.05 4.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.1 mt -130.31 177.14 7.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.816 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -148.17 101.02 3.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.45 -168.16 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.525 2.15 . . . . 0.0 112.268 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.09 116.06 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -167.14 -48.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.75 122.83 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.54 -169.15 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -108.77 163.59 13.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -91.22 -65.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.73 132.14 0.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.574 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.42 -23.57 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp 65.24 93.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.949 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -150.59 131.13 7.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.77 159.67 8.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.471 2.114 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -62.97 -37.98 89.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.408 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 4.6 m120 -66.54 -41.92 87.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -60.11 -44.57 94.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.402 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 13.2 mmm-85 -58.57 -43.41 89.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 41.3 mt -61.29 -39.38 90.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.986 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -72.11 -52.66 15.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.265 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -42.19 99.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.919 0.39 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 39' ' ' ARG . 9.3 mm-40 -69.02 -29.4 67.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.491 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 55.7 tp -61.77 -47.24 86.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.981 0.419 . . . . 0.0 110.36 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.27 -41.42 99.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.59 -48.82 78.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -63.93 -50.86 58.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.12 -47.97 81.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -62.55 -26.54 68.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.794 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.41 163.41 24.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.403 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG21 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.74 -177.19 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.12 -68.98 1.35 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.047 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -84.52 -3.91 58.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 51' ' ' VAL . . . 53.21 35.53 50.01 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.373 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 p -71.37 -15.66 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.648 0.261 . . . . 0.0 111.603 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.9 m -154.13 175.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.386 . . . . 0.0 111.115 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -161.38 110.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.538 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CH2' ' CB ' ' A' ' 141' ' ' LYS . 27.6 p90 -98.96 132.12 44.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.692 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.82 175.31 19.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.122 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ASP . 1.1 mt -85.39 14.41 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.217 -0.491 . . . . 0.0 112.03 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 66.97 -68.55 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.081 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 3.2 t0 -101.66 -47.22 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.981 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 14.8 m-20 93.03 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.33 30.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 109.495 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.68 -164.44 0.97 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.307 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mtt -116.03 124.41 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.001 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p 57.88 21.85 8.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 51.28 59.73 4.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -81.47 -57.09 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 135.9 45.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.456 ' CE3' HD12 ' A' ' 140' ' ' ILE . 75.0 m95 -135.31 171.72 14.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 0.0 111.354 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.6 165.71 25.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.346 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.437 ' HA3' HD22 ' A' ' 144' ' ' LEU . . . -157.39 110.41 0.44 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.074 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtp -90.09 153.09 20.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 88' ' ' TYR . 29.8 mt -151.71 139.22 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.1 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD12 HG21 ' A' ' 76' ' ' ILE . 17.5 mt -114.35 149.13 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.29 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.75 138.79 14.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.955 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.29 146.88 25.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 112.12 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 13.2 Cg_endo -56.22 147.62 65.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.833 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 77.35 44.75 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.481 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 76.7 p -161.87 152.94 18.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.428 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -52.71 -37.02 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.572 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.448 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 82.0 m-85 -81.84 -14.04 56.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.042 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -46.85 140.3 4.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.208 0.528 . . . . 0.0 112.191 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m120 45.96 42.2 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.012 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.7 mmt-85 -139.72 86.17 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 88' ' ' TYR . 4.1 mp -47.25 164.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 75' ' ' ILE . 43.5 m-85 -154.34 128.02 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 111.242 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 m -92.87 154.66 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.467 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.1 mp -152.38 160.63 43.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 116.03 12.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.73 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.6 149.01 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.684 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.7 134.83 39.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 110.904 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 98' ' ' TYR . 1.4 p -120.23 -178.33 3.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.175 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.39 -157.71 8.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.51 -25.29 14.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.618 2.212 . . . . 0.0 112.604 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 95.63 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.861 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 2.3 t80 -97.19 -65.11 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.59 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 42.8 Cg_endo -67.44 -1.68 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.655 1.57 . . . . 0.0 112.651 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -109.51 -6.06 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.363 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.03 157.95 33.98 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.69 125.98 20.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.678 2.252 . . . . 0.0 112.074 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.477 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 90.9 Cg_endo -81.55 163.69 18.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.553 2.169 . . . . 0.0 112.708 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -95.22 90.26 5.8 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.554 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.85 138.71 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.246 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -150.2 125.21 9.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.581 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 3.4 m-85 -70.52 153.66 42.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.19 -40.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.28 0.562 . . . . 0.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.5 t -68.31 -176.39 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 50.5 mmtt -87.68 94.62 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.779 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.581 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 1.2 tt -130.68 145.69 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.865 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -126.37 102.32 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.89 157.39 36.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.009 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -54.5 -58.89 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.238 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.405 ' CA ' ' CB ' ' A' ' 127' ' ' ALA . . . -79.77 -16.7 76.8 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.425 ' CG2' HG12 ' A' ' 123' ' ' VAL . 62.8 t -94.92 136.61 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.925 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.91 179.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.8 m -133.09 34.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.986 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -152.57 -47.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.39 -37.25 6.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.125 0.488 . . . . 0.0 110.296 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.31 2.36 41.29 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.011 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 t -58.89 110.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.425 HG12 ' CG2' ' A' ' 116' ' ' VAL . 3.7 t -76.94 112.77 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.408 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -64.19 110.91 4.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.25 -18.53 37.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.496 2.131 . . . . 0.0 112.403 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -47.82 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.7 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' CB ' ' CA ' ' A' ' 115' ' ' GLY . . . -67.91 -42.7 80.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.1 mm -69.01 123.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.5 t -66.06 -55.86 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.457 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 138' ' ' TYR . 8.6 p -49.97 -32.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.479 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.49 -49.51 8.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.769 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.52 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.306 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -134.81 43.87 2.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.912 0.387 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -49.55 148.64 2.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.433 ' HG3' ' CE2' ' A' ' 138' ' ' TYR . 1.5 mt-30 -130.54 -171.93 2.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 37.8 t30 -104.25 58.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -160.52 -27.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.716 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.433 ' CE2' ' HG3' ' A' ' 135' ' ' GLN . 22.6 m-85 -70.78 172.03 9.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.465 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.2 m -156.07 -176.42 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.368 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.456 HD12 ' CE3' ' A' ' 71' ' ' TRP . 33.4 mt -53.87 -44.43 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.247 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 21.8 pttt -58.57 -37.48 75.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.42 HG13 ' CD1' ' A' ' 138' ' ' TYR . 41.3 t -68.36 -39.23 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 109.627 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.1 t -61.82 -53.39 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.835 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.437 HD22 ' HA3' ' A' ' 73' ' ' GLY . 20.9 mt -61.4 -43.78 98.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.64 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.89 -40.21 79.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -53.04 62.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.65 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.441 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 16.2 mt -50.56 -46.21 57.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 110.658 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -62.15 -34.4 76.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.941 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -61.44 -43.04 99.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.958 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 3.6 mt -63.56 -44.75 93.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.448 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 15.1 mtt -58.32 -29.77 66.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.928 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.6 mtm -76.9 -15.95 59.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.3 m -64.94 141.23 58.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 10.8 tptt -51.28 -53.24 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.07 -23.1 65.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.747 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.12 -25.91 23.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.722 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 14.5 ptm -86.64 19.23 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.089 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.86 -30.72 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.282 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.8 mt -54.72 144.23 46.39 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.554 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.38 150.3 68.56 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.238 1.958 . . . . 0.0 112.04 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.428 ' HG3' HG23 ' A' ' 82' ' ' ILE . 25.0 mm-40 -146.49 116.59 4.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 110' ' ' LYS . 80.9 Cg_exo -50.29 129.19 25.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.509 2.139 . . . . 0.0 112.141 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.1 65.04 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.725 2.284 . . . . 0.0 112.812 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER 166.88 143.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.24 38.81 2.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.137 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 28.2 pt20 -69.53 158.57 34.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 51.8 m -77.39 176.27 9.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.41 127.89 38.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -102.96 -45.52 4.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.986 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.719 0.295 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.23 142.46 45.94 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.655 2.237 . . . . 0.0 112.311 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.53 172.17 39.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.33 -175.08 2.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.39 82.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -160.48 105.69 1.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.746 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' GLN . . . 84.04 -41.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.546 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t 65.93 149.43 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -136.89 -178.37 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.27 31.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 118.9 34.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.55 -47.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.81 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.54 -61.21 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m 68.3 -69.01 0.16 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 78.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.04 177.86 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 t -158.81 101.08 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -123.63 118.83 28.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 153.03 35.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.57 -102.71 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 60.66 165.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.63 156.2 47.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.41 143.91 98.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.777 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.49 117.0 4.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.531 2.154 . . . . 0.0 112.384 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -140.73 -174.86 4.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.09 -44.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -69.18 132.82 47.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -141.88 -67.26 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.823 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.5 m -114.93 141.2 48.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -68.11 107.55 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.34 -92.02 0.74 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.666 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t 70.15 -65.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.731 0.3 . . . . 0.0 111.254 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.67 16.02 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.405 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -80.67 131.52 60.66 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.012 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -59.59 155.88 39.93 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.394 2.063 . . . . 0.0 112.046 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? -62.32 -41.95 98.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.237 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.416 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 1.7 t30 -60.57 -32.78 71.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.744 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -55.41 -54.58 41.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 6.0 mmt180 -57.68 -38.73 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.083 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 69.9 mt -61.86 -52.26 64.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.23 -50.49 70.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -61.67 -46.36 90.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.4 mt-10 -70.56 -29.33 65.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.399 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 54.5 tp -62.12 -35.21 78.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.358 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 -34.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.2 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.17 -34.28 70.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.511 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.493 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -85.02 -34.39 15.09 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.41 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -51.98 -43.77 63.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.872 0.368 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -62.47 -29.45 70.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.505 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . 87.77 35.13 9.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.613 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER 40.41 -170.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.13 -83.35 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.734 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.96 -23.84 48.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.73 32.35 59.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.479 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -72.52 -13.31 61.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 m -154.77 171.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.747 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -161.76 111.02 1.53 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 34.7 p90 -103.86 130.08 51.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -142.35 -139.05 3.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.066 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.7 mt -125.17 145.68 49.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -66.01 -31.68 72.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 2.0 t70 -105.95 -54.99 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 4.0 t70 96.48 -1.17 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.31 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -158.02 29.61 0.26 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.12 174.89 8.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.2 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.18 13.74 33.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -155.21 115.67 3.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.751 0.31 . . . . 0.0 110.788 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.24 58.86 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -66.5 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 98.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.791 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.426 ' CE3' HD12 ' A' ' 140' ' ' ILE . 62.0 m95 -88.78 152.09 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 147.39 26.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -140.31 99.53 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.996 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -92.45 149.29 21.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 44.6 mt -150.85 144.99 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 111.607 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 76' ' ' ILE . 18.5 mt -120.11 149.23 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.4 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.14 123.26 7.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.023 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.47 142.28 71.18 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.488 2.125 . . . . 0.0 111.996 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 42.6 Cg_exo -57.07 146.14 82.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.699 2.266 . . . . 0.0 112.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 81.61 42.46 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.825 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 15.7 p -162.52 155.83 20.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.863 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.23 -40.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.937 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 67.2 m-85 -79.43 -18.0 53.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.841 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.6 pt-20 -41.28 143.87 0.39 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.279 0.561 . . . . 0.0 112.474 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.5 t30 45.65 54.35 7.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.822 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 4.8 mmt85 -152.72 107.27 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.492 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 5.1 mp -67.16 165.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.481 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 27.5 m-85 -150.75 130.72 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.983 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.513 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 28.2 t -93.12 148.28 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.141 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.1 mp -152.27 160.02 43.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.046 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.8 mtmt -143.56 117.23 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.6 mp -106.28 127.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.99 117.14 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.7 m -126.3 159.46 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.63 -126.53 0.82 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.02 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.378 2.052 . . . . 0.0 112.401 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 69.46 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.546 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.2 t80 -90.26 -64.5 0.18 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.042 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 72.9 Cg_endo -74.98 3.99 5.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.391 1.394 . . . . 0.0 112.307 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -113.13 -11.02 13.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.757 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.53 146.81 18.0 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.4 110.17 0.57 Allowed 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 122.825 2.35 . . . . 0.0 112.188 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 45.7 Cg_endo -67.89 -176.2 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -94.93 95.37 8.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.42 138.15 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.645 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -150.2 138.31 20.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.192 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 111' ' ' ILE . 14.3 m-85 -83.85 137.98 33.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.879 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.0 t -93.63 -39.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.224 0.535 . . . . 0.0 109.867 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.0 t -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.924 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -94.11 82.8 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.523 HG23 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -112.57 149.09 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.53 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -126.23 102.95 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.9 ttm -124.37 155.39 38.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.953 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -54.54 -52.88 60.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.18 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -86.21 -14.47 66.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.037 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.456 ' CG2' HG11 ' A' ' 123' ' ' VAL . 48.6 t -98.95 132.21 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.15 167.84 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.7 m -123.68 31.05 6.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.2 p -142.69 -47.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -104.69 -37.16 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.131 0.491 . . . . 0.0 110.119 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.32 43.61 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.998 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG11 ' CG2' ' A' ' 116' ' ' VAL . 8.8 t -77.21 111.93 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.685 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.79 125.2 89.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 -15.85 24.62 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.421 2.08 . . . . 0.0 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -72.43 -42.46 65.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.938 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -77.6 -46.73 21.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.038 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.407 HG13 HG12 ' A' ' 123' ' ' VAL . 21.3 mm -62.46 132.29 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.3 p -67.36 -56.0 11.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.408 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.406 ' CG2' ' CG2' ' A' ' 128' ' ' ILE . 3.2 m -49.93 -36.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.618 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.71 -43.71 19.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.652 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.74 62.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -139.08 55.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -49.67 157.87 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 138' ' ' TYR . 9.0 mm100 -131.32 -166.65 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.34 -40.42 9.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 t -79.3 -3.89 48.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.394 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' CE1' ' HG3' ' A' ' 135' ' ' GLN . 5.2 m-30 -72.46 151.8 42.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.845 0.355 . . . . 0.0 111.045 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 p -156.34 -176.5 6.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.426 HD12 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mp -53.12 -29.96 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.28 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.478 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 8.6 pttt -71.04 -40.27 71.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.406 ' N ' ' HG3' ' A' ' 141' ' ' LYS . 66.4 t -68.88 -35.53 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.503 0.668 . . . . 0.0 109.453 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.4 t -67.85 -52.81 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.002 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 22.4 mt -62.72 -47.75 82.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.916 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -60.32 -48.86 79.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.529 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.98 -53.23 60.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.826 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 4.3 pp -60.63 -41.05 94.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.952 0.405 . . . . 0.0 110.301 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.418 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.68 -31.63 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.061 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -59.37 -44.6 92.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 156' ' ' ASN . 1.0 OUTLIER -63.37 -46.81 84.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.228 179.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 11.7 mtp -48.67 -39.11 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttp -77.33 -27.68 52.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.8 147.97 52.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.481 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 1.7 mmmp? -51.16 -25.58 5.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.58 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -54.86 36.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.012 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 150' ' ' LEU . 12.8 m-80 -88.2 -30.96 19.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.481 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 2.7 ptm -72.91 52.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.112 0.482 . . . . 0.0 111.297 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.15 -42.68 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.024 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt -53.79 150.55 13.66 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.595 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.93 126.0 14.55 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.373 2.049 . . . . 0.0 112.43 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.416 ' OE1' ' CE2' ' A' ' 83' ' ' TYR . 35.8 mm-40 -84.38 120.4 74.33 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.224 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -64.65 164.85 22.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.259 1.973 . . . . 0.0 111.896 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.57 89.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.375 2.05 . . . . 0.0 112.019 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.62 151.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 111.05 -67.91 0.22 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.403 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -70.24 132.31 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.5 m -77.3 -167.48 0.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 109' ' ' THR . 1.2 m-85 -86.23 120.56 27.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.783 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -81.83 -59.24 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.864 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.598 0.237 . . . . 0.0 111.497 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 1' ' ' MET . 92.8 Cg_endo -81.34 -40.98 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.556 2.171 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 121.95 -67.85 0.45 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.58 141.94 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.32 59.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 -49.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.59 22.36 6.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.415 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -175.93 133.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 2.2 p90 -128.97 -54.25 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -163.69 148.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.799 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -108.23 102.01 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.6 m -93.09 134.62 35.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.8 -22.96 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 t -105.1 91.47 3.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.18 160.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.58 123.28 11.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.46 170.47 19.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.96 99.56 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -125.35 153.64 43.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.98 -123.55 0.66 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -117.47 41.34 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.84 -54.53 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -110.34 98.36 35.61 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.55 -25.88 61.18 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 147.36 22.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -146.57 -58.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.78 91.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -114.86 120.92 41.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.6 t -155.49 130.92 9.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -119.12 125.89 50.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.77 27.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.56 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.61 107.24 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -86.52 -38.38 17.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -80.22 139.48 52.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.427 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 52.1 Cg_exo -54.43 126.73 23.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.459 2.106 . . . . 0.0 112.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -38.67 84.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -65.77 -36.4 83.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 35' ' ' PRO . 4.0 m-85 -55.32 -53.86 50.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.716 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 8.1 tpp180 -57.51 -42.89 83.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 73.5 mt -59.44 -40.81 88.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.982 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.1 mt -72.22 -52.72 15.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.641 0.258 . . . . 0.0 111.366 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.76 -36.87 82.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 32.4 mt-10 -76.56 -28.91 56.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.0 tp -62.29 -35.08 77.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.137 0.494 . . . . 0.0 110.033 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -41.8 45.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.371 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -38.39 76.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.918 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.66 -58.29 5.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.693 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -58.0 -36.02 72.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -76.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.68 168.21 39.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG12 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.43 -176.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 111.166 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.05 97.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.682 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.61 22.18 12.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.718 0.294 . . . . 0.0 111.274 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.4 46.95 44.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.698 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.676 0.274 . . . . 0.0 111.297 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -154.41 175.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.955 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.91 110.65 1.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.463 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.466 ' CH2' ' CB ' ' A' ' 141' ' ' LYS . 28.6 p90 -100.12 87.45 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -143.49 12.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.767 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.0 mt -120.4 140.65 51.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.775 0.322 . . . . 0.0 111.024 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.88 -56.39 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.59 -114.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.656 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -176.19 20.49 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.659 0.266 . . . . 0.0 111.543 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -157.35 -49.86 0.07 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 42.82 -166.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.772 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.3 mtm -115.04 -34.73 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -154.49 26.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.989 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 53.13 40.82 31.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -51.86 12.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -78.86 95.97 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.713 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 40.8 m95 -89.06 165.36 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -127.08 118.5 24.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.617 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.64 119.12 4.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.662 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mtp -93.73 154.39 17.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 30.4 mt -152.27 138.06 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.846 0.355 . . . . 0.0 111.761 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 76' ' ' ILE . 17.9 mt -116.79 149.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.415 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.83 146.8 18.34 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.11 141.18 11.56 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.827 2.351 . . . . 0.0 112.25 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 58.0 Cg_exo -51.81 141.77 43.99 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.546 2.164 . . . . 0.0 112.798 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER 79.06 41.18 0.09 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.529 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 43.4 p -159.68 152.42 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -47.77 -39.14 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 111.316 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' CE ' ' A' ' 151' ' ' MET . 89.9 m-85 -78.8 -22.61 46.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.909 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -41.52 135.25 2.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 56.22 20.48 4.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.925 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.13 105.45 11.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.797 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' O ' ' CD1' ' A' ' 88' ' ' TYR . 47.1 mt -70.65 165.05 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 35.6 m-85 -150.25 130.22 13.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.02 0.438 . . . . 0.0 111.197 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 30.9 t -93.76 151.29 19.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.4 mp -151.29 160.31 43.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.0 ttmt -139.01 114.51 9.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 4.6 mp -106.42 120.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.355 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -94.25 122.23 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.801 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.72 -169.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.98 -153.42 15.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.01 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.304 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -96.65 74.22 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.587 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.7 t80 -96.71 -52.8 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 2.3 Cg_endo -80.25 3.95 7.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.776 1.651 . . . . 0.0 112.224 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -114.5 -18.57 11.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.14 73.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.88 124.43 16.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.578 2.185 . . . . 0.0 112.325 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 89.0 Cg_endo -77.91 167.83 23.09 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.64 2.227 . . . . 0.0 112.223 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -96.45 89.23 4.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.239 0.543 . . . . 0.0 110.351 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 38.3 t -93.56 141.15 15.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.051 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -150.25 128.84 12.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.091 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.568 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 8.4 m-85 -75.23 123.15 24.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.7 t -75.72 -40.74 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.337 0.589 . . . . 0.0 109.499 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.415 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 7.4 t -69.75 -177.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.864 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 14.0 mttt -97.99 97.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.756 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.568 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -126.55 151.14 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.835 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -126.21 102.77 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.423 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 31.3 ttm -124.42 153.08 42.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -52.53 -26.16 12.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . -123.15 22.49 7.11 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.041 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.406 ' CG2' HG11 ' A' ' 123' ' ' VAL . 57.6 t -136.09 126.54 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.661 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 138.01 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 t -101.89 54.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.2 p -176.79 -39.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -102.81 -34.47 8.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 109.974 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.96 64.75 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.983 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.77 115.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 107' ' ' PHE . 15.0 t -77.51 115.18 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.8 OUTLIER -65.13 113.2 10.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.531 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.21 -12.3 34.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.52 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.23 -49.95 31.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -69.97 -51.71 30.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 31.7 mm -57.81 132.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -60.33 2.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.202 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.414 HG22 ' CG2' ' A' ' 128' ' ' ILE . 10.4 m -49.99 -30.15 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.717 0.294 . . . . 0.0 111.739 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 4.0 mm? -83.85 -47.63 10.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.6 -31.65 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.474 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -135.83 42.46 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -50.55 117.46 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.226 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -99.9 -176.79 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -92.03 56.07 2.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.9 p -159.45 -18.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.446 ' CZ ' ' NE2' ' A' ' 135' ' ' GLN . 19.2 m-85 -71.85 169.84 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.08 0.467 . . . . 0.0 111.416 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.74 -176.38 5.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.475 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.445 HD11 ' CE2' ' A' ' 71' ' ' TRP . 66.8 mt -56.22 -47.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 111.32 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.466 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 11.5 ptpt -60.69 -34.86 74.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.768 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.54 -37.62 77.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.452 0.644 . . . . 0.0 109.392 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 36.6 t -63.58 -52.88 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.843 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 21.1 mt -62.55 -48.75 78.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.698 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -60.36 -46.08 91.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.565 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -61.09 -53.47 56.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.735 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.423 HD23 ' CZ ' ' A' ' 107' ' ' PHE . 3.5 pp -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 73.4 ttt-85 -65.13 -33.42 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.741 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -43.68 90.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.961 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 147' ' ' LEU . 1.1 mt -66.3 -38.19 87.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.106 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.453 ' CE ' ' CE1' ' A' ' 83' ' ' TYR . 8.7 mtt -54.97 -35.57 64.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.729 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 53.2 mtm -75.74 -12.55 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.226 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.85 26.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.6 mtpp -59.13 -44.07 92.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.19 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.38 -33.25 73.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.757 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.81 -39.2 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.534 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -72.44 1.5 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 111.574 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -111.91 -32.42 6.61 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 110.154 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.81 147.19 43.57 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.13 141.13 75.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.383 2.055 . . . . 0.0 111.811 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -146.57 117.66 4.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.59 164.46 4.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.464 2.109 . . . . 0.0 112.249 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.29 134.1 26.1 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.573 2.182 . . . . 0.0 112.255 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -47.04 162.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.307 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 111.08 -55.63 0.49 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.475 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -69.75 158.51 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.3 m -160.74 148.2 15.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.679 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 109' ' ' THR . 23.1 m-85 -57.62 109.14 0.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.912 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 p 62.89 142.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.78 -46.0 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.558 2.172 . . . . 0.0 112.299 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.43 89.36 0.16 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 159.93 41.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.65 156.49 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.59 116.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.95 -71.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.4 p -138.46 17.47 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.214 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.61 -71.89 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 175.8 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.037 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 160.25 12.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.72 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 -74.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -65.86 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t 62.44 49.85 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm 60.8 68.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.6 -34.22 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 p -62.26 154.32 27.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.15 123.08 49.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.0 110.3 6.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.81 62.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 142.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.4 tp -110.78 -67.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.06 148.27 18.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.64 117.2 3.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.307 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -82.89 112.94 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -134.17 33.5 3.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.94 80.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -137.04 84.17 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.04 178.51 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -138.4 98.12 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.33 154.22 25.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.572 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.53 165.97 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -111.05 101.01 9.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.818 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.6 m -150.65 105.2 3.07 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.03 161.71 43.09 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.416 2.077 . . . . 0.0 112.409 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -54.48 -34.47 61.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 34.7 m120 -68.27 -36.97 80.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.27 -57.62 11.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.013 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -57.6 -43.29 84.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.555 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 53.7 mt -62.8 -38.3 90.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 12.8 mt -72.13 -52.72 15.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.24 -43.25 98.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 98.2 mt-10 -68.01 -32.1 72.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 59.1 tp -61.44 -42.64 99.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.311 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.34 -50.78 68.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.799 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.95 -40.45 80.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -69.26 -58.55 6.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.66 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.76 -39.86 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 111.111 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -58.12 -72.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.36 158.02 9.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.576 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.24 -175.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.93 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.36 104.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.471 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.94 20.25 11.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.834 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.81 47.97 30.51 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.805 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.9 p -71.73 -18.04 62.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 111.254 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.7 m -156.85 169.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.735 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -160.93 111.18 1.73 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.571 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.496 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 30.7 p90 -102.21 96.42 6.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -109.83 -144.4 10.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.912 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.1 mt -121.17 131.96 54.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.255 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -66.57 -33.59 76.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -135.77 101.43 4.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 76.0 m-20 -67.95 49.01 0.05 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 63' ' ' ASP . 2.7 mm-40 -157.69 27.03 0.28 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -167.77 1.86 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.286 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -123.08 -67.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.655 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 p -86.46 -8.77 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.317 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.4 72.64 0.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.8 0.333 . . . . 0.0 110.671 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.36 -55.34 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -77.99 97.07 5.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 27.2 m95 -91.79 152.02 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.804 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 1.9 m -102.23 144.95 30.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' LEU . . . -136.06 103.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.73 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtp -92.59 151.66 20.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 30.8 mt -151.82 142.72 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.765 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.23 149.42 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.323 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.29 148.92 17.75 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.004 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HG3' ' HG2' ' A' ' 152' ' ' MET . 92.0 Cg_endo -79.77 132.36 9.69 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.909 2.406 . . . . 0.0 111.975 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 15.8 Cg_endo -56.86 83.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.709 2.273 . . . . 0.0 112.583 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 81' ' ' THR . 5.2 ptt180 161.32 30.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.715 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 74.9 p -162.08 163.65 28.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.93 -37.97 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 97.0 m-85 -79.44 -11.61 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.153 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 5.1 pt-20 -51.71 146.41 7.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 t30 44.62 29.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.611 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 1.6 mmt180 -131.29 99.64 4.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 75' ' ' ILE . 5.0 mp -62.7 166.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.796 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 33.8 m-85 -150.82 130.21 12.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.032 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.503 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 40.5 m -92.97 151.19 20.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.187 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 89' ' ' SER . 4.2 mp -152.41 160.17 43.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.7 OUTLIER -141.15 114.37 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.83 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mp -106.35 120.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.481 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 130.04 40.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.428 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.49 ' CB ' ' CD2' ' A' ' 98' ' ' TYR . 4.0 p -127.88 -179.03 4.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.18 -149.0 5.75 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.077 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.07 -78.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.466 2.11 . . . . 0.0 111.819 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 25.9 mtmt -82.76 77.32 9.52 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.667 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -91.26 -52.37 0.29 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 3.4 Cg_exo -79.31 5.0 6.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.984 1.789 . . . . 0.0 112.516 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -120.2 -8.14 9.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.343 179.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.46 62.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.667 0.27 . . . . 0.0 111.252 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 122.37 11.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.6 Cg_endo -82.29 175.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.721 2.28 . . . . 0.0 112.432 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -97.54 90.19 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.88 138.9 18.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.058 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.19 130.18 13.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.026 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.553 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 10.6 m-85 -76.01 126.7 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.1 t -78.95 -39.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.354 0.597 . . . . 0.0 109.634 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.7 t -69.07 -176.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.067 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 30.1 mttt -99.14 87.52 3.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.553 ' CG2' ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -116.87 153.52 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.95 -178.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -126.35 102.78 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.736 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.427 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 1.9 tpp -123.98 156.48 36.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.227 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -53.61 -43.37 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.164 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.05 28.41 11.17 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.944 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.404 ' CG2' HG13 ' A' ' 123' ' ' VAL . 76.9 t -135.4 130.17 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.824 0.345 . . . . 0.0 110.689 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.55 158.26 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -118.67 26.71 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.48 -51.42 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.5 -34.13 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.007 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.65 0.63 34.59 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.919 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.86 113.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.404 HG13 ' CG2' ' A' ' 116' ' ' VAL . 13.1 t -76.67 115.17 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.471 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 110.14 3.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.918 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.38 -15.76 47.22 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.446 2.097 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -46.72 58.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -70.5 -42.65 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.699 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.03 103.78 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -53.96 -55.64 25.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 138' ' ' TYR . 7.2 p -49.97 -31.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.15 -48.69 9.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.825 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.11 69.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.09 34.44 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.404 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 54.8 t-105 -49.37 132.22 20.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -121.26 -178.34 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -86.11 61.06 6.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.9 m -160.85 -28.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.433 ' CD1' HG13 ' A' ' 142' ' ' VAL . 19.3 m-85 -70.96 168.16 17.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.425 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.09 -176.43 5.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.246 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.436 ' CG1' ' OH ' ' A' ' 98' ' ' TYR . 10.7 mt -55.94 -51.34 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.282 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 ptpt -53.16 -35.06 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 138' ' ' TYR . 40.9 t -69.04 -41.19 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.47 0.652 . . . . 0.0 109.547 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.61 -53.13 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.342 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 28.5 mt -63.09 -48.54 78.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.741 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.86 -46.53 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -60.0 -53.16 61.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.568 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 148' ' ' ARG . 4.4 pp -62.0 -38.39 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 5.7 ttt-85 -69.59 -30.71 68.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.803 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -43.68 90.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.837 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.33 -42.43 92.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.848 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.445 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 21.3 mtt -50.97 -35.26 32.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.81 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' MET . . . . . 0.413 ' HG2' ' HG3' ' A' ' 78' ' ' PRO . 69.8 mtm -74.44 -22.21 59.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.94 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.6 m -65.79 158.3 28.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 28.7 mttp -65.19 -32.19 73.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -46.94 85.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.128 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -87.15 -21.76 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.471 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -82.56 13.64 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -116.52 -30.38 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.194 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.7 mt -55.41 148.85 30.93 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.829 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.63 149.57 89.61 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.156 . . . . 0.0 112.047 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.413 ' HG3' HG21 ' A' ' 82' ' ' ILE . 20.0 mm-40 -146.31 133.71 10.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' A' ' 164' ' ' GLU . 37.0 Cg_endo -65.85 126.31 15.73 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.94 75.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.365 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.1 OUTLIER 166.96 -168.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.67 21.96 3.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.656 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.63 158.56 35.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 111.171 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.6 p -80.3 -170.69 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.977 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 110' ' ' LYS . 10.7 m-85 -91.24 83.15 5.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.4 m -101.55 125.54 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.54 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 111.747 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 14.8 m-80 -52.53 -35.63 53.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.491 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -55.37 -53.54 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.288 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 22.4 tpp180 -57.53 -40.16 78.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.42 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 78.8 mt -60.67 -51.46 69.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 64.3 mt -62.05 -52.75 62.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.447 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.43 -43.13 99.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 80.6 mm-40 -72.41 -28.47 63.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.706 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 44.7 tp -61.35 -42.49 98.79 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.53 -49.26 56.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.791 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.27 78.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.216 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -71.27 -51.31 18.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.649 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.18 -44.28 92.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -58.4 -56.21 25.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.19 170.01 15.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.677 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -138.95 -177.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 111.076 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.61 108.95 1.36 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.663 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 16.08 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.578 0.228 . . . . 0.0 111.272 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.42 50.72 17.39 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.981 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -70.52 -23.34 62.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 75' ' ' ILE . 22.7 m -155.01 173.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.556 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -160.86 112.0 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.977 0.418 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.485 ' HH2' HG11 ' A' ' 51' ' ' VAL . 25.2 p90 -101.14 81.66 2.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.84 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.77 179.01 35.39 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.995 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.843 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -90.38 144.58 25.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.843 HD23 HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.0 m -97.72 -66.8 0.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.38 93.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.588 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 81.6 m95 -90.87 169.27 11.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.056 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -135.22 124.69 24.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.616 ' CA ' HD11 ' A' ' 144' ' ' LEU . . . -120.64 115.95 3.07 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.804 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -91.1 157.17 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 147' ' ' LEU . 25.6 mt -152.86 141.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.819 0.342 . . . . 0.0 111.748 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.47 149.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.731 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -79.43 139.57 21.83 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.865 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 72.0 Cg_endo -87.69 127.42 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.973 2.449 . . . . 0.0 112.109 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 81.7 Cg_exo -47.52 139.9 16.98 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.552 2.168 . . . . 0.0 112.99 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 79.7 40.47 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 31.0 p -159.09 151.75 21.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.78 -39.63 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 151' ' ' MET . 49.8 m-85 -80.27 -21.57 42.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.114 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.2 pt-20 -38.36 138.01 0.51 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 55.03 45.94 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.711 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -143.69 112.76 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.4 mp -70.45 160.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.425 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' N ' HG22 ' A' ' 87' ' ' ILE . 15.3 m-85 -151.9 126.76 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.41 . . . . 0.0 111.208 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.2 t -94.94 151.83 18.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -150.96 160.37 43.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.14 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.63 114.81 10.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.744 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.36 120.75 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.214 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -93.95 120.54 34.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -128.63 105.19 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.53 -110.64 2.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.387 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.1 118.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.153 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 4.8 mtpp 61.81 87.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -105.27 -66.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.896 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 55.4 Cg_endo -69.63 2.91 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.439 1.426 . . . . 0.0 112.952 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 16.4 pt-20 -112.06 -9.34 13.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.663 0.268 . . . . 0.0 111.041 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' HD2' ' A' ' 102' ' ' PRO . . . -151.62 164.56 19.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 45.7 Cg_exo -57.01 123.29 13.49 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.694 2.263 . . . . 0.0 112.382 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . 93.2 Cg_endo -80.07 167.81 19.52 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.726 2.284 . . . . 0.0 112.317 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.19 89.11 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 92' ' ' ILE . 40.5 t -94.24 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.126 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 129.71 12.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.953 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.5 m-85 -75.2 130.93 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.31 -45.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.301 0.572 . . . . 0.0 109.647 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 9.9 t -69.0 -179.38 1.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.689 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 8.5 mmtt -88.95 105.23 17.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.934 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -132.25 153.15 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.771 -178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 111' ' ' ILE . 4.3 m-20 -125.98 102.6 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.565 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.665 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 18.4 ttm -124.3 144.71 49.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.17 -32.71 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.288 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.691 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -101.78 -10.65 39.87 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.09 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.856 HG22 HG13 ' A' ' 123' ' ' VAL . 46.1 t -111.75 126.36 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.399 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.18 165.64 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -111.77 30.25 7.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.66 -58.16 1.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.808 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 122' ' ' VAL . 2.5 m-20 -104.9 -34.16 8.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.08 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.3 32.14 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.7 t -58.89 110.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.856 HG13 HG22 ' A' ' 116' ' ' VAL . 2.8 t -76.81 104.74 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.356 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.83 123.34 83.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.704 ' HB3' HD23 ' A' ' 131' ' ' LEU . 57.6 Cg_endo -70.92 -13.15 31.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.386 2.057 . . . . 0.0 112.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -72.31 -35.11 68.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.795 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.691 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -85.4 -46.56 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 131' ' ' LEU . 22.8 mm -65.9 129.91 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.74 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 88.5 p -67.48 -59.16 3.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.595 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG13 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m -49.79 -30.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.864 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -83.18 -43.66 15.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.731 0.3 . . . . 0.0 110.644 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.84 -54.86 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -105.92 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -48.5 139.86 8.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' A' ' 138' ' ' TYR . 4.3 pt20 -127.37 -170.71 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -86.39 -25.58 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -12.17 59.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 135' ' ' GLN . 12.3 m-30 -73.92 155.43 38.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.43 . . . . 0.0 111.302 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.2 p -155.9 -176.4 5.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.4 mt -57.95 -44.45 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . 1.3 pttt -61.03 -34.88 75.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.657 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.3 t -68.34 -40.62 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.477 0.656 . . . . 0.0 109.446 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 105' ' ' VAL . 37.4 t -61.22 -53.03 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.966 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.616 HD11 ' CA ' ' A' ' 73' ' ' GLY . 25.0 mt -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.967 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.14 -42.57 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.028 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 130' ' ' VAL . 3.0 tp10 -68.99 -53.09 22.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 148' ' ' ARG . 3.5 pp -57.17 -42.63 81.49 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.945 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.801 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -67.03 -33.3 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 0.0 110.078 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -59.16 -41.8 89.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.054 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.5 mt -66.7 -38.15 86.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.912 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.7 mtp -58.25 -30.56 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' MET . . . . . 0.413 ' CE ' ' CZ ' ' A' ' 148' ' ' ARG . 2.4 mtt -76.84 -26.3 54.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.677 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.1 m -65.42 162.66 17.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 12.1 ttmm -63.58 -27.78 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.85 -53.73 51.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.923 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.414 ' CB ' ' HA ' ' A' ' 151' ' ' MET . 51.4 m-20 -91.4 -22.96 20.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.464 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -80.72 19.64 0.82 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 5.1 mmpt? -118.34 -31.87 4.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.85 0.357 . . . . 0.0 110.33 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.47 150.54 23.83 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.66 125.9 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.282 1.988 . . . . 0.0 112.458 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -83.71 154.86 65.27 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.798 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.402 ' HG3' ' HB2' ' A' ' 110' ' ' LYS . 58.4 Cg_endo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 122.473 2.115 . . . . 0.0 112.21 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 14.7 pt20 . . . . . 0 N--CA 1.459 -0.02 0 CA-C-O 120.725 0.297 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 18.6 m -76.9 -168.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.914 0.388 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -60.94 -35.0 75.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.54 -54.02 49.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.2 mmt180 -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.477 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.1 mt -61.29 -39.43 90.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.6 mt -72.11 -52.82 14.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.37 -42.08 98.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 6.9 mm-40 -69.62 -29.6 67.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.491 HD13 ' HG ' ' A' ' 60' ' ' LEU . 31.7 tp -63.35 -45.18 92.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.893 0.378 . . . . 0.0 110.667 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.69 -43.31 89.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.018 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -52.81 63.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.26 -31.61 81.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.625 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.16 -41.82 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.031 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.878 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.57 173.58 43.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.576 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -154.49 -177.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 111.231 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.02 103.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.625 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.36 19.29 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.602 0.239 . . . . 0.0 111.307 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.35 43.98 35.08 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.779 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -70.18 -19.51 63.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 75' ' ' ILE . 30.1 m -155.03 172.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 111.46 1.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.742 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.478 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 31.9 p90 -102.9 97.02 7.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.686 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.13 21.55 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.108 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.957 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -105.64 143.69 33.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.788 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.957 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -82.95 -44.01 15.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.447 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 60' ' ' LEU . 69.6 mtt-85 -77.45 139.84 39.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.303 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.474 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 71.2 m95 -135.31 144.37 46.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -102.1 120.48 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.8 108.88 2.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.675 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -95.15 150.92 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.805 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.1 mt -152.25 138.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.917 0.389 . . . . 0.0 111.743 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.31 149.28 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.169 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -91.64 120.34 6.0 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.114 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.24 141.15 95.24 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.547 2.165 . . . . 0.0 111.925 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 21.1 Cg_endo -60.37 145.81 97.91 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.877 2.385 . . . . 0.0 113.278 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 80.53 43.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.818 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 80' ' ' ARG . 4.4 p -162.75 158.72 23.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.06 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.402 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -52.53 -40.2 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.0 110.95 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 30.1 m-85 -79.69 -18.69 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.913 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.8 pt-20 -40.74 148.27 0.1 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 41.4 57.08 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.298 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.5 mmt85 -155.86 111.38 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.2 mp -66.55 165.07 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 87' ' ' ILE . 13.4 m-85 -149.43 133.31 17.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.083 0.468 . . . . 0.0 111.439 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.489 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 68.0 m -94.96 148.0 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.3 mp -151.3 160.07 43.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 14.8 mtpp -142.22 113.26 7.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 110.25 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.32 148.92 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.268 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 69' ' ' THR . 12.5 mt-10 -131.53 130.59 42.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.332 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.74 -169.16 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.59 -133.2 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.427 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 113.12 2.26 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.452 2.101 . . . . 0.0 112.146 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 60.05 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.646 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.3 t80 -83.23 -63.71 0.25 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.371 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 58.7 Cg_endo -70.91 1.83 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.666 1.578 . . . . 0.0 112.688 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -111.62 -13.77 13.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.674 0.273 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.83 61.07 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 111.312 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.49 122.43 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.614 2.209 . . . . 0.0 112.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -82.37 175.24 9.16 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.744 2.296 . . . . 0.0 112.739 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 106' ' ' ARG . 17.3 t80 -94.84 121.41 36.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.802 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 92' ' ' ILE . 38.9 t -135.04 138.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.239 0.543 . . . . 0.0 111.596 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -150.28 128.72 12.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.49 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.933 ' CE2' HD21 ' A' ' 90' ' ' LEU . 11.7 m-85 -71.55 131.93 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.97 -39.35 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.23 0.538 . . . . 0.0 109.634 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.514 HG21 ' CD2' ' A' ' 88' ' ' TYR . 5.0 t -68.59 -173.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.692 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 3.0 mmtt -99.51 69.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.439 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.746 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 153.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.8 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.11 101.91 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpp -124.89 153.52 42.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -54.89 -44.06 73.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.328 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.652 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -99.13 -6.54 55.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.277 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 123' ' ' VAL . 47.2 t -108.78 131.75 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.1 165.21 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m -113.05 -12.57 13.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 t -109.33 -33.3 6.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.32 . . . . 0.0 111.001 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -104.43 -39.61 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.03 0.443 . . . . 0.0 110.427 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.55 -1.58 69.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.053 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.9 t -58.84 112.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 116' ' ' VAL . 10.9 t -77.47 109.73 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.633 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.58 110.31 3.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.98 -19.24 62.0 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.547 2.164 . . . . 0.0 112.432 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -49.77 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.976 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.652 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -68.59 -40.93 80.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.573 ' CG2' HG12 ' A' ' 130' ' ' VAL . 29.6 mm -67.71 129.22 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -67.56 -54.56 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.636 ' CG2' HG12 ' A' ' 142' ' ' VAL . 6.7 p -50.08 -36.61 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.496 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -83.03 -44.5 15.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.8 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.88 45.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.66 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -48.83 136.89 13.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.368 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.68 -170.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.04 -36.85 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -0.53 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.552 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 142' ' ' VAL . 4.3 m-30 -72.56 154.49 40.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 111.099 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.0 p -156.07 -176.27 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 44.1 mt -54.7 -37.86 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 20.2 ttpp -61.44 -39.74 91.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.202 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.636 HG12 ' CG2' ' A' ' 130' ' ' VAL . 46.9 t -68.52 -33.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.932 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 105' ' ' VAL . 24.7 t -69.16 -53.43 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.674 HD22 HD11 ' A' ' 75' ' ' ILE . 26.8 mt -64.77 -48.32 74.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.066 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -59.45 -49.73 76.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.758 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 4.2 tp10 -60.15 -53.06 62.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.5 pp -58.33 -41.59 84.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.87 ' N ' HD12 ' A' ' 147' ' ' LEU . 8.4 tmm_? -62.61 -34.07 76.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.28 86.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.826 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.0 mt -60.83 -48.1 83.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.871 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 30.0 mtt -51.58 -35.74 42.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.776 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.6 ttm -74.04 -14.59 61.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.71 164.44 14.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.0 tttt -65.32 -48.85 71.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.25 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.06 -31.17 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.025 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.07 -25.16 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 24.4 ptm -88.1 42.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.815 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -141.19 -35.15 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.3 mt -52.88 151.11 8.88 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.317 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.77 122.58 8.98 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.144 1.896 . . . . 0.0 112.73 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HG2' HG12 ' A' ' 82' ' ' ILE . 17.2 mm-40 -86.91 152.86 54.27 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.9 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.343 0.285 0 C-N-CA 122.462 2.108 . . . . 0.0 111.972 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.655 0.264 . . . . 0.0 111.025 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.0 m -79.7 175.82 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.647 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 109' ' ' THR . 14.9 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -53.41 -36.91 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -52.56 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -58.19 -39.08 78.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.68 HD22 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -63.56 -53.88 44.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.765 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.5 mt -58.94 -51.48 69.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 0.0 111.226 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.75 -49.79 73.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.15 -28.61 68.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.6 tp -62.31 -42.55 99.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -30.47 65.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -74.21 -64.77 2.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.64 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.62 -44.06 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -59.35 -25.92 64.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.92 161.82 26.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.68 -178.0 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.972 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.09 -63.63 5.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.818 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.58 -6.52 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.85 31.98 32.68 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.443 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 p -72.52 -17.01 61.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 144' ' ' LEU . 35.5 m -152.14 175.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.945 0.403 . . . . 0.0 111.161 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.05 110.78 1.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.335 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 28.5 p90 -100.0 105.36 17.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.59 148.47 18.07 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.9 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.0 HD11 HD23 ' A' ' 68' ' ' LEU . 1.7 mt -54.66 130.22 39.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.956 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.148 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.8 m -80.8 -27.47 36.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.754 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -99.64 147.79 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 111.168 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.576 ' CE2' HD11 ' A' ' 140' ' ' ILE . 70.4 m95 -134.84 160.99 36.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -130.4 118.09 20.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.36 118.41 4.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.244 -0.979 . . . . 0.0 114.178 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -92.9 150.3 20.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 90' ' ' LEU . 47.5 mt -150.02 138.0 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 111.759 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -95.34 148.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.45 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -73.21 116.01 5.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 8.4 Cg_endo -50.68 128.33 23.64 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.463 2.108 . . . . 0.0 111.873 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 33.0 Cg_exo -61.16 172.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.376 2.051 . . . . 0.0 112.598 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 3.9 mpp_? 44.42 41.78 4.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.737 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' MET . 0.6 OUTLIER -162.14 161.66 28.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.688 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.4 OUTLIER -43.91 -29.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.02 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' C ' ' A' ' 84' ' ' GLU . 68.2 m-85 -80.03 -21.01 44.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -23.9 124.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 t30 49.21 69.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.904 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.1 mmt180 -154.24 106.26 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 88' ' ' TYR . 50.3 mt -69.69 165.37 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.908 ' CE2' HD12 ' A' ' 111' ' ' ILE . 29.9 m-85 -153.2 128.19 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.033 0.444 . . . . 0.0 111.441 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.543 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 33.3 t -94.01 149.29 21.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -151.56 160.63 43.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 0.0 111.323 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 108' ' ' VAL . 26.2 mttt -136.21 115.34 12.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.3 mp -107.05 126.47 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.348 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 51.3 mt-10 -95.38 126.13 40.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.87 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 p -114.29 -178.32 3.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.98 -164.16 13.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.4 -40.58 62.14 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.661 2.241 . . . . 0.0 112.457 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 73.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.462 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 1.3 t80 -76.52 -58.48 1.15 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.432 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 59.6 Cg_endo -71.09 0.42 6.65 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.882 1.722 . . . . 0.0 112.836 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -120.09 9.72 11.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.448 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.64 20.61 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 111.551 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.0 119.78 7.27 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 0.0 112.361 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 50.9 Cg_endo -84.07 164.26 13.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.869 2.379 . . . . 0.0 112.531 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 28.7 t80 -97.94 98.58 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.491 . . . . 0.0 110.28 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.8 t -95.12 138.51 20.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.024 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.89 120.46 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 1.087 ' CD2' HG21 ' A' ' 111' ' ' ILE . 4.1 m-85 -65.87 155.53 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.743 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.487 HG21 ' HE3' ' A' ' 91' ' ' LYS . 25.0 t -110.04 -51.47 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.105 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 88' ' ' TYR . 6.7 t -67.35 -175.81 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.942 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 11.1 mmtm -88.57 110.76 21.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.087 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.4 tt -138.79 150.35 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.715 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.463 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.46 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.8 tpp -124.56 152.9 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -34.97 62.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -118.2 25.12 8.42 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.126 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.967 HG22 HG13 ' A' ' 123' ' ' VAL . 48.5 t -130.83 126.0 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.797 0.332 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.89 151.69 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 p -112.78 28.37 8.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -131.08 -55.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -105.25 -34.31 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.18 1.0 33.52 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.956 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.95 111.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.967 HG13 HG22 ' A' ' 116' ' ' VAL . 5.2 t -77.34 117.69 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.682 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.86 112.92 9.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.519 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HB3' HD23 ' A' ' 131' ' ' LEU . 36.4 Cg_endo -65.43 -17.23 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.311 2.007 . . . . 0.0 112.333 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -37.92 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.756 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.602 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -80.76 -38.29 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.509 ' CG2' HG12 ' A' ' 130' ' ' VAL . 48.8 mm -76.41 121.75 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.8 p -67.23 -55.2 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.372 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.651 HG23 ' CD2' ' A' ' 138' ' ' TYR . 14.8 p -49.97 -32.45 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 125' ' ' PRO . 1.4 mp -83.57 -50.51 8.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.71 32.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.16 52.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' HD3' ' A' ' 103' ' ' PRO . 63.2 t-105 -49.92 140.11 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 2.1 mm100 -117.67 -172.22 2.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.75 -32.81 15.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 m -78.97 -12.22 60.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.651 ' CD2' HG23 ' A' ' 130' ' ' VAL . 10.9 m-30 -72.75 152.17 41.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 111.032 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -155.98 -176.36 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.576 HD11 ' CE2' ' A' ' 71' ' ' TRP . 50.1 mt -53.96 -40.08 43.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 2.0 ptpt -60.59 -39.75 89.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 138' ' ' TYR . 34.7 t -69.27 -38.39 77.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.922 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 20.7 t -62.53 -53.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.055 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 75' ' ' ILE . 22.7 mt -63.86 -43.7 95.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.535 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -57.66 -39.95 78.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -51.49 69.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.579 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.972 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 11.6 mt -49.5 -46.07 47.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.961 0.41 . . . . 0.0 110.588 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.4 77.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.746 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -61.13 -42.76 99.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -64.64 -48.21 75.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 35.7 mtt -54.56 -27.62 40.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 25.7 mtm -76.27 -19.95 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.3 t -65.07 157.32 28.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -65.15 -46.14 82.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.35 -28.77 69.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -87.77 -27.71 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.528 ' CB ' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -88.94 22.92 2.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -124.31 -33.46 3.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.65 145.07 41.93 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.8 125.02 13.54 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.26 1.973 . . . . 0.0 112.215 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HG2' HG12 ' A' ' 82' ' ' ILE . 30.2 mm-40 -84.07 124.67 74.11 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 122.175 1.917 . . . . 0.0 111.999 179.837 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.513 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.2 pt20 . . . . . 0 CA--C 1.524 -0.053 0 CA-C-O 120.949 0.404 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.4 p -78.15 145.31 35.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.148 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 2.9 m-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.738 0.304 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.6 p30 -66.09 -29.01 69.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -50.24 70.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.196 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.6 mmt85 -66.41 -36.74 83.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 43.4 mt -60.01 -41.18 91.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.2 mt -72.13 -52.73 15.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.537 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -41.34 98.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 74.4 mm-40 -70.51 -29.3 65.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.75 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 51.1 tp -61.89 -46.82 87.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.258 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.52 -49.65 74.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.876 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.93 -29.72 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -78.45 -44.14 11.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.724 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -76.8 -43.75 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.671 0.272 . . . . 0.0 111.097 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -52.86 -28.12 21.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.99 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.91 179.08 18.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -141.11 -177.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.83 -86.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.608 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.59 -16.42 61.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.569 0.224 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.845 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 71.35 31.43 65.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.2 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 56' ' ' VAL . 30.4 p -73.0 -9.52 58.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 75' ' ' ILE . 20.4 m -156.19 165.22 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.998 0.428 . . . . 0.0 111.172 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -162.0 111.04 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.406 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 27.2 p90 -101.57 130.82 47.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.36 -160.16 8.66 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.576 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 68' ' ' LEU . 5.7 mt -116.54 127.67 54.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.821 0.343 . . . . 0.0 110.951 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -179.78 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.713 ' HB3' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.904 0.383 . . . . 0.0 110.661 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 -63.66 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -72.24 98.31 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.702 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 50.9 m95 -90.2 158.52 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.78 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.57 148.58 25.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -141.62 102.13 0.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.761 -1.209 . . . . 0.0 113.754 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtp -93.96 146.15 24.13 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.827 HD13 HD11 ' A' ' 147' ' ' LEU . 52.7 mt -150.74 126.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.771 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -102.74 149.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.126 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -90.49 140.81 15.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.952 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.4 Cg_endo -83.97 136.38 6.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.792 2.328 . . . . 0.0 112.093 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 77.0 Cg_exo -48.65 144.49 14.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.641 2.228 . . . . 0.0 113.127 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 75.45 43.72 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.795 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 49.8 p -161.16 147.01 14.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.378 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.61 -36.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.052 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 49.1 m-85 -80.91 -22.36 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.963 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -39.41 148.41 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 84' ' ' GLU . 26.0 p30 41.08 47.8 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.418 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.4 mmt85 -148.39 109.86 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.692 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 88' ' ' TYR . 43.1 mt -68.52 166.15 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.57 ' N ' HG22 ' A' ' 87' ' ' ILE . 28.0 m-85 -150.25 132.33 15.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 46.8 t -93.46 147.4 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.58 160.15 43.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.102 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 4.1 mtpp -143.44 115.56 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.43 120.68 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 103' ' ' PRO . 51.0 mt-10 -94.17 124.05 37.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.1 p -113.02 -169.5 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.27 -136.97 5.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.556 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.69 130.49 26.47 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.594 2.196 . . . . 0.0 112.124 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.48 59.61 3.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.9 t80 -84.63 -55.51 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.635 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.0 Cg_endo -78.13 5.6 5.27 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.961 1.774 . . . . 0.0 112.568 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -123.74 -4.48 8.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.23 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.32 18.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.986 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' HB3' HD23 ' A' ' 131' ' ' LEU . 6.0 Cg_exo -77.26 110.97 3.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.723 2.282 . . . . 0.0 112.009 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 97.8 Cg_endo -76.78 -99.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.358 2.038 . . . . 0.0 112.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -149.9 131.45 14.84 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.731 0.3 . . . . 0.0 111.49 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 92' ' ' ILE . 44.2 t -135.54 139.51 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.332 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.3 ptt180 -150.25 141.66 23.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.955 ' CE2' HD21 ' A' ' 90' ' ' LEU . 22.8 m-85 -83.97 139.92 32.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.837 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 167' ' ' CYS . 19.1 t -93.66 -40.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.443 HG21 ' CD2' ' A' ' 88' ' ' TYR . 4.9 t -68.52 -173.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.879 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 5.4 mmtt -97.23 76.77 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 110.166 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.927 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -103.76 149.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.476 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -126.09 102.32 7.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.743 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.428 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -124.74 150.37 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -26.73 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.705 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -116.8 16.24 13.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.09 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HG13 ' A' ' 123' ' ' VAL . 76.6 t -137.61 122.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.71 165.84 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 96.4 p -117.01 21.75 13.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -51.5 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 110.586 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.536 ' CG ' HG23 ' A' ' 122' ' ' VAL . 11.6 p30 -103.11 -32.17 9.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.937 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 94.29 5.92 61.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.049 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.536 HG23 ' CG ' ' A' ' 120' ' ' ASN . 39.7 t -58.84 112.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 116' ' ' VAL . 11.9 t -78.16 106.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' GLY . 8.6 t0 -65.86 116.56 33.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HB3' HD22 ' A' ' 131' ' ' LEU . 41.1 Cg_endo -66.74 -14.89 45.65 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.403 2.069 . . . . 0.0 112.388 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -72.39 -36.11 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.782 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.705 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -84.91 -36.54 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 19.9 mm -74.42 128.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 t -67.77 -54.74 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.736 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.587 HG12 HG22 ' A' ' 128' ' ' ILE . 12.6 p -49.9 -33.01 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -85.25 -45.59 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.86 55.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -135.53 42.59 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CE3' HG22 ' A' ' 130' ' ' VAL . 73.3 t-105 -49.42 125.2 10.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 2.9 tt0 -81.93 175.83 10.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -96.45 31.45 2.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.08 9.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.812 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 135' ' ' GLN . 10.2 m-30 -75.09 177.56 6.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.734 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -156.85 -176.56 6.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.776 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 62.4 mt -57.91 -37.03 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 24.7 ttpt -62.83 -37.03 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.551 HG12 HG21 ' A' ' 130' ' ' VAL . 42.7 t -68.83 -34.8 66.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.005 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.43 -53.24 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 75' ' ' ILE . 24.5 mt -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.998 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.31 -44.82 95.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 2.6 tp10 -61.95 -53.3 57.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.867 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.3 pp -60.61 -37.97 83.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.399 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 ttp-105 -64.44 -36.2 83.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 109.932 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 45.1 mtt-85 -59.04 -40.5 85.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.701 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 147' ' ' LEU . 5.9 mt -62.13 -41.14 97.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.778 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.76 ' HE3' HD13 ' A' ' 147' ' ' LEU . 60.7 mtt -55.9 -34.98 66.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.469 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' MET . . . . . 0.426 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 10.8 mtm -75.57 -14.21 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 154.22 38.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 3.0 mttt -62.24 -50.79 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -35.41 76.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.396 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -86.78 -20.74 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.813 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -92.7 24.45 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 111.227 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -117.75 -32.02 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.501 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.3 mt -54.72 138.52 62.2 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.471 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.36 121.54 8.51 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.224 1.95 . . . . 0.0 112.729 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -87.67 113.68 55.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.133 1.889 . . . . 0.0 112.055 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 9.2 pt20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.625 ' HB2' HG12 ' A' ' 108' ' ' VAL . 31.9 p -76.39 -170.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.606 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 6.3 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.978 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -67.74 -35.38 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.92 26.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 tpp180 -57.61 -41.68 81.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.468 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 68' ' ' LEU . 22.5 mt -62.71 -36.07 81.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 mt -72.03 -52.68 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.02 -47.44 77.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 73.1 mm-40 -63.33 -32.88 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.025 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 57.8 tp -63.01 -45.46 92.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.13 -47.57 85.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -32.67 67.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.442 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -84.03 -40.64 8.54 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.688 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -69.52 -47.98 62.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.999 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -61.65 -28.6 69.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.717 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.4 174.62 15.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.593 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -127.48 138.58 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.082 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.61 -70.6 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.535 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.53 11.27 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 51' ' ' VAL . . . -75.32 110.1 2.96 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.631 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -72.66 -17.42 61.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 75' ' ' ILE . 33.1 m -93.72 176.45 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.459 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.36 112.79 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.344 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.505 ' CZ3' HG23 ' A' ' 56' ' ' VAL . 32.7 p90 -105.47 102.27 11.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.72 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.63 147.82 16.88 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.0 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.608 HD11 HD23 ' A' ' 68' ' ' LEU . 4.6 mt -55.18 155.51 4.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 94' ' ' CYS . 6.9 m -93.88 -60.72 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -69.99 91.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.634 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 88.2 m95 -89.11 160.29 17.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.713 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.65 123.39 22.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.691 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 144' ' ' LEU . . . -113.17 171.06 13.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.789 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.4 mtp -142.58 151.15 41.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.211 -0.495 . . . . 0.0 109.815 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.666 HG12 HG12 ' A' ' 56' ' ' VAL . 48.2 mt -150.27 120.91 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 111.847 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -93.37 149.1 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.253 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -88.67 143.13 17.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.65 130.36 3.75 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.984 2.456 . . . . 0.0 112.097 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 74.3 Cg_exo -48.47 141.05 20.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 113.039 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER 80.46 40.67 0.07 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 51.7 p -160.64 150.28 17.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.743 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.81 -37.53 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 111.157 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 25.3 m-85 -79.85 -22.85 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.841 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -38.52 145.65 0.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 43.18 54.72 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.123 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 64.8 mmt-85 -154.18 107.21 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.734 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 87' ' ' ILE . 3.9 mp -66.2 167.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 20.7 m-85 -150.26 128.3 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 0.0 111.018 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 17.0 t -90.05 149.7 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.332 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -152.52 160.34 43.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.035 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.0 OUTLIER -142.9 116.65 9.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 92' ' ' ILE . 5.0 mp -106.6 124.11 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.441 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.98 105.77 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' THR . 81.6 m -105.5 120.97 42.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -122.59 -145.29 6.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.524 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.89 116.55 2.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 62.32 76.71 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.598 ' CD2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.66 -62.72 0.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 47.8 Cg_endo -68.53 -1.64 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.651 1.567 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -114.67 8.88 16.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.036 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.48 143.38 3.42 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.317 . . . . 0.0 111.289 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.32 118.37 5.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.763 2.309 . . . . 0.0 112.239 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 91.5 Cg_endo -80.8 -179.61 5.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 61.3 t80 -97.04 100.09 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 92' ' ' ILE . 25.6 t -94.51 137.78 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HA ' HG23 ' A' ' 123' ' ' VAL . 2.7 ptm180 -150.28 118.58 6.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.909 ' CD2' HG21 ' A' ' 111' ' ' ILE . 15.8 m-85 -62.31 149.27 42.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.507 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.59 -42.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.144 0.497 . . . . 0.0 110.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.5 t -68.62 -176.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.009 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -92.79 76.52 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.909 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -104.99 150.1 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.868 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -125.99 102.68 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 10.5 ttm -124.45 153.97 41.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.235 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -38.22 66.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -110.74 23.96 18.32 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.925 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 123' ' ' VAL . 58.7 t -132.72 128.33 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.683 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.67 157.38 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -116.88 28.47 8.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.5 t -135.05 -52.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -105.35 -33.07 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.083 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.13 0.82 44.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.988 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.558 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 54.8 t -58.91 110.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 116' ' ' VAL . 19.5 t -77.06 115.11 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.685 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.19 115.06 17.98 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.15 -12.15 34.93 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.305 2.004 . . . . 0.0 112.605 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -33.71 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.639 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -89.02 -33.86 17.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 130' ' ' VAL . 38.0 mm -73.99 122.15 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -67.49 -54.55 19.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.364 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.659 HG23 ' CE2' ' A' ' 138' ' ' TYR . 11.4 p -49.94 -32.39 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.532 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.94 -51.76 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.28 -34.21 60.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -123.11 51.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -49.02 155.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.245 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -132.81 179.6 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -37.64 18.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -79.81 -1.51 39.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.444 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.659 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.4 m-30 -73.11 160.56 31.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.1 m -156.52 -176.55 6.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 71' ' ' TRP . 72.6 mt -59.36 -38.84 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -64.68 -34.56 78.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.37 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 138' ' ' TYR . 47.2 t -67.76 -37.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 109.409 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.2 t -66.94 -53.1 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.942 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.422 HD11 ' HA3' ' A' ' 73' ' ' GLY . 20.7 mt -61.64 -44.29 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.976 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -57.54 -41.94 81.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.11 -48.65 80.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 150' ' ' LEU . 12.7 mt -52.41 -45.99 66.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -42.44 86.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.215 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -61.96 -46.84 87.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.438 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.1 mt -61.01 -32.27 71.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.437 ' HA ' ' HB3' ' A' ' 156' ' ' ASN . 3.4 mtt -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.4 mtp -76.42 -12.7 60.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.425 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.2 m -65.22 154.59 37.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -58.58 -51.08 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -28.78 69.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.375 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 2.7 m-80 -88.16 -28.76 21.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 82' ' ' ILE . 4.0 ppp? -88.78 22.38 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.224 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -121.76 -30.37 4.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 45.5 mt -54.85 143.17 52.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 159' ' ' LEU . 16.6 Cg_exo -68.73 125.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.452 2.102 . . . . 0.0 112.779 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 24.9 mm-40 -84.97 157.47 59.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.324 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 6.7 Cg_endo . . . . . 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.055 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.854 0.359 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 41.8 m -77.53 -176.23 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' A' ' 109' ' ' THR . 11.4 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 3.4 ppt_? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.411 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 26.3 m120 -59.38 -34.82 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.637 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -52.52 63.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.733 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -60.83 -34.16 74.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.524 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 79.8 mt -63.14 -48.87 76.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.805 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.0 mt -69.64 -46.28 66.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -62.71 -50.34 71.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.602 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -64.99 -28.5 69.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.774 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 60.9 tp -61.99 -44.27 97.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 110.503 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.67 -44.05 87.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -59.51 5.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 58' ' ' TRP . . . -59.35 -47.25 91.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.706 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -57.0 -47.26 81.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -53.96 44.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.993 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.19 -176.25 40.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.673 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -155.67 -178.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.06 106.64 1.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.67 13.65 9.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.56 0.219 . . . . 0.0 111.318 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 47.65 43.85 22.36 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.876 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -71.39 -16.95 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.189 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 75' ' ' ILE . 25.5 m -155.74 172.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.511 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.25 113.31 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.901 0.381 . . . . 0.0 111.197 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.469 ' HB2' HG21 ' A' ' 140' ' ' ILE . 35.9 p90 -108.11 114.85 29.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.08 -158.38 10.0 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.971 HD11 HD23 ' A' ' 68' ' ' LEU . 5.2 mt -114.26 144.87 42.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.004 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.971 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.809 0.337 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -65.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.071 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 99.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.518 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 49.3 m95 -90.13 155.39 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.642 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -102.04 158.65 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.18 153.3 24.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.203 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 31.6 mtp -145.66 147.62 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.764 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 50.3 mt -151.38 120.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 111.796 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -93.77 149.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.392 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.57 140.43 16.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.825 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 93.0 Cg_endo -78.62 136.74 13.94 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.628 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.5 Cg_endo -53.52 142.6 58.95 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 112.829 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.61 42.75 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.535 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 68.9 p -160.4 154.5 23.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.846 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.59 -37.65 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 111.141 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CE1' ' OE1' ' A' ' 161' ' ' GLN . 51.4 m-85 -80.09 -22.28 42.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.907 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -40.37 136.44 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.173 0.511 . . . . 0.0 112.362 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 56.58 49.14 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.467 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -148.71 108.21 3.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.038 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.5 mp -69.08 165.4 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.604 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 23.5 m-85 -152.2 121.22 6.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.583 ' C ' HD12 ' A' ' 90' ' ' LEU . 43.0 m -88.91 151.24 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.721 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.9 mp -153.99 160.29 41.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.106 0.479 . . . . 0.0 111.511 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 2.9 mmtp -137.75 116.23 12.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.257 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.59 120.71 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.492 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 58.2 mt-10 -94.08 117.64 30.39 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.722 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.64 -169.14 1.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.767 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.21 -147.76 8.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.08 -70.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.546 2.164 . . . . 0.0 112.378 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.85 68.36 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.894 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -87.94 -61.36 0.24 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.589 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 60.8 Cg_endo -71.97 2.25 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.619 1.546 . . . . 0.0 112.764 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -119.66 7.64 11.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.659 0.266 . . . . 0.0 111.079 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.52 151.35 12.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.11 123.1 11.8 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.25 167.0 22.06 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 54.0 t80 -95.55 89.44 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.294 0.568 . . . . 0.0 110.445 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 92' ' ' ILE . 22.3 t -92.32 143.39 11.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' HA ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -149.97 118.72 6.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.035 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.896 ' CE1' HD13 ' A' ' 147' ' ' LEU . 7.9 m-85 -65.15 127.95 33.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 90' ' ' LEU . 27.1 t -84.44 -46.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.251 0.548 . . . . 0.0 110.182 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 88' ' ' TYR . 8.2 t -69.21 -175.76 0.82 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 162' ' ' PRO . 5.9 mmtt -90.52 102.79 15.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.813 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.874 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -129.7 146.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 111.63 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -125.94 102.26 7.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.656 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 3.6 ttm -125.1 159.05 32.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -55.84 -27.91 53.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.159 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.766 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -126.64 30.01 4.32 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.265 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.065 HG22 HG13 ' A' ' 123' ' ' VAL . 59.9 t -137.86 127.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -59.43 151.23 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.271 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.0 25.92 10.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.49 -46.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.505 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -102.36 -34.77 9.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.492 . . . . 0.0 109.815 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 99.16 -1.76 57.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 120' ' ' ASN . 37.5 t -58.83 110.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.065 HG13 HG22 ' A' ' 116' ' ' VAL . 4.7 t -76.17 110.8 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.75 113.27 10.24 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.944 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 39.3 Cg_endo -66.49 -15.7 48.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.381 2.054 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -36.16 67.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -88.1 -28.63 21.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.297 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 44.8 mm -80.44 132.18 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -55.34 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.534 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.67 HG13 HD12 ' A' ' 131' ' ' LEU . 7.2 p -49.88 -37.43 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.67 HD12 HG13 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.11 -46.61 10.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.11 -29.37 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -135.44 48.29 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -49.59 132.11 21.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -165.69 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -96.68 -39.01 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 t -80.76 2.51 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.688 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' A' ' 130' ' ' VAL . 5.0 m-30 -72.8 156.79 38.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 111.158 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 -176.37 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 71' ' ' TRP . 74.0 mt -55.25 -44.97 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.064 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -56.72 -37.85 71.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 138' ' ' TYR . 40.4 t -69.04 -35.95 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.996 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 18.5 t -65.71 -53.84 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.533 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 75' ' ' ILE . 24.7 mt -64.37 -45.88 85.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.888 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.34 -31.35 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.22 -52.24 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 150' ' ' LEU . 9.6 mt -49.61 -46.08 48.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -64.26 -37.92 89.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.984 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 20.2 mtt180 -63.01 -44.28 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.991 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.4 mt -65.43 -32.68 74.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.341 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 32.0 mtt -68.41 -29.11 67.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 30.2 mtm -76.23 -10.96 59.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.324 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.1 t -64.88 151.36 45.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.1 OUTLIER -52.93 -54.8 29.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -61.19 -24.78 66.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.47 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -86.88 -34.31 19.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.411 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 27.1 ptm -87.08 43.01 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.043 0.449 . . . . 0.0 110.84 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -144.23 -39.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.375 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.7 mt -52.97 145.67 22.16 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.29 124.95 14.72 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.197 1.932 . . . . 0.0 112.067 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG2' HG12 ' A' ' 82' ' ' ILE . 74.0 mm-40 -85.26 119.08 72.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.549 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 110' ' ' LYS . 56.6 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.622 2.215 . . . . 0.0 112.03 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.436 ' CG ' ' CG ' ' A' ' 110' ' ' LYS . 29.6 pt20 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.822 0.344 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.24 174.02 11.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.802 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.59 -50.8 69.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -57.86 -45.36 86.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 97.3 mt -63.87 -34.11 77.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.756 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.678 HD23 HD21 ' A' ' 68' ' ' LEU . 50.3 mt -72.12 -52.89 14.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 110.976 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.51 -49.64 68.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.6 mt-10 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.716 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.594 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.3 tp -63.44 -49.17 74.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.907 0.385 . . . . 0.0 110.588 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -54.98 -56.63 17.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.15 -25.69 59.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -72.36 -55.42 6.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.722 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -69.19 -47.87 63.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.301 . . . . 0.0 111.333 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -39.67 68.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.884 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.44 170.84 12.5 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.779 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -122.23 -177.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.77 -93.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -23.12 66.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.779 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 83.49 27.75 38.26 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.395 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -72.24 -10.32 59.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 75' ' ' ILE . 35.1 m -154.24 171.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.69 111.69 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.759 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.474 ' NE1' ' HA3' ' A' ' 47' ' ' GLY . 35.3 p90 -103.48 157.5 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.547 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.83 174.0 30.23 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.323 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -86.83 11.99 12.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.403 -0.399 . . . . 0.0 112.024 -179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 111.037 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.693 ' HA ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.239 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.77 -55.72 3.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.57 138.84 40.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.536 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 77.3 m95 -135.36 164.73 27.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.89 -179.84 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.285 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 58' ' ' TRP . . . -164.53 159.08 31.98 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.402 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.9 mtp -144.88 148.68 34.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 147' ' ' LEU . 56.6 mt -152.3 121.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.76 149.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -98.95 148.01 18.68 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.131 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 90.6 Cg_endo -82.24 144.22 13.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.783 2.322 . . . . 0.0 112.112 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.1 Cg_endo -53.17 142.35 55.81 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.74 2.293 . . . . 0.0 112.673 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.4 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.82 41.28 0.1 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.52 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.44 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.7 p -159.93 150.0 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -47.22 -37.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 111.192 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.51 ' CD1' HG22 ' A' ' 82' ' ' ILE . 65.9 m-85 -79.95 -21.66 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.72 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -42.33 137.7 1.94 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 112.165 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.5 42.06 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.645 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 79.1 mmt-85 -144.61 107.06 4.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.6 mp -67.39 167.34 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.184 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.623 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 26.7 m-85 -147.98 125.96 12.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 38.1 t -88.84 148.7 23.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.434 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 2.9 mp -151.4 160.16 43.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.183 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -142.77 114.78 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.518 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.7 mp -106.34 149.16 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.858 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.31 125.69 29.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.568 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.35 -179.18 3.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.307 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.8 -144.57 8.18 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.64 113.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.121 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 70.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.938 0.399 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.549 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.1 t80 -83.51 -60.12 0.35 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 61.0 Cg_endo -72.31 3.35 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.869 1.712 . . . . 0.0 112.993 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.41 -6.23 10.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 111.228 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.49 151.84 44.28 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.37 123.25 12.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.65 2.234 . . . . 0.0 112.339 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.497 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 96.6 Cg_endo -80.53 173.16 12.61 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.689 2.259 . . . . 0.0 112.438 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.89 89.13 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.202 0.525 . . . . 0.0 110.455 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 143' ' ' VAL . 50.1 t -95.77 138.74 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.153 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -150.15 126.52 10.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.884 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 1.045 ' CD2' HG21 ' A' ' 111' ' ' ILE . 9.9 m-85 -73.77 135.66 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.14 -41.59 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -69.24 -178.51 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.082 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 40.6 mttt -93.43 91.02 6.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.744 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -121.48 144.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -122.7 102.99 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.0 ttm -124.34 157.35 35.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -54.22 -38.67 65.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.663 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . . . -112.36 25.98 11.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.958 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.907 HG22 HG13 ' A' ' 123' ' ' VAL . 81.1 t -137.72 126.62 33.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -59.81 149.32 31.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.07 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -110.9 28.43 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.792 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.64 -46.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -103.79 -33.68 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 0.0 110.027 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.7 -4.45 56.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.753 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.3 t -58.83 115.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 116' ' ' VAL . 11.8 t -76.74 108.13 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.619 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 115' ' ' GLY . 3.5 t0 -64.95 110.73 4.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 131' ' ' LEU . 43.2 Cg_endo -67.61 -13.12 37.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.992 . . . . 0.0 112.433 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -30.51 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.663 ' HB3' ' CA ' ' A' ' 115' ' ' GLY . . . -93.09 -48.08 6.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.654 ' CG2' HG12 ' A' ' 130' ' ' VAL . 24.5 mm -61.02 131.51 26.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.7 p -67.49 -54.47 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.454 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.654 HG12 ' CG2' ' A' ' 128' ' ' ILE . 7.2 p -49.87 -32.79 8.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.552 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 125' ' ' PRO . 61.9 mt -84.24 -53.03 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.722 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.45 -24.06 18.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.512 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -136.73 45.12 2.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 111.016 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 70.5 t-105 -50.38 138.5 16.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.053 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -108.36 -170.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.925 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.57 -40.52 12.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.46 1.92 27.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.552 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.618 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 m-30 -72.75 151.76 41.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.3 p -155.43 -176.33 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.805 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.491 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 65.6 mt -51.19 -48.08 32.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.26 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -55.37 -39.48 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.659 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 45.7 t -69.03 -37.61 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.289 0.566 . . . . 0.0 110.017 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 105' ' ' VAL . 22.4 t -63.38 -53.77 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.093 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 75' ' ' ILE . 25.7 mt -64.98 -45.06 87.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.878 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -61.34 -51.08 70.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.075 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -59.76 -53.47 57.6 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -57.59 -37.7 73.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.056 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.741 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.6 tmt_? -64.49 -33.8 76.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.695 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.35 89.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.899 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.7 mt -62.63 -40.45 97.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.451 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 22.9 mtt -55.22 -34.7 64.16 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.615 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.3 mtm -75.43 -13.96 60.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.103 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 t -65.56 158.31 27.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 15.7 mttm -65.41 -49.87 67.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.14 -30.07 70.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.321 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -86.91 -26.17 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.653 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -89.74 46.66 1.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -143.17 -39.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.35 155.62 9.37 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.589 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.11 142.16 60.28 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.288 1.992 . . . . 0.0 111.8 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 82' ' ' ILE . 6.3 mm-40 -146.63 98.67 4.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.477 2.118 . . . . 0.0 112.199 179.889 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.4 m -157.64 169.72 24.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 110' ' ' LYS . 16.2 m-85 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.69 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.1 tmm_? . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.0 m120 -54.96 -35.61 64.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.36 -51.91 65.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.664 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 12.9 mmt-85 -57.95 -40.32 80.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD2' ' A' ' 98' ' ' TYR . 90.5 mt -61.82 -50.67 71.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 79.8 mt -62.81 -51.59 66.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.453 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.97 -47.97 82.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.097 0.475 . . . . 0.0 110.303 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 51.0 mt-10 -67.93 -26.66 66.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.464 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 43.1 tp -60.7 -45.35 94.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.12 -37.08 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.43 -42.59 78.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.476 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -77.01 -40.64 24.63 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.676 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -66.1 -40.58 90.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -59.28 -76.16 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.12 165.68 36.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -148.51 -177.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.365 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.12 104.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.933 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 56.53 22.28 6.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.595 0.236 . . . . 0.0 111.497 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.472 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.07 46.35 50.66 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.794 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.6 p -71.4 -22.5 61.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.273 . . . . 0.0 111.206 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG12 HG12 ' A' ' 75' ' ' ILE . 28.1 m -154.93 173.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.78 110.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.341 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.49 ' CH2' HG11 ' A' ' 51' ' ' VAL . 26.5 p90 -99.92 96.26 7.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -105.66 -152.95 20.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.585 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 60' ' ' LEU . 4.9 mt -121.81 147.61 45.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 111.148 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.954 -179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD12 HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.883 0.373 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.85 -56.28 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.59 105.35 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.431 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 30.4 m95 -89.5 150.86 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.669 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -101.99 113.29 26.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -110.75 106.54 2.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.913 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtp -90.63 147.32 23.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 90' ' ' LEU . 56.8 mt -149.61 150.14 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.872 0.368 . . . . 0.0 111.447 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mt -105.89 148.83 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.231 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -76.09 117.22 5.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.256 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 5.9 Cg_endo -48.8 142.56 18.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.425 2.083 . . . . 0.0 112.0 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 61.0 Cg_endo -73.01 175.97 9.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.418 2.079 . . . . 0.0 112.753 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 40.92 41.8 1.33 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.592 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 80' ' ' ARG . 6.8 p -162.0 160.97 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -43.65 -28.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.883 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 84' ' ' GLU . 72.0 m-85 -79.58 -22.09 44.2 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -24.16 125.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 45.55 72.9 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 22.5 mmt180 -157.43 104.66 2.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -66.02 167.64 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' N ' HG22 ' A' ' 87' ' ' ILE . 60.1 m-85 -153.4 128.67 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.546 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -93.17 145.87 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.82 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.5 mp -149.43 160.44 43.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.282 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.9 OUTLIER -138.61 111.49 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.188 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.0 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.33 120.15 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -93.85 133.16 37.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.739 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 98' ' ' TYR . 21.5 p -115.35 -169.3 1.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.14 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.85 -147.04 15.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.234 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.6 119.03 4.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.478 2.119 . . . . 0.0 111.999 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp 59.46 75.19 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.852 0.358 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.811 ' CD2' HD21 ' A' ' 40' ' ' LEU . 6.1 t80 -86.52 -54.49 0.39 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.84 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.6 Cg_endo -82.57 8.76 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.991 1.794 . . . . 0.0 112.236 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.92 3.87 7.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.81 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.21 143.34 3.57 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.61 110.95 2.48 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.847 2.365 . . . . 0.0 112.632 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 73.0 Cg_endo -76.9 -96.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.505 2.137 . . . . 0.0 112.416 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.773 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 59.8 t80 -148.17 136.02 20.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.894 0.378 . . . . 0.0 111.651 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.0 HG22 HG23 ' A' ' 92' ' ' ILE . 38.6 t -135.75 140.28 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.395 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.4 ptt180 -150.5 139.43 20.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.965 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 1.065 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.8 m-85 -77.44 114.83 16.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.868 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.65 -46.68 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.164 0.507 . . . . 0.0 110.273 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 88' ' ' TYR . 9.5 t -68.6 -179.83 1.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.06 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.409 ' HB3' ' HG3' ' A' ' 162' ' ' PRO . 27.3 mttt -88.68 120.22 29.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.065 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -157.84 153.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.506 ' N ' HD13 ' A' ' 111' ' ' ILE . 52.5 m-20 -125.94 102.03 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.43 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 150' ' ' LEU . 7.6 ttm -125.24 143.49 50.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 113' ' ' MET . 2.4 m-80 -58.03 79.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.008 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 113' ' ' MET . . . 145.94 -35.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.284 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.921 HG22 HG13 ' A' ' 123' ' ' VAL . 58.5 t -89.16 139.3 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -59.71 138.45 57.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.0 p -96.14 48.88 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 p -178.07 -38.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.464 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -102.45 -37.73 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.095 0.474 . . . . 0.0 109.991 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.16 -5.58 61.24 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.126 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.773 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 24.4 t -58.54 111.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.089 0.444 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 116' ' ' VAL . 7.4 t -77.08 110.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.477 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.59 110.28 3.84 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.0 Cg_exo -62.2 -17.71 58.3 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.353 2.035 . . . . 0.0 112.326 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -72.43 -43.79 63.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.6 63.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.79 HG23 ' OE1' ' A' ' 146' ' ' GLU . 44.4 mm -81.91 130.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -59.88 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 146' ' ' GLU . 12.5 m -49.7 -30.82 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.662 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 mp -84.39 -45.22 12.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.21 -63.38 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 58.89 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -49.15 164.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -152.98 173.92 14.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.49 -27.24 63.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.194 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.52 -24.76 41.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 142' ' ' VAL . 14.8 m-85 -73.56 144.72 45.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.256 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.81 -176.32 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.364 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 58' ' ' TRP . 62.5 mt -50.09 -39.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.715 0.293 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 14.6 ttpp -61.7 -45.73 92.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.328 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 138' ' ' TYR . 19.4 t -67.45 -35.6 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.884 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.9 t -62.99 -53.81 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.917 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 75' ' ' ILE . 21.6 mt -64.36 -44.6 90.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.556 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -57.66 -40.62 79.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.985 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.889 ' OE1' HD11 ' A' ' 150' ' ' LEU . 2.7 tm-20 -59.97 -53.03 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.91 HD13 ' CE1' ' A' ' 107' ' ' PHE . 7.5 mt -50.25 -45.9 54.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -62.94 -38.15 89.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.755 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -46.52 88.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.206 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' OE1' ' A' ' 146' ' ' GLU . 1.6 mt -59.43 -46.28 89.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.34 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 2.5 mtt -61.13 -25.41 66.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -75.76 -20.4 58.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -65.26 154.57 37.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 11.6 mttm -65.13 -45.79 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -27.38 68.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.41 -27.67 22.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.348 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -89.72 45.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.098 0.475 . . . . 0.0 110.698 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -138.82 -38.56 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.1 mt -53.18 147.3 18.22 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.461 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.83 125.89 12.05 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.285 1.99 . . . . 0.0 112.535 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -83.7 157.39 64.07 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 110' ' ' LYS . 36.8 Cg_exo . . . . . 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 112.207 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 29.4 p -78.74 -168.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 2.2 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.852 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.675 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.5 tmm_? . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -32.9 51.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -54.93 37.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.3 mmt-85 -57.52 -37.74 73.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 110.196 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 36' ' ' ARG . 91.9 mt -61.87 -38.35 87.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.25 -52.74 15.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.396 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -63.51 -50.02 71.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 91.5 mt-10 -60.34 -32.34 71.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.551 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.8 tp -62.66 -43.7 98.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.941 0.401 . . . . 0.0 110.38 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.73 -56.13 26.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.25 -45.02 84.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -65.08 -44.31 94.41 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.768 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -67.8 -48.04 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.185 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -22.84 64.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.83 167.18 27.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.265 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -115.62 -176.96 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 0.0 111.163 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -47.14 -86.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.195 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.91 -14.42 61.05 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 72.92 37.73 56.54 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.26 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -72.35 -17.1 61.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.59 0.233 . . . . 0.0 111.53 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 75' ' ' ILE . 31.8 m -154.26 174.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.942 0.401 . . . . 0.0 111.336 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.78 111.07 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.272 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.495 ' HB2' HG21 ' A' ' 140' ' ' ILE . 34.8 p90 -103.01 73.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.042 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.41 -170.29 46.36 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.773 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.048 HD11 HD23 ' A' ' 68' ' ' LEU . 2.5 mt -104.72 141.7 36.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.845 0.355 . . . . 0.0 111.035 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.796 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -58.17 -65.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 146.28 52.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 63.8 m95 -134.9 146.68 49.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -102.04 121.44 42.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -118.44 109.8 1.83 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.679 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mtp -94.33 152.47 18.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 147' ' ' LEU . 37.4 mt -152.31 129.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 111.697 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.8 mt -102.85 149.26 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -85.09 143.42 20.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.02 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.2 Cg_endo -84.2 134.02 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.826 2.351 . . . . 0.0 111.942 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 71.0 Cg_exo -48.79 143.22 17.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.502 2.135 . . . . 0.0 112.987 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER 74.17 43.97 0.27 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.504 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 30.7 p -160.06 149.45 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.623 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -46.91 -36.82 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.065 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 94.4 m-85 -80.27 -22.27 41.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.1 pt-20 -42.54 133.09 3.47 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.79 11.91 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.622 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -115.28 104.17 11.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 88' ' ' TYR . 40.5 mt -61.79 169.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.282 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.607 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.4 m-85 -152.42 129.73 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.389 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.6 m -93.84 146.41 23.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.83 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -151.06 160.19 44.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.5 mtpt -141.68 114.53 8.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.72 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.13 120.79 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.182 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.08 126.78 40.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.8 p -113.53 -172.02 1.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.19 -140.08 7.77 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.589 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.72 120.46 5.94 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.205 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mttt 51.44 70.3 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -88.58 -63.0 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 70.5 Cg_endo -73.47 3.7 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.605 1.536 . . . . 0.0 112.478 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.54 -4.43 12.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.33 161.26 29.81 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.59 123.88 14.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.655 2.237 . . . . 0.0 112.474 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.17 171.76 15.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.641 2.228 . . . . 0.0 112.31 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -96.39 89.37 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.473 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 92' ' ' ILE . 25.6 t -93.71 139.3 18.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.455 HH12 HG22 ' A' ' 108' ' ' VAL . 2.9 ptm180 -150.42 120.22 7.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.935 ' CD2' HG21 ' A' ' 111' ' ' ILE . 20.5 m-85 -65.56 139.44 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG22 HH12 ' A' ' 106' ' ' ARG . 21.0 t -91.45 -42.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.865 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.409 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -69.05 -178.63 1.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.803 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 166' ' ' GLN . 0.3 OUTLIER -93.36 76.44 4.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.935 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -99.6 152.0 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.475 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.73 102.48 7.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.676 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.477 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 12.4 ttm -124.69 148.01 48.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.236 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -28.36 51.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -120.07 28.01 6.52 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.012 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.018 HG22 HG13 ' A' ' 123' ' ' VAL . 94.1 t -136.25 131.99 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 110.726 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -59.49 132.34 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.993 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 m -97.81 31.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.987 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -141.38 -48.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.28 -34.73 7.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 106.08 -4.12 38.45 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 113.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.796 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 116' ' ' VAL . 10.2 t -76.76 119.41 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.726 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER -65.33 110.72 4.69 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.49 -20.8 71.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.383 2.056 . . . . 0.0 112.407 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -45.04 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.806 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.568 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -71.48 -52.41 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.543 ' CG2' HG12 ' A' ' 130' ' ' VAL . 14.6 mm -58.1 128.1 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.0 t -67.39 -56.32 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.453 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 138' ' ' TYR . 9.2 p -49.95 -30.84 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.352 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.06 -55.06 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.06 -25.08 19.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.272 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -134.2 51.04 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CZ3' ' CD ' ' A' ' 103' ' ' PRO . 57.0 t-105 -49.44 160.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.246 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 3.1 tt0 -140.62 177.16 8.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -77.32 -39.74 46.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 m -80.0 0.36 31.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.561 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.1 m-30 -72.78 149.66 43.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.962 0.411 . . . . 0.0 111.151 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -155.7 -176.45 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.36 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 31.7 mt -58.17 -37.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.721 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 6.5 ttpm? -62.04 -40.17 94.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 138' ' ' TYR . 22.0 t -67.88 -40.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.678 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 105' ' ' VAL . 32.2 t -61.13 -53.22 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.328 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 75' ' ' ILE . 27.0 mt -64.14 -44.8 91.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.847 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.31 -48.85 79.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.641 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 142' ' ' VAL . 1.5 tp10 -60.0 -53.26 59.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.6 pp -57.77 -41.0 81.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.814 0.34 . . . . 0.0 110.45 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.796 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.3 tmm_? -63.83 -33.09 74.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.168 0.509 . . . . 0.0 109.876 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -58.5 -44.85 89.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.101 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.8 mt -61.82 -41.97 98.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.887 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.418 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 14.7 mtt -56.44 -29.43 61.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 9.7 mtm -74.21 -22.69 59.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.3 t -65.96 158.09 29.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.054 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 6.2 mttt -65.41 -36.03 82.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.151 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.6 -44.33 97.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.008 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 20.4 m-20 -87.7 -20.8 25.74 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.472 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -88.74 23.43 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.81 -30.99 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.276 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.0 mt -54.71 145.5 40.4 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.83 124.69 10.87 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.263 1.976 . . . . 0.0 112.673 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 7.1 mm-40 -85.06 158.04 59.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.832 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 40.6 Cg_endo . . . . . 0 C--N 1.344 0.328 0 C-N-CA 122.333 2.022 . . . . 0.0 111.932 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 7.2 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.0 m -160.0 135.57 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CE1' ' HE2' ' A' ' 110' ' ' LYS . 24.6 m-85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.422 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.676 HH11 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HG3' ' A' ' 36' ' ' ARG . 5.0 m120 -71.26 -44.85 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -58.16 -44.39 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 0.0 110.455 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -60.59 -40.48 91.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.365 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.676 HD11 HH11 ' A' ' 36' ' ' ARG . 80.4 mt -60.58 -53.65 54.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.888 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.55 -50.82 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.7 -43.98 97.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 89.6 mt-10 -71.71 -27.79 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.32 -46.01 91.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.84 0.352 . . . . 0.0 110.586 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 13.6 mt-10 -68.47 -44.06 75.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -27.72 43.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.484 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -88.13 -30.44 17.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -83.47 -43.7 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 10.0 mmtt -58.45 -62.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.898 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 174.71 45.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.737 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -153.04 -177.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.85 105.09 1.37 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.49 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 66.89 14.09 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.556 0.217 . . . . 0.0 111.33 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.737 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.05 41.33 29.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.875 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 p -71.43 -18.91 62.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 111.13 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' HG21 ' A' ' 51' ' ' VAL . 21.1 m -155.1 169.8 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 m -161.73 110.99 1.54 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.675 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.544 ' CH2' HG11 ' A' ' 51' ' ' VAL . 32.4 p90 -103.81 143.45 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -151.82 -136.09 2.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.039 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.945 HD11 HD23 ' A' ' 68' ' ' LEU . 10.6 mt -132.61 133.04 43.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.743 0.306 . . . . 0.0 110.905 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.038 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.945 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 94' ' ' CYS . 2.9 m -97.78 -61.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.2 93.62 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.675 ' CE3' HD13 ' A' ' 140' ' ' ILE . 40.5 m95 -90.06 152.63 21.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.01 152.08 21.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.724 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -143.71 102.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.629 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.4 mtp -94.17 147.06 23.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 147' ' ' LEU . 45.5 mt -151.78 138.06 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.74 0.305 . . . . 0.0 111.588 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mt -99.26 148.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.118 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 83' ' ' TYR . . . -78.69 117.97 4.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.266 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 Cg_endo -54.41 146.86 49.61 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.163 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 13.4 Cg_exo -69.3 173.64 10.26 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.635 2.224 . . . . 0.0 112.73 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 41.48 43.14 2.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.792 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 80' ' ' ARG . 19.9 p -161.3 158.17 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.42 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.517 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -44.32 -27.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.541 ' CZ ' ' NE2' ' A' ' 161' ' ' GLN . 53.6 m-85 -78.79 -24.56 44.54 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -22.01 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.21 65.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.753 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 9.4 mmt180 -152.87 102.9 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 88' ' ' TYR . 11.0 mt -67.56 168.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.208 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.587 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.9 m-85 -150.34 132.91 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 0.0 110.992 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 48.7 m -94.18 146.7 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.296 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.855 HD21 ' CE2' ' A' ' 107' ' ' PHE . 3.8 mp -151.7 159.89 43.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.96 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.624 ' HE3' HG21 ' A' ' 108' ' ' VAL . 28.1 mttt -144.54 117.91 9.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.519 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 105' ' ' VAL . 5.0 mp -106.2 123.65 61.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -93.82 108.67 20.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.794 ' O ' HG23 ' A' ' 69' ' ' THR . 57.4 m -113.54 152.55 30.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.65 -149.36 4.95 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.592 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.78 -48.63 18.54 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.665 2.243 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 77.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -101.79 -66.68 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 98' ' ' TYR . 55.2 Cg_endo -69.76 -0.94 7.63 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.346 1.364 . . . . 0.0 112.312 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.22 -4.69 16.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.986 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.61 144.22 8.01 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 120.836 0.351 . . . . 0.0 111.308 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.01 110.07 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.868 2.378 . . . . 0.0 112.042 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 41.6 Cg_endo -67.56 -176.17 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.444 2.096 . . . . 0.0 112.244 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -94.76 94.63 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 111.197 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.719 HG22 HG23 ' A' ' 92' ' ' ILE . 44.6 t -96.32 138.54 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.781 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' A' ' 123' ' ' VAL . 1.9 ptm180 -150.22 126.12 10.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.864 ' CD2' HG21 ' A' ' 111' ' ' ILE . 25.1 m-85 -68.1 126.78 30.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 91' ' ' LYS . 38.2 t -78.35 -41.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.262 0.553 . . . . 0.0 109.948 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.4 t -68.41 -175.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.828 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' A' ' 168' ' ' TYR . 11.9 mttt -98.83 68.02 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.512 . . . . 0.0 110.274 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.864 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.343 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.47 101.89 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.1 ttm -125.2 157.5 36.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -54.67 -52.86 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -89.19 -11.64 64.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.109 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 1.011 HG22 HG13 ' A' ' 123' ' ' VAL . 43.7 t -107.19 121.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.42 143.75 52.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.925 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -98.25 29.15 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 p -140.0 -43.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.628 ' HB3' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -102.23 -32.74 9.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 110.033 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -3.16 81.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.874 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 120' ' ' ASN . 46.3 t -58.96 110.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.011 HG13 HG22 ' A' ' 116' ' ' VAL . 3.4 t -77.69 107.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -63.77 109.99 3.25 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.849 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.401 ' CB ' HD23 ' A' ' 131' ' ' LEU . 39.1 Cg_exo -60.41 -23.28 74.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.323 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -41.33 66.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.532 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -74.65 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 123' ' ' VAL . 35.5 mm -75.46 133.25 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.734 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.5 -58.84 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.016 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 HG12 ' A' ' 142' ' ' VAL . 14.9 p -49.85 -33.91 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.795 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD1' HG13 ' A' ' 130' ' ' VAL . 7.4 mp -81.91 -41.85 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.84 69.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.86 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 47.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -48.03 157.22 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.28 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 179.28 7.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 9.0 p30 -78.71 -31.98 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -79.13 -12.77 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.226 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.541 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.2 m-30 -72.87 153.74 40.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -156.16 -176.39 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.675 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.9 mt -54.92 -35.14 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.497 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -67.39 -38.93 85.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.707 HG12 HG21 ' A' ' 130' ' ' VAL . 49.1 t -68.63 -37.67 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HA ' HG11 ' A' ' 130' ' ' VAL . 38.5 t -63.5 -52.9 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.551 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.672 HD22 HD11 ' A' ' 75' ' ' ILE . 42.6 mt -62.48 -43.68 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.956 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -61.96 -51.11 69.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.054 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -59.8 -53.36 58.82 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 75' ' ' ILE . 4.6 pp -56.08 -40.76 74.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.987 0.422 . . . . 0.0 110.134 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 ttt-85 -62.6 -34.16 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.73 -38.47 78.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.538 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.6 mt -64.08 -41.48 97.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 34.7 mtt -55.7 -32.36 63.24 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.283 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -19.82 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.949 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -65.12 159.83 22.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' MET . 4.6 mtpm? -65.21 -36.01 82.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.301 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.78 -35.86 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -89.57 -11.63 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 14.1 ptm -90.61 24.57 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 111.187 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.07 -37.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.823 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.7 mt -54.37 157.66 4.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.413 ' C ' ' HG2' ' A' ' 161' ' ' GLN . 44.0 Cg_endo -66.11 146.59 82.31 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.326 2.017 . . . . 0.0 112.116 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.541 ' NE2' ' CZ ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -146.26 103.04 4.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.586 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.374 2.049 . . . . 0.0 112.204 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.737 0.303 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 83.8 m -155.99 154.3 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.609 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 109' ' ' THR . 24.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.835 0.35 . . . . 0.0 110.873 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -65.02 -34.81 79.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -55.72 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.3 mmt180 -58.47 -39.26 79.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.812 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 84.1 mt -61.72 -40.31 94.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.16 -52.57 15.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.64 -43.18 99.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.921 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 72.7 mm-40 -68.63 -29.72 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.797 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 64.0 tp -62.85 -47.13 84.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.6 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -58.11 -41.63 83.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -66.45 -62.81 4.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.586 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -52.28 -39.7 60.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.987 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -72.74 -27.48 62.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.57 170.01 22.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.515 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -113.04 -177.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.9 -76.72 0.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' HG23 ' A' ' 55' ' ' THR . 0.5 OUTLIER -73.95 -14.27 61.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.222 . . . . 0.0 111.288 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 68.6 28.65 73.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.44 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 53' ' ' ASP . 13.9 p -71.88 -12.32 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.585 0.231 . . . . 0.0 111.426 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.847 HG12 HG12 ' A' ' 75' ' ' ILE . 3.9 m -154.21 161.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.776 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.01 124.83 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.795 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ3' HG23 ' A' ' 56' ' ' VAL . 4.4 p90 -114.87 -179.12 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.28 44.12 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.057 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD23 ' A' ' 68' ' ' LEU . 4.7 mt -99.46 120.79 40.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.981 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 m -75.01 -68.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.31 142.68 50.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.752 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.812 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 92.0 m95 -135.17 144.16 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.293 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 159.9 14.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 156.81 26.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.885 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 24.5 mtp -145.48 147.25 31.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.712 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.847 HG12 HG12 ' A' ' 56' ' ' VAL . 41.3 mt -150.57 120.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.823 0.344 . . . . 0.0 111.759 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mt -86.66 149.21 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.429 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -74.69 134.0 16.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.844 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 84.1 Cg_endo -78.39 127.61 8.32 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.192 . . . . 0.0 111.737 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.8 Cg_endo -50.04 141.21 30.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.628 2.219 . . . . 0.0 112.727 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 75.4 44.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.235 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 17.6 p -159.4 154.55 25.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.442 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.11 -38.51 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.989 0.424 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 42.3 m-85 -80.35 -20.62 43.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.026 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.4 pt-20 -41.85 133.06 2.93 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 66.99 41.38 2.7 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.553 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 84' ' ' GLU . 2.4 mpt_? -149.59 115.7 5.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.718 0.294 . . . . 0.0 111.362 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 88' ' ' TYR . 37.1 mt -65.57 168.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.021 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 22.5 m-85 -153.32 119.53 5.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.586 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.8 m -88.77 153.17 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.632 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.0 mp -153.75 160.28 42.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.369 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -137.87 114.16 10.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.452 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.003 HG23 HG22 ' A' ' 105' ' ' VAL . 4.4 mp -106.19 121.45 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.494 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 40.4 mt-10 -94.25 127.6 40.21 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.787 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 83.8 m -132.19 121.46 23.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.69 -153.02 25.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.423 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 76.7 Cg_exo -49.94 -36.34 43.51 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.644 2.229 . . . . 0.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 118.21 32.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.531 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.6 t80 -135.93 -67.35 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.22 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.6 Cg_endo -69.37 0.92 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.439 1.426 . . . . 0.0 112.5 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -107.41 -20.59 13.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.313 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.25 161.03 28.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 0.0 111.469 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.58 119.17 6.21 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.659 2.239 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -86.49 -123.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.873 2.382 . . . . 0.0 111.675 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' H ' ' HB2' ' A' ' 103' ' ' PRO . 12.4 t80 -145.93 129.49 16.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.677 0.275 . . . . 0.0 110.693 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 92' ' ' ILE . 24.2 t -135.36 140.55 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.631 ' HA ' HG23 ' A' ' 123' ' ' VAL . 32.1 ptt85 -150.3 122.51 8.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.167 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.912 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.2 m-85 -60.03 141.21 56.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.446 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 90' ' ' LEU . 38.9 t -96.27 -44.05 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 110.327 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 88' ' ' TYR . 7.2 t -68.22 -175.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -91.25 86.97 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.977 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.912 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -119.46 151.47 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.481 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -126.07 102.33 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.649 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 147' ' ' LEU . 27.9 ttm -124.45 143.97 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -52.36 -25.75 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -111.58 15.3 27.04 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HG13 ' A' ' 123' ' ' VAL . 86.9 t -137.74 127.69 36.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.797 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.7 165.89 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.055 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' CZ ' ' A' ' 168' ' ' TYR . 15.6 m -106.22 -16.86 14.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.198 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.1 m -77.39 -61.45 1.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.62 -38.04 6.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 107.7 21.18 8.01 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.56 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.09 111.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 116' ' ' VAL . 3.3 t -77.49 100.91 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.3 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -64.74 119.75 60.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.421 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.3 Cg_exo -62.01 -14.99 40.59 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.505 2.137 . . . . 0.0 112.638 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -28.83 63.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.684 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -95.38 -28.22 15.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.256 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 123' ' ' VAL . 34.9 mm -77.18 128.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -67.52 -60.03 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.356 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 146' ' ' GLU . 16.9 m -49.98 -32.53 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.553 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.421 HD23 ' CB ' ' A' ' 125' ' ' PRO . 1.1 tp -83.67 -43.01 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.617 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.18 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 54.79 1.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -47.85 158.09 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.545 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -142.64 178.12 7.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.37 -30.57 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.017 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.8 p -79.31 -9.82 59.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.395 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -73.3 155.15 39.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.6 m -156.17 -176.52 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.3 mt -58.5 -41.57 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 pttt -62.36 -36.62 82.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 0.0 110.273 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.47 -37.94 78.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.436 0.636 . . . . 0.0 109.59 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.65 -53.34 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.941 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD12 ' CE3' ' A' ' 58' ' ' TRP . 21.9 mt -61.5 -46.02 91.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.689 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.02 -30.04 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.071 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 130' ' ' VAL . 16.6 tp10 -72.83 -48.54 36.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.01 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.9 mt -54.74 -45.94 74.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.69 -38.88 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.819 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 5.7 ttm180 -61.62 -43.99 97.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.051 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -62.02 -41.88 98.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.417 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 12.0 mtm -62.04 -27.66 69.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.2 mtm -75.95 -16.9 59.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.95 154.52 37.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -60.53 -43.25 97.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.12 -32.9 73.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.909 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 44.6 m-80 -86.76 -36.66 18.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 6.9 ptm -78.92 48.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 110.987 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -146.6 -39.57 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.316 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.9 mt -52.3 148.16 12.37 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.497 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.95 121.95 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.258 1.972 . . . . 0.0 112.659 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' A' ' 82' ' ' ILE . 87.4 mm-40 -87.54 122.59 70.48 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.046 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.221 1.947 . . . . 0.0 111.864 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.829 0.347 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 35.5 m -75.81 -179.36 4.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.524 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 4.6 m120 -66.54 -41.92 87.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 41' ' ' LEU . 11.1 m-85 -60.11 -44.57 94.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 13.2 mmm-85 -58.57 -43.41 89.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 41.3 mt -61.29 -39.38 90.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.986 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.593 HD23 HD21 ' A' ' 68' ' ' LEU . 6.6 mt -72.11 -52.66 15.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -42.19 99.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.919 0.39 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 9.3 mm-40 -69.02 -29.4 67.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.491 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 55.7 tp -61.77 -47.24 86.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.981 0.419 . . . . 0.0 110.36 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.27 -41.42 99.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.59 -48.82 78.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -63.93 -50.86 58.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.12 -47.97 81.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -62.55 -26.54 68.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.794 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.41 163.41 24.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.403 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.74 -177.19 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.12 -68.98 1.35 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.047 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -84.52 -3.91 58.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 53.21 35.53 50.01 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.373 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 p -71.37 -15.66 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.648 0.261 . . . . 0.0 111.603 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 HG12 ' A' ' 75' ' ' ILE . 33.9 m -154.13 175.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.386 . . . . 0.0 111.115 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -161.38 110.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.538 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.45 ' HB2' HG21 ' A' ' 140' ' ' ILE . 27.6 p90 -98.96 132.12 44.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.692 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.82 175.31 19.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.122 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 68' ' ' LEU . 1.1 mt -85.39 14.41 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.217 -0.491 . . . . 0.0 112.03 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.081 179.897 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.784 0.326 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -81.47 -57.09 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 135.9 45.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 75.0 m95 -135.31 171.72 14.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 0.0 111.354 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -137.6 165.71 25.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.346 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -157.39 110.41 0.44 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.074 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtp -90.09 153.09 20.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 144' ' ' LEU . 29.8 mt -151.71 139.22 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.1 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.5 mt -114.35 149.13 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.29 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.75 138.79 14.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.955 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.29 146.88 25.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 112.12 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 13.2 Cg_endo -56.22 147.62 65.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.833 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 77.35 44.75 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.481 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 80' ' ' ARG . 76.7 p -161.87 152.94 18.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -52.71 -37.02 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.572 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 82.0 m-85 -81.84 -14.04 56.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.042 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -46.85 140.3 4.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.208 0.528 . . . . 0.0 112.191 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m120 45.96 42.2 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.012 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.7 mmt-85 -139.72 86.17 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.1 mp -47.25 164.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.569 ' N ' HG22 ' A' ' 87' ' ' ILE . 43.5 m-85 -154.34 128.02 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 111.242 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 m -92.87 154.66 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.467 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -152.38 160.63 43.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -136.65 116.03 12.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.73 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.6 149.01 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.684 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.7 134.83 39.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 110.904 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 98' ' ' TYR . 1.4 p -120.23 -178.33 3.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.175 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.39 -157.71 8.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.51 -25.29 14.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.618 2.212 . . . . 0.0 112.604 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 95.63 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.861 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 2.3 t80 -97.19 -65.11 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.59 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 42.8 Cg_endo -67.44 -1.68 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.655 1.57 . . . . 0.0 112.651 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -109.51 -6.06 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.363 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.03 157.95 33.98 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.69 125.98 20.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.678 2.252 . . . . 0.0 112.074 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 90.9 Cg_endo -81.55 163.69 18.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.553 2.169 . . . . 0.0 112.708 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -95.22 90.26 5.8 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.554 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG21 ' CG1' ' A' ' 143' ' ' VAL . 24.8 t -93.85 138.71 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.246 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -150.2 125.21 9.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 1.111 ' CD2' HG21 ' A' ' 111' ' ' ILE . 3.4 m-85 -70.52 153.66 42.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.19 -40.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.28 0.562 . . . . 0.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 89' ' ' SER . 6.5 t -68.31 -176.39 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 50.5 mmtt -87.68 94.62 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.779 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.111 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.2 tt -130.68 145.69 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.865 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -126.37 102.32 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.89 157.39 36.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.009 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -54.5 -58.89 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.238 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -79.77 -16.7 76.8 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 123' ' ' VAL . 62.8 t -94.92 136.61 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.925 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.91 179.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.8 m -133.09 34.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.986 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -152.57 -47.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 122' ' ' VAL . 7.5 p30 -105.39 -37.25 6.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.125 0.488 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.31 2.36 41.29 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.011 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 120' ' ' ASN . 30.8 t -58.89 110.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 116' ' ' VAL . 3.7 t -76.94 112.77 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.408 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -64.19 110.91 4.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB3' HD23 ' A' ' 131' ' ' LEU . 32.4 Cg_exo -58.25 -18.53 37.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.496 2.131 . . . . 0.0 112.403 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -47.82 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.7 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.604 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -67.91 -42.7 80.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.479 ' CG2' HG12 ' A' ' 130' ' ' VAL . 44.1 mm -69.01 123.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.5 t -66.06 -55.86 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.457 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 128' ' ' ILE . 8.6 p -49.97 -32.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.479 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -84.49 -49.51 8.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.52 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.306 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -134.81 43.87 2.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.912 0.387 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -49.55 148.64 2.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 138' ' ' TYR . 1.5 mt-30 -130.54 -171.93 2.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 37.8 t30 -104.25 58.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -160.52 -27.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.716 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.468 ' CD1' HG11 ' A' ' 142' ' ' VAL . 22.6 m-85 -70.78 172.03 9.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.465 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.2 m -156.07 -176.42 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.368 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.597 HD13 ' CE3' ' A' ' 71' ' ' TRP . 33.4 mt -53.87 -44.43 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.247 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 21.8 pttt -58.57 -37.48 75.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 138' ' ' TYR . 41.3 t -68.36 -39.23 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 109.627 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 105' ' ' VAL . 18.1 t -61.82 -53.39 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.835 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 75' ' ' ILE . 20.9 mt -61.4 -43.78 98.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.64 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.89 -40.21 79.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -53.04 62.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.65 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.9 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 16.2 mt -50.56 -46.21 57.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 110.658 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -62.15 -34.4 76.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.941 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -61.44 -43.04 99.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.958 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.6 mt -63.56 -44.75 93.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.437 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 15.1 mtt -58.32 -29.77 66.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.928 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.6 mtm -76.9 -15.95 59.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.3 m -64.94 141.23 58.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 10.8 tptt -51.28 -53.24 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.07 -23.1 65.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.747 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.12 -25.91 23.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.722 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 14.5 ptm -86.64 19.23 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.089 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.86 -30.72 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.282 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.8 mt -54.72 144.23 46.39 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.554 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.38 150.3 68.56 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.238 1.958 . . . . 0.0 112.04 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.53 ' HG3' HG23 ' A' ' 82' ' ' ILE . 25.0 mm-40 -146.49 116.59 4.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 110' ' ' LYS . 80.9 Cg_exo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 122.509 2.139 . . . . 0.0 112.141 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 28.2 pt20 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.865 0.364 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 51.8 m -77.39 176.27 9.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 1.7 t30 -60.57 -32.78 71.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.744 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -54.58 41.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 6.0 mmt180 -57.68 -38.73 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.083 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 98' ' ' TYR . 69.9 mt -61.86 -52.26 64.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.23 -50.49 70.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -61.67 -46.36 90.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.4 mt-10 -70.56 -29.33 65.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.399 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 54.5 tp -62.12 -35.21 78.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.358 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 -34.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.2 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.17 -34.28 70.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.511 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.493 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -85.02 -34.39 15.09 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.41 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -51.98 -43.77 63.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.872 0.368 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -62.47 -29.45 70.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.505 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . 87.77 35.13 9.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.613 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER 40.41 -170.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.13 -83.35 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.734 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.96 -23.84 48.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 73.73 32.35 59.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -72.52 -13.31 61.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 75' ' ' ILE . 25.0 m -154.77 171.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.747 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -161.76 111.02 1.53 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 34.7 p90 -103.86 130.08 51.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -142.35 -139.05 3.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.066 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.733 HD11 HD23 ' A' ' 68' ' ' LEU . 7.7 mt -125.17 145.68 49.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.905 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.733 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.89 0.376 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -91.88 -66.5 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 98.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.791 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.596 ' CE3' HD13 ' A' ' 140' ' ' ILE . 62.0 m95 -88.78 152.09 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 147.39 26.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -140.31 99.53 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.996 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -92.45 149.29 21.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.6 mt -150.85 144.99 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 111.607 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -120.11 149.23 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.4 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.14 123.26 7.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.023 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 20.6 Cg_exo -65.47 142.28 71.18 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.488 2.125 . . . . 0.0 111.996 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 42.6 Cg_exo -57.07 146.14 82.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.699 2.266 . . . . 0.0 112.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 81' ' ' THR . 7.3 mtt180 81.61 42.46 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.825 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' ARG . 15.7 p -162.52 155.83 20.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.863 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -51.23 -40.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.937 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 67.2 m-85 -79.43 -18.0 53.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.841 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.6 pt-20 -41.28 143.87 0.39 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.279 0.561 . . . . 0.0 112.474 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.5 t30 45.65 54.35 7.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.822 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 4.8 mmt85 -152.72 107.27 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.492 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.1 mp -67.16 165.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.481 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HG22 ' A' ' 87' ' ' ILE . 27.5 m-85 -150.75 130.72 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.983 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 28.2 t -93.12 148.28 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.141 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.907 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.1 mp -152.27 160.02 43.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.046 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.8 mtmt -143.56 117.23 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.774 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.28 127.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.99 117.14 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' O ' HG23 ' A' ' 69' ' ' THR . 15.7 m -126.3 159.46 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.63 -126.53 0.82 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.02 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.378 2.052 . . . . 0.0 112.401 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 69.46 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.2 t80 -90.26 -64.5 0.18 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.042 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 72.9 Cg_endo -74.98 3.99 5.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.391 1.394 . . . . 0.0 112.307 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -113.13 -11.02 13.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.757 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.53 146.81 18.0 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.4 110.17 0.57 Allowed 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 122.825 2.35 . . . . 0.0 112.188 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 45.7 Cg_endo -67.89 -176.2 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 46.1 t80 -94.93 95.37 8.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 92' ' ' ILE . 48.1 t -95.42 138.15 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.645 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' VAL . 3.2 ptt-85 -150.2 138.31 20.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.984 ' CD2' HG21 ' A' ' 111' ' ' ILE . 14.3 m-85 -83.85 137.98 33.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.879 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 167' ' ' CYS . 19.0 t -93.63 -39.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.224 0.535 . . . . 0.0 109.867 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.0 t -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.924 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -94.11 82.8 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.984 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -112.57 149.09 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.53 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -126.23 102.95 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.525 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.9 ttm -124.37 155.39 38.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.953 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -54.54 -52.88 60.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.18 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.715 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -86.21 -14.47 66.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.037 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 123' ' ' VAL . 48.6 t -98.95 132.21 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.15 167.84 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.7 m -123.68 31.05 6.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.2 p -142.69 -47.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -104.69 -37.16 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.131 0.491 . . . . 0.0 110.119 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.32 43.61 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.998 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 21.5 t -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 116' ' ' VAL . 8.8 t -77.21 111.93 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.685 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.79 125.2 89.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 -15.85 24.62 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.421 2.08 . . . . 0.0 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -72.43 -42.46 65.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.938 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.715 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -77.6 -46.73 21.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.406 ' CG2' ' CG2' ' A' ' 130' ' ' VAL . 21.3 mm -62.46 132.29 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.3 p -67.36 -56.0 11.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.408 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 146' ' ' GLU . 3.2 m -49.93 -36.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.618 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 130' ' ' VAL . 6.6 mp -80.71 -43.71 19.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.652 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.74 62.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -139.08 55.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 61.9 t-105 -49.67 157.87 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HG3' ' CE1' ' A' ' 138' ' ' TYR . 38.7 mm-40 -131.32 -166.65 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.34 -40.42 9.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 t -79.3 -3.89 48.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.394 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.46 ' HA ' HG21 ' A' ' 142' ' ' VAL . 5.2 m-30 -72.46 151.8 42.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.845 0.355 . . . . 0.0 111.045 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 p -156.34 -176.5 6.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.596 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mp -53.12 -29.96 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.28 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 8.6 pttt -71.04 -40.27 71.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 138' ' ' TYR . 66.4 t -68.88 -35.53 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.503 0.668 . . . . 0.0 109.453 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 105' ' ' VAL . 40.4 t -67.85 -52.81 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 75' ' ' ILE . 22.4 mt -62.72 -47.75 82.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.916 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -60.32 -48.86 79.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.529 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.585 ' HG2' HG13 ' A' ' 130' ' ' VAL . 7.3 tp10 -59.98 -53.23 60.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.826 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.837 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -60.63 -41.05 94.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.952 0.405 . . . . 0.0 110.301 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.68 -31.63 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.061 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -59.37 -44.6 92.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -63.37 -46.81 84.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.228 179.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 11.7 mtp -48.67 -39.11 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttp -77.33 -27.68 52.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -65.8 147.97 52.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 1.7 mmmp? -51.16 -25.58 5.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.58 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -54.86 36.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.012 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 12.8 m-80 -88.2 -30.96 19.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 81' ' ' THR . 2.7 ptm -72.91 52.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.112 0.482 . . . . 0.0 111.297 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.15 -42.68 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.024 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt -53.79 150.55 13.66 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.595 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.93 126.0 14.55 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.373 2.049 . . . . 0.0 112.43 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 35.8 mm-40 -84.38 120.4 74.33 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.224 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 161' ' ' GLN . 19.9 Cg_exo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.259 1.973 . . . . 0.0 111.896 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.5 m -77.3 -167.48 0.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 109' ' ' THR . 1.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 9.7 p-10 -65.77 -36.4 83.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -55.32 -53.86 50.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.716 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 8.1 tpp180 -57.51 -42.89 83.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 73.5 mt -59.44 -40.81 88.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.982 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 90.1 mt -72.22 -52.72 15.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.641 0.258 . . . . 0.0 111.366 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.76 -36.87 82.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 32.4 mt-10 -76.56 -28.91 56.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.0 tp -62.29 -35.08 77.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.137 0.494 . . . . 0.0 110.033 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -41.8 45.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.371 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -38.39 76.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.918 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.66 -58.29 5.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.693 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -58.0 -36.02 72.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -76.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.68 168.21 39.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.617 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.43 -176.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 111.166 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.05 97.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.682 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.61 22.18 12.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.718 0.294 . . . . 0.0 111.274 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 50.4 46.95 44.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.698 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.676 0.274 . . . . 0.0 111.297 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 75' ' ' ILE . 34.1 m -154.41 175.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.955 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.91 110.65 1.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.463 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.617 ' CH2' HG11 ' A' ' 51' ' ' VAL . 28.6 p90 -100.12 87.45 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -143.49 12.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.767 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.655 HD11 ' CD2' ' A' ' 68' ' ' LEU . 6.0 mt -120.4 140.65 51.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.775 0.322 . . . . 0.0 111.024 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.655 ' CD2' HD11 ' A' ' 60' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -51.86 12.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -78.86 95.97 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.713 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 40.8 m95 -89.06 165.36 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -127.08 118.5 24.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.617 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -114.64 119.12 4.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.662 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mtp -93.73 154.39 17.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.824 HD13 HD11 ' A' ' 147' ' ' LEU . 30.4 mt -152.27 138.06 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.846 0.355 . . . . 0.0 111.761 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -116.79 149.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.415 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.83 146.8 18.34 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.11 141.18 11.56 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.827 2.351 . . . . 0.0 112.25 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 58.0 Cg_exo -51.81 141.77 43.99 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.546 2.164 . . . . 0.0 112.798 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER 79.06 41.18 0.09 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.529 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.4 p -159.68 152.42 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -47.77 -39.14 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 111.316 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' CE ' ' A' ' 151' ' ' MET . 89.9 m-85 -78.8 -22.61 46.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.909 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -41.52 135.25 2.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 56.22 20.48 4.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.925 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.13 105.45 11.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.797 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 88' ' ' TYR . 47.1 mt -70.65 165.05 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 35.6 m-85 -150.25 130.22 13.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.02 0.438 . . . . 0.0 111.197 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 30.9 t -93.76 151.29 19.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.4 mp -151.29 160.31 43.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.0 ttmt -139.01 114.51 9.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.557 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.42 120.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.355 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 18.9 mt-10 -94.25 122.23 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.801 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.72 -169.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.98 -153.42 15.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.01 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.304 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -96.65 74.22 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.587 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.7 t80 -96.71 -52.8 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 2.3 Cg_endo -80.25 3.95 7.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.776 1.651 . . . . 0.0 112.224 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -114.5 -18.57 11.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.14 73.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HB3' HD13 ' A' ' 131' ' ' LEU . 48.2 Cg_exo -55.88 124.43 16.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.578 2.185 . . . . 0.0 112.325 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 89.0 Cg_endo -77.91 167.83 23.09 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.64 2.227 . . . . 0.0 112.223 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 87.3 t80 -96.45 89.23 4.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.239 0.543 . . . . 0.0 110.351 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.622 HG21 HG11 ' A' ' 143' ' ' VAL . 38.3 t -93.56 141.15 15.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.051 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -150.25 128.84 12.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.091 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 1.067 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.4 m-85 -75.23 123.15 24.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.492 HG22 ' HE3' ' A' ' 91' ' ' LYS . 20.7 t -75.72 -40.74 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.337 0.589 . . . . 0.0 109.499 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.415 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 7.4 t -69.75 -177.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.864 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 14.0 mttt -97.99 97.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.756 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.067 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -126.55 151.14 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.835 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' N ' HD13 ' A' ' 111' ' ' ILE . 21.4 t-20 -126.21 102.77 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 31.3 ttm -124.42 153.08 42.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -52.53 -26.16 12.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -123.15 22.49 7.11 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.041 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 123' ' ' VAL . 57.6 t -136.09 126.54 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.661 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 138.01 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 t -101.89 54.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.2 p -176.79 -39.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -102.81 -34.47 8.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 109.974 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.96 64.75 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.983 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.77 115.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 116' ' ' VAL . 15.0 t -77.51 115.18 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.8 OUTLIER -65.13 113.2 10.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.531 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.403 ' CB ' ' HB3' ' A' ' 131' ' ' LEU . 36.6 Cg_endo -65.21 -12.3 34.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.52 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.23 -49.95 31.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -69.97 -51.71 30.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 31.7 mm -57.81 132.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -60.33 2.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.202 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 146' ' ' GLU . 10.4 m -49.99 -30.15 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.717 0.294 . . . . 0.0 111.739 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.541 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 mm? -83.85 -47.63 10.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.6 -31.65 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.474 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -135.83 42.46 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -50.55 117.46 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.226 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -99.9 -176.79 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 3.9 m-20 -92.03 56.07 2.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.9 p -159.45 -18.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.2 m-85 -71.85 169.84 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.08 0.467 . . . . 0.0 111.416 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.74 -176.38 5.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.475 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.511 HD13 ' CE3' ' A' ' 71' ' ' TRP . 66.8 mt -56.22 -47.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 111.32 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.466 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 11.5 ptpt -60.69 -34.86 74.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.768 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 138' ' ' TYR . 21.4 t -68.54 -37.62 77.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.452 0.644 . . . . 0.0 109.392 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 105' ' ' VAL . 36.6 t -63.58 -52.88 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.843 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.56 HD22 HD11 ' A' ' 75' ' ' ILE . 21.1 mt -62.55 -48.75 78.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.698 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -60.36 -46.08 91.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.565 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HG2' HG22 ' A' ' 130' ' ' VAL . 9.1 tp10 -61.09 -53.47 56.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.735 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.824 HD11 HD13 ' A' ' 75' ' ' ILE . 3.5 pp -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 147' ' ' LEU . 73.4 ttt-85 -65.13 -33.42 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.741 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -43.68 90.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.961 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.1 mt -66.3 -38.19 87.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.106 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.453 ' CE ' ' CE1' ' A' ' 83' ' ' TYR . 8.7 mtt -54.97 -35.57 64.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.729 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 53.2 mtm -75.74 -12.55 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.226 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.85 26.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.6 mtpp -59.13 -44.07 92.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.19 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.38 -33.25 73.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.757 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 0.8 OUTLIER -87.81 -39.2 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.547 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -72.44 1.5 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 111.574 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -111.91 -32.42 6.61 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 110.154 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.81 147.19 43.57 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.13 141.13 75.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.383 2.055 . . . . 0.0 111.811 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -146.57 117.66 4.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.464 2.109 . . . . 0.0 112.249 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.3 m -160.74 148.2 15.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.679 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 109' ' ' THR . 23.1 m-85 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.896 0.379 . . . . 0.0 111.034 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.473 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 34.7 m120 -68.27 -36.97 80.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.27 -57.62 11.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.013 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -57.6 -43.29 84.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.555 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.715 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 53.7 mt -62.8 -38.3 90.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 12.8 mt -72.13 -52.72 15.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.24 -43.25 98.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 98.2 mt-10 -68.01 -32.1 72.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 59.1 tp -61.44 -42.64 99.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.311 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.34 -50.78 68.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.799 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.95 -40.45 80.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -69.26 -58.55 6.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.66 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.76 -39.86 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 111.111 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -58.12 -72.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.36 158.02 9.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.576 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.404 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -130.24 -175.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.93 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.36 104.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.471 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.94 20.25 11.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.834 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.81 47.97 30.51 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.805 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 56' ' ' VAL . 27.9 p -71.73 -18.04 62.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 111.254 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG12 HG12 ' A' ' 75' ' ' ILE . 19.7 m -156.85 169.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.735 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -160.93 111.18 1.73 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.571 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.51 ' HB2' HG21 ' A' ' 140' ' ' ILE . 30.7 p90 -102.21 96.42 6.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -109.83 -144.4 10.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.912 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.015 HD11 HD23 ' A' ' 68' ' ' LEU . 7.1 mt -121.17 131.96 54.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.255 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.015 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.8 0.333 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -89.36 -55.34 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -77.99 97.07 5.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.715 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 27.2 m95 -91.79 152.02 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.804 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 1.9 m -102.23 144.95 30.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -136.06 103.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.73 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtp -92.59 151.66 20.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 147' ' ' LEU . 30.8 mt -151.82 142.72 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.765 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.23 149.42 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.323 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.29 148.92 17.75 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.004 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HG3' ' HG2' ' A' ' 152' ' ' MET . 92.0 Cg_endo -79.77 132.36 9.69 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.909 2.406 . . . . 0.0 111.975 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 15.8 Cg_endo -56.86 83.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.709 2.273 . . . . 0.0 112.583 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 81' ' ' THR . 5.2 ptt180 161.32 30.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.715 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 74.9 p -162.08 163.65 28.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.93 -37.97 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 97.0 m-85 -79.44 -11.61 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.153 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 5.1 pt-20 -51.71 146.41 7.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 t30 44.62 29.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.611 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 1.6 mmt180 -131.29 99.64 4.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -62.7 166.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.796 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 33.8 m-85 -150.82 130.21 12.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.032 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 40.5 m -92.97 151.19 20.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.187 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.41 160.17 43.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.7 OUTLIER -141.15 114.37 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.83 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 105' ' ' VAL . 4.8 mp -106.35 120.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.481 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 130.04 40.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.428 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 69' ' ' THR . 4.0 p -127.88 -179.03 4.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.18 -149.0 5.75 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.077 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.07 -78.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.466 2.11 . . . . 0.0 111.819 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.76 77.32 9.52 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.674 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -91.26 -52.37 0.29 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 3.4 Cg_exo -79.31 5.0 6.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.984 1.789 . . . . 0.0 112.516 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -8.14 9.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.343 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . . . -139.92 150.46 62.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.667 0.27 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 101' ' ' ALA . 31.3 Cg_exo -59.28 122.37 11.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.6 Cg_endo -82.29 175.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.721 2.28 . . . . 0.0 112.432 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -97.54 90.19 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 143' ' ' VAL . 41.8 t -91.88 138.9 18.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.058 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.19 130.18 13.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.026 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 1.061 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.6 m-85 -76.01 126.7 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.1 t -78.95 -39.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.354 0.597 . . . . 0.0 109.634 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.7 t -69.07 -176.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.067 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 30.1 mttt -99.14 87.52 3.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.061 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -116.87 153.52 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.95 -178.34 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.49 ' N ' HD13 ' A' ' 111' ' ' ILE . 10.6 t-20 -126.35 102.78 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.736 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.437 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 1.9 tpp -123.98 156.48 36.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.227 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -53.61 -43.37 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.164 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -109.05 28.41 11.17 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.944 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.968 HG22 HG13 ' A' ' 123' ' ' VAL . 76.9 t -135.4 130.17 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.824 0.345 . . . . 0.0 110.689 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.55 158.26 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -118.67 26.71 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.48 -51.42 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.5 -34.13 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.007 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.65 0.63 34.59 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.919 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.86 113.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 116' ' ' VAL . 13.1 t -76.67 115.17 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.471 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 110.14 3.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.918 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.38 -15.76 47.22 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.446 2.097 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -46.72 58.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -70.5 -42.65 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.699 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 131' ' ' LEU . 32.8 mm -70.03 103.78 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.647 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -53.96 -55.64 25.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 142' ' ' VAL . 7.2 p -49.97 -31.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' H ' HG22 ' A' ' 128' ' ' ILE . 1.3 tp -84.15 -48.69 9.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.11 69.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.09 34.44 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.427 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 54.8 t-105 -49.37 132.22 20.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -121.26 -178.34 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -86.11 61.06 6.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.9 m -160.85 -28.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.816 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.3 m-85 -70.96 168.16 17.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.425 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.09 -176.43 5.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.246 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.664 HD13 ' CE3' ' A' ' 71' ' ' TRP . 10.7 mt -55.94 -51.34 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.282 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 ptpt -53.16 -35.06 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.816 HG11 ' CD1' ' A' ' 138' ' ' TYR . 40.9 t -69.04 -41.19 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.47 0.652 . . . . 0.0 109.547 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 105' ' ' VAL . 40.5 t -62.61 -53.13 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.342 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.707 HD22 HD11 ' A' ' 75' ' ' ILE . 28.5 mt -63.09 -48.54 78.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.741 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.86 -46.53 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -60.0 -53.16 61.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.568 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 148' ' ' ARG . 4.4 pp -62.0 -38.39 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.838 ' N ' HD12 ' A' ' 147' ' ' LEU . 5.7 ttt-85 -69.59 -30.71 68.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.803 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -43.68 90.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.837 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.756 HD12 ' HA ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -65.33 -42.43 92.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.848 178.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 21.3 mtt -50.97 -35.26 32.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.81 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' MET . . . . . 0.424 ' HG2' ' HG3' ' A' ' 78' ' ' PRO . 69.8 mtm -74.44 -22.21 59.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.94 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.6 m -65.79 158.3 28.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 28.7 mttp -65.19 -32.19 73.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -46.94 85.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.128 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -87.15 -21.76 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.48 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -82.56 13.64 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -116.52 -30.38 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.194 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.7 mt -55.41 148.85 30.93 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.829 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.63 149.57 89.61 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.156 . . . . 0.0 112.047 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 82' ' ' ILE . 20.0 mm-40 -146.31 133.71 10.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.87 0.367 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.6 p -80.3 -170.69 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.977 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 110' ' ' LYS . 10.7 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.99 131.2 20.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.603 2.202 . . . . 0.0 112.299 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.87 -146.91 4.9 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -152.77 30.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG22 ' HE2' ' A' ' 9' ' ' TYR . 28.4 t -127.71 136.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -49.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.3 -66.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.173 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -179.34 3.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.627 ' HE2' HG22 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -171.13 -167.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.51 152.47 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 60.09 104.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.23 106.98 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -103.43 -59.59 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.0 p -95.73 113.66 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -105.63 30.69 5.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mp -141.7 -48.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -69.71 157.71 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -53.74 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.6 -67.91 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.99 95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -135.53 138.4 43.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 tt -142.18 83.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.36 140.0 45.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.13 105.84 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.522 2.148 . . . . 0.0 112.304 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.62 153.02 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -164.12 -65.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.55 163.39 14.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -143.59 31.43 1.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.33 139.11 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -92.92 165.49 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.0 99.92 1.25 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.528 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.6 134.5 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.05 158.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.457 ' CG2' ' HD2' ' A' ' 35' ' ' PRO . 14.1 p -80.22 141.01 53.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.816 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 73.9 Cg_exo -49.54 142.38 23.92 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.362 2.042 . . . . 0.0 112.344 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.58 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.747 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 14.8 m-80 -52.53 -35.63 53.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.491 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . 8.0 t80 -55.37 -53.54 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.288 . . . . 0.0 111.045 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 22.4 tpp180 -57.53 -40.16 78.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.42 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 78.8 mt -60.67 -51.46 69.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 64.3 mt -62.05 -52.75 62.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.447 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.43 -43.13 99.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 80.6 mm-40 -72.41 -28.47 63.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.706 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 44.7 tp -61.35 -42.49 98.79 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.53 -49.26 56.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.791 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.27 78.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.216 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -71.27 -51.31 18.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.649 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.18 -44.28 92.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -58.4 -56.21 25.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.19 170.01 15.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.677 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -138.95 -177.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 111.076 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.61 108.95 1.36 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.663 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 16.08 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.578 0.228 . . . . 0.0 111.272 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.42 50.72 17.39 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.981 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -70.52 -23.34 62.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 75' ' ' ILE . 22.7 m -155.01 173.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.556 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -160.86 112.0 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.977 0.418 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.485 ' HH2' HG11 ' A' ' 51' ' ' VAL . 25.2 p90 -101.14 81.66 2.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.84 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.77 179.01 35.39 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.995 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.843 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -90.38 144.58 25.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -76.93 -56.63 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.05 106.4 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 3.6 m-20 -68.17 46.38 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 39.0 mp0 -157.38 27.03 0.29 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.45 -169.81 2.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.353 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.8 mmt -130.6 -60.49 0.99 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.582 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.743 ' C ' HD12 ' A' ' 68' ' ' LEU . 4.4 t -86.68 -8.28 57.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.416 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.843 HD23 HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER 55.94 81.99 0.11 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.0 m -97.72 -66.8 0.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.38 93.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.588 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 81.6 m95 -90.87 169.27 11.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.056 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -135.22 124.69 24.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.616 ' CA ' HD11 ' A' ' 144' ' ' LEU . . . -120.64 115.95 3.07 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.804 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -91.1 157.17 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 147' ' ' LEU . 25.6 mt -152.86 141.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.819 0.342 . . . . 0.0 111.748 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.47 149.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.731 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -79.43 139.57 21.83 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.865 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 72.0 Cg_endo -87.69 127.42 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.973 2.449 . . . . 0.0 112.109 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 81.7 Cg_exo -47.52 139.9 16.98 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.552 2.168 . . . . 0.0 112.99 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 79.7 40.47 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 31.0 p -159.09 151.75 21.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.78 -39.63 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 151' ' ' MET . 49.8 m-85 -80.27 -21.57 42.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.114 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.2 pt-20 -38.36 138.01 0.51 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 55.03 45.94 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.711 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -143.69 112.76 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.4 mp -70.45 160.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.425 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' N ' HG22 ' A' ' 87' ' ' ILE . 15.3 m-85 -151.9 126.76 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.41 . . . . 0.0 111.208 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.2 t -94.94 151.83 18.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -150.96 160.37 43.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.14 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.63 114.81 10.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.744 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.36 120.75 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.214 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -93.95 120.54 34.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -128.63 105.19 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.53 -110.64 2.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.387 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.1 118.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.153 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 4.8 mtpp 61.81 87.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -105.27 -66.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.896 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 55.4 Cg_endo -69.63 2.91 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.439 1.426 . . . . 0.0 112.952 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 16.4 pt-20 -112.06 -9.34 13.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.663 0.268 . . . . 0.0 111.041 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' HD2' ' A' ' 102' ' ' PRO . . . -151.62 164.56 19.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 45.7 Cg_exo -57.01 123.29 13.49 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.694 2.263 . . . . 0.0 112.382 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . 93.2 Cg_endo -80.07 167.81 19.52 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.726 2.284 . . . . 0.0 112.317 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.19 89.11 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 92' ' ' ILE . 40.5 t -94.24 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.126 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 129.71 12.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.953 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.5 m-85 -75.2 130.93 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.31 -45.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.301 0.572 . . . . 0.0 109.647 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 9.9 t -69.0 -179.38 1.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.689 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 8.5 mmtt -88.95 105.23 17.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.934 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -132.25 153.15 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.771 -178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 111' ' ' ILE . 4.3 m-20 -125.98 102.6 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.565 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.665 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 18.4 ttm -124.3 144.71 49.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.17 -32.71 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.288 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.691 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -101.78 -10.65 39.87 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.09 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.856 HG22 HG13 ' A' ' 123' ' ' VAL . 46.1 t -111.75 126.36 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.399 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.18 165.64 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -111.77 30.25 7.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.66 -58.16 1.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.808 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 122' ' ' VAL . 2.5 m-20 -104.9 -34.16 8.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.08 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.3 32.14 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.7 t -58.89 110.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.856 HG13 HG22 ' A' ' 116' ' ' VAL . 2.8 t -76.81 104.74 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.356 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.83 123.34 83.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.704 ' HB3' HD23 ' A' ' 131' ' ' LEU . 57.6 Cg_endo -70.92 -13.15 31.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.386 2.057 . . . . 0.0 112.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -72.31 -35.11 68.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.795 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.691 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -85.4 -46.56 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 131' ' ' LEU . 22.8 mm -65.9 129.91 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.74 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 88.5 p -67.48 -59.16 3.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.595 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG13 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m -49.79 -30.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.864 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -83.18 -43.66 15.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.731 0.3 . . . . 0.0 110.644 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.84 -54.86 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -105.92 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -48.5 139.86 8.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' A' ' 138' ' ' TYR . 4.3 pt20 -127.37 -170.71 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -86.39 -25.58 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -12.17 59.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 135' ' ' GLN . 12.3 m-30 -73.92 155.43 38.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.43 . . . . 0.0 111.302 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.2 p -155.9 -176.4 5.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.4 mt -57.95 -44.45 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . 1.3 pttt -61.03 -34.88 75.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.657 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.3 t -68.34 -40.62 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.477 0.656 . . . . 0.0 109.446 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 105' ' ' VAL . 37.4 t -61.22 -53.03 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.966 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.616 HD11 ' CA ' ' A' ' 73' ' ' GLY . 25.0 mt -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.967 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.14 -42.57 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.028 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 130' ' ' VAL . 3.0 tp10 -68.99 -53.09 22.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 148' ' ' ARG . 3.5 pp -57.17 -42.63 81.49 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.945 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.801 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -67.03 -33.3 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 0.0 110.078 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -59.16 -41.8 89.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.054 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.5 mt -66.7 -38.15 86.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.912 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.7 mtp -58.25 -30.56 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' MET . . . . . 0.413 ' CE ' ' CZ ' ' A' ' 148' ' ' ARG . 2.4 mtt -76.84 -26.3 54.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.677 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.1 m -65.42 162.66 17.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 12.1 ttmm -63.58 -27.78 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.85 -53.73 51.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.923 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.414 ' CB ' ' HA ' ' A' ' 151' ' ' MET . 51.4 m-20 -91.4 -22.96 20.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.464 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -80.72 19.64 0.82 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 5.1 mmpt? -118.34 -31.87 4.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.85 0.357 . . . . 0.0 110.33 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.47 150.54 23.83 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.66 125.9 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.282 1.988 . . . . 0.0 112.458 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -83.71 154.86 65.27 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.798 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 58.4 Cg_endo -71.9 160.51 47.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.473 2.115 . . . . 0.0 112.21 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 5.6 Cg_endo -87.32 34.93 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.144 2.563 . . . . 0.0 112.902 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 169.2 163.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.009 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.29 32.98 6.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.413 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 14.7 pt20 -69.59 158.62 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.297 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 18.6 m -76.9 -168.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -99.91 -31.35 11.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 155.25 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.945 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.748 0.309 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.64 166.21 26.77 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.514 2.143 . . . . 0.0 112.338 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.77 -120.27 1.02 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.477 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.4 31.02 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -78.18 140.25 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 60.56 82.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -98.48 108.84 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.37 162.95 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.943 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.8 mt -113.74 -178.34 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -44.44 4.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.69 111.19 23.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -123.15 21.95 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m 59.97 64.93 1.18 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.894 0.378 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.24 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.85 142.95 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.31 95.53 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.11 126.39 53.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.06 179.97 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.63 120.06 0.71 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -167.65 33.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.61 -31.8 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -59.27 126.61 82.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.83 133.08 16.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.72 -37.42 4.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -73.4 106.35 5.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.58 -169.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.14 152.36 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.5 p -164.46 167.91 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -66.55 -75.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.08 178.66 43.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.58 -27.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 111.199 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 62.87 122.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -80.06 144.7 59.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.79 148.68 44.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -61.01 -38.47 86.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -60.94 -35.0 75.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.54 -54.02 49.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.2 mmt180 -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.477 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.1 mt -61.29 -39.43 90.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.6 mt -72.11 -52.82 14.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.37 -42.08 98.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 6.9 mm-40 -69.62 -29.6 67.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.491 HD13 ' HG ' ' A' ' 60' ' ' LEU . 31.7 tp -63.35 -45.18 92.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.893 0.378 . . . . 0.0 110.667 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.69 -43.31 89.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.018 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -52.81 63.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.26 -31.61 81.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.625 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.16 -41.82 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.031 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.878 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.57 173.58 43.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.576 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -154.49 -177.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 111.231 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.02 103.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.625 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.36 19.29 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.602 0.239 . . . . 0.0 111.307 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.35 43.98 35.08 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.779 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -70.18 -19.51 63.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 75' ' ' ILE . 30.1 m -155.03 172.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 111.46 1.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.742 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.478 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 31.9 p90 -102.9 97.02 7.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.686 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.13 21.55 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.108 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.957 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -105.64 143.69 33.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.788 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.38 -46.25 73.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -94.8 -49.97 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.695 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 9.9 t0 97.49 -6.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -155.68 28.49 0.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.17 162.61 14.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.289 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.1 mtp -78.92 -54.0 6.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.428 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -86.99 88.73 7.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.359 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.957 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.15 56.56 2.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -82.95 -44.01 15.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.447 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 60' ' ' LEU . 69.6 mtt-85 -77.45 139.84 39.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.303 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.474 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 71.2 m95 -135.31 144.37 46.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -102.1 120.48 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.8 108.88 2.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.675 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -95.15 150.92 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.805 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.1 mt -152.25 138.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.917 0.389 . . . . 0.0 111.743 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.31 149.28 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.169 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -91.64 120.34 6.0 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.114 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.24 141.15 95.24 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.547 2.165 . . . . 0.0 111.925 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 21.1 Cg_endo -60.37 145.81 97.91 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.877 2.385 . . . . 0.0 113.278 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 80.53 43.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.818 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 80' ' ' ARG . 4.4 p -162.75 158.72 23.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.06 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.402 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -52.53 -40.2 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.0 110.95 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 30.1 m-85 -79.69 -18.69 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.913 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.8 pt-20 -40.74 148.27 0.1 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 41.4 57.08 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.298 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.5 mmt85 -155.86 111.38 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.2 mp -66.55 165.07 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 87' ' ' ILE . 13.4 m-85 -149.43 133.31 17.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.083 0.468 . . . . 0.0 111.439 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.489 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 68.0 m -94.96 148.0 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.3 mp -151.3 160.07 43.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 14.8 mtpp -142.22 113.26 7.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 110.25 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.32 148.92 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.268 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 69' ' ' THR . 12.5 mt-10 -131.53 130.59 42.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.332 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.74 -169.16 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.59 -133.2 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.427 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 113.12 2.26 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.452 2.101 . . . . 0.0 112.146 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 60.05 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.646 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.3 t80 -83.23 -63.71 0.25 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.371 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 58.7 Cg_endo -70.91 1.83 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.666 1.578 . . . . 0.0 112.688 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -111.62 -13.77 13.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.674 0.273 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.83 61.07 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 111.312 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.49 122.43 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.614 2.209 . . . . 0.0 112.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -82.37 175.24 9.16 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.744 2.296 . . . . 0.0 112.739 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 106' ' ' ARG . 17.3 t80 -94.84 121.41 36.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.802 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 92' ' ' ILE . 38.9 t -135.04 138.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.239 0.543 . . . . 0.0 111.596 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -150.28 128.72 12.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.49 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.933 ' CE2' HD21 ' A' ' 90' ' ' LEU . 11.7 m-85 -71.55 131.93 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.97 -39.35 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.23 0.538 . . . . 0.0 109.634 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.514 HG21 ' CD2' ' A' ' 88' ' ' TYR . 5.0 t -68.59 -173.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.692 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 3.0 mmtt -99.51 69.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.439 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.746 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 153.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.8 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.11 101.91 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpp -124.89 153.52 42.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -54.89 -44.06 73.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.328 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.652 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -99.13 -6.54 55.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.277 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 123' ' ' VAL . 47.2 t -108.78 131.75 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.1 165.21 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m -113.05 -12.57 13.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 t -109.33 -33.3 6.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.32 . . . . 0.0 111.001 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -104.43 -39.61 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.03 0.443 . . . . 0.0 110.427 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.55 -1.58 69.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.053 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.9 t -58.84 112.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 116' ' ' VAL . 10.9 t -77.47 109.73 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.633 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.58 110.31 3.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.98 -19.24 62.0 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.547 2.164 . . . . 0.0 112.432 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -49.77 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.976 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.652 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -68.59 -40.93 80.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.573 ' CG2' HG12 ' A' ' 130' ' ' VAL . 29.6 mm -67.71 129.22 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -67.56 -54.56 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.636 ' CG2' HG12 ' A' ' 142' ' ' VAL . 6.7 p -50.08 -36.61 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.496 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -83.03 -44.5 15.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.8 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.88 45.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.66 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -48.83 136.89 13.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.368 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.68 -170.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.04 -36.85 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -0.53 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.552 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 142' ' ' VAL . 4.3 m-30 -72.56 154.49 40.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 111.099 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.0 p -156.07 -176.27 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 44.1 mt -54.7 -37.86 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 20.2 ttpp -61.44 -39.74 91.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.202 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.636 HG12 ' CG2' ' A' ' 130' ' ' VAL . 46.9 t -68.52 -33.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.932 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 105' ' ' VAL . 24.7 t -69.16 -53.43 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.674 HD22 HD11 ' A' ' 75' ' ' ILE . 26.8 mt -64.77 -48.32 74.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.066 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -59.45 -49.73 76.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.758 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 4.2 tp10 -60.15 -53.06 62.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.5 pp -58.33 -41.59 84.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.87 ' N ' HD12 ' A' ' 147' ' ' LEU . 8.4 tmm_? -62.61 -34.07 76.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.28 86.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.826 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.0 mt -60.83 -48.1 83.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.871 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 30.0 mtt -51.58 -35.74 42.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.776 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.6 ttm -74.04 -14.59 61.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.71 164.44 14.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.0 tttt -65.32 -48.85 71.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.25 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.06 -31.17 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.025 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.07 -25.16 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 24.4 ptm -88.1 42.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.815 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -141.19 -35.15 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.3 mt -52.88 151.11 8.88 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.317 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.77 122.58 8.98 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.144 1.896 . . . . 0.0 112.73 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HG2' HG12 ' A' ' 82' ' ' ILE . 17.2 mm-40 -86.91 152.86 54.27 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.9 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.81 118.22 5.53 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.462 2.108 . . . . 0.0 111.972 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 164' ' ' GLU . 72.4 Cg_endo -76.91 72.94 5.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.464 2.11 . . . . 0.0 112.599 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 0.2 OUTLIER 165.97 -59.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.768 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.35 18.09 10.71 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.41 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -70.3 144.56 51.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.025 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.0 m -79.7 175.82 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.647 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 109' ' ' THR . 14.9 m-85 -69.14 136.18 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.969 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.18 156.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.601 0.238 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.46 -44.48 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.455 2.104 . . . . 0.0 112.334 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.83 -161.18 24.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.561 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -132.48 141.92 49.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.6 p -80.62 60.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -87.73 -63.73 1.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.982 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -142.25 165.35 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mt -136.46 127.76 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.45 39.55 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -104.82 -51.58 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.102 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -94.36 -51.44 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t 61.71 167.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 127.43 17.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 125.93 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 t -136.12 106.1 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -108.25 31.44 5.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -155.18 76.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.66 83.1 0.35 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.548 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtm105 -67.41 152.65 45.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.808 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.69 170.96 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.37 149.94 97.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 149.46 21.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.613 2.209 . . . . 0.0 112.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -64.42 130.92 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -128.67 36.27 4.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -116.87 88.23 2.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -80.8 132.65 35.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 95.6 m -68.29 166.79 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.41 134.88 34.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.34 83.78 0.39 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.83 164.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -97.79 148.64 23.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.21 154.46 74.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.41 161.85 5.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.672 2.248 . . . . 0.0 112.066 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -54.13 -52.34 61.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.264 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -53.41 -36.91 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -52.56 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -58.19 -39.08 78.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.68 HD22 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -63.56 -53.88 44.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.765 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.5 mt -58.94 -51.48 69.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 0.0 111.226 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.75 -49.79 73.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.15 -28.61 68.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.6 tp -62.31 -42.55 99.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -30.47 65.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -74.21 -64.77 2.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.64 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.62 -44.06 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -59.35 -25.92 64.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.92 161.82 26.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.68 -178.0 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.972 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.09 -63.63 5.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.818 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.58 -6.52 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.85 31.98 32.68 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.443 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 p -72.52 -17.01 61.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 144' ' ' LEU . 35.5 m -152.14 175.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.945 0.403 . . . . 0.0 111.161 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.05 110.78 1.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.335 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 28.5 p90 -100.0 105.36 17.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.59 148.47 18.07 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.9 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.0 HD11 HD23 ' A' ' 68' ' ' LEU . 1.7 mt -54.66 130.22 39.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.956 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.97 -62.07 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.148 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 5.2 t0 -76.44 -53.6 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 5.2 t70 96.04 -3.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.041 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -158.17 29.86 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -80.44 -164.77 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.432 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.28 118.84 37.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.384 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.556 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.1 p 62.95 12.74 6.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.856 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 46.41 63.3 1.93 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.8 m -80.8 -27.47 36.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.754 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -99.64 147.79 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 111.168 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.576 ' CE2' HD11 ' A' ' 140' ' ' ILE . 70.4 m95 -134.84 160.99 36.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -130.4 118.09 20.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.36 118.41 4.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.244 -0.979 . . . . 0.0 114.178 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -92.9 150.3 20.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 90' ' ' LEU . 47.5 mt -150.02 138.0 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 111.759 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -95.34 148.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.45 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -73.21 116.01 5.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 8.4 Cg_endo -50.68 128.33 23.64 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.463 2.108 . . . . 0.0 111.873 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 33.0 Cg_exo -61.16 172.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.376 2.051 . . . . 0.0 112.598 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 3.9 mpp_? 44.42 41.78 4.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.737 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' MET . 0.6 OUTLIER -162.14 161.66 28.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.688 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.4 OUTLIER -43.91 -29.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.02 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' C ' ' A' ' 84' ' ' GLU . 68.2 m-85 -80.03 -21.01 44.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -23.9 124.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 t30 49.21 69.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.904 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.1 mmt180 -154.24 106.26 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 88' ' ' TYR . 50.3 mt -69.69 165.37 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.908 ' CE2' HD12 ' A' ' 111' ' ' ILE . 29.9 m-85 -153.2 128.19 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.033 0.444 . . . . 0.0 111.441 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.543 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 33.3 t -94.01 149.29 21.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -151.56 160.63 43.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 0.0 111.323 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 108' ' ' VAL . 26.2 mttt -136.21 115.34 12.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.3 mp -107.05 126.47 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.348 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 51.3 mt-10 -95.38 126.13 40.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.87 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 p -114.29 -178.32 3.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.98 -164.16 13.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.4 -40.58 62.14 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.661 2.241 . . . . 0.0 112.457 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 73.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.462 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 1.3 t80 -76.52 -58.48 1.15 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.432 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 59.6 Cg_endo -71.09 0.42 6.65 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.882 1.722 . . . . 0.0 112.836 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -120.09 9.72 11.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.448 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.64 20.61 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 111.551 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.0 119.78 7.27 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 0.0 112.361 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 50.9 Cg_endo -84.07 164.26 13.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.869 2.379 . . . . 0.0 112.531 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 28.7 t80 -97.94 98.58 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.491 . . . . 0.0 110.28 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.8 t -95.12 138.51 20.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.024 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.89 120.46 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 1.087 ' CD2' HG21 ' A' ' 111' ' ' ILE . 4.1 m-85 -65.87 155.53 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.743 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.487 HG21 ' HE3' ' A' ' 91' ' ' LYS . 25.0 t -110.04 -51.47 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.105 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 88' ' ' TYR . 6.7 t -67.35 -175.81 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.942 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 11.1 mmtm -88.57 110.76 21.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.087 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.4 tt -138.79 150.35 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.715 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.463 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.46 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.8 tpp -124.56 152.9 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -34.97 62.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -118.2 25.12 8.42 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.126 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.967 HG22 HG13 ' A' ' 123' ' ' VAL . 48.5 t -130.83 126.0 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.797 0.332 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.89 151.69 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 p -112.78 28.37 8.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -131.08 -55.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -105.25 -34.31 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.18 1.0 33.52 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.956 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.95 111.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.967 HG13 HG22 ' A' ' 116' ' ' VAL . 5.2 t -77.34 117.69 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.682 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.86 112.92 9.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.519 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HB3' HD23 ' A' ' 131' ' ' LEU . 36.4 Cg_endo -65.43 -17.23 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.311 2.007 . . . . 0.0 112.333 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -37.92 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.756 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.602 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -80.76 -38.29 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.509 ' CG2' HG12 ' A' ' 130' ' ' VAL . 48.8 mm -76.41 121.75 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.8 p -67.23 -55.2 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.372 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.651 HG23 ' CD2' ' A' ' 138' ' ' TYR . 14.8 p -49.97 -32.45 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 125' ' ' PRO . 1.4 mp -83.57 -50.51 8.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.71 32.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.16 52.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' HD3' ' A' ' 103' ' ' PRO . 63.2 t-105 -49.92 140.11 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 2.1 mm100 -117.67 -172.22 2.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.75 -32.81 15.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 m -78.97 -12.22 60.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.651 ' CD2' HG23 ' A' ' 130' ' ' VAL . 10.9 m-30 -72.75 152.17 41.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 111.032 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -155.98 -176.36 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.576 HD11 ' CE2' ' A' ' 71' ' ' TRP . 50.1 mt -53.96 -40.08 43.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 2.0 ptpt -60.59 -39.75 89.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 138' ' ' TYR . 34.7 t -69.27 -38.39 77.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.922 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 20.7 t -62.53 -53.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.055 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 75' ' ' ILE . 22.7 mt -63.86 -43.7 95.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.535 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -57.66 -39.95 78.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -51.49 69.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.579 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.972 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 11.6 mt -49.5 -46.07 47.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.961 0.41 . . . . 0.0 110.588 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.4 77.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.746 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -61.13 -42.76 99.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -64.64 -48.21 75.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 35.7 mtt -54.56 -27.62 40.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 25.7 mtm -76.27 -19.95 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.3 t -65.07 157.32 28.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -65.15 -46.14 82.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.35 -28.77 69.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -87.77 -27.71 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.528 ' CB ' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -88.94 22.92 2.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -124.31 -33.46 3.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.65 145.07 41.93 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.8 125.02 13.54 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.26 1.973 . . . . 0.0 112.215 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HG2' HG12 ' A' ' 82' ' ' ILE . 30.2 mm-40 -84.07 124.67 74.11 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.25 118.16 4.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.175 1.917 . . . . 0.0 111.999 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.75 87.55 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.0 112.467 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 167.91 -35.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 57.62 21.86 44.15 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.351 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.513 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.2 pt20 -70.67 158.23 36.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.4 p -78.15 145.31 35.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.148 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 2.9 m-85 -58.64 112.63 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 t -111.11 100.57 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.925 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mmm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.666 0.27 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 178.27 5.55 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.585 2.19 . . . . 0.0 112.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 123.04 139.8 5.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -108.81 165.63 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.82 127.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.31 -47.03 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.76 -46.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -160.44 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -75.38 173.54 10.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -114.0 70.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.73 109.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.09 108.78 17.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -23.2 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.26 148.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -64.37 162.47 14.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 110.87 11.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.11 100.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -114.15 99.14 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.76 165.86 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.44 22.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.523 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -90.46 129.5 36.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.745 0.307 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 22' ' ' LEU . 3.4 mm? -114.75 117.87 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -67.22 151.39 97.19 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.5 -64.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.467 2.111 . . . . 0.0 112.261 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.3 -80.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.52 -70.93 0.11 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 49.28 94.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -85.25 167.86 15.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.08 92.05 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.32 107.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.09 -118.18 2.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.409 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -68.12 148.35 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.001 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -46.06 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 34' ' ' VAL . 12.9 p -80.58 126.75 77.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.0 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.7 161.67 2.01 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.381 2.054 . . . . 0.0 112.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? -76.45 -41.81 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.6 p30 -66.09 -29.01 69.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -50.24 70.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.196 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.6 mmt85 -66.41 -36.74 83.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 43.4 mt -60.01 -41.18 91.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.2 mt -72.13 -52.73 15.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.537 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -41.34 98.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 74.4 mm-40 -70.51 -29.3 65.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.75 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 51.1 tp -61.89 -46.82 87.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.258 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.52 -49.65 74.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.876 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.93 -29.72 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -78.45 -44.14 11.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.724 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -76.8 -43.75 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.671 0.272 . . . . 0.0 111.097 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -52.86 -28.12 21.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.99 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.91 179.08 18.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -141.11 -177.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.83 -86.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.608 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.59 -16.42 61.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.569 0.224 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.845 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 71.35 31.43 65.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.2 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 56' ' ' VAL . 30.4 p -73.0 -9.52 58.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 75' ' ' ILE . 20.4 m -156.19 165.22 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.998 0.428 . . . . 0.0 111.172 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -162.0 111.04 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.406 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 27.2 p90 -101.57 130.82 47.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.36 -160.16 8.66 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.576 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 68' ' ' LEU . 5.7 mt -116.54 127.67 54.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.821 0.343 . . . . 0.0 110.951 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -51.65 -64.56 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -79.64 -64.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.961 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 3.1 t70 96.1 2.23 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.148 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -157.22 29.54 0.29 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.69 -165.34 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.278 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.84 -40.42 88.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.834 ' OG1' HD12 ' A' ' 68' ' ' LEU . 1.5 t -154.6 -117.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD12 ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER -153.88 58.61 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.904 0.383 . . . . 0.0 110.661 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 -63.66 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -72.24 98.31 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.702 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 50.9 m95 -90.2 158.52 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.78 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.57 148.58 25.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -141.62 102.13 0.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.761 -1.209 . . . . 0.0 113.754 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtp -93.96 146.15 24.13 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.827 HD13 HD11 ' A' ' 147' ' ' LEU . 52.7 mt -150.74 126.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.771 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -102.74 149.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.126 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -90.49 140.81 15.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.952 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.4 Cg_endo -83.97 136.38 6.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.792 2.328 . . . . 0.0 112.093 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 77.0 Cg_exo -48.65 144.49 14.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.641 2.228 . . . . 0.0 113.127 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 75.45 43.72 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.795 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 49.8 p -161.16 147.01 14.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.378 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.61 -36.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.052 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 49.1 m-85 -80.91 -22.36 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.963 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -39.41 148.41 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 84' ' ' GLU . 26.0 p30 41.08 47.8 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.418 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.4 mmt85 -148.39 109.86 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.692 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 88' ' ' TYR . 43.1 mt -68.52 166.15 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.57 ' N ' HG22 ' A' ' 87' ' ' ILE . 28.0 m-85 -150.25 132.33 15.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 46.8 t -93.46 147.4 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.58 160.15 43.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.102 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 4.1 mtpp -143.44 115.56 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.43 120.68 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 103' ' ' PRO . 51.0 mt-10 -94.17 124.05 37.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.1 p -113.02 -169.5 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.27 -136.97 5.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.556 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.69 130.49 26.47 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.594 2.196 . . . . 0.0 112.124 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.48 59.61 3.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.9 t80 -84.63 -55.51 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.635 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.0 Cg_endo -78.13 5.6 5.27 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.961 1.774 . . . . 0.0 112.568 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -123.74 -4.48 8.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.23 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.32 18.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.986 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' HB3' HD23 ' A' ' 131' ' ' LEU . 6.0 Cg_exo -77.26 110.97 3.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.723 2.282 . . . . 0.0 112.009 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 97.8 Cg_endo -76.78 -99.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.358 2.038 . . . . 0.0 112.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -149.9 131.45 14.84 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.731 0.3 . . . . 0.0 111.49 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 92' ' ' ILE . 44.2 t -135.54 139.51 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.332 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.3 ptt180 -150.25 141.66 23.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.955 ' CE2' HD21 ' A' ' 90' ' ' LEU . 22.8 m-85 -83.97 139.92 32.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.837 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 167' ' ' CYS . 19.1 t -93.66 -40.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.443 HG21 ' CD2' ' A' ' 88' ' ' TYR . 4.9 t -68.52 -173.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.879 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 5.4 mmtt -97.23 76.77 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 110.166 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.927 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -103.76 149.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.476 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -126.09 102.32 7.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.743 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.428 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -124.74 150.37 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -26.73 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.705 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -116.8 16.24 13.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.09 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HG13 ' A' ' 123' ' ' VAL . 76.6 t -137.61 122.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.71 165.84 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 96.4 p -117.01 21.75 13.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -51.5 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 110.586 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.536 ' CG ' HG23 ' A' ' 122' ' ' VAL . 11.6 p30 -103.11 -32.17 9.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.937 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 94.29 5.92 61.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.049 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.536 HG23 ' CG ' ' A' ' 120' ' ' ASN . 39.7 t -58.84 112.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 116' ' ' VAL . 11.9 t -78.16 106.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' GLY . 8.6 t0 -65.86 116.56 33.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HB3' HD22 ' A' ' 131' ' ' LEU . 41.1 Cg_endo -66.74 -14.89 45.65 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.403 2.069 . . . . 0.0 112.388 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -72.39 -36.11 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.782 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.705 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -84.91 -36.54 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 19.9 mm -74.42 128.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 t -67.77 -54.74 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.736 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.587 HG12 HG22 ' A' ' 128' ' ' ILE . 12.6 p -49.9 -33.01 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -85.25 -45.59 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.86 55.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -135.53 42.59 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CE3' HG22 ' A' ' 130' ' ' VAL . 73.3 t-105 -49.42 125.2 10.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 2.9 tt0 -81.93 175.83 10.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -96.45 31.45 2.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.08 9.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.812 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 135' ' ' GLN . 10.2 m-30 -75.09 177.56 6.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.734 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -156.85 -176.56 6.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.776 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 62.4 mt -57.91 -37.03 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 24.7 ttpt -62.83 -37.03 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.551 HG12 HG21 ' A' ' 130' ' ' VAL . 42.7 t -68.83 -34.8 66.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.005 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.43 -53.24 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 75' ' ' ILE . 24.5 mt -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.998 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.31 -44.82 95.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 2.6 tp10 -61.95 -53.3 57.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.867 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.3 pp -60.61 -37.97 83.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.399 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 ttp-105 -64.44 -36.2 83.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 109.932 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 45.1 mtt-85 -59.04 -40.5 85.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.701 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 147' ' ' LEU . 5.9 mt -62.13 -41.14 97.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.778 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.76 ' HE3' HD13 ' A' ' 147' ' ' LEU . 60.7 mtt -55.9 -34.98 66.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.469 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' MET . . . . . 0.426 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 10.8 mtm -75.57 -14.21 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 154.22 38.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 3.0 mttt -62.24 -50.79 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -35.41 76.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.396 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -86.78 -20.74 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.813 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -92.7 24.45 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 111.227 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -117.75 -32.02 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.501 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.3 mt -54.72 138.52 62.2 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.471 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.36 121.54 8.51 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.224 1.95 . . . . 0.0 112.729 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -87.67 113.68 55.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.33 117.8 3.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.133 1.889 . . . . 0.0 112.055 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.69 105.12 1.94 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.712 2.275 . . . . 0.0 112.336 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 167.33 -40.79 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.35 11.99 82.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.0 pt20 -70.31 158.56 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.625 ' HB2' HG12 ' A' ' 108' ' ' VAL . 31.9 p -76.39 -170.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.606 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 6.3 m-85 -90.77 -43.91 9.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.978 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -172.66 81.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.632 0.253 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.82 -43.05 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.451 2.101 . . . . 0.0 112.304 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.52 112.71 0.36 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.417 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.77 159.41 42.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.5 p -80.61 114.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.86 92.97 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -110.07 -26.22 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.224 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -58.83 99.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 11.3 p90 -176.92 143.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.8 mt 60.96 92.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 -75.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -145.96 -47.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.77 -44.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m 62.42 168.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 171.08 10.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.07 -179.02 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -83.83 75.53 10.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -100.5 31.54 3.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.14 87.6 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 139.44 14.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.497 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 114.66 26.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mt -108.12 -63.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.66 130.24 22.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.43 169.64 22.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.478 2.119 . . . . 0.0 112.325 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.1 mtm105 -102.52 36.82 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.28 -41.31 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 60.94 -175.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -86.23 115.26 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -134.83 31.46 3.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.84 -178.55 17.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.2 p -164.7 -44.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.173 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.1 mttt 59.61 174.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 m -150.61 135.23 9.66 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.16 144.11 48.86 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.353 2.035 . . . . 0.0 112.17 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -38.56 79.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -67.74 -35.38 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.92 26.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 tpp180 -57.61 -41.68 81.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.468 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 68' ' ' LEU . 22.5 mt -62.71 -36.07 81.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 mt -72.03 -52.68 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.02 -47.44 77.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 73.1 mm-40 -63.33 -32.88 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.025 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 57.8 tp -63.01 -45.46 92.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.13 -47.57 85.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -32.67 67.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.442 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -84.03 -40.64 8.54 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.688 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -69.52 -47.98 62.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.999 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -61.65 -28.6 69.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.717 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.4 174.62 15.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.593 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -127.48 138.58 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.082 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.61 -70.6 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.535 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.53 11.27 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 51' ' ' VAL . . . -75.32 110.1 2.96 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.631 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -72.66 -17.42 61.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 75' ' ' ILE . 33.1 m -93.72 176.45 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.459 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.36 112.79 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.344 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.505 ' CZ3' HG23 ' A' ' 56' ' ' VAL . 32.7 p90 -105.47 102.27 11.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.72 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.63 147.82 16.88 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.0 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.608 HD11 HD23 ' A' ' 68' ' ' LEU . 4.6 mt -55.18 155.51 4.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -31.28 42.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.849 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.92 102.94 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -68.25 42.71 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -159.74 31.69 0.19 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.36 -173.66 2.39 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.61 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.2 mtm -122.6 1.05 9.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.213 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -154.21 118.64 4.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.817 0.342 . . . . 0.0 110.538 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.66 61.47 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 94' ' ' CYS . 6.9 m -93.88 -60.72 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -69.99 91.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.634 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 88.2 m95 -89.11 160.29 17.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.713 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.65 123.39 22.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.691 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 144' ' ' LEU . . . -113.17 171.06 13.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.789 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.4 mtp -142.58 151.15 41.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.211 -0.495 . . . . 0.0 109.815 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.666 HG12 HG12 ' A' ' 56' ' ' VAL . 48.2 mt -150.27 120.91 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 111.847 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -93.37 149.1 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.253 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -88.67 143.13 17.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.65 130.36 3.75 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.984 2.456 . . . . 0.0 112.097 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 74.3 Cg_exo -48.47 141.05 20.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 113.039 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER 80.46 40.67 0.07 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 51.7 p -160.64 150.28 17.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.743 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.81 -37.53 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 111.157 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 25.3 m-85 -79.85 -22.85 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.841 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -38.52 145.65 0.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 43.18 54.72 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.123 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 64.8 mmt-85 -154.18 107.21 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.734 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 87' ' ' ILE . 3.9 mp -66.2 167.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 20.7 m-85 -150.26 128.3 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 0.0 111.018 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 17.0 t -90.05 149.7 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.332 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -152.52 160.34 43.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.035 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.0 OUTLIER -142.9 116.65 9.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 92' ' ' ILE . 5.0 mp -106.6 124.11 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.441 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.98 105.77 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' THR . 81.6 m -105.5 120.97 42.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -122.59 -145.29 6.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.524 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.89 116.55 2.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 62.32 76.71 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.598 ' CD2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.66 -62.72 0.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 47.8 Cg_endo -68.53 -1.64 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.651 1.567 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -114.67 8.88 16.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.036 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.48 143.38 3.42 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.317 . . . . 0.0 111.289 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.32 118.37 5.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.763 2.309 . . . . 0.0 112.239 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 91.5 Cg_endo -80.8 -179.61 5.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 61.3 t80 -97.04 100.09 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 92' ' ' ILE . 25.6 t -94.51 137.78 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HA ' HG23 ' A' ' 123' ' ' VAL . 2.7 ptm180 -150.28 118.58 6.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.909 ' CD2' HG21 ' A' ' 111' ' ' ILE . 15.8 m-85 -62.31 149.27 42.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.507 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.59 -42.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.144 0.497 . . . . 0.0 110.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.5 t -68.62 -176.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.009 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -92.79 76.52 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.909 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -104.99 150.1 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.868 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -125.99 102.68 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 10.5 ttm -124.45 153.97 41.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.235 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -38.22 66.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -110.74 23.96 18.32 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.925 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 123' ' ' VAL . 58.7 t -132.72 128.33 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.683 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.67 157.38 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -116.88 28.47 8.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.5 t -135.05 -52.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -105.35 -33.07 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.083 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.13 0.82 44.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.988 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.558 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 54.8 t -58.91 110.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 116' ' ' VAL . 19.5 t -77.06 115.11 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.685 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.19 115.06 17.98 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.15 -12.15 34.93 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.305 2.004 . . . . 0.0 112.605 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -33.71 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.639 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -89.02 -33.86 17.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 130' ' ' VAL . 38.0 mm -73.99 122.15 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -67.49 -54.55 19.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.364 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.659 HG23 ' CE2' ' A' ' 138' ' ' TYR . 11.4 p -49.94 -32.39 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.532 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.94 -51.76 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.28 -34.21 60.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -123.11 51.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -49.02 155.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.245 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -132.81 179.6 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -37.64 18.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -79.81 -1.51 39.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.444 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.659 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.4 m-30 -73.11 160.56 31.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.1 m -156.52 -176.55 6.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 71' ' ' TRP . 72.6 mt -59.36 -38.84 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -64.68 -34.56 78.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.37 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 138' ' ' TYR . 47.2 t -67.76 -37.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 109.409 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.2 t -66.94 -53.1 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.942 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.422 HD11 ' HA3' ' A' ' 73' ' ' GLY . 20.7 mt -61.64 -44.29 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.976 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -57.54 -41.94 81.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.11 -48.65 80.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 150' ' ' LEU . 12.7 mt -52.41 -45.99 66.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -42.44 86.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.215 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -61.96 -46.84 87.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.438 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.1 mt -61.01 -32.27 71.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.437 ' HA ' ' HB3' ' A' ' 156' ' ' ASN . 3.4 mtt -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.4 mtp -76.42 -12.7 60.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.425 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.2 m -65.22 154.59 37.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -58.58 -51.08 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -28.78 69.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.375 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 2.7 m-80 -88.16 -28.76 21.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 82' ' ' ILE . 4.0 ppp? -88.78 22.38 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.224 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -121.76 -30.37 4.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 45.5 mt -54.85 143.17 52.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 159' ' ' LEU . 16.6 Cg_exo -68.73 125.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.452 2.102 . . . . 0.0 112.779 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 24.9 mm-40 -84.97 157.47 59.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.324 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 6.7 Cg_endo -50.0 164.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.055 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.79 24.72 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.842 2.361 . . . . 0.0 113.578 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 169.59 -33.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.03 24.3 4.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 158.38 34.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 41.8 m -77.53 -176.23 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' A' ' 109' ' ' THR . 11.4 m-85 -76.84 167.45 21.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 t -175.94 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 1' ' ' MET . 94.1 Cg_endo -82.15 -39.23 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.52 2.147 . . . . 0.0 112.407 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 62.05 88.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.37 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.95 101.09 10.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 7' ' ' ALA . 11.1 p -108.98 127.73 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -55.72 -35.91 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' H ' HG22 ' A' ' 5' ' ' VAL . . . 52.22 22.64 2.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.481 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.8 t -174.45 106.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -132.04 -62.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 mt 54.84 -174.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.193 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -104.65 125.47 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.89 138.79 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -43.89 2.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -87.79 159.31 18.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -131.8 155.0 48.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 17' ' ' SER . 1.2 tt -121.08 142.15 50.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.58 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -129.27 -61.79 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' HD21 ' A' ' 16' ' ' LEU . 1.1 t70 -90.4 148.93 22.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -139.89 -54.79 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.64 -145.42 7.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -158.84 168.13 27.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.92 173.58 11.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -142.83 118.02 6.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.42 143.59 58.35 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.431 2.088 . . . . 0.0 112.223 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.19 -178.84 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -160.76 -45.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.815 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -152.32 177.77 10.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -106.37 -42.25 5.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.77 -174.2 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 60.54 108.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.49 179.05 5.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.409 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.0 p -140.9 -45.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 32' ' ' VAL . 11.9 mttm -163.41 159.96 22.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.612 ' O ' HG23 ' A' ' 34' ' ' VAL . 22.7 m -150.53 94.15 3.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.5 155.53 46.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.558 2.172 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 3.4 ppt_? -55.32 -40.37 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.049 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.411 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 26.3 m120 -59.38 -34.82 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.637 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -52.52 63.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.733 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -60.83 -34.16 74.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.524 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 79.8 mt -63.14 -48.87 76.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.805 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.0 mt -69.64 -46.28 66.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -62.71 -50.34 71.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.602 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -64.99 -28.5 69.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.774 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 60.9 tp -61.99 -44.27 97.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 110.503 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.67 -44.05 87.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -59.51 5.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 58' ' ' TRP . . . -59.35 -47.25 91.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.706 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -57.0 -47.26 81.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -53.96 44.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.993 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.19 -176.25 40.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.673 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -155.67 -178.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.06 106.64 1.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.67 13.65 9.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.56 0.219 . . . . 0.0 111.318 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 47.65 43.85 22.36 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.876 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -71.39 -16.95 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.189 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 75' ' ' ILE . 25.5 m -155.74 172.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.511 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.25 113.31 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.901 0.381 . . . . 0.0 111.197 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.469 ' HB2' HG21 ' A' ' 140' ' ' ILE . 35.9 p90 -108.11 114.85 29.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.08 -158.38 10.0 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.971 HD11 HD23 ' A' ' 68' ' ' LEU . 5.2 mt -114.26 144.87 42.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.004 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -70.64 -47.01 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -92.55 -46.34 7.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 17.4 m-20 93.46 -2.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.285 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -158.05 30.23 0.25 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 109.556 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -163.64 0.77 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.257 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.534 ' C ' HG23 ' A' ' 67' ' ' THR . 9.4 mtt -123.8 131.62 53.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.988 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 66' ' ' MET . 1.5 p 75.9 -11.25 1.15 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.971 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 46.26 57.41 5.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.809 0.337 . . . . 0.0 111.248 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -65.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.071 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 99.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.518 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 49.3 m95 -90.13 155.39 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.642 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -102.04 158.65 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.18 153.3 24.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.203 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 31.6 mtp -145.66 147.62 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.764 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 50.3 mt -151.38 120.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 111.796 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -93.77 149.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.392 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.57 140.43 16.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.825 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 93.0 Cg_endo -78.62 136.74 13.94 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.628 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.5 Cg_endo -53.52 142.6 58.95 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 112.829 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.61 42.75 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.535 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 68.9 p -160.4 154.5 23.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.846 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.59 -37.65 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 111.141 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CE1' ' OE1' ' A' ' 161' ' ' GLN . 51.4 m-85 -80.09 -22.28 42.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.907 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -40.37 136.44 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.173 0.511 . . . . 0.0 112.362 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 56.58 49.14 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.467 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -148.71 108.21 3.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.038 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.5 mp -69.08 165.4 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.604 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 23.5 m-85 -152.2 121.22 6.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.583 ' C ' HD12 ' A' ' 90' ' ' LEU . 43.0 m -88.91 151.24 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.721 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.9 mp -153.99 160.29 41.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.106 0.479 . . . . 0.0 111.511 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 2.9 mmtp -137.75 116.23 12.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.257 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.59 120.71 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.492 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 58.2 mt-10 -94.08 117.64 30.39 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.722 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.64 -169.14 1.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.767 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.21 -147.76 8.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.08 -70.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.546 2.164 . . . . 0.0 112.378 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.85 68.36 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.894 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -87.94 -61.36 0.24 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.589 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 60.8 Cg_endo -71.97 2.25 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.619 1.546 . . . . 0.0 112.764 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -119.66 7.64 11.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.659 0.266 . . . . 0.0 111.079 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.52 151.35 12.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.11 123.1 11.8 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.25 167.0 22.06 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 54.0 t80 -95.55 89.44 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.294 0.568 . . . . 0.0 110.445 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 92' ' ' ILE . 22.3 t -92.32 143.39 11.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' HA ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -149.97 118.72 6.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.035 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.896 ' CE1' HD13 ' A' ' 147' ' ' LEU . 7.9 m-85 -65.15 127.95 33.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 90' ' ' LEU . 27.1 t -84.44 -46.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.251 0.548 . . . . 0.0 110.182 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 88' ' ' TYR . 8.2 t -69.21 -175.76 0.82 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 162' ' ' PRO . 5.9 mmtt -90.52 102.79 15.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.813 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.874 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -129.7 146.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 111.63 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -125.94 102.26 7.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.656 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 3.6 ttm -125.1 159.05 32.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -55.84 -27.91 53.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.159 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.766 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -126.64 30.01 4.32 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.265 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.065 HG22 HG13 ' A' ' 123' ' ' VAL . 59.9 t -137.86 127.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -59.43 151.23 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.271 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.0 25.92 10.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.49 -46.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.505 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -102.36 -34.77 9.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.492 . . . . 0.0 109.815 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 99.16 -1.76 57.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 120' ' ' ASN . 37.5 t -58.83 110.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.065 HG13 HG22 ' A' ' 116' ' ' VAL . 4.7 t -76.17 110.8 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.75 113.27 10.24 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.944 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 39.3 Cg_endo -66.49 -15.7 48.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.381 2.054 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -36.16 67.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -88.1 -28.63 21.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.297 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 44.8 mm -80.44 132.18 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -55.34 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.534 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.67 HG13 HD12 ' A' ' 131' ' ' LEU . 7.2 p -49.88 -37.43 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.67 HD12 HG13 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.11 -46.61 10.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.11 -29.37 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -135.44 48.29 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -49.59 132.11 21.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -165.69 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -96.68 -39.01 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 t -80.76 2.51 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.688 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' A' ' 130' ' ' VAL . 5.0 m-30 -72.8 156.79 38.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 111.158 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 -176.37 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 71' ' ' TRP . 74.0 mt -55.25 -44.97 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.064 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -56.72 -37.85 71.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 138' ' ' TYR . 40.4 t -69.04 -35.95 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.996 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 18.5 t -65.71 -53.84 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.533 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 75' ' ' ILE . 24.7 mt -64.37 -45.88 85.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.888 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.34 -31.35 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.22 -52.24 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 150' ' ' LEU . 9.6 mt -49.61 -46.08 48.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -64.26 -37.92 89.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.984 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 20.2 mtt180 -63.01 -44.28 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.991 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.4 mt -65.43 -32.68 74.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.341 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 32.0 mtt -68.41 -29.11 67.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 30.2 mtm -76.23 -10.96 59.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.324 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.1 t -64.88 151.36 45.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.1 OUTLIER -52.93 -54.8 29.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -61.19 -24.78 66.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.47 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -86.88 -34.31 19.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.411 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 27.1 ptm -87.08 43.01 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.043 0.449 . . . . 0.0 110.84 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -144.23 -39.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.375 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.7 mt -52.97 145.67 22.16 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.29 124.95 14.72 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.197 1.932 . . . . 0.0 112.067 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG2' HG12 ' A' ' 82' ' ' ILE . 74.0 mm-40 -85.26 119.08 72.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.549 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 110' ' ' LYS . 56.6 Cg_exo -51.99 165.89 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.622 2.215 . . . . 0.0 112.03 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 165' ' ' GLY . 89.6 Cg_exo -43.09 175.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.03 2.487 . . . . 0.0 113.011 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 165' ' ' GLY . 4.4 mp0 -44.44 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.309 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 163' ' ' PRO . . . 20.86 50.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.795 -0.639 . . . . 0.0 114.537 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.436 ' CG ' ' CG ' ' A' ' 110' ' ' LYS . 5.3 pt20 -71.19 158.35 36.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.556 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.24 174.02 11.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -89.46 86.67 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 m -144.71 38.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.987 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.905 179.892 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.609 0.242 . . . . 0.0 111.46 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 59.8 Cg_endo -72.38 -27.78 15.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.398 2.066 . . . . 0.0 112.32 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.99 -174.31 12.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.86 134.32 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.97 -44.77 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 63.0 145.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.64 -50.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p -90.81 110.45 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.54 -170.53 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.6 mt -52.54 -51.3 60.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.21 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tttt 67.79 27.42 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 55.27 -177.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -127.72 21.95 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t 57.8 -177.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.948 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -157.38 146.36 19.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 175.18 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 122.91 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.2 77.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -176.47 170.83 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.85 89.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.23 48.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.424 . . . . 0.0 110.903 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.58 -48.5 8.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -138.63 151.18 68.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.97 -167.69 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.525 2.15 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.86 164.21 14.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.44 39.96 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -132.1 34.31 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.03 37.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 90.26 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.03 98.88 10.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.53 88.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -109.01 143.22 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.54 110.09 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.61 130.79 6.89 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 38' ' ' PHE . 51.1 Cg_exo -53.7 161.87 4.07 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.436 2.091 . . . . 0.0 112.233 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.11 -38.21 76.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.423 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -55.59 -50.8 69.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -57.86 -45.36 86.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 97.3 mt -63.87 -34.11 77.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.756 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.678 HD23 HD21 ' A' ' 68' ' ' LEU . 50.3 mt -72.12 -52.89 14.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 110.976 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.51 -49.64 68.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.6 mt-10 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.716 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.594 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.3 tp -63.44 -49.17 74.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.907 0.385 . . . . 0.0 110.588 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -54.98 -56.63 17.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.15 -25.69 59.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -72.36 -55.42 6.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.722 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -69.19 -47.87 63.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.301 . . . . 0.0 111.333 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -39.67 68.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.884 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.44 170.84 12.5 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.779 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -122.23 -177.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.77 -93.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -23.12 66.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.779 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 83.49 27.75 38.26 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.395 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -72.24 -10.32 59.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 75' ' ' ILE . 35.1 m -154.24 171.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.69 111.69 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.759 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.474 ' NE1' ' HA3' ' A' ' 47' ' ' GLY . 35.3 p90 -103.48 157.5 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.547 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.83 174.0 30.23 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.323 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -86.83 11.99 12.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.403 -0.399 . . . . 0.0 112.024 -179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 66.88 -68.47 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' LEU . 4.0 m-20 -130.3 121.91 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.787 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.43 46.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.91 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -159.24 28.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -88.8 -172.75 3.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.361 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.0 mtt -131.26 130.21 42.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.047 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.627 ' C ' HD12 ' A' ' 68' ' ' LEU . 4.5 p 59.12 18.79 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.693 ' HA ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 47.03 65.77 1.16 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.239 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.77 -55.72 3.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.57 138.84 40.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.536 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 77.3 m95 -135.36 164.73 27.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.89 -179.84 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.285 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 58' ' ' TRP . . . -164.53 159.08 31.98 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.402 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.9 mtp -144.88 148.68 34.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 147' ' ' LEU . 56.6 mt -152.3 121.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.76 149.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -98.95 148.01 18.68 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.131 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 90.6 Cg_endo -82.24 144.22 13.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.783 2.322 . . . . 0.0 112.112 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.1 Cg_endo -53.17 142.35 55.81 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.74 2.293 . . . . 0.0 112.673 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.4 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.82 41.28 0.1 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.52 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.44 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.7 p -159.93 150.0 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -47.22 -37.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 111.192 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.51 ' CD1' HG22 ' A' ' 82' ' ' ILE . 65.9 m-85 -79.95 -21.66 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.72 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -42.33 137.7 1.94 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 112.165 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.5 42.06 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.645 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 79.1 mmt-85 -144.61 107.06 4.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.6 mp -67.39 167.34 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.184 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.623 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 26.7 m-85 -147.98 125.96 12.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 38.1 t -88.84 148.7 23.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.434 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 2.9 mp -151.4 160.16 43.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.183 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -142.77 114.78 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.518 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.7 mp -106.34 149.16 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.858 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.31 125.69 29.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.568 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.35 -179.18 3.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.307 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.8 -144.57 8.18 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.64 113.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.121 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 70.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.938 0.399 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.549 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.1 t80 -83.51 -60.12 0.35 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 61.0 Cg_endo -72.31 3.35 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.869 1.712 . . . . 0.0 112.993 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.41 -6.23 10.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 111.228 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.49 151.84 44.28 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.37 123.25 12.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.65 2.234 . . . . 0.0 112.339 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.497 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 96.6 Cg_endo -80.53 173.16 12.61 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.689 2.259 . . . . 0.0 112.438 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.89 89.13 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.202 0.525 . . . . 0.0 110.455 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 143' ' ' VAL . 50.1 t -95.77 138.74 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.153 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -150.15 126.52 10.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.884 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 1.045 ' CD2' HG21 ' A' ' 111' ' ' ILE . 9.9 m-85 -73.77 135.66 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.14 -41.59 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -69.24 -178.51 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.082 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 40.6 mttt -93.43 91.02 6.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.744 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -121.48 144.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -122.7 102.99 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.0 ttm -124.34 157.35 35.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -54.22 -38.67 65.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.663 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . . . -112.36 25.98 11.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.958 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.907 HG22 HG13 ' A' ' 123' ' ' VAL . 81.1 t -137.72 126.62 33.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -59.81 149.32 31.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.07 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -110.9 28.43 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.792 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.64 -46.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -103.79 -33.68 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 0.0 110.027 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.7 -4.45 56.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.753 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.3 t -58.83 115.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 116' ' ' VAL . 11.8 t -76.74 108.13 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.619 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 115' ' ' GLY . 3.5 t0 -64.95 110.73 4.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 131' ' ' LEU . 43.2 Cg_endo -67.61 -13.12 37.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.992 . . . . 0.0 112.433 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -30.51 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.663 ' HB3' ' CA ' ' A' ' 115' ' ' GLY . . . -93.09 -48.08 6.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.654 ' CG2' HG12 ' A' ' 130' ' ' VAL . 24.5 mm -61.02 131.51 26.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.7 p -67.49 -54.47 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.454 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.654 HG12 ' CG2' ' A' ' 128' ' ' ILE . 7.2 p -49.87 -32.79 8.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.552 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 125' ' ' PRO . 61.9 mt -84.24 -53.03 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.722 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.45 -24.06 18.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.512 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -136.73 45.12 2.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 111.016 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 70.5 t-105 -50.38 138.5 16.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.053 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -108.36 -170.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.925 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.57 -40.52 12.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.46 1.92 27.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.552 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.618 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 m-30 -72.75 151.76 41.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.3 p -155.43 -176.33 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.805 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.491 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 65.6 mt -51.19 -48.08 32.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.26 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -55.37 -39.48 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.659 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 45.7 t -69.03 -37.61 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.289 0.566 . . . . 0.0 110.017 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 105' ' ' VAL . 22.4 t -63.38 -53.77 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.093 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 75' ' ' ILE . 25.7 mt -64.98 -45.06 87.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.878 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -61.34 -51.08 70.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.075 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -59.76 -53.47 57.6 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -57.59 -37.7 73.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.056 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.741 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.6 tmt_? -64.49 -33.8 76.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.695 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.35 89.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.899 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.7 mt -62.63 -40.45 97.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.451 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 22.9 mtt -55.22 -34.7 64.16 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.615 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.3 mtm -75.43 -13.96 60.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.103 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 t -65.56 158.31 27.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 15.7 mttm -65.41 -49.87 67.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.14 -30.07 70.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.321 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -86.91 -26.17 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.653 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -89.74 46.66 1.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -143.17 -39.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.35 155.62 9.37 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.589 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.11 142.16 60.28 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.288 1.992 . . . . 0.0 111.8 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 82' ' ' ILE . 6.3 mm-40 -146.63 98.67 4.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.47 149.09 18.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.477 2.118 . . . . 0.0 112.199 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.84 158.68 55.19 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.565 2.177 . . . . 0.0 112.458 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.4 ' OE1' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -48.64 174.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.34 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.4 -66.84 1.72 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -69.72 158.48 35.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.4 m -157.64 169.72 24.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 110' ' ' LYS . 16.2 m-85 -74.39 84.15 1.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.2 m -120.09 166.12 13.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.865 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.87 -28.27 24.95 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.87 -156.14 20.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.409 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -80.48 76.48 7.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.73 118.59 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 66.34 -76.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -145.7 -50.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 1.8 p 84.13 -19.56 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.685 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.2 t80 66.89 -70.77 0.1 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.75 0.31 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.25 148.44 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -159.84 174.87 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 60.62 -179.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -71.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.3 p -120.69 29.98 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 62.52 123.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 16' ' ' LEU . 1.3 pp -152.83 100.81 2.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -138.99 121.55 16.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.62 -34.55 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 61.31 -178.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.96 134.5 4.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.81 76.12 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -160.96 127.25 3.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.13 126.59 28.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.827 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.37 -62.47 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.405 2.07 . . . . 0.0 112.295 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -84.38 178.35 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -151.99 -57.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.96 178.2 4.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -151.32 -178.29 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -91.86 96.15 10.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -104.16 105.58 15.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 32' ' ' VAL . . . 93.29 -107.31 3.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.428 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 32' ' ' VAL . 12.6 p 43.67 36.25 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.649 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 155.94 34.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.14 114.38 46.29 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 38' ' ' PHE . 36.9 Cg_endo -65.88 161.95 37.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.423 2.082 . . . . 0.0 112.229 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.69 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.1 tmm_? -55.8 -51.31 67.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.0 m120 -54.96 -35.61 64.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CD1' ' HG2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -55.36 -51.91 65.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.664 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 12.9 mmt-85 -57.95 -40.32 80.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD2' ' A' ' 98' ' ' TYR . 90.5 mt -61.82 -50.67 71.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 79.8 mt -62.81 -51.59 66.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.453 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.97 -47.97 82.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.097 0.475 . . . . 0.0 110.303 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 51.0 mt-10 -67.93 -26.66 66.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.464 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 43.1 tp -60.7 -45.35 94.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.12 -37.08 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.43 -42.59 78.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.476 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -77.01 -40.64 24.63 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.676 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -66.1 -40.58 90.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -59.28 -76.16 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.12 165.68 36.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -148.51 -177.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.365 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.12 104.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.933 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 56.53 22.28 6.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.595 0.236 . . . . 0.0 111.497 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.472 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.07 46.35 50.66 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.794 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.6 p -71.4 -22.5 61.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.273 . . . . 0.0 111.206 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG12 HG12 ' A' ' 75' ' ' ILE . 28.1 m -154.93 173.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.78 110.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.341 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.49 ' CH2' HG11 ' A' ' 51' ' ' VAL . 26.5 p90 -99.92 96.26 7.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -105.66 -152.95 20.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.585 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 60' ' ' LEU . 4.9 mt -121.81 147.61 45.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 111.148 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.69 -41.64 86.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.954 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 5.7 t0 -110.23 -49.75 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 11.0 t0 95.61 -2.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.278 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.93 30.03 0.26 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.55 166.29 16.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.276 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.1 mtm -83.37 1.36 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 p -154.55 103.1 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD12 HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -82.99 58.46 4.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.723 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.85 -56.28 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.59 105.35 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.431 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 30.4 m95 -89.5 150.86 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.669 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -101.99 113.29 26.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -110.75 106.54 2.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.913 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtp -90.63 147.32 23.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 90' ' ' LEU . 56.8 mt -149.61 150.14 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.872 0.368 . . . . 0.0 111.447 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mt -105.89 148.83 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.231 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -76.09 117.22 5.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.256 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 5.9 Cg_endo -48.8 142.56 18.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.425 2.083 . . . . 0.0 112.0 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 61.0 Cg_endo -73.01 175.97 9.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.418 2.079 . . . . 0.0 112.753 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 40.92 41.8 1.33 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.592 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 80' ' ' ARG . 6.8 p -162.0 160.97 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -43.65 -28.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.883 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 84' ' ' GLU . 72.0 m-85 -79.58 -22.09 44.2 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -24.16 125.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 45.55 72.9 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 22.5 mmt180 -157.43 104.66 2.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -66.02 167.64 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' N ' HG22 ' A' ' 87' ' ' ILE . 60.1 m-85 -153.4 128.67 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.546 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -93.17 145.87 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.82 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.5 mp -149.43 160.44 43.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.282 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.9 OUTLIER -138.61 111.49 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.188 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.0 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.33 120.15 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -93.85 133.16 37.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.739 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 98' ' ' TYR . 21.5 p -115.35 -169.3 1.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.14 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.85 -147.04 15.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.234 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.6 119.03 4.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.478 2.119 . . . . 0.0 111.999 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp 59.46 75.19 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.852 0.358 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.811 ' CD2' HD21 ' A' ' 40' ' ' LEU . 6.1 t80 -86.52 -54.49 0.39 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.84 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.6 Cg_endo -82.57 8.76 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.991 1.794 . . . . 0.0 112.236 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.92 3.87 7.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.81 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.21 143.34 3.57 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.61 110.95 2.48 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.847 2.365 . . . . 0.0 112.632 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 73.0 Cg_endo -76.9 -96.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.505 2.137 . . . . 0.0 112.416 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.773 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 59.8 t80 -148.17 136.02 20.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.894 0.378 . . . . 0.0 111.651 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.0 HG22 HG23 ' A' ' 92' ' ' ILE . 38.6 t -135.75 140.28 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.395 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.4 ptt180 -150.5 139.43 20.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.965 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 1.065 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.8 m-85 -77.44 114.83 16.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.868 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.65 -46.68 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.164 0.507 . . . . 0.0 110.273 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 88' ' ' TYR . 9.5 t -68.6 -179.83 1.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.06 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.409 ' HB3' ' HG3' ' A' ' 162' ' ' PRO . 27.3 mttt -88.68 120.22 29.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.065 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -157.84 153.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.506 ' N ' HD13 ' A' ' 111' ' ' ILE . 52.5 m-20 -125.94 102.03 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.43 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 150' ' ' LEU . 7.6 ttm -125.24 143.49 50.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 113' ' ' MET . 2.4 m-80 -58.03 79.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.008 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 113' ' ' MET . . . 145.94 -35.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.284 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.921 HG22 HG13 ' A' ' 123' ' ' VAL . 58.5 t -89.16 139.3 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -59.71 138.45 57.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.0 p -96.14 48.88 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 p -178.07 -38.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.464 ' HB3' HG23 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -102.45 -37.73 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.095 0.474 . . . . 0.0 109.991 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.16 -5.58 61.24 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.126 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.773 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 24.4 t -58.54 111.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.089 0.444 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 116' ' ' VAL . 7.4 t -77.08 110.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.477 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.59 110.28 3.84 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.0 Cg_exo -62.2 -17.71 58.3 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.353 2.035 . . . . 0.0 112.326 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -72.43 -43.79 63.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.6 63.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.79 HG23 ' OE1' ' A' ' 146' ' ' GLU . 44.4 mm -81.91 130.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -59.88 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 146' ' ' GLU . 12.5 m -49.7 -30.82 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.662 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 mp -84.39 -45.22 12.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.21 -63.38 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 58.89 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -49.15 164.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -152.98 173.92 14.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.49 -27.24 63.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.194 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.52 -24.76 41.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 142' ' ' VAL . 14.8 m-85 -73.56 144.72 45.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.256 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.81 -176.32 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.364 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 58' ' ' TRP . 62.5 mt -50.09 -39.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.715 0.293 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 14.6 ttpp -61.7 -45.73 92.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.328 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 138' ' ' TYR . 19.4 t -67.45 -35.6 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.884 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.9 t -62.99 -53.81 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.917 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 75' ' ' ILE . 21.6 mt -64.36 -44.6 90.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.556 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -57.66 -40.62 79.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.985 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.889 ' OE1' HD11 ' A' ' 150' ' ' LEU . 2.7 tm-20 -59.97 -53.03 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.91 HD13 ' CE1' ' A' ' 107' ' ' PHE . 7.5 mt -50.25 -45.9 54.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -62.94 -38.15 89.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.755 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -46.52 88.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.206 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' OE1' ' A' ' 146' ' ' GLU . 1.6 mt -59.43 -46.28 89.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.34 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 2.5 mtt -61.13 -25.41 66.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -75.76 -20.4 58.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -65.26 154.57 37.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 11.6 mttm -65.13 -45.79 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -27.38 68.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.41 -27.67 22.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.348 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -89.72 45.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.098 0.475 . . . . 0.0 110.698 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -138.82 -38.56 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.1 mt -53.18 147.3 18.22 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.461 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.83 125.89 12.05 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.285 1.99 . . . . 0.0 112.535 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -83.7 157.39 64.07 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 110' ' ' LYS . 36.8 Cg_exo -56.88 165.19 5.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 112.207 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.52 19.86 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.806 2.337 . . . . 0.0 112.967 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 168.44 -174.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.62 21.99 40.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.62 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.12 158.12 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 29.4 p -78.74 -168.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 2.2 m-85 -85.11 155.79 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.47 32.92 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.78 -46.42 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.598 2.199 . . . . 0.0 112.295 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.81 -90.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.32 74.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.11 -48.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 43.74 68.49 0.52 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.463 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.71 -44.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 m 61.62 159.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 1.2 p90 -157.48 161.1 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.763 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 9' ' ' TYR . 8.2 mt 74.0 -59.56 0.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.58 79.68 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -158.35 133.95 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.55 -60.79 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -171.41 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 109.44 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.67 113.47 26.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 p -160.74 176.95 10.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -128.04 -44.22 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 69.0 -67.69 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.84 -106.76 0.55 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 174.44 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD12 ' HB2' ' A' ' 23' ' ' GLU . 3.2 pp -103.81 -38.13 7.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' HB2' HD12 ' A' ' 22' ' ' LEU . 22.8 mt-10 -158.19 102.24 1.72 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.66 58.54 6.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.599 2.199 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -69.78 -69.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.91 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.69 102.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -132.28 101.63 5.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.04 83.48 2.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.72 91.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.06 29.0 0.52 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 32' ' ' VAL . 23.4 m -62.49 102.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.062 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -159.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -78.58 142.05 61.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.644 0.259 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.5 151.86 22.73 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.675 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.5 tmm_? -56.0 -48.95 74.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -32.9 51.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -54.93 37.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.3 mmt-85 -57.52 -37.74 73.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 110.196 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 36' ' ' ARG . 91.9 mt -61.87 -38.35 87.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.25 -52.74 15.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.396 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -63.51 -50.02 71.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 91.5 mt-10 -60.34 -32.34 71.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.551 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.8 tp -62.66 -43.7 98.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.941 0.401 . . . . 0.0 110.38 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.73 -56.13 26.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.25 -45.02 84.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -65.08 -44.31 94.41 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.768 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -67.8 -48.04 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.185 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -22.84 64.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.83 167.18 27.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.265 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -115.62 -176.96 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 0.0 111.163 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -47.14 -86.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.195 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.91 -14.42 61.05 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 72.92 37.73 56.54 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.26 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -72.35 -17.1 61.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.59 0.233 . . . . 0.0 111.53 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 75' ' ' ILE . 31.8 m -154.26 174.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.942 0.401 . . . . 0.0 111.336 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.78 111.07 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.272 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.495 ' HB2' HG21 ' A' ' 140' ' ' ILE . 34.8 p90 -103.01 73.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.042 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.41 -170.29 46.36 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.773 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.048 HD11 HD23 ' A' ' 68' ' ' LEU . 2.5 mt -104.72 141.7 36.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.845 0.355 . . . . 0.0 111.035 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.6 -32.64 73.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.6 t70 -169.4 129.98 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.64 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.76 33.38 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 62' ' ' ASP . 34.5 mm-40 -158.81 29.33 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.62 1.94 47.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.824 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.58 113.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.011 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.401 ' C ' HD12 ' A' ' 68' ' ' LEU . 2.8 p 62.35 15.56 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.601 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER 44.71 47.15 8.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -58.17 -65.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 146.28 52.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 63.8 m95 -134.9 146.68 49.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -102.04 121.44 42.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -118.44 109.8 1.83 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.679 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mtp -94.33 152.47 18.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 147' ' ' LEU . 37.4 mt -152.31 129.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 111.697 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.8 mt -102.85 149.26 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -85.09 143.42 20.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.02 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.2 Cg_endo -84.2 134.02 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.826 2.351 . . . . 0.0 111.942 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 71.0 Cg_exo -48.79 143.22 17.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.502 2.135 . . . . 0.0 112.987 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER 74.17 43.97 0.27 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.504 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 30.7 p -160.06 149.45 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.623 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -46.91 -36.82 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.065 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 94.4 m-85 -80.27 -22.27 41.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.1 pt-20 -42.54 133.09 3.47 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.79 11.91 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.622 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -115.28 104.17 11.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 88' ' ' TYR . 40.5 mt -61.79 169.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.282 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.607 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.4 m-85 -152.42 129.73 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.389 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.6 m -93.84 146.41 23.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.83 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -151.06 160.19 44.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.5 mtpt -141.68 114.53 8.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.72 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.13 120.79 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.182 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.08 126.78 40.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.8 p -113.53 -172.02 1.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.19 -140.08 7.77 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.589 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.72 120.46 5.94 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.205 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mttt 51.44 70.3 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -88.58 -63.0 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 70.5 Cg_endo -73.47 3.7 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.605 1.536 . . . . 0.0 112.478 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.54 -4.43 12.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.33 161.26 29.81 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.59 123.88 14.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.655 2.237 . . . . 0.0 112.474 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.17 171.76 15.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.641 2.228 . . . . 0.0 112.31 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -96.39 89.37 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.473 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 92' ' ' ILE . 25.6 t -93.71 139.3 18.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.455 HH12 HG22 ' A' ' 108' ' ' VAL . 2.9 ptm180 -150.42 120.22 7.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.935 ' CD2' HG21 ' A' ' 111' ' ' ILE . 20.5 m-85 -65.56 139.44 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG22 HH12 ' A' ' 106' ' ' ARG . 21.0 t -91.45 -42.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.865 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.409 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -69.05 -178.63 1.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.803 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 166' ' ' GLN . 0.3 OUTLIER -93.36 76.44 4.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.935 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -99.6 152.0 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.475 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.73 102.48 7.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.676 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.477 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 12.4 ttm -124.69 148.01 48.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.236 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.02 -28.36 51.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -120.07 28.01 6.52 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.012 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.018 HG22 HG13 ' A' ' 123' ' ' VAL . 94.1 t -136.25 131.99 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 110.726 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -59.49 132.34 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.993 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 m -97.81 31.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.987 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -141.38 -48.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.28 -34.73 7.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 106.08 -4.12 38.45 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 113.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.796 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 116' ' ' VAL . 10.2 t -76.76 119.41 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.726 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER -65.33 110.72 4.69 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.49 -20.8 71.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.383 2.056 . . . . 0.0 112.407 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -45.04 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.806 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.568 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -71.48 -52.41 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.543 ' CG2' HG12 ' A' ' 130' ' ' VAL . 14.6 mm -58.1 128.1 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.0 t -67.39 -56.32 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.453 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 138' ' ' TYR . 9.2 p -49.95 -30.84 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.352 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.06 -55.06 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.06 -25.08 19.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.272 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -134.2 51.04 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CZ3' ' CD ' ' A' ' 103' ' ' PRO . 57.0 t-105 -49.44 160.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.246 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 3.1 tt0 -140.62 177.16 8.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -77.32 -39.74 46.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 m -80.0 0.36 31.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.561 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.1 m-30 -72.78 149.66 43.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.962 0.411 . . . . 0.0 111.151 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -155.7 -176.45 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.36 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 31.7 mt -58.17 -37.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.721 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 6.5 ttpm? -62.04 -40.17 94.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 138' ' ' TYR . 22.0 t -67.88 -40.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.678 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 105' ' ' VAL . 32.2 t -61.13 -53.22 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.328 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 75' ' ' ILE . 27.0 mt -64.14 -44.8 91.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.847 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.31 -48.85 79.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.641 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 142' ' ' VAL . 1.5 tp10 -60.0 -53.26 59.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.6 pp -57.77 -41.0 81.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.814 0.34 . . . . 0.0 110.45 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.796 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.3 tmm_? -63.83 -33.09 74.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.168 0.509 . . . . 0.0 109.876 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -58.5 -44.85 89.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.101 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.8 mt -61.82 -41.97 98.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.887 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.418 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 14.7 mtt -56.44 -29.43 61.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 9.7 mtm -74.21 -22.69 59.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.3 t -65.96 158.09 29.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.054 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 6.2 mttt -65.41 -36.03 82.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.151 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.6 -44.33 97.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.008 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 20.4 m-20 -87.7 -20.8 25.74 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.472 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -88.74 23.43 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.81 -30.99 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.276 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.0 mt -54.71 145.5 40.4 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.83 124.69 10.87 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.263 1.976 . . . . 0.0 112.673 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 7.1 mm-40 -85.06 158.04 59.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.832 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 40.6 Cg_endo -66.76 118.25 5.4 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.333 2.022 . . . . 0.0 111.932 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 12.0 Cg_exo -70.99 55.79 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.768 2.312 . . . . 0.0 112.882 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 165.12 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.823 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -93.9 45.67 2.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.131 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 7.2 mm-40 -69.72 159.06 34.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 0.0 111.436 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.0 m -160.0 135.57 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CE1' ' HE2' ' A' ' 110' ' ' LYS . 24.6 m-85 -46.61 146.81 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.422 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.3 84.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.825 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.666 0.27 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.4 141.13 34.63 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.522 2.148 . . . . 0.0 112.271 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.04 -73.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.28 92.18 3.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 5' ' ' VAL . 9.4 p -101.49 53.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 127.4 32.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.38 22.55 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.297 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m 62.04 108.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -69.9 147.51 50.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.4 mt 60.0 161.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -160.56 170.94 19.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -121.22 179.53 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -132.26 -50.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 p -168.73 153.9 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -82.8 -32.1 27.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -171.25 125.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 m -156.47 86.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.39 87.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -165.68 110.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.18 93.78 1.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.54 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.61 30.79 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.42 105.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.73 142.57 25.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 59.71 6.32 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 112.337 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.89 88.53 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -165.56 -44.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.78 95.68 7.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 150.77 20.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.07 -80.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttp 53.33 94.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.36 93.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.577 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 32' ' ' VAL . 15.3 t -136.76 32.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -176.99 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.667 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 34' ' ' VAL . 17.7 m -79.47 112.62 30.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 22.5 Cg_exo -64.81 137.53 54.02 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.676 HH11 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 82.24 -48.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.755 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HG3' ' A' ' 36' ' ' ARG . 5.0 m120 -71.26 -44.85 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -58.16 -44.39 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 0.0 110.455 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -60.59 -40.48 91.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.365 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.676 HD11 HH11 ' A' ' 36' ' ' ARG . 80.4 mt -60.58 -53.65 54.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.888 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.55 -50.82 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.7 -43.98 97.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 89.6 mt-10 -71.71 -27.79 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.32 -46.01 91.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.84 0.352 . . . . 0.0 110.586 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 13.6 mt-10 -68.47 -44.06 75.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -27.72 43.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.484 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -88.13 -30.44 17.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -83.47 -43.7 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 10.0 mmtt -58.45 -62.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.898 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 174.71 45.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.737 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -153.04 -177.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.85 105.09 1.37 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.49 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 66.89 14.09 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.556 0.217 . . . . 0.0 111.33 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.737 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.05 41.33 29.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.875 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 p -71.43 -18.91 62.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 111.13 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' HG21 ' A' ' 51' ' ' VAL . 21.1 m -155.1 169.8 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 m -161.73 110.99 1.54 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.675 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' CH2' HG11 ' A' ' 51' ' ' VAL . 32.4 p90 -103.81 143.45 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -151.82 -136.09 2.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.039 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.945 HD11 HD23 ' A' ' 68' ' ' LEU . 10.6 mt -132.61 133.04 43.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.743 0.306 . . . . 0.0 110.905 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.14 -53.56 56.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.038 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 9.0 t70 -110.05 -48.62 3.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.969 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.743 ' HA ' HD13 ' A' ' 60' ' ' LEU . 2.5 t70 95.96 21.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.968 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -157.17 29.53 0.3 Allowed 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.04 -166.03 1.42 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.205 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.52 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -84.97 109.71 18.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 66' ' ' MET . 15.0 t 46.7 35.6 3.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.945 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 55.52 80.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 94' ' ' CYS . 2.9 m -97.78 -61.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.2 93.62 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.675 ' CE3' HD13 ' A' ' 140' ' ' ILE . 40.5 m95 -90.06 152.63 21.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.01 152.08 21.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.724 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -143.71 102.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.629 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.4 mtp -94.17 147.06 23.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 147' ' ' LEU . 45.5 mt -151.78 138.06 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.74 0.305 . . . . 0.0 111.588 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mt -99.26 148.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.118 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 83' ' ' TYR . . . -78.69 117.97 4.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.266 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 Cg_endo -54.41 146.86 49.61 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.163 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 13.4 Cg_exo -69.3 173.64 10.26 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.635 2.224 . . . . 0.0 112.73 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 41.48 43.14 2.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.792 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 80' ' ' ARG . 19.9 p -161.3 158.17 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.42 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.517 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -44.32 -27.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.541 ' CZ ' ' NE2' ' A' ' 161' ' ' GLN . 53.6 m-85 -78.79 -24.56 44.54 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -22.01 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.21 65.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.753 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 9.4 mmt180 -152.87 102.9 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 88' ' ' TYR . 11.0 mt -67.56 168.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.208 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.587 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.9 m-85 -150.34 132.91 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 0.0 110.992 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 48.7 m -94.18 146.7 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.296 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.855 HD21 ' CE2' ' A' ' 107' ' ' PHE . 3.8 mp -151.7 159.89 43.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.96 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.624 ' HE3' HG21 ' A' ' 108' ' ' VAL . 28.1 mttt -144.54 117.91 9.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.519 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 105' ' ' VAL . 5.0 mp -106.2 123.65 61.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -93.82 108.67 20.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.794 ' O ' HG23 ' A' ' 69' ' ' THR . 57.4 m -113.54 152.55 30.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.65 -149.36 4.95 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.592 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.78 -48.63 18.54 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.665 2.243 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 77.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -101.79 -66.68 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 98' ' ' TYR . 55.2 Cg_endo -69.76 -0.94 7.63 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.346 1.364 . . . . 0.0 112.312 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.22 -4.69 16.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.986 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.61 144.22 8.01 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 120.836 0.351 . . . . 0.0 111.308 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.01 110.07 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.868 2.378 . . . . 0.0 112.042 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 41.6 Cg_endo -67.56 -176.17 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.444 2.096 . . . . 0.0 112.244 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -94.76 94.63 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 111.197 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.719 HG22 HG23 ' A' ' 92' ' ' ILE . 44.6 t -96.32 138.54 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.781 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' A' ' 123' ' ' VAL . 1.9 ptm180 -150.22 126.12 10.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.864 ' CD2' HG21 ' A' ' 111' ' ' ILE . 25.1 m-85 -68.1 126.78 30.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 91' ' ' LYS . 38.2 t -78.35 -41.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.262 0.553 . . . . 0.0 109.948 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.4 t -68.41 -175.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.828 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' A' ' 168' ' ' TYR . 11.9 mttt -98.83 68.02 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.512 . . . . 0.0 110.274 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.864 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.343 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.47 101.89 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.1 ttm -125.2 157.5 36.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -54.67 -52.86 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -89.19 -11.64 64.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.109 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 1.011 HG22 HG13 ' A' ' 123' ' ' VAL . 43.7 t -107.19 121.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.42 143.75 52.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.925 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -98.25 29.15 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 p -140.0 -43.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.628 ' HB3' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -102.23 -32.74 9.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 110.033 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -3.16 81.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.874 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 120' ' ' ASN . 46.3 t -58.96 110.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.011 HG13 HG22 ' A' ' 116' ' ' VAL . 3.4 t -77.69 107.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -63.77 109.99 3.25 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.849 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.401 ' CB ' HD23 ' A' ' 131' ' ' LEU . 39.1 Cg_exo -60.41 -23.28 74.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.323 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -41.33 66.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.532 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -74.65 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 123' ' ' VAL . 35.5 mm -75.46 133.25 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.734 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.5 -58.84 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.016 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 HG12 ' A' ' 142' ' ' VAL . 14.9 p -49.85 -33.91 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.795 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD1' HG13 ' A' ' 130' ' ' VAL . 7.4 mp -81.91 -41.85 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.84 69.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.86 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 47.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -48.03 157.22 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.28 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 179.28 7.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 9.0 p30 -78.71 -31.98 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -79.13 -12.77 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.226 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.541 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.2 m-30 -72.87 153.74 40.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -156.16 -176.39 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.675 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.9 mt -54.92 -35.14 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.497 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -67.39 -38.93 85.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.707 HG12 HG21 ' A' ' 130' ' ' VAL . 49.1 t -68.63 -37.67 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HA ' HG11 ' A' ' 130' ' ' VAL . 38.5 t -63.5 -52.9 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.551 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.672 HD22 HD11 ' A' ' 75' ' ' ILE . 42.6 mt -62.48 -43.68 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.956 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -61.96 -51.11 69.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.054 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -59.8 -53.36 58.82 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 75' ' ' ILE . 4.6 pp -56.08 -40.76 74.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.987 0.422 . . . . 0.0 110.134 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 ttt-85 -62.6 -34.16 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.73 -38.47 78.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.538 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.6 mt -64.08 -41.48 97.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 34.7 mtt -55.7 -32.36 63.24 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.283 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -19.82 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.949 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -65.12 159.83 22.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' MET . 4.6 mtpm? -65.21 -36.01 82.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.301 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.78 -35.86 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -89.57 -11.63 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 14.1 ptm -90.61 24.57 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 111.187 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.07 -37.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.823 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.7 mt -54.37 157.66 4.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.413 ' C ' ' HG2' ' A' ' 161' ' ' GLN . 44.0 Cg_endo -66.11 146.59 82.31 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.326 2.017 . . . . 0.0 112.116 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.541 ' NE2' ' CZ ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -146.26 103.04 4.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.586 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 52.2 Cg_exo -55.74 117.96 4.66 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.374 2.049 . . . . 0.0 112.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 2.2 Cg_endo -81.49 90.4 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.813 2.342 . . . . 0.0 112.321 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.54 -173.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.876 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.27 30.62 8.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.369 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.09 158.63 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 83.8 m -155.99 154.3 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.609 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 109' ' ' THR . 24.7 m-85 -54.64 111.08 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.1 m -142.37 30.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.917 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.653 0.263 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.17 128.51 22.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.547 2.164 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.03 -110.39 3.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.438 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.34 167.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 5' ' ' VAL . 14.3 p -98.21 42.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.999 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.85 90.74 0.81 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.56 -37.32 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 m -85.66 125.72 33.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.97 158.66 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mt 60.31 176.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tttt 68.25 -69.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m 63.14 130.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.952 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -130.17 -72.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p 55.72 -171.27 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.45 120.05 6.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.19 138.2 31.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.01 -169.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.79 37.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.07 56.13 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -152.04 17.26 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 64.52 -78.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.7 139.97 47.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.64 127.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.22 -168.17 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.5 2.133 . . . . 0.0 112.232 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -126.52 36.44 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt 65.07 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.1 87.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -171.48 115.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.2 m -76.41 112.97 13.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.57 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.043 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.46 8.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -133.21 141.98 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -117.71 -66.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -80.03 128.03 75.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.53 152.09 17.04 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.35 2.033 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -66.07 -40.94 91.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -65.02 -34.81 79.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -55.72 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.3 mmt180 -58.47 -39.26 79.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.812 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 84.1 mt -61.72 -40.31 94.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.16 -52.57 15.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.64 -43.18 99.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.921 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 72.7 mm-40 -68.63 -29.72 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.797 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 64.0 tp -62.85 -47.13 84.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.6 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -58.11 -41.63 83.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -66.45 -62.81 4.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.586 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -52.28 -39.7 60.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.987 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -72.74 -27.48 62.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.57 170.01 22.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.515 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -113.04 -177.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.9 -76.72 0.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' HG23 ' A' ' 55' ' ' THR . 0.5 OUTLIER -73.95 -14.27 61.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.222 . . . . 0.0 111.288 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 68.6 28.65 73.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.44 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 53' ' ' ASP . 13.9 p -71.88 -12.32 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.585 0.231 . . . . 0.0 111.426 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.847 HG12 HG12 ' A' ' 75' ' ' ILE . 3.9 m -154.21 161.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.776 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.01 124.83 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.795 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ3' HG23 ' A' ' 56' ' ' VAL . 4.4 p90 -114.87 -179.12 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.28 44.12 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.057 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD23 ' A' ' 68' ' ' LEU . 4.7 mt -99.46 120.79 40.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.981 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.41 -34.77 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -101.05 -53.89 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 9.6 t0 94.91 1.55 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -158.63 30.03 0.23 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.333 0.587 . . . . 0.0 109.598 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.62 -165.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.306 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mtt -111.74 122.14 46.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.519 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.4 p 61.1 17.18 7.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.522 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER 47.35 70.74 0.38 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 m -75.01 -68.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.31 142.68 50.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.752 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.812 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 92.0 m95 -135.17 144.16 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.293 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 159.9 14.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 156.81 26.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.885 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 24.5 mtp -145.48 147.25 31.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.712 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.847 HG12 HG12 ' A' ' 56' ' ' VAL . 41.3 mt -150.57 120.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.823 0.344 . . . . 0.0 111.759 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mt -86.66 149.21 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.429 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -74.69 134.0 16.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.844 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 84.1 Cg_endo -78.39 127.61 8.32 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.192 . . . . 0.0 111.737 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.8 Cg_endo -50.04 141.21 30.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.628 2.219 . . . . 0.0 112.727 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 75.4 44.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.235 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 17.6 p -159.4 154.55 25.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.442 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.11 -38.51 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.989 0.424 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 42.3 m-85 -80.35 -20.62 43.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.026 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.4 pt-20 -41.85 133.06 2.93 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 66.99 41.38 2.7 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.553 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 84' ' ' GLU . 2.4 mpt_? -149.59 115.7 5.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.718 0.294 . . . . 0.0 111.362 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 88' ' ' TYR . 37.1 mt -65.57 168.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.021 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 22.5 m-85 -153.32 119.53 5.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.586 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.8 m -88.77 153.17 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.632 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.0 mp -153.75 160.28 42.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.369 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -137.87 114.16 10.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.452 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.003 HG23 HG22 ' A' ' 105' ' ' VAL . 4.4 mp -106.19 121.45 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.494 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 40.4 mt-10 -94.25 127.6 40.21 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.787 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 83.8 m -132.19 121.46 23.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.69 -153.02 25.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.423 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 76.7 Cg_exo -49.94 -36.34 43.51 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.644 2.229 . . . . 0.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 118.21 32.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.531 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.6 t80 -135.93 -67.35 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.22 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.6 Cg_endo -69.37 0.92 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.439 1.426 . . . . 0.0 112.5 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -107.41 -20.59 13.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.313 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.25 161.03 28.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 0.0 111.469 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.58 119.17 6.21 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.659 2.239 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -86.49 -123.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.873 2.382 . . . . 0.0 111.675 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' H ' ' HB2' ' A' ' 103' ' ' PRO . 12.4 t80 -145.93 129.49 16.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.677 0.275 . . . . 0.0 110.693 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 92' ' ' ILE . 24.2 t -135.36 140.55 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.631 ' HA ' HG23 ' A' ' 123' ' ' VAL . 32.1 ptt85 -150.3 122.51 8.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.167 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.912 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.2 m-85 -60.03 141.21 56.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.446 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 90' ' ' LEU . 38.9 t -96.27 -44.05 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 110.327 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 88' ' ' TYR . 7.2 t -68.22 -175.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -91.25 86.97 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.977 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.912 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -119.46 151.47 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.481 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -126.07 102.33 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.649 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 147' ' ' LEU . 27.9 ttm -124.45 143.97 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -52.36 -25.75 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -111.58 15.3 27.04 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HG13 ' A' ' 123' ' ' VAL . 86.9 t -137.74 127.69 36.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.797 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.7 165.89 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.055 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' CZ ' ' A' ' 168' ' ' TYR . 15.6 m -106.22 -16.86 14.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.198 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.1 m -77.39 -61.45 1.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.62 -38.04 6.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 107.7 21.18 8.01 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.56 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.09 111.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 116' ' ' VAL . 3.3 t -77.49 100.91 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.3 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -64.74 119.75 60.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.421 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.3 Cg_exo -62.01 -14.99 40.59 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.505 2.137 . . . . 0.0 112.638 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -28.83 63.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.684 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -95.38 -28.22 15.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.256 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 123' ' ' VAL . 34.9 mm -77.18 128.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -67.52 -60.03 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.356 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 146' ' ' GLU . 16.9 m -49.98 -32.53 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.553 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.421 HD23 ' CB ' ' A' ' 125' ' ' PRO . 1.1 tp -83.67 -43.01 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.617 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.18 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 54.79 1.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -47.85 158.09 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.545 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -142.64 178.12 7.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -82.37 -30.57 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.017 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.8 p -79.31 -9.82 59.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.395 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -73.3 155.15 39.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.6 m -156.17 -176.52 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.3 mt -58.5 -41.57 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 pttt -62.36 -36.62 82.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 0.0 110.273 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.47 -37.94 78.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.436 0.636 . . . . 0.0 109.59 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.65 -53.34 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.941 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD12 ' CE3' ' A' ' 58' ' ' TRP . 21.9 mt -61.5 -46.02 91.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.689 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.02 -30.04 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.071 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 130' ' ' VAL . 16.6 tp10 -72.83 -48.54 36.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.01 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.9 mt -54.74 -45.94 74.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.69 -38.88 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.819 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 5.7 ttm180 -61.62 -43.99 97.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.051 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -62.02 -41.88 98.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.417 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 12.0 mtm -62.04 -27.66 69.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.2 mtm -75.95 -16.9 59.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.95 154.52 37.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -60.53 -43.25 97.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.12 -32.9 73.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.909 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 44.6 m-80 -86.76 -36.66 18.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 6.9 ptm -78.92 48.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 110.987 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -146.6 -39.57 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.316 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.9 mt -52.3 148.16 12.37 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.497 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.95 121.95 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.258 1.972 . . . . 0.0 112.659 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' A' ' 82' ' ' ILE . 87.4 mm-40 -87.54 122.59 70.48 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.046 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.48 136.42 63.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.221 1.947 . . . . 0.0 111.864 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.623 ' O ' ' CB ' ' A' ' 164' ' ' GLU . 55.7 Cg_endo -70.09 97.28 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.42 2.08 . . . . 0.0 112.666 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.623 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 8.7 tt0 114.99 155.41 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.714 0.806 . . . . 0.0 110.889 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.04 35.12 4.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.304 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -69.33 158.48 34.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.956 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 35.5 m -75.81 -179.36 4.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.524 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -90.4 131.54 36.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.6 t 60.19 77.59 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.576 0.227 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.39 126.94 11.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.447 2.098 . . . . 0.0 112.308 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.13 93.65 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.586 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 62.05 114.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.92 -15.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.51 104.98 0.05 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.43 -28.24 9.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t 68.16 -70.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -177.51 -61.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.08 178.33 6.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -134.13 174.58 10.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.97 92.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 pt20 -119.22 -3.01 10.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.39 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER 85.44 -25.6 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.643 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.97 108.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.13 91.75 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.7 m -158.57 175.19 13.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.27 138.5 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -128.98 126.49 39.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.87 -68.14 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -147.83 110.05 4.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.1 mt -130.31 177.14 7.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.816 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -148.17 101.02 3.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.45 -168.16 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.525 2.15 . . . . 0.0 112.268 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.09 116.06 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -167.14 -48.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.75 122.83 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.54 -169.15 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -108.77 163.59 13.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -91.22 -65.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.73 132.14 0.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.574 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.42 -23.57 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp 65.24 93.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.949 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' PHE . 21.6 t -150.59 131.13 7.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.77 159.67 8.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.471 2.114 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -62.97 -37.98 89.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 4.6 m120 -66.54 -41.92 87.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 41' ' ' LEU . 11.1 m-85 -60.11 -44.57 94.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 13.2 mmm-85 -58.57 -43.41 89.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 41.3 mt -61.29 -39.38 90.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.986 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.593 HD23 HD21 ' A' ' 68' ' ' LEU . 6.6 mt -72.11 -52.66 15.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -42.19 99.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.919 0.39 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 9.3 mm-40 -69.02 -29.4 67.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.491 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 55.7 tp -61.77 -47.24 86.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.981 0.419 . . . . 0.0 110.36 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.27 -41.42 99.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.59 -48.82 78.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -63.93 -50.86 58.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.12 -47.97 81.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -62.55 -26.54 68.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.794 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.41 163.41 24.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.403 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.74 -177.19 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.12 -68.98 1.35 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.047 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -84.52 -3.91 58.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 53.21 35.53 50.01 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.373 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 p -71.37 -15.66 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.648 0.261 . . . . 0.0 111.603 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 HG12 ' A' ' 75' ' ' ILE . 33.9 m -154.13 175.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.386 . . . . 0.0 111.115 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -161.38 110.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.538 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.45 ' HB2' HG21 ' A' ' 140' ' ' ILE . 27.6 p90 -98.96 132.12 44.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.692 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.82 175.31 19.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.122 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 68' ' ' LEU . 1.1 mt -85.39 14.41 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.217 -0.491 . . . . 0.0 112.03 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 66.97 -68.55 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.081 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 3.2 t0 -101.66 -47.22 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.981 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 14.8 m-20 93.03 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.33 30.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 109.495 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.68 -164.44 0.97 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.307 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mtt -116.03 124.41 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.001 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p 57.88 21.85 8.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER 51.28 59.73 4.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.145 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -81.47 -57.09 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 135.9 45.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 75.0 m95 -135.31 171.72 14.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 0.0 111.354 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -137.6 165.71 25.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.346 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -157.39 110.41 0.44 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.074 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtp -90.09 153.09 20.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 144' ' ' LEU . 29.8 mt -151.71 139.22 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.1 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.5 mt -114.35 149.13 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.29 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.75 138.79 14.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.955 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.29 146.88 25.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 112.12 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 13.2 Cg_endo -56.22 147.62 65.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.833 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 77.35 44.75 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.481 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 80' ' ' ARG . 76.7 p -161.87 152.94 18.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -52.71 -37.02 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.572 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 82.0 m-85 -81.84 -14.04 56.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.042 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -46.85 140.3 4.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.208 0.528 . . . . 0.0 112.191 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m120 45.96 42.2 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.012 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.7 mmt-85 -139.72 86.17 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.1 mp -47.25 164.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.569 ' N ' HG22 ' A' ' 87' ' ' ILE . 43.5 m-85 -154.34 128.02 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 111.242 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 m -92.87 154.66 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.467 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -152.38 160.63 43.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -136.65 116.03 12.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.73 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.6 149.01 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.684 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.7 134.83 39.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 110.904 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 98' ' ' TYR . 1.4 p -120.23 -178.33 3.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.175 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.39 -157.71 8.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.51 -25.29 14.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.618 2.212 . . . . 0.0 112.604 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 95.63 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.861 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 2.3 t80 -97.19 -65.11 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.59 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 42.8 Cg_endo -67.44 -1.68 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.655 1.57 . . . . 0.0 112.651 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -109.51 -6.06 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.363 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.03 157.95 33.98 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.69 125.98 20.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.678 2.252 . . . . 0.0 112.074 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 90.9 Cg_endo -81.55 163.69 18.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.553 2.169 . . . . 0.0 112.708 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -95.22 90.26 5.8 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.554 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG21 ' CG1' ' A' ' 143' ' ' VAL . 24.8 t -93.85 138.71 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.246 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -150.2 125.21 9.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 1.111 ' CD2' HG21 ' A' ' 111' ' ' ILE . 3.4 m-85 -70.52 153.66 42.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.19 -40.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.28 0.562 . . . . 0.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 89' ' ' SER . 6.5 t -68.31 -176.39 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 50.5 mmtt -87.68 94.62 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.779 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.111 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.2 tt -130.68 145.69 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.865 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -126.37 102.32 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.89 157.39 36.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.009 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -54.5 -58.89 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.238 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -79.77 -16.7 76.8 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 123' ' ' VAL . 62.8 t -94.92 136.61 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.925 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.91 179.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.8 m -133.09 34.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.986 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -152.57 -47.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 122' ' ' VAL . 7.5 p30 -105.39 -37.25 6.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.125 0.488 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.31 2.36 41.29 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.011 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 120' ' ' ASN . 30.8 t -58.89 110.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 116' ' ' VAL . 3.7 t -76.94 112.77 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.408 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -64.19 110.91 4.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB3' HD23 ' A' ' 131' ' ' LEU . 32.4 Cg_exo -58.25 -18.53 37.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.496 2.131 . . . . 0.0 112.403 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -47.82 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.7 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.604 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -67.91 -42.7 80.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.479 ' CG2' HG12 ' A' ' 130' ' ' VAL . 44.1 mm -69.01 123.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.5 t -66.06 -55.86 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.457 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 128' ' ' ILE . 8.6 p -49.97 -32.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.479 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -84.49 -49.51 8.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.52 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.306 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -134.81 43.87 2.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.912 0.387 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -49.55 148.64 2.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 138' ' ' TYR . 1.5 mt-30 -130.54 -171.93 2.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 37.8 t30 -104.25 58.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -160.52 -27.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.716 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.468 ' CD1' HG11 ' A' ' 142' ' ' VAL . 22.6 m-85 -70.78 172.03 9.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.465 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.2 m -156.07 -176.42 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.368 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.597 HD13 ' CE3' ' A' ' 71' ' ' TRP . 33.4 mt -53.87 -44.43 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.247 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 21.8 pttt -58.57 -37.48 75.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 138' ' ' TYR . 41.3 t -68.36 -39.23 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 109.627 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 105' ' ' VAL . 18.1 t -61.82 -53.39 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.835 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 75' ' ' ILE . 20.9 mt -61.4 -43.78 98.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.64 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.89 -40.21 79.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -53.04 62.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.65 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.9 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 16.2 mt -50.56 -46.21 57.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 110.658 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -62.15 -34.4 76.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.941 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -61.44 -43.04 99.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.958 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.6 mt -63.56 -44.75 93.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.437 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 15.1 mtt -58.32 -29.77 66.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.928 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.6 mtm -76.9 -15.95 59.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.3 m -64.94 141.23 58.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 10.8 tptt -51.28 -53.24 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.07 -23.1 65.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.747 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.12 -25.91 23.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.722 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 14.5 ptm -86.64 19.23 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.089 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.86 -30.72 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.282 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.8 mt -54.72 144.23 46.39 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.554 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.38 150.3 68.56 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.238 1.958 . . . . 0.0 112.04 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.53 ' HG3' HG23 ' A' ' 82' ' ' ILE . 25.0 mm-40 -146.49 116.59 4.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 80.9 Cg_exo -50.29 129.19 25.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.509 2.139 . . . . 0.0 112.141 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 23.9 Cg_exo -64.1 65.04 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.725 2.284 . . . . 0.0 112.812 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER 166.88 143.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.24 38.81 2.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.137 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 28.2 pt20 -69.53 158.57 34.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 51.8 m -77.39 176.27 9.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.41 127.89 38.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -102.96 -45.52 4.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.986 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.719 0.295 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.23 142.46 45.94 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.655 2.237 . . . . 0.0 112.311 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.53 172.17 39.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.33 -175.08 2.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.39 82.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -160.48 105.69 1.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.746 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 6' ' ' GLN . . . 84.04 -41.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.546 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t 65.93 149.43 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -136.89 -178.37 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.27 31.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 118.9 34.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.55 -47.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.81 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.54 -61.21 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m 68.3 -69.01 0.16 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 78.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.04 177.86 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 t -158.81 101.08 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -123.63 118.83 28.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 153.03 35.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.57 -102.71 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 60.66 165.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.63 156.2 47.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.41 143.91 98.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.777 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.49 117.0 4.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.531 2.154 . . . . 0.0 112.384 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -140.73 -174.86 4.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.09 -44.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -69.18 132.82 47.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -141.88 -67.26 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.823 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.453 ' HB2' HG22 ' A' ' 32' ' ' VAL . 85.5 m -114.93 141.2 48.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -68.11 107.55 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' CA ' HG12 ' A' ' 34' ' ' VAL . . . 107.34 -92.02 0.74 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.666 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 29' ' ' CYS . 16.0 t 70.15 -65.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.731 0.3 . . . . 0.0 111.254 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.67 16.02 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.405 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG12 ' CA ' ' A' ' 31' ' ' GLY . 13.8 p -80.67 131.52 60.66 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -59.59 155.88 39.93 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.394 2.063 . . . . 0.0 112.046 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? -62.32 -41.95 98.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.237 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 1.7 t30 -60.57 -32.78 71.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.744 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -55.41 -54.58 41.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 6.0 mmt180 -57.68 -38.73 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.083 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 98' ' ' TYR . 69.9 mt -61.86 -52.26 64.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.23 -50.49 70.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -61.67 -46.36 90.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.4 mt-10 -70.56 -29.33 65.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.399 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 54.5 tp -62.12 -35.21 78.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.358 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 -34.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.2 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.17 -34.28 70.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.511 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.493 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -85.02 -34.39 15.09 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.41 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -51.98 -43.77 63.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.872 0.368 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -62.47 -29.45 70.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.505 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . 87.77 35.13 9.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.613 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER 40.41 -170.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.13 -83.35 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.734 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.96 -23.84 48.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 73.73 32.35 59.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -72.52 -13.31 61.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 75' ' ' ILE . 25.0 m -154.77 171.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.747 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -161.76 111.02 1.53 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 34.7 p90 -103.86 130.08 51.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -142.35 -139.05 3.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.066 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.733 HD11 HD23 ' A' ' 68' ' ' LEU . 7.7 mt -125.17 145.68 49.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -66.01 -31.68 72.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 2.0 t70 -105.95 -54.99 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 4.0 t70 96.48 -1.17 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.31 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -158.02 29.61 0.26 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.12 174.89 8.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.2 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.18 13.74 33.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -155.21 115.67 3.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.751 0.31 . . . . 0.0 110.788 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.733 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -83.24 58.86 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.748 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -91.88 -66.5 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 98.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.791 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.596 ' CE3' HD13 ' A' ' 140' ' ' ILE . 62.0 m95 -88.78 152.09 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 147.39 26.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -140.31 99.53 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.996 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -92.45 149.29 21.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.6 mt -150.85 144.99 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 111.607 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -120.11 149.23 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.4 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.14 123.26 7.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.023 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 20.6 Cg_exo -65.47 142.28 71.18 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.488 2.125 . . . . 0.0 111.996 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 42.6 Cg_exo -57.07 146.14 82.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.699 2.266 . . . . 0.0 112.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 81' ' ' THR . 7.3 mtt180 81.61 42.46 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.825 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' ARG . 15.7 p -162.52 155.83 20.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.863 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -51.23 -40.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.937 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 67.2 m-85 -79.43 -18.0 53.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.841 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.6 pt-20 -41.28 143.87 0.39 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.279 0.561 . . . . 0.0 112.474 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.5 t30 45.65 54.35 7.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.822 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 4.8 mmt85 -152.72 107.27 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.492 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.1 mp -67.16 165.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.481 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HG22 ' A' ' 87' ' ' ILE . 27.5 m-85 -150.75 130.72 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.983 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 28.2 t -93.12 148.28 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.141 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.907 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.1 mp -152.27 160.02 43.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.046 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.8 mtmt -143.56 117.23 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.774 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.28 127.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.99 117.14 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' O ' HG23 ' A' ' 69' ' ' THR . 15.7 m -126.3 159.46 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.63 -126.53 0.82 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.02 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.378 2.052 . . . . 0.0 112.401 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 69.46 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.2 t80 -90.26 -64.5 0.18 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.042 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 72.9 Cg_endo -74.98 3.99 5.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.391 1.394 . . . . 0.0 112.307 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -113.13 -11.02 13.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.757 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.53 146.81 18.0 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.4 110.17 0.57 Allowed 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 122.825 2.35 . . . . 0.0 112.188 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 45.7 Cg_endo -67.89 -176.2 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 46.1 t80 -94.93 95.37 8.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 92' ' ' ILE . 48.1 t -95.42 138.15 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.645 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' VAL . 3.2 ptt-85 -150.2 138.31 20.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.984 ' CD2' HG21 ' A' ' 111' ' ' ILE . 14.3 m-85 -83.85 137.98 33.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.879 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 167' ' ' CYS . 19.0 t -93.63 -39.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.224 0.535 . . . . 0.0 109.867 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.0 t -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.924 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -94.11 82.8 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.984 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -112.57 149.09 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.53 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -126.23 102.95 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.525 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.9 ttm -124.37 155.39 38.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.953 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -54.54 -52.88 60.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.18 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.715 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -86.21 -14.47 66.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.037 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 123' ' ' VAL . 48.6 t -98.95 132.21 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.15 167.84 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.7 m -123.68 31.05 6.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.2 p -142.69 -47.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -104.69 -37.16 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.131 0.491 . . . . 0.0 110.119 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.32 43.61 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.998 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 21.5 t -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 116' ' ' VAL . 8.8 t -77.21 111.93 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.685 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.79 125.2 89.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 -15.85 24.62 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.421 2.08 . . . . 0.0 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -72.43 -42.46 65.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.938 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.715 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -77.6 -46.73 21.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.406 ' CG2' ' CG2' ' A' ' 130' ' ' VAL . 21.3 mm -62.46 132.29 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.3 p -67.36 -56.0 11.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.408 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 146' ' ' GLU . 3.2 m -49.93 -36.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.618 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 130' ' ' VAL . 6.6 mp -80.71 -43.71 19.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.652 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.74 62.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -139.08 55.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 61.9 t-105 -49.67 157.87 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HG3' ' CE1' ' A' ' 138' ' ' TYR . 38.7 mm-40 -131.32 -166.65 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.34 -40.42 9.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 t -79.3 -3.89 48.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.394 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.46 ' HA ' HG21 ' A' ' 142' ' ' VAL . 5.2 m-30 -72.46 151.8 42.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.845 0.355 . . . . 0.0 111.045 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 p -156.34 -176.5 6.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.596 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mp -53.12 -29.96 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.28 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 8.6 pttt -71.04 -40.27 71.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 138' ' ' TYR . 66.4 t -68.88 -35.53 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.503 0.668 . . . . 0.0 109.453 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 105' ' ' VAL . 40.4 t -67.85 -52.81 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 75' ' ' ILE . 22.4 mt -62.72 -47.75 82.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.916 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -60.32 -48.86 79.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.529 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.585 ' HG2' HG13 ' A' ' 130' ' ' VAL . 7.3 tp10 -59.98 -53.23 60.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.826 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.837 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -60.63 -41.05 94.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.952 0.405 . . . . 0.0 110.301 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.68 -31.63 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.061 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -59.37 -44.6 92.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -63.37 -46.81 84.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.228 179.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 11.7 mtp -48.67 -39.11 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttp -77.33 -27.68 52.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -65.8 147.97 52.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 1.7 mmmp? -51.16 -25.58 5.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.58 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -54.86 36.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.012 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 12.8 m-80 -88.2 -30.96 19.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 81' ' ' THR . 2.7 ptm -72.91 52.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.112 0.482 . . . . 0.0 111.297 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.15 -42.68 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.024 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt -53.79 150.55 13.66 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.595 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.93 126.0 14.55 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.373 2.049 . . . . 0.0 112.43 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 35.8 mm-40 -84.38 120.4 74.33 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.224 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 161' ' ' GLN . 19.9 Cg_exo -64.65 164.85 22.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.259 1.973 . . . . 0.0 111.896 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.57 89.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.375 2.05 . . . . 0.0 112.019 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.62 151.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 111.05 -67.91 0.22 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.403 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -70.24 132.31 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.5 m -77.3 -167.48 0.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 109' ' ' THR . 1.2 m-85 -86.23 120.56 27.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.783 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -81.83 -59.24 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.864 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.598 0.237 . . . . 0.0 111.497 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 1' ' ' MET . 92.8 Cg_endo -81.34 -40.98 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.556 2.171 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 121.95 -67.85 0.45 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.58 141.94 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.5 p -109.32 59.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 -49.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.59 22.36 6.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.415 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -175.93 133.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 2.2 p90 -128.97 -54.25 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -163.69 148.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.799 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -108.23 102.01 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.746 ' HB2' HD23 ' A' ' 16' ' ' LEU . 49.6 m -93.09 134.62 35.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.8 -22.96 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 t -105.1 91.47 3.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.18 160.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.58 123.28 11.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.447 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -151.46 170.47 19.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.96 99.56 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -125.35 153.64 43.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.98 -123.55 0.66 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -117.47 41.34 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.84 -54.53 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -110.34 98.36 35.61 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.55 -25.88 61.18 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 147.36 22.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -146.57 -58.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.78 91.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -114.86 120.92 41.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.6 t -155.49 130.92 9.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -119.12 125.89 50.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.77 27.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.56 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.61 107.24 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -86.52 -38.38 17.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -80.22 139.48 52.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 52.1 Cg_exo -54.43 126.73 23.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.459 2.106 . . . . 0.0 112.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -38.67 84.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 9.7 p-10 -65.77 -36.4 83.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 35' ' ' PRO . 4.0 m-85 -55.32 -53.86 50.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.716 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 8.1 tpp180 -57.51 -42.89 83.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 73.5 mt -59.44 -40.81 88.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.982 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 90.1 mt -72.22 -52.72 15.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.641 0.258 . . . . 0.0 111.366 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.76 -36.87 82.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 32.4 mt-10 -76.56 -28.91 56.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.0 tp -62.29 -35.08 77.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.137 0.494 . . . . 0.0 110.033 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -41.8 45.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.371 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -38.39 76.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.918 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.66 -58.29 5.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.693 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -58.0 -36.02 72.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -76.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.68 168.21 39.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.617 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.43 -176.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 111.166 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.05 97.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.682 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.61 22.18 12.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.718 0.294 . . . . 0.0 111.274 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 50.4 46.95 44.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.698 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.676 0.274 . . . . 0.0 111.297 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 75' ' ' ILE . 34.1 m -154.41 175.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.955 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.91 110.65 1.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.463 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.617 ' CH2' HG11 ' A' ' 51' ' ' VAL . 28.6 p90 -100.12 87.45 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -143.49 12.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.767 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.655 HD11 ' CD2' ' A' ' 68' ' ' LEU . 6.0 mt -120.4 140.65 51.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.775 0.322 . . . . 0.0 111.024 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.88 -56.39 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.59 -114.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.656 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -176.19 20.49 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.659 0.266 . . . . 0.0 111.543 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -157.35 -49.86 0.07 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 42.82 -166.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.772 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.3 mtm -115.04 -34.73 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -154.49 26.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.989 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.655 ' CD2' HD11 ' A' ' 60' ' ' LEU . 1.0 OUTLIER 53.13 40.82 31.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -51.86 12.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -78.86 95.97 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.713 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 40.8 m95 -89.06 165.36 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -127.08 118.5 24.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.617 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -114.64 119.12 4.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.662 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mtp -93.73 154.39 17.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.824 HD13 HD11 ' A' ' 147' ' ' LEU . 30.4 mt -152.27 138.06 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.846 0.355 . . . . 0.0 111.761 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -116.79 149.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.415 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.83 146.8 18.34 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.11 141.18 11.56 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.827 2.351 . . . . 0.0 112.25 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 58.0 Cg_exo -51.81 141.77 43.99 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.546 2.164 . . . . 0.0 112.798 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER 79.06 41.18 0.09 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.529 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.4 p -159.68 152.42 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -47.77 -39.14 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 111.316 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' CE ' ' A' ' 151' ' ' MET . 89.9 m-85 -78.8 -22.61 46.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.909 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -41.52 135.25 2.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 56.22 20.48 4.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.925 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.13 105.45 11.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.797 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 88' ' ' TYR . 47.1 mt -70.65 165.05 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 35.6 m-85 -150.25 130.22 13.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.02 0.438 . . . . 0.0 111.197 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 30.9 t -93.76 151.29 19.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.4 mp -151.29 160.31 43.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.0 ttmt -139.01 114.51 9.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.557 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.42 120.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.355 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 18.9 mt-10 -94.25 122.23 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.801 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.72 -169.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.98 -153.42 15.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.01 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.304 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -96.65 74.22 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.587 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.7 t80 -96.71 -52.8 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 2.3 Cg_endo -80.25 3.95 7.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.776 1.651 . . . . 0.0 112.224 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -114.5 -18.57 11.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.14 73.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HB3' HD13 ' A' ' 131' ' ' LEU . 48.2 Cg_exo -55.88 124.43 16.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.578 2.185 . . . . 0.0 112.325 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 89.0 Cg_endo -77.91 167.83 23.09 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.64 2.227 . . . . 0.0 112.223 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 87.3 t80 -96.45 89.23 4.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.239 0.543 . . . . 0.0 110.351 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.622 HG21 HG11 ' A' ' 143' ' ' VAL . 38.3 t -93.56 141.15 15.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.051 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -150.25 128.84 12.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.091 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 1.067 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.4 m-85 -75.23 123.15 24.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.492 HG22 ' HE3' ' A' ' 91' ' ' LYS . 20.7 t -75.72 -40.74 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.337 0.589 . . . . 0.0 109.499 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.415 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 7.4 t -69.75 -177.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.864 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 14.0 mttt -97.99 97.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.756 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.067 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -126.55 151.14 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.835 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' N ' HD13 ' A' ' 111' ' ' ILE . 21.4 t-20 -126.21 102.77 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 31.3 ttm -124.42 153.08 42.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -52.53 -26.16 12.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -123.15 22.49 7.11 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.041 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 123' ' ' VAL . 57.6 t -136.09 126.54 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.661 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 138.01 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 t -101.89 54.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.2 p -176.79 -39.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -102.81 -34.47 8.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 109.974 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.96 64.75 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.983 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.77 115.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 116' ' ' VAL . 15.0 t -77.51 115.18 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.8 OUTLIER -65.13 113.2 10.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.531 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.403 ' CB ' ' HB3' ' A' ' 131' ' ' LEU . 36.6 Cg_endo -65.21 -12.3 34.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.52 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.23 -49.95 31.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -69.97 -51.71 30.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 31.7 mm -57.81 132.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -60.33 2.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.202 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 146' ' ' GLU . 10.4 m -49.99 -30.15 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.717 0.294 . . . . 0.0 111.739 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.541 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 mm? -83.85 -47.63 10.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.6 -31.65 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.474 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -135.83 42.46 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -50.55 117.46 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.226 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -99.9 -176.79 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 3.9 m-20 -92.03 56.07 2.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.9 p -159.45 -18.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.2 m-85 -71.85 169.84 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.08 0.467 . . . . 0.0 111.416 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.74 -176.38 5.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.475 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.511 HD13 ' CE3' ' A' ' 71' ' ' TRP . 66.8 mt -56.22 -47.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 111.32 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.466 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 11.5 ptpt -60.69 -34.86 74.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.768 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 138' ' ' TYR . 21.4 t -68.54 -37.62 77.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.452 0.644 . . . . 0.0 109.392 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 105' ' ' VAL . 36.6 t -63.58 -52.88 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.843 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.56 HD22 HD11 ' A' ' 75' ' ' ILE . 21.1 mt -62.55 -48.75 78.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.698 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -60.36 -46.08 91.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.565 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HG2' HG22 ' A' ' 130' ' ' VAL . 9.1 tp10 -61.09 -53.47 56.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.735 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.824 HD11 HD13 ' A' ' 75' ' ' ILE . 3.5 pp -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 147' ' ' LEU . 73.4 ttt-85 -65.13 -33.42 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.741 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -43.68 90.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.961 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.1 mt -66.3 -38.19 87.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.106 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.453 ' CE ' ' CE1' ' A' ' 83' ' ' TYR . 8.7 mtt -54.97 -35.57 64.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.729 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 53.2 mtm -75.74 -12.55 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.226 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.85 26.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.6 mtpp -59.13 -44.07 92.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.19 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.38 -33.25 73.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.757 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 0.8 OUTLIER -87.81 -39.2 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.547 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -72.44 1.5 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 111.574 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -111.91 -32.42 6.61 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 110.154 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.81 147.19 43.57 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.13 141.13 75.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.383 2.055 . . . . 0.0 111.811 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -146.57 117.66 4.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.59 164.46 4.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.464 2.109 . . . . 0.0 112.249 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.29 134.1 26.1 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.573 2.182 . . . . 0.0 112.255 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -47.04 162.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.307 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 111.08 -55.63 0.49 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.475 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -69.75 158.51 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.3 m -160.74 148.2 15.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.679 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 109' ' ' THR . 23.1 m-85 -57.62 109.14 0.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.912 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 p 62.89 142.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.78 -46.0 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.558 2.172 . . . . 0.0 112.299 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.43 89.36 0.16 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 159.93 41.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 6' ' ' GLN . 21.5 t -149.65 156.49 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.44 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 61.59 116.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.95 -71.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.4 p -138.46 17.47 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.214 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.61 -71.89 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 175.8 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.037 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 160.25 12.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.72 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 -74.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -65.86 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t 62.44 49.85 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm 60.8 68.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.6 -34.22 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 p -62.26 154.32 27.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.15 123.08 49.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.0 110.3 6.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.81 62.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 142.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.4 tp -110.78 -67.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.06 148.27 18.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.64 117.2 3.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.307 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -82.89 112.94 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -134.17 33.5 3.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.94 80.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -137.04 84.17 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.04 178.51 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -138.4 98.12 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.33 154.22 25.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.572 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.53 165.97 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -111.05 101.01 9.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.818 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' VAL . 8.6 m -150.65 105.2 3.07 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.03 161.71 43.09 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.416 2.077 . . . . 0.0 112.409 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -54.48 -34.47 61.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.473 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 34.7 m120 -68.27 -36.97 80.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.27 -57.62 11.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.013 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -57.6 -43.29 84.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.555 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.715 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 53.7 mt -62.8 -38.3 90.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 12.8 mt -72.13 -52.72 15.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.24 -43.25 98.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 98.2 mt-10 -68.01 -32.1 72.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 59.1 tp -61.44 -42.64 99.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.311 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.34 -50.78 68.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.799 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.95 -40.45 80.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -69.26 -58.55 6.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.66 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.76 -39.86 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 111.111 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -58.12 -72.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.36 158.02 9.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.576 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.404 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -130.24 -175.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.93 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.36 104.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.471 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.94 20.25 11.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.834 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.81 47.97 30.51 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.805 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 56' ' ' VAL . 27.9 p -71.73 -18.04 62.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 111.254 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG12 HG12 ' A' ' 75' ' ' ILE . 19.7 m -156.85 169.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.735 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -160.93 111.18 1.73 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.571 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.51 ' HB2' HG21 ' A' ' 140' ' ' ILE . 30.7 p90 -102.21 96.42 6.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -109.83 -144.4 10.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.912 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.015 HD11 HD23 ' A' ' 68' ' ' LEU . 7.1 mt -121.17 131.96 54.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.255 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -66.57 -33.59 76.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -135.77 101.43 4.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -67.95 49.01 0.05 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -157.69 27.03 0.28 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -167.77 1.86 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.286 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -123.08 -67.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.655 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.749 ' O ' HD12 ' A' ' 68' ' ' LEU . 29.3 p -86.46 -8.77 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.015 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 63.4 72.64 0.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.8 0.333 . . . . 0.0 110.671 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -89.36 -55.34 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -77.99 97.07 5.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.715 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 27.2 m95 -91.79 152.02 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.804 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 1.9 m -102.23 144.95 30.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -136.06 103.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.73 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtp -92.59 151.66 20.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 147' ' ' LEU . 30.8 mt -151.82 142.72 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.765 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.23 149.42 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.323 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.29 148.92 17.75 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.004 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HG3' ' HG2' ' A' ' 152' ' ' MET . 92.0 Cg_endo -79.77 132.36 9.69 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.909 2.406 . . . . 0.0 111.975 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 15.8 Cg_endo -56.86 83.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.709 2.273 . . . . 0.0 112.583 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 81' ' ' THR . 5.2 ptt180 161.32 30.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.715 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 74.9 p -162.08 163.65 28.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.93 -37.97 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 97.0 m-85 -79.44 -11.61 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.153 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 5.1 pt-20 -51.71 146.41 7.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 t30 44.62 29.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.611 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 1.6 mmt180 -131.29 99.64 4.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -62.7 166.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.796 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 33.8 m-85 -150.82 130.21 12.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.032 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 40.5 m -92.97 151.19 20.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.187 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.41 160.17 43.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.7 OUTLIER -141.15 114.37 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.83 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 105' ' ' VAL . 4.8 mp -106.35 120.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.481 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 130.04 40.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.428 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 69' ' ' THR . 4.0 p -127.88 -179.03 4.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.18 -149.0 5.75 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.077 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.07 -78.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.466 2.11 . . . . 0.0 111.819 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.76 77.32 9.52 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.674 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -91.26 -52.37 0.29 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 3.4 Cg_exo -79.31 5.0 6.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.984 1.789 . . . . 0.0 112.516 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -8.14 9.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.343 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . . . -139.92 150.46 62.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.667 0.27 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 101' ' ' ALA . 31.3 Cg_exo -59.28 122.37 11.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.6 Cg_endo -82.29 175.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.721 2.28 . . . . 0.0 112.432 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -97.54 90.19 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 143' ' ' VAL . 41.8 t -91.88 138.9 18.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.058 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.19 130.18 13.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.026 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 1.061 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.6 m-85 -76.01 126.7 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.1 t -78.95 -39.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.354 0.597 . . . . 0.0 109.634 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.7 t -69.07 -176.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.067 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 30.1 mttt -99.14 87.52 3.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.061 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -116.87 153.52 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.95 -178.34 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.49 ' N ' HD13 ' A' ' 111' ' ' ILE . 10.6 t-20 -126.35 102.78 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.736 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.437 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 1.9 tpp -123.98 156.48 36.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.227 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -53.61 -43.37 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.164 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -109.05 28.41 11.17 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.944 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.968 HG22 HG13 ' A' ' 123' ' ' VAL . 76.9 t -135.4 130.17 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.824 0.345 . . . . 0.0 110.689 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.55 158.26 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -118.67 26.71 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.48 -51.42 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.5 -34.13 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.007 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.65 0.63 34.59 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.919 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.86 113.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 116' ' ' VAL . 13.1 t -76.67 115.17 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.471 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 110.14 3.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.918 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.38 -15.76 47.22 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.446 2.097 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -46.72 58.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -70.5 -42.65 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.699 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 131' ' ' LEU . 32.8 mm -70.03 103.78 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.647 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -53.96 -55.64 25.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 142' ' ' VAL . 7.2 p -49.97 -31.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' H ' HG22 ' A' ' 128' ' ' ILE . 1.3 tp -84.15 -48.69 9.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.11 69.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.09 34.44 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.427 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 54.8 t-105 -49.37 132.22 20.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -121.26 -178.34 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -86.11 61.06 6.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.9 m -160.85 -28.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.816 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.3 m-85 -70.96 168.16 17.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.425 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.09 -176.43 5.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.246 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.664 HD13 ' CE3' ' A' ' 71' ' ' TRP . 10.7 mt -55.94 -51.34 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.282 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 ptpt -53.16 -35.06 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.816 HG11 ' CD1' ' A' ' 138' ' ' TYR . 40.9 t -69.04 -41.19 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.47 0.652 . . . . 0.0 109.547 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 105' ' ' VAL . 40.5 t -62.61 -53.13 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.342 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.707 HD22 HD11 ' A' ' 75' ' ' ILE . 28.5 mt -63.09 -48.54 78.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.741 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.86 -46.53 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -60.0 -53.16 61.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.568 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 148' ' ' ARG . 4.4 pp -62.0 -38.39 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.838 ' N ' HD12 ' A' ' 147' ' ' LEU . 5.7 ttt-85 -69.59 -30.71 68.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.803 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -43.68 90.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.837 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.756 HD12 ' HA ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -65.33 -42.43 92.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.848 178.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 21.3 mtt -50.97 -35.26 32.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.81 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' MET . . . . . 0.424 ' HG2' ' HG3' ' A' ' 78' ' ' PRO . 69.8 mtm -74.44 -22.21 59.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.94 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.6 m -65.79 158.3 28.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 28.7 mttp -65.19 -32.19 73.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -46.94 85.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.128 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -87.15 -21.76 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.48 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -82.56 13.64 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -116.52 -30.38 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.194 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.7 mt -55.41 148.85 30.93 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.829 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.63 149.57 89.61 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.156 . . . . 0.0 112.047 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 82' ' ' ILE . 20.0 mm-40 -146.31 133.71 10.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 37.0 Cg_endo -65.85 126.31 15.73 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 28.5 Cg_exo -61.94 75.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.365 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.1 OUTLIER 166.96 -168.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.67 21.96 3.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.656 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.63 158.56 35.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 111.171 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.6 p -80.3 -170.69 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.977 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 110' ' ' LYS . 10.7 m-85 -91.24 83.15 5.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.4 m -101.55 125.54 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.54 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.686 0.279 . . . . 0.0 111.747 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 14.8 m-80 -52.53 -35.63 53.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.491 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -55.37 -53.54 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.288 . . . . 0.0 111.045 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 22.4 tpp180 -57.53 -40.16 78.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.42 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 78.8 mt -60.67 -51.46 69.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 64.3 mt -62.05 -52.75 62.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.447 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.43 -43.13 99.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 80.6 mm-40 -72.41 -28.47 63.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.706 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 44.7 tp -61.35 -42.49 98.79 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.53 -49.26 56.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.791 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.27 78.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.216 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -71.27 -51.31 18.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.649 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.18 -44.28 92.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -58.4 -56.21 25.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.19 170.01 15.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.677 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -138.95 -177.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 111.076 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.61 108.95 1.36 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.663 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 16.08 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.578 0.228 . . . . 0.0 111.272 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.42 50.72 17.39 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.981 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -70.52 -23.34 62.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 75' ' ' ILE . 22.7 m -155.01 173.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.556 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -160.86 112.0 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.977 0.418 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.485 ' HH2' HG11 ' A' ' 51' ' ' VAL . 25.2 p90 -101.14 81.66 2.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.84 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.77 179.01 35.39 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.995 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.843 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -90.38 144.58 25.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.843 HD23 HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.0 m -97.72 -66.8 0.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.38 93.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.588 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 81.6 m95 -90.87 169.27 11.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.056 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -135.22 124.69 24.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.616 ' CA ' HD11 ' A' ' 144' ' ' LEU . . . -120.64 115.95 3.07 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.804 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -91.1 157.17 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 147' ' ' LEU . 25.6 mt -152.86 141.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.819 0.342 . . . . 0.0 111.748 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.47 149.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.731 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -79.43 139.57 21.83 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.865 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 72.0 Cg_endo -87.69 127.42 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.973 2.449 . . . . 0.0 112.109 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 81.7 Cg_exo -47.52 139.9 16.98 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.552 2.168 . . . . 0.0 112.99 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 79.7 40.47 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 31.0 p -159.09 151.75 21.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.78 -39.63 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 151' ' ' MET . 49.8 m-85 -80.27 -21.57 42.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.114 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.2 pt-20 -38.36 138.01 0.51 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 55.03 45.94 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.711 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -143.69 112.76 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.4 mp -70.45 160.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.425 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' N ' HG22 ' A' ' 87' ' ' ILE . 15.3 m-85 -151.9 126.76 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.41 . . . . 0.0 111.208 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.2 t -94.94 151.83 18.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -150.96 160.37 43.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.14 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.63 114.81 10.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.744 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.36 120.75 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.214 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -93.95 120.54 34.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -128.63 105.19 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.53 -110.64 2.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.387 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.1 118.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.153 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 4.8 mtpp 61.81 87.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -105.27 -66.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.896 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 55.4 Cg_endo -69.63 2.91 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.439 1.426 . . . . 0.0 112.952 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 16.4 pt-20 -112.06 -9.34 13.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.663 0.268 . . . . 0.0 111.041 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' HD2' ' A' ' 102' ' ' PRO . . . -151.62 164.56 19.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 45.7 Cg_exo -57.01 123.29 13.49 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.694 2.263 . . . . 0.0 112.382 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . 93.2 Cg_endo -80.07 167.81 19.52 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.726 2.284 . . . . 0.0 112.317 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.19 89.11 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 92' ' ' ILE . 40.5 t -94.24 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.126 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 129.71 12.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.953 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.5 m-85 -75.2 130.93 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.31 -45.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.301 0.572 . . . . 0.0 109.647 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 9.9 t -69.0 -179.38 1.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.689 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 8.5 mmtt -88.95 105.23 17.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.934 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -132.25 153.15 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.771 -178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 111' ' ' ILE . 4.3 m-20 -125.98 102.6 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.565 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.665 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 18.4 ttm -124.3 144.71 49.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.17 -32.71 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.288 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.691 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -101.78 -10.65 39.87 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.09 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.856 HG22 HG13 ' A' ' 123' ' ' VAL . 46.1 t -111.75 126.36 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.399 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.18 165.64 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -111.77 30.25 7.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.66 -58.16 1.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.808 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 122' ' ' VAL . 2.5 m-20 -104.9 -34.16 8.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.08 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.3 32.14 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.7 t -58.89 110.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.856 HG13 HG22 ' A' ' 116' ' ' VAL . 2.8 t -76.81 104.74 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.356 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.83 123.34 83.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.704 ' HB3' HD23 ' A' ' 131' ' ' LEU . 57.6 Cg_endo -70.92 -13.15 31.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.386 2.057 . . . . 0.0 112.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -72.31 -35.11 68.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.795 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.691 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -85.4 -46.56 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 131' ' ' LEU . 22.8 mm -65.9 129.91 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.74 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 88.5 p -67.48 -59.16 3.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.595 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.595 HG13 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m -49.79 -30.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.864 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -83.18 -43.66 15.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.731 0.3 . . . . 0.0 110.644 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.84 -54.86 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -105.92 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -48.5 139.86 8.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' A' ' 138' ' ' TYR . 14.8 pt20 -127.37 -170.71 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -86.39 -25.58 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -12.17 59.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 135' ' ' GLN . 12.3 m-30 -73.92 155.43 38.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.43 . . . . 0.0 111.302 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.2 p -155.9 -176.4 5.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.4 mt -57.95 -44.45 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . 1.3 pttt -61.03 -34.88 75.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.657 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.3 t -68.34 -40.62 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.477 0.656 . . . . 0.0 109.446 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 105' ' ' VAL . 37.4 t -61.22 -53.03 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.966 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.616 HD11 ' CA ' ' A' ' 73' ' ' GLY . 25.0 mt -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.967 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.14 -42.57 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.028 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 130' ' ' VAL . 3.0 tp10 -68.99 -53.09 22.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 148' ' ' ARG . 3.5 pp -57.17 -42.63 81.49 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.945 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.801 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -67.03 -33.3 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 0.0 110.078 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -59.16 -41.8 89.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.054 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.5 mt -66.7 -38.15 86.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.912 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.7 mtp -58.25 -30.56 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . 0.413 ' CE ' ' CZ ' ' A' ' 148' ' ' ARG . 2.4 mtt -76.84 -26.3 54.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.677 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.1 m -65.42 162.66 17.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 12.1 ttmm -63.58 -27.78 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.85 -53.73 51.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.923 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.414 ' CB ' ' HA ' ' A' ' 151' ' ' MET . 51.4 m-20 -91.4 -22.96 20.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.464 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -80.72 19.64 0.82 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 5.1 mmpt? -118.34 -31.87 4.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.85 0.357 . . . . 0.0 110.33 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.47 150.54 23.83 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.66 125.9 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.282 1.988 . . . . 0.0 112.458 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -83.71 154.86 65.27 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.798 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.402 ' HG3' ' HB2' ' A' ' 110' ' ' LYS . 58.4 Cg_endo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 122.473 2.115 . . . . 0.0 112.21 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 14.7 pt20 . . . . . 0 N--CA 1.459 -0.02 0 CA-C-O 120.725 0.297 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 18.6 m -76.9 -168.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.914 0.388 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -60.94 -35.0 75.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.54 -54.02 49.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.2 mmt180 -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.477 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.1 mt -61.29 -39.43 90.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.6 mt -72.11 -52.82 14.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.37 -42.08 98.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 6.9 mm-40 -69.62 -29.6 67.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.491 HD13 ' HG ' ' A' ' 60' ' ' LEU . 31.7 tp -63.35 -45.18 92.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.893 0.378 . . . . 0.0 110.667 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.69 -43.31 89.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.018 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -52.81 63.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.26 -31.61 81.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.625 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.16 -41.82 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.031 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.878 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.57 173.58 43.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.576 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -154.49 -177.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 111.231 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.02 103.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.625 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.36 19.29 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.602 0.239 . . . . 0.0 111.307 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.35 43.98 35.08 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.779 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -70.18 -19.51 63.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 75' ' ' ILE . 30.1 m -155.03 172.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 111.46 1.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.742 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.478 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 31.9 p90 -102.9 97.02 7.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.686 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.13 21.55 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.108 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.957 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -105.64 143.69 33.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.788 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.957 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.895 0.378 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -82.95 -44.01 15.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.447 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 60' ' ' LEU . 69.6 mtt-85 -77.45 139.84 39.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.303 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.474 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 71.2 m95 -135.31 144.37 46.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -102.1 120.48 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.8 108.88 2.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.675 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -95.15 150.92 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.805 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.1 mt -152.25 138.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.917 0.389 . . . . 0.0 111.743 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.31 149.28 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.169 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -91.64 120.34 6.0 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.114 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.24 141.15 95.24 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.547 2.165 . . . . 0.0 111.925 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 21.1 Cg_endo -60.37 145.81 97.91 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.877 2.385 . . . . 0.0 113.278 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 80.53 43.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.818 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 80' ' ' ARG . 4.4 p -162.75 158.72 23.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.06 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.402 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -52.53 -40.2 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.0 110.95 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 30.1 m-85 -79.69 -18.69 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.913 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.8 pt-20 -40.74 148.27 0.1 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 41.4 57.08 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.298 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.5 mmt85 -155.86 111.38 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.2 mp -66.55 165.07 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 87' ' ' ILE . 13.4 m-85 -149.43 133.31 17.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.083 0.468 . . . . 0.0 111.439 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.489 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 68.0 m -94.96 148.0 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.3 mp -151.3 160.07 43.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 14.8 mtpp -142.22 113.26 7.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 110.25 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.32 148.92 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.268 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 69' ' ' THR . 12.5 mt-10 -131.53 130.59 42.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.332 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.74 -169.16 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.59 -133.2 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.427 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 113.12 2.26 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.452 2.101 . . . . 0.0 112.146 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 60.05 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.646 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.3 t80 -83.23 -63.71 0.25 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.371 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 58.7 Cg_endo -70.91 1.83 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.666 1.578 . . . . 0.0 112.688 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -111.62 -13.77 13.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.674 0.273 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.83 61.07 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 111.312 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.49 122.43 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.614 2.209 . . . . 0.0 112.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -82.37 175.24 9.16 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.744 2.296 . . . . 0.0 112.739 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 106' ' ' ARG . 17.3 t80 -94.84 121.41 36.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.802 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 92' ' ' ILE . 38.9 t -135.04 138.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.239 0.543 . . . . 0.0 111.596 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -150.28 128.72 12.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.49 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.933 ' CE2' HD21 ' A' ' 90' ' ' LEU . 11.7 m-85 -71.55 131.93 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.97 -39.35 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.23 0.538 . . . . 0.0 109.634 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.514 HG21 ' CD2' ' A' ' 88' ' ' TYR . 5.0 t -68.59 -173.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.692 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 3.0 mmtt -99.51 69.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.439 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.746 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 153.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.8 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.11 101.91 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpp -124.89 153.52 42.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -54.89 -44.06 73.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.328 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.652 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -99.13 -6.54 55.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.277 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 123' ' ' VAL . 47.2 t -108.78 131.75 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.1 165.21 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m -113.05 -12.57 13.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 t -109.33 -33.3 6.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.32 . . . . 0.0 111.001 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -104.43 -39.61 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.03 0.443 . . . . 0.0 110.427 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.55 -1.58 69.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.053 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.9 t -58.84 112.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 116' ' ' VAL . 10.9 t -77.47 109.73 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.633 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.58 110.31 3.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.98 -19.24 62.0 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.547 2.164 . . . . 0.0 112.432 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -49.77 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.976 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.652 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -68.59 -40.93 80.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.573 ' CG2' HG12 ' A' ' 130' ' ' VAL . 29.6 mm -67.71 129.22 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -67.56 -54.56 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.636 ' CG2' HG12 ' A' ' 142' ' ' VAL . 6.7 p -50.08 -36.61 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.496 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -83.03 -44.5 15.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.8 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.88 45.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.66 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -48.83 136.89 13.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.368 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.68 -170.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.04 -36.85 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -0.53 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.552 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 142' ' ' VAL . 4.3 m-30 -72.56 154.49 40.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 111.099 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.0 p -156.07 -176.27 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 44.1 mt -54.7 -37.86 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 20.2 ttpp -61.44 -39.74 91.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.202 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.636 HG12 ' CG2' ' A' ' 130' ' ' VAL . 46.9 t -68.52 -33.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.932 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 105' ' ' VAL . 24.7 t -69.16 -53.43 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.674 HD22 HD11 ' A' ' 75' ' ' ILE . 26.8 mt -64.77 -48.32 74.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.066 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -59.45 -49.73 76.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.758 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 4.2 tp10 -60.15 -53.06 62.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.5 pp -58.33 -41.59 84.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.87 ' N ' HD12 ' A' ' 147' ' ' LEU . 8.4 tmm_? -62.61 -34.07 76.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.28 86.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.826 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.0 mt -60.83 -48.1 83.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.871 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 30.0 mtt -51.58 -35.74 42.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.776 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.6 ttm -74.04 -14.59 61.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.71 164.44 14.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.0 tttt -65.32 -48.85 71.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.25 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.06 -31.17 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.025 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.07 -25.16 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 24.4 ptm -88.1 42.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.815 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -141.19 -35.15 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.3 mt -52.88 151.11 8.88 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.317 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.77 122.58 8.98 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.144 1.896 . . . . 0.0 112.73 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HG2' HG12 ' A' ' 82' ' ' ILE . 17.2 mm-40 -86.91 152.86 54.27 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.9 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 C--N 1.343 0.285 0 C-N-CA 122.462 2.108 . . . . 0.0 111.972 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.655 0.264 . . . . 0.0 111.025 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.0 m -79.7 175.82 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.647 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 109' ' ' THR . 14.9 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.698 0.285 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -53.41 -36.91 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -52.56 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -58.19 -39.08 78.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.68 HD22 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -63.56 -53.88 44.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.765 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.5 mt -58.94 -51.48 69.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 0.0 111.226 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.75 -49.79 73.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.15 -28.61 68.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.6 tp -62.31 -42.55 99.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -30.47 65.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -74.21 -64.77 2.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.64 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.62 -44.06 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -59.35 -25.92 64.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.92 161.82 26.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.68 -178.0 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.972 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.09 -63.63 5.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.818 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.58 -6.52 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.85 31.98 32.68 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.443 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 p -72.52 -17.01 61.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 144' ' ' LEU . 35.5 m -152.14 175.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.945 0.403 . . . . 0.0 111.161 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.05 110.78 1.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.335 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 28.5 p90 -100.0 105.36 17.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.59 148.47 18.07 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.9 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.0 HD11 HD23 ' A' ' 68' ' ' LEU . 1.7 mt -54.66 130.22 39.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.956 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.148 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.8 m -80.8 -27.47 36.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.754 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -99.64 147.79 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 111.168 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.576 ' CE2' HD11 ' A' ' 140' ' ' ILE . 70.4 m95 -134.84 160.99 36.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -130.4 118.09 20.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.36 118.41 4.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.244 -0.979 . . . . 0.0 114.178 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -92.9 150.3 20.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 90' ' ' LEU . 47.5 mt -150.02 138.0 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 111.759 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -95.34 148.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.45 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -73.21 116.01 5.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 8.4 Cg_endo -50.68 128.33 23.64 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.463 2.108 . . . . 0.0 111.873 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 33.0 Cg_exo -61.16 172.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.376 2.051 . . . . 0.0 112.598 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 3.9 mpp_? 44.42 41.78 4.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.737 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' MET . 0.6 OUTLIER -162.14 161.66 28.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.688 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.4 OUTLIER -43.91 -29.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.02 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' C ' ' A' ' 84' ' ' GLU . 68.2 m-85 -80.03 -21.01 44.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -23.9 124.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 t30 49.21 69.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.904 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.1 mmt180 -154.24 106.26 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 88' ' ' TYR . 50.3 mt -69.69 165.37 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.908 ' CE2' HD12 ' A' ' 111' ' ' ILE . 29.9 m-85 -153.2 128.19 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.033 0.444 . . . . 0.0 111.441 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.543 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 33.3 t -94.01 149.29 21.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -151.56 160.63 43.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 0.0 111.323 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 108' ' ' VAL . 26.2 mttt -136.21 115.34 12.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.3 mp -107.05 126.47 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.348 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 51.3 mt-10 -95.38 126.13 40.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.87 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 p -114.29 -178.32 3.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.98 -164.16 13.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.4 -40.58 62.14 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.661 2.241 . . . . 0.0 112.457 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 73.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.462 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 1.3 t80 -76.52 -58.48 1.15 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.432 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 59.6 Cg_endo -71.09 0.42 6.65 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.882 1.722 . . . . 0.0 112.836 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -120.09 9.72 11.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.448 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.64 20.61 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 111.551 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.0 119.78 7.27 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 0.0 112.361 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 50.9 Cg_endo -84.07 164.26 13.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.869 2.379 . . . . 0.0 112.531 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 28.7 t80 -97.94 98.58 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.491 . . . . 0.0 110.28 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.8 t -95.12 138.51 20.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.024 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.89 120.46 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 1.087 ' CD2' HG21 ' A' ' 111' ' ' ILE . 4.1 m-85 -65.87 155.53 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.743 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.487 HG21 ' HE3' ' A' ' 91' ' ' LYS . 25.0 t -110.04 -51.47 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.105 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 88' ' ' TYR . 6.7 t -67.35 -175.81 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.942 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 11.1 mmtm -88.57 110.76 21.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.087 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.4 tt -138.79 150.35 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.715 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.463 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.46 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.8 tpp -124.56 152.9 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -34.97 62.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -118.2 25.12 8.42 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.126 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.967 HG22 HG13 ' A' ' 123' ' ' VAL . 48.5 t -130.83 126.0 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.797 0.332 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.89 151.69 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 p -112.78 28.37 8.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -131.08 -55.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -105.25 -34.31 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.18 1.0 33.52 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.956 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.95 111.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.967 HG13 HG22 ' A' ' 116' ' ' VAL . 5.2 t -77.34 117.69 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.682 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.86 112.92 9.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.519 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HB3' HD23 ' A' ' 131' ' ' LEU . 36.4 Cg_endo -65.43 -17.23 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.311 2.007 . . . . 0.0 112.333 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -37.92 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.756 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.602 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -80.76 -38.29 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.509 ' CG2' HG12 ' A' ' 130' ' ' VAL . 48.8 mm -76.41 121.75 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.8 p -67.23 -55.2 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.372 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.651 HG23 ' CD2' ' A' ' 138' ' ' TYR . 14.8 p -49.97 -32.45 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 125' ' ' PRO . 1.4 mp -83.57 -50.51 8.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.71 32.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.16 52.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' HD3' ' A' ' 103' ' ' PRO . 63.2 t-105 -49.92 140.11 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 2.1 mm100 -117.67 -172.22 2.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.75 -32.81 15.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 m -78.97 -12.22 60.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.651 ' CD2' HG23 ' A' ' 130' ' ' VAL . 10.9 m-30 -72.75 152.17 41.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 111.032 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -155.98 -176.36 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.576 HD11 ' CE2' ' A' ' 71' ' ' TRP . 50.1 mt -53.96 -40.08 43.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 2.0 ptpt -60.59 -39.75 89.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 138' ' ' TYR . 34.7 t -69.27 -38.39 77.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.922 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 20.7 t -62.53 -53.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.055 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 75' ' ' ILE . 22.7 mt -63.86 -43.7 95.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.535 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -57.66 -39.95 78.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -51.49 69.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.579 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.972 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 11.6 mt -49.5 -46.07 47.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.961 0.41 . . . . 0.0 110.588 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.4 77.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.746 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -61.13 -42.76 99.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -64.64 -48.21 75.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 35.7 mtt -54.56 -27.62 40.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 25.7 mtm -76.27 -19.95 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.3 t -65.07 157.32 28.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -65.15 -46.14 82.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.35 -28.77 69.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -87.77 -27.71 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.528 ' CB ' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -88.94 22.92 2.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -124.31 -33.46 3.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.65 145.07 41.93 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.8 125.02 13.54 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.26 1.973 . . . . 0.0 112.215 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HG2' HG12 ' A' ' 82' ' ' ILE . 30.2 mm-40 -84.07 124.67 74.11 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 122.175 1.917 . . . . 0.0 111.999 179.837 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.513 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.2 pt20 . . . . . 0 CA--C 1.524 -0.053 0 CA-C-O 120.949 0.404 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.4 p -78.15 145.31 35.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.148 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 2.9 m-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.738 0.304 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.6 p30 -66.09 -29.01 69.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -50.24 70.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.196 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.6 mmt85 -66.41 -36.74 83.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 43.4 mt -60.01 -41.18 91.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.2 mt -72.13 -52.73 15.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.537 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -41.34 98.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 74.4 mm-40 -70.51 -29.3 65.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.75 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 51.1 tp -61.89 -46.82 87.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.258 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.52 -49.65 74.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.876 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.93 -29.72 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -78.45 -44.14 11.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.724 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -76.8 -43.75 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.671 0.272 . . . . 0.0 111.097 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -52.86 -28.12 21.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.99 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.91 179.08 18.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -141.11 -177.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.83 -86.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.608 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.59 -16.42 61.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.569 0.224 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.845 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 71.35 31.43 65.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.2 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 56' ' ' VAL . 30.4 p -73.0 -9.52 58.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 75' ' ' ILE . 20.4 m -156.19 165.22 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.998 0.428 . . . . 0.0 111.172 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -162.0 111.04 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.406 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 27.2 p90 -101.57 130.82 47.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.36 -160.16 8.66 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.576 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 68' ' ' LEU . 5.7 mt -116.54 127.67 54.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.821 0.343 . . . . 0.0 110.951 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -179.78 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.713 ' HB3' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.904 0.383 . . . . 0.0 110.661 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 -63.66 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -72.24 98.31 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.702 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 50.9 m95 -90.2 158.52 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.78 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.57 148.58 25.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -141.62 102.13 0.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.761 -1.209 . . . . 0.0 113.754 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtp -93.96 146.15 24.13 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.827 HD13 HD11 ' A' ' 147' ' ' LEU . 52.7 mt -150.74 126.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.771 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -102.74 149.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.126 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -90.49 140.81 15.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.952 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.4 Cg_endo -83.97 136.38 6.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.792 2.328 . . . . 0.0 112.093 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 77.0 Cg_exo -48.65 144.49 14.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.641 2.228 . . . . 0.0 113.127 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 75.45 43.72 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.795 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 49.8 p -161.16 147.01 14.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.378 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.61 -36.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.052 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 49.1 m-85 -80.91 -22.36 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.963 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -39.41 148.41 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 84' ' ' GLU . 26.0 p30 41.08 47.8 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.418 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.4 mmt85 -148.39 109.86 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.692 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 88' ' ' TYR . 43.1 mt -68.52 166.15 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.57 ' N ' HG22 ' A' ' 87' ' ' ILE . 28.0 m-85 -150.25 132.33 15.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 46.8 t -93.46 147.4 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.58 160.15 43.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.102 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 4.1 mtpp -143.44 115.56 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.43 120.68 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 103' ' ' PRO . 51.0 mt-10 -94.17 124.05 37.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.1 p -113.02 -169.5 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.27 -136.97 5.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.556 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.69 130.49 26.47 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.594 2.196 . . . . 0.0 112.124 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.48 59.61 3.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.9 t80 -84.63 -55.51 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.635 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.0 Cg_endo -78.13 5.6 5.27 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.961 1.774 . . . . 0.0 112.568 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -123.74 -4.48 8.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.23 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.32 18.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.986 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.543 ' HB3' HD23 ' A' ' 131' ' ' LEU . 6.0 Cg_exo -77.26 110.97 3.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.723 2.282 . . . . 0.0 112.009 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 97.8 Cg_endo -76.78 -99.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.358 2.038 . . . . 0.0 112.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -149.9 131.45 14.84 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.731 0.3 . . . . 0.0 111.49 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 92' ' ' ILE . 44.2 t -135.54 139.51 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.332 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.3 ptt180 -150.25 141.66 23.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.955 ' CE2' HD21 ' A' ' 90' ' ' LEU . 22.8 m-85 -83.97 139.92 32.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.837 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 167' ' ' CYS . 19.1 t -93.66 -40.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.443 HG21 ' CD2' ' A' ' 88' ' ' TYR . 4.9 t -68.52 -173.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.879 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 5.4 mmtt -97.23 76.77 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 110.166 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.927 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -103.76 149.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.476 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -126.09 102.32 7.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.743 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.428 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -124.74 150.37 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -26.73 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.705 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -116.8 16.24 13.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.09 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HG13 ' A' ' 123' ' ' VAL . 76.6 t -137.61 122.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.71 165.84 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 96.4 p -117.01 21.75 13.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -51.5 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 110.586 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.536 ' CG ' HG23 ' A' ' 122' ' ' VAL . 11.6 p30 -103.11 -32.17 9.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.937 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 94.29 5.92 61.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.049 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.536 HG23 ' CG ' ' A' ' 120' ' ' ASN . 39.7 t -58.84 112.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 116' ' ' VAL . 11.9 t -78.16 106.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' GLY . 8.6 t0 -65.86 116.56 33.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HB3' HD22 ' A' ' 131' ' ' LEU . 41.1 Cg_endo -66.74 -14.89 45.65 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.403 2.069 . . . . 0.0 112.388 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -72.39 -36.11 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.782 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.705 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -84.91 -36.54 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 19.9 mm -74.42 128.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 t -67.77 -54.74 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.736 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.587 HG12 HG22 ' A' ' 128' ' ' ILE . 12.6 p -49.9 -33.01 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -85.25 -45.59 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.86 55.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -135.53 42.59 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CE3' HG22 ' A' ' 130' ' ' VAL . 73.3 t-105 -49.42 125.2 10.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 2.9 tt0 -81.93 175.83 10.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -96.45 31.45 2.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.08 9.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.812 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 135' ' ' GLN . 10.2 m-30 -75.09 177.56 6.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.734 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -156.85 -176.56 6.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.776 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 62.4 mt -57.91 -37.03 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 24.7 ttpt -62.83 -37.03 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.551 HG12 HG21 ' A' ' 130' ' ' VAL . 42.7 t -68.83 -34.8 66.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.005 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.43 -53.24 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 75' ' ' ILE . 24.5 mt -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.998 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.31 -44.82 95.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 2.6 tp10 -61.95 -53.3 57.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.867 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.3 pp -60.61 -37.97 83.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.399 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 ttp-105 -64.44 -36.2 83.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 109.932 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 45.1 mtt-85 -59.04 -40.5 85.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.701 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 147' ' ' LEU . 5.9 mt -62.13 -41.14 97.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.778 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.76 ' HE3' HD13 ' A' ' 147' ' ' LEU . 60.7 mtt -55.9 -34.98 66.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.469 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . 0.426 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 10.8 mtm -75.57 -14.21 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 154.22 38.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 3.0 mttt -62.24 -50.79 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -35.41 76.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.396 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -86.78 -20.74 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.813 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -92.7 24.45 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 111.227 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -117.75 -32.02 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.501 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.3 mt -54.72 138.52 62.2 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.471 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.36 121.54 8.51 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.224 1.95 . . . . 0.0 112.729 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -87.67 113.68 55.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 C--N 1.344 0.34 0 C-N-CA 122.133 1.889 . . . . 0.0 112.055 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.0 pt20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.625 ' HB2' HG12 ' A' ' 108' ' ' VAL . 31.9 p -76.39 -170.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.606 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 6.3 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.978 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -67.74 -35.38 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.92 26.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 tpp180 -57.61 -41.68 81.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.468 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 68' ' ' LEU . 22.5 mt -62.71 -36.07 81.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 mt -72.03 -52.68 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.02 -47.44 77.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 73.1 mm-40 -63.33 -32.88 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.025 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 57.8 tp -63.01 -45.46 92.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.13 -47.57 85.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -32.67 67.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.442 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -84.03 -40.64 8.54 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.688 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -69.52 -47.98 62.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.999 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -61.65 -28.6 69.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.717 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.4 174.62 15.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.593 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -127.48 138.58 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.082 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.61 -70.6 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.535 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.53 11.27 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 51' ' ' VAL . . . -75.32 110.1 2.96 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.631 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -72.66 -17.42 61.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 75' ' ' ILE . 33.1 m -93.72 176.45 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.459 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.36 112.79 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.344 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.505 ' CZ3' HG23 ' A' ' 56' ' ' VAL . 32.7 p90 -105.47 102.27 11.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.72 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.63 147.82 16.88 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.0 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.608 HD11 HD23 ' A' ' 68' ' ' LEU . 4.6 mt -55.18 155.51 4.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 94' ' ' CYS . 6.9 m -93.88 -60.72 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -69.99 91.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.634 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 88.2 m95 -89.11 160.29 17.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.713 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.65 123.39 22.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.691 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 144' ' ' LEU . . . -113.17 171.06 13.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.789 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.4 mtp -142.58 151.15 41.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.211 -0.495 . . . . 0.0 109.815 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.666 HG12 HG12 ' A' ' 56' ' ' VAL . 48.2 mt -150.27 120.91 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 111.847 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -93.37 149.1 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.253 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -88.67 143.13 17.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.65 130.36 3.75 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.984 2.456 . . . . 0.0 112.097 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 74.3 Cg_exo -48.47 141.05 20.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 113.039 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER 80.46 40.67 0.07 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 51.7 p -160.64 150.28 17.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.743 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.81 -37.53 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 111.157 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 25.3 m-85 -79.85 -22.85 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.841 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -38.52 145.65 0.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 43.18 54.72 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.123 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 64.8 mmt-85 -154.18 107.21 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.734 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 87' ' ' ILE . 3.9 mp -66.2 167.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 20.7 m-85 -150.26 128.3 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 0.0 111.018 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 17.0 t -90.05 149.7 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.332 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -152.52 160.34 43.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.035 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.0 OUTLIER -142.9 116.65 9.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 92' ' ' ILE . 5.0 mp -106.6 124.11 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.441 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.98 105.77 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' THR . 81.6 m -105.5 120.97 42.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -122.59 -145.29 6.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.524 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.89 116.55 2.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 62.32 76.71 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.598 ' CD2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.66 -62.72 0.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 47.8 Cg_endo -68.53 -1.64 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.651 1.567 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -114.67 8.88 16.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.036 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.48 143.38 3.42 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.317 . . . . 0.0 111.289 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.32 118.37 5.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.763 2.309 . . . . 0.0 112.239 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 91.5 Cg_endo -80.8 -179.61 5.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 61.3 t80 -97.04 100.09 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 92' ' ' ILE . 25.6 t -94.51 137.78 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HA ' HG23 ' A' ' 123' ' ' VAL . 2.7 ptm180 -150.28 118.58 6.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.909 ' CD2' HG21 ' A' ' 111' ' ' ILE . 15.8 m-85 -62.31 149.27 42.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.507 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.59 -42.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.144 0.497 . . . . 0.0 110.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.5 t -68.62 -176.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.009 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -92.79 76.52 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.909 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -104.99 150.1 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.868 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -125.99 102.68 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 10.5 ttm -124.45 153.97 41.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.235 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -38.22 66.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -110.74 23.96 18.32 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.925 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 123' ' ' VAL . 58.7 t -132.72 128.33 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.683 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.67 157.38 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -116.88 28.47 8.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.5 t -135.05 -52.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -105.35 -33.07 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.083 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.13 0.82 44.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.988 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.558 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 54.8 t -58.91 110.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 116' ' ' VAL . 19.5 t -77.06 115.11 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.685 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.19 115.06 17.98 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.15 -12.15 34.93 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.305 2.004 . . . . 0.0 112.605 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -33.71 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.639 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -89.02 -33.86 17.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 130' ' ' VAL . 38.0 mm -73.99 122.15 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -67.49 -54.55 19.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.364 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.659 HG23 ' CE2' ' A' ' 138' ' ' TYR . 11.4 p -49.94 -32.39 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.532 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.94 -51.76 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.28 -34.21 60.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -123.11 51.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -49.02 155.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.245 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -132.81 179.6 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -37.64 18.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -79.81 -1.51 39.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.444 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.659 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.4 m-30 -73.11 160.56 31.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.1 m -156.52 -176.55 6.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 71' ' ' TRP . 72.6 mt -59.36 -38.84 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -64.68 -34.56 78.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.37 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 138' ' ' TYR . 47.2 t -67.76 -37.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 109.409 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.2 t -66.94 -53.1 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.942 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.422 HD11 ' HA3' ' A' ' 73' ' ' GLY . 20.7 mt -61.64 -44.29 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.976 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -57.54 -41.94 81.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.11 -48.65 80.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 150' ' ' LEU . 12.7 mt -52.41 -45.99 66.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -42.44 86.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.215 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -61.96 -46.84 87.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.438 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.1 mt -61.01 -32.27 71.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.437 ' HA ' ' HB3' ' A' ' 156' ' ' ASN . 3.4 mtt -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.4 mtp -76.42 -12.7 60.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.425 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.2 m -65.22 154.59 37.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -58.58 -51.08 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -28.78 69.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.375 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 2.7 m-80 -88.16 -28.76 21.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 82' ' ' ILE . 4.0 ppp? -88.78 22.38 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.224 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -121.76 -30.37 4.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 45.5 mt -54.85 143.17 52.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 159' ' ' LEU . 16.6 Cg_exo -68.73 125.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.452 2.102 . . . . 0.0 112.779 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 24.9 mm-40 -84.97 157.47 59.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.324 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 6.7 Cg_endo . . . . . 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.055 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 120.854 0.359 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 41.8 m -77.53 -176.23 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' A' ' 109' ' ' THR . 11.4 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 3.4 ppt_? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.828 0.347 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.411 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 26.3 m120 -59.38 -34.82 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.637 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -52.52 63.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.733 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -60.83 -34.16 74.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.524 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.518 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 79.8 mt -63.14 -48.87 76.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.805 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.0 mt -69.64 -46.28 66.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -62.71 -50.34 71.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.602 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -64.99 -28.5 69.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.774 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 60.9 tp -61.99 -44.27 97.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 110.503 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.67 -44.05 87.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -59.51 5.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 58' ' ' TRP . . . -59.35 -47.25 91.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.706 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -57.0 -47.26 81.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -53.96 44.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.993 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.19 -176.25 40.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.673 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -155.67 -178.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.06 106.64 1.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.67 13.65 9.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.56 0.219 . . . . 0.0 111.318 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 47.65 43.85 22.36 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.876 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -71.39 -16.95 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.189 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 75' ' ' ILE . 25.5 m -155.74 172.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.511 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.25 113.31 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.901 0.381 . . . . 0.0 111.197 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.469 ' HB2' HG21 ' A' ' 140' ' ' ILE . 35.9 p90 -108.11 114.85 29.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.08 -158.38 10.0 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.971 HD11 HD23 ' A' ' 68' ' ' LEU . 5.2 mt -114.26 144.87 42.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.004 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.971 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.809 0.337 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -65.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.071 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 99.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.518 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 49.3 m95 -90.13 155.39 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.642 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -102.04 158.65 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.18 153.3 24.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.203 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 31.6 mtp -145.66 147.62 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.764 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 50.3 mt -151.38 120.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 111.796 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -93.77 149.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.392 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.57 140.43 16.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.825 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 93.0 Cg_endo -78.62 136.74 13.94 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.628 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.5 Cg_endo -53.52 142.6 58.95 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 112.829 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.61 42.75 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.535 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 68.9 p -160.4 154.5 23.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.846 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.59 -37.65 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 111.141 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CE1' ' OE1' ' A' ' 161' ' ' GLN . 51.4 m-85 -80.09 -22.28 42.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.907 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -40.37 136.44 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.173 0.511 . . . . 0.0 112.362 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 56.58 49.14 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.467 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -148.71 108.21 3.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.038 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.5 mp -69.08 165.4 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.604 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 23.5 m-85 -152.2 121.22 6.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.583 ' C ' HD12 ' A' ' 90' ' ' LEU . 43.0 m -88.91 151.24 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.721 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.9 mp -153.99 160.29 41.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.106 0.479 . . . . 0.0 111.511 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 2.9 mmtp -137.75 116.23 12.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.257 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.59 120.71 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.492 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 58.2 mt-10 -94.08 117.64 30.39 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.722 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.64 -169.14 1.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.767 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.21 -147.76 8.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.08 -70.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.546 2.164 . . . . 0.0 112.378 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.85 68.36 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.894 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.554 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -87.94 -61.36 0.24 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.589 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 60.8 Cg_endo -71.97 2.25 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.619 1.546 . . . . 0.0 112.764 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -119.66 7.64 11.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.659 0.266 . . . . 0.0 111.079 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.52 151.35 12.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.11 123.1 11.8 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.25 167.0 22.06 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 54.0 t80 -95.55 89.44 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.294 0.568 . . . . 0.0 110.445 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 92' ' ' ILE . 22.3 t -92.32 143.39 11.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' HA ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -149.97 118.72 6.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.035 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.896 ' CE1' HD13 ' A' ' 147' ' ' LEU . 7.9 m-85 -65.15 127.95 33.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 90' ' ' LEU . 27.1 t -84.44 -46.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.251 0.548 . . . . 0.0 110.182 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 88' ' ' TYR . 8.2 t -69.21 -175.76 0.82 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 162' ' ' PRO . 5.9 mmtt -90.52 102.79 15.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.813 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.874 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -129.7 146.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 111.63 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -125.94 102.26 7.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.656 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 3.6 ttm -125.1 159.05 32.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -55.84 -27.91 53.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.159 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.766 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -126.64 30.01 4.32 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.265 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.065 HG22 HG13 ' A' ' 123' ' ' VAL . 59.9 t -137.86 127.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -59.43 151.23 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.271 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.0 25.92 10.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.49 -46.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.505 ' HB3' HG23 ' A' ' 122' ' ' VAL . 2.1 t30 -102.36 -34.77 9.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.492 . . . . 0.0 109.815 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 99.16 -1.76 57.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 120' ' ' ASN . 37.5 t -58.83 110.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.065 HG13 HG22 ' A' ' 116' ' ' VAL . 4.7 t -76.17 110.8 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.75 113.27 10.24 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.944 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 39.3 Cg_endo -66.49 -15.7 48.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.381 2.054 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -36.16 67.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -88.1 -28.63 21.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.297 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 44.8 mm -80.44 132.18 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -55.34 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.534 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.67 HG13 HD12 ' A' ' 131' ' ' LEU . 7.2 p -49.88 -37.43 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.67 HD12 HG13 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.11 -46.61 10.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.11 -29.37 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -135.44 48.29 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -49.59 132.11 21.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -165.69 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -96.68 -39.01 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 t -80.76 2.51 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.688 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' A' ' 130' ' ' VAL . 5.0 m-30 -72.8 156.79 38.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 111.158 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 -176.37 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 71' ' ' TRP . 74.0 mt -55.25 -44.97 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.064 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -56.72 -37.85 71.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 138' ' ' TYR . 40.4 t -69.04 -35.95 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.996 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 18.5 t -65.71 -53.84 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.533 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 75' ' ' ILE . 24.7 mt -64.37 -45.88 85.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.888 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.34 -31.35 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.22 -52.24 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 150' ' ' LEU . 9.6 mt -49.61 -46.08 48.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -64.26 -37.92 89.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.984 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 20.2 mtt180 -63.01 -44.28 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.991 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.4 mt -65.43 -32.68 74.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.341 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 32.0 mtt -68.41 -29.11 67.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 30.2 mtm -76.23 -10.96 59.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.324 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.1 t -64.88 151.36 45.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.1 OUTLIER -52.93 -54.8 29.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -61.19 -24.78 66.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.47 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -86.88 -34.31 19.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.411 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 27.1 ptm -87.08 43.01 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.043 0.449 . . . . 0.0 110.84 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -144.23 -39.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.375 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.7 mt -52.97 145.67 22.16 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.29 124.95 14.72 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.197 1.932 . . . . 0.0 112.067 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG2' HG12 ' A' ' 82' ' ' ILE . 74.0 mm-40 -85.26 119.08 72.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.549 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 110' ' ' LYS . 56.6 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.622 2.215 . . . . 0.0 112.03 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.436 ' CG ' ' CG ' ' A' ' 110' ' ' LYS . 29.6 pt20 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.822 0.344 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.24 174.02 11.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.802 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.797 0.332 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.59 -50.8 69.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.826 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -57.86 -45.36 86.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 97.3 mt -63.87 -34.11 77.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.756 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.678 HD23 HD21 ' A' ' 68' ' ' LEU . 50.3 mt -72.12 -52.89 14.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 110.976 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.51 -49.64 68.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.6 mt-10 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.716 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.594 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.3 tp -63.44 -49.17 74.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.907 0.385 . . . . 0.0 110.588 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -54.98 -56.63 17.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.15 -25.69 59.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -72.36 -55.42 6.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.722 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -69.19 -47.87 63.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.301 . . . . 0.0 111.333 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -39.67 68.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.884 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.44 170.84 12.5 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.779 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -122.23 -177.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.77 -93.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -23.12 66.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.779 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 83.49 27.75 38.26 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.395 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -72.24 -10.32 59.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 75' ' ' ILE . 35.1 m -154.24 171.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.69 111.69 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.759 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.474 ' NE1' ' HA3' ' A' ' 47' ' ' GLY . 35.3 p90 -103.48 157.5 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.547 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.83 174.0 30.23 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.323 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -86.83 11.99 12.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.403 -0.399 . . . . 0.0 112.024 -179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 111.037 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.693 ' HA ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.239 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.77 -55.72 3.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.57 138.84 40.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.536 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 77.3 m95 -135.36 164.73 27.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.89 -179.84 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.285 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 58' ' ' TRP . . . -164.53 159.08 31.98 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.402 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.9 mtp -144.88 148.68 34.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 147' ' ' LEU . 56.6 mt -152.3 121.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.76 149.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -98.95 148.01 18.68 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.131 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 90.6 Cg_endo -82.24 144.22 13.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.783 2.322 . . . . 0.0 112.112 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.1 Cg_endo -53.17 142.35 55.81 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.74 2.293 . . . . 0.0 112.673 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.4 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.82 41.28 0.1 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.52 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.44 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.7 p -159.93 150.0 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -47.22 -37.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 111.192 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.51 ' CD1' HG22 ' A' ' 82' ' ' ILE . 65.9 m-85 -79.95 -21.66 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.72 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -42.33 137.7 1.94 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 112.165 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.5 42.06 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.645 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 79.1 mmt-85 -144.61 107.06 4.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.6 mp -67.39 167.34 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.184 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.623 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 26.7 m-85 -147.98 125.96 12.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 38.1 t -88.84 148.7 23.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.434 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 2.9 mp -151.4 160.16 43.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.183 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -142.77 114.78 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.518 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.7 mp -106.34 149.16 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.858 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.31 125.69 29.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.568 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.35 -179.18 3.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.307 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.8 -144.57 8.18 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.64 113.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.121 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 70.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.938 0.399 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.549 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.1 t80 -83.51 -60.12 0.35 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 61.0 Cg_endo -72.31 3.35 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.869 1.712 . . . . 0.0 112.993 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.41 -6.23 10.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 111.228 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.49 151.84 44.28 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.37 123.25 12.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.65 2.234 . . . . 0.0 112.339 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.497 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 96.6 Cg_endo -80.53 173.16 12.61 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.689 2.259 . . . . 0.0 112.438 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.89 89.13 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.202 0.525 . . . . 0.0 110.455 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 143' ' ' VAL . 50.1 t -95.77 138.74 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.153 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -150.15 126.52 10.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.884 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 1.045 ' CD2' HG21 ' A' ' 111' ' ' ILE . 9.9 m-85 -73.77 135.66 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.14 -41.59 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -69.24 -178.51 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.082 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 40.6 mttt -93.43 91.02 6.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.744 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -121.48 144.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -122.7 102.99 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.0 ttm -124.34 157.35 35.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -54.22 -38.67 65.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.663 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . . . -112.36 25.98 11.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.958 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.907 HG22 HG13 ' A' ' 123' ' ' VAL . 81.1 t -137.72 126.62 33.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -59.81 149.32 31.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.07 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -110.9 28.43 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.792 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.64 -46.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -103.79 -33.68 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 0.0 110.027 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.7 -4.45 56.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.753 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.3 t -58.83 115.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 116' ' ' VAL . 11.8 t -76.74 108.13 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.619 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 115' ' ' GLY . 3.5 t0 -64.95 110.73 4.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 131' ' ' LEU . 43.2 Cg_endo -67.61 -13.12 37.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.992 . . . . 0.0 112.433 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -30.51 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.663 ' HB3' ' CA ' ' A' ' 115' ' ' GLY . . . -93.09 -48.08 6.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.654 ' CG2' HG12 ' A' ' 130' ' ' VAL . 24.5 mm -61.02 131.51 26.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.7 p -67.49 -54.47 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.454 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.654 HG12 ' CG2' ' A' ' 128' ' ' ILE . 7.2 p -49.87 -32.79 8.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.552 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 125' ' ' PRO . 61.9 mt -84.24 -53.03 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.722 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.45 -24.06 18.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.512 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -136.73 45.12 2.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 111.016 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 70.5 t-105 -50.38 138.5 16.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.053 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -108.36 -170.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.925 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.57 -40.52 12.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.46 1.92 27.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.552 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.618 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 m-30 -72.75 151.76 41.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.3 p -155.43 -176.33 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.805 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.491 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 65.6 mt -51.19 -48.08 32.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.26 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -55.37 -39.48 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.659 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 45.7 t -69.03 -37.61 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.289 0.566 . . . . 0.0 110.017 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 105' ' ' VAL . 22.4 t -63.38 -53.77 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.093 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 75' ' ' ILE . 25.7 mt -64.98 -45.06 87.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.878 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -61.34 -51.08 70.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.075 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -59.76 -53.47 57.6 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -57.59 -37.7 73.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.056 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.741 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.6 tmt_? -64.49 -33.8 76.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.695 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.35 89.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.899 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.7 mt -62.63 -40.45 97.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.451 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 22.9 mtt -55.22 -34.7 64.16 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.615 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.3 mtm -75.43 -13.96 60.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.103 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 t -65.56 158.31 27.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 15.7 mttm -65.41 -49.87 67.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.14 -30.07 70.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.321 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -86.91 -26.17 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.653 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -89.74 46.66 1.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -143.17 -39.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.35 155.62 9.37 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.589 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.11 142.16 60.28 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.288 1.992 . . . . 0.0 111.8 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 82' ' ' ILE . 6.3 mm-40 -146.63 98.67 4.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--N 1.345 0.35 0 C-N-CA 122.477 2.118 . . . . 0.0 112.199 179.889 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.4 m -157.64 169.72 24.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 110' ' ' LYS . 16.2 m-85 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.69 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.1 tmm_? . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.0 m120 -54.96 -35.61 64.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.36 -51.91 65.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.664 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 12.9 mmt-85 -57.95 -40.32 80.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD2' ' A' ' 98' ' ' TYR . 90.5 mt -61.82 -50.67 71.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 79.8 mt -62.81 -51.59 66.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.453 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.97 -47.97 82.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.097 0.475 . . . . 0.0 110.303 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 51.0 mt-10 -67.93 -26.66 66.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.464 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 43.1 tp -60.7 -45.35 94.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.12 -37.08 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.43 -42.59 78.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.476 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -77.01 -40.64 24.63 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.676 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -66.1 -40.58 90.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -59.28 -76.16 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.12 165.68 36.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -148.51 -177.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.365 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.12 104.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.933 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 56.53 22.28 6.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.595 0.236 . . . . 0.0 111.497 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.472 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.07 46.35 50.66 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.794 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.6 p -71.4 -22.5 61.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.273 . . . . 0.0 111.206 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG12 HG12 ' A' ' 75' ' ' ILE . 28.1 m -154.93 173.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.78 110.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.341 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.49 ' CH2' HG11 ' A' ' 51' ' ' VAL . 26.5 p90 -99.92 96.26 7.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -105.66 -152.95 20.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.585 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 60' ' ' LEU . 4.9 mt -121.81 147.61 45.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 111.148 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.954 -179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD12 HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.883 0.373 . . . . 0.0 110.723 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.85 -56.28 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.59 105.35 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.431 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 30.4 m95 -89.5 150.86 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.669 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -101.99 113.29 26.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -110.75 106.54 2.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.913 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtp -90.63 147.32 23.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 90' ' ' LEU . 56.8 mt -149.61 150.14 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.872 0.368 . . . . 0.0 111.447 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mt -105.89 148.83 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.231 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -76.09 117.22 5.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.256 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 5.9 Cg_endo -48.8 142.56 18.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.425 2.083 . . . . 0.0 112.0 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 61.0 Cg_endo -73.01 175.97 9.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.418 2.079 . . . . 0.0 112.753 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 40.92 41.8 1.33 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.592 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 80' ' ' ARG . 6.8 p -162.0 160.97 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -43.65 -28.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.883 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 84' ' ' GLU . 72.0 m-85 -79.58 -22.09 44.2 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -24.16 125.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 45.55 72.9 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 22.5 mmt180 -157.43 104.66 2.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -66.02 167.64 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' N ' HG22 ' A' ' 87' ' ' ILE . 60.1 m-85 -153.4 128.67 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.546 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -93.17 145.87 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.82 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.5 mp -149.43 160.44 43.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.282 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.9 OUTLIER -138.61 111.49 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.188 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.0 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.33 120.15 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -93.85 133.16 37.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.739 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 98' ' ' TYR . 21.5 p -115.35 -169.3 1.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.14 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.85 -147.04 15.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.234 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.6 119.03 4.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.478 2.119 . . . . 0.0 111.999 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp 59.46 75.19 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.852 0.358 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.811 ' CD2' HD21 ' A' ' 40' ' ' LEU . 6.1 t80 -86.52 -54.49 0.39 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.84 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.6 Cg_endo -82.57 8.76 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.991 1.794 . . . . 0.0 112.236 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.92 3.87 7.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.81 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.21 143.34 3.57 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.61 110.95 2.48 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.847 2.365 . . . . 0.0 112.632 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 73.0 Cg_endo -76.9 -96.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.505 2.137 . . . . 0.0 112.416 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.773 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 59.8 t80 -148.17 136.02 20.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.894 0.378 . . . . 0.0 111.651 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.0 HG22 HG23 ' A' ' 92' ' ' ILE . 38.6 t -135.75 140.28 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.395 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.4 ptt180 -150.5 139.43 20.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.965 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 1.065 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.8 m-85 -77.44 114.83 16.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.868 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.65 -46.68 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.164 0.507 . . . . 0.0 110.273 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 88' ' ' TYR . 9.5 t -68.6 -179.83 1.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.06 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.409 ' HB3' ' HG3' ' A' ' 162' ' ' PRO . 27.3 mttt -88.68 120.22 29.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.065 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -157.84 153.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.506 ' N ' HD13 ' A' ' 111' ' ' ILE . 52.5 m-20 -125.94 102.03 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.43 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 150' ' ' LEU . 7.6 ttm -125.24 143.49 50.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 113' ' ' MET . 2.4 m-80 -58.03 79.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.008 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 113' ' ' MET . . . 145.94 -35.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.284 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.921 HG22 HG13 ' A' ' 123' ' ' VAL . 58.5 t -89.16 139.3 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -59.71 138.45 57.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.0 p -96.14 48.88 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 p -178.07 -38.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.464 ' HB3' HG23 ' A' ' 122' ' ' VAL . 1.5 t30 -102.45 -37.73 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.095 0.474 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.16 -5.58 61.24 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.126 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.773 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 24.4 t -58.54 111.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.089 0.444 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 116' ' ' VAL . 7.4 t -77.08 110.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.477 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.59 110.28 3.84 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.0 Cg_exo -62.2 -17.71 58.3 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.353 2.035 . . . . 0.0 112.326 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -72.43 -43.79 63.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.6 63.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.79 HG23 ' OE1' ' A' ' 146' ' ' GLU . 44.4 mm -81.91 130.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -59.88 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 146' ' ' GLU . 12.5 m -49.7 -30.82 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.662 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 mp -84.39 -45.22 12.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.21 -63.38 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 58.89 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -49.15 164.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -152.98 173.92 14.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.49 -27.24 63.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.194 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.52 -24.76 41.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 142' ' ' VAL . 14.8 m-85 -73.56 144.72 45.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.256 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.81 -176.32 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.364 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 58' ' ' TRP . 62.5 mt -50.09 -39.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.715 0.293 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 14.6 ttpp -61.7 -45.73 92.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.328 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 138' ' ' TYR . 19.4 t -67.45 -35.6 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.884 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.9 t -62.99 -53.81 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.917 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 75' ' ' ILE . 21.6 mt -64.36 -44.6 90.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.556 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -57.66 -40.62 79.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.985 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.889 ' OE1' HD11 ' A' ' 150' ' ' LEU . 2.7 tm-20 -59.97 -53.03 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.91 HD13 ' CE1' ' A' ' 107' ' ' PHE . 7.5 mt -50.25 -45.9 54.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -62.94 -38.15 89.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.755 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -46.52 88.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.206 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' OE1' ' A' ' 146' ' ' GLU . 1.6 mt -59.43 -46.28 89.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.34 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 2.5 mtt -61.13 -25.41 66.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -75.76 -20.4 58.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -65.26 154.57 37.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 11.6 mttm -65.13 -45.79 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -27.38 68.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.41 -27.67 22.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.348 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -89.72 45.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.098 0.475 . . . . 0.0 110.698 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -138.82 -38.56 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.1 mt -53.18 147.3 18.22 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.461 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.83 125.89 12.05 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.285 1.99 . . . . 0.0 112.535 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -83.7 157.39 64.07 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 110' ' ' LYS . 36.8 Cg_exo . . . . . 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 112.207 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 29.4 p -78.74 -168.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 2.2 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.852 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.675 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.5 tmm_? . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -32.9 51.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -54.93 37.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.3 mmt-85 -57.52 -37.74 73.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 110.196 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 36' ' ' ARG . 91.9 mt -61.87 -38.35 87.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.25 -52.74 15.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.396 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -63.51 -50.02 71.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 91.5 mt-10 -60.34 -32.34 71.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.551 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.8 tp -62.66 -43.7 98.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.941 0.401 . . . . 0.0 110.38 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.73 -56.13 26.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.25 -45.02 84.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -65.08 -44.31 94.41 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.768 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -67.8 -48.04 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.185 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -22.84 64.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.83 167.18 27.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.265 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -115.62 -176.96 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 0.0 111.163 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -47.14 -86.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.195 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.91 -14.42 61.05 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 72.92 37.73 56.54 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.26 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -72.35 -17.1 61.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.59 0.233 . . . . 0.0 111.53 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 75' ' ' ILE . 31.8 m -154.26 174.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.942 0.401 . . . . 0.0 111.336 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.78 111.07 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.272 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.495 ' HB2' HG21 ' A' ' 140' ' ' ILE . 34.8 p90 -103.01 73.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.042 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.41 -170.29 46.36 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.773 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.048 HD11 HD23 ' A' ' 68' ' ' LEU . 2.5 mt -104.72 141.7 36.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.845 0.355 . . . . 0.0 111.035 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.796 179.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -58.17 -65.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 146.28 52.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 63.8 m95 -134.9 146.68 49.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -102.04 121.44 42.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -118.44 109.8 1.83 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.679 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mtp -94.33 152.47 18.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 147' ' ' LEU . 37.4 mt -152.31 129.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 111.697 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.8 mt -102.85 149.26 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -85.09 143.42 20.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.02 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.2 Cg_endo -84.2 134.02 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.826 2.351 . . . . 0.0 111.942 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 71.0 Cg_exo -48.79 143.22 17.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.502 2.135 . . . . 0.0 112.987 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER 74.17 43.97 0.27 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.504 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 30.7 p -160.06 149.45 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.623 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -46.91 -36.82 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.065 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 94.4 m-85 -80.27 -22.27 41.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.1 pt-20 -42.54 133.09 3.47 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.79 11.91 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.622 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -115.28 104.17 11.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 88' ' ' TYR . 40.5 mt -61.79 169.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.282 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.607 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.4 m-85 -152.42 129.73 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.389 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.6 m -93.84 146.41 23.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.83 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -151.06 160.19 44.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.5 mtpt -141.68 114.53 8.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.72 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.13 120.79 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.182 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.08 126.78 40.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.8 p -113.53 -172.02 1.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.19 -140.08 7.77 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.589 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.72 120.46 5.94 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.205 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mttt 51.44 70.3 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -88.58 -63.0 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 70.5 Cg_endo -73.47 3.7 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.605 1.536 . . . . 0.0 112.478 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.54 -4.43 12.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.33 161.26 29.81 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.59 123.88 14.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.655 2.237 . . . . 0.0 112.474 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.17 171.76 15.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.641 2.228 . . . . 0.0 112.31 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -96.39 89.37 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.473 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 92' ' ' ILE . 25.6 t -93.71 139.3 18.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.455 HH12 HG22 ' A' ' 108' ' ' VAL . 2.9 ptm180 -150.42 120.22 7.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.935 ' CD2' HG21 ' A' ' 111' ' ' ILE . 20.5 m-85 -65.56 139.44 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG22 HH12 ' A' ' 106' ' ' ARG . 21.0 t -91.45 -42.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.865 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.409 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -69.05 -178.63 1.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.803 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 166' ' ' GLN . 0.3 OUTLIER -93.36 76.44 4.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.935 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -99.6 152.0 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.475 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.73 102.48 7.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.676 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.477 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 12.4 ttm -124.69 148.01 48.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.236 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -55.02 -28.36 51.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -120.07 28.01 6.52 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.012 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.018 HG22 HG13 ' A' ' 123' ' ' VAL . 94.1 t -136.25 131.99 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 110.726 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -59.49 132.34 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.993 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 m -97.81 31.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.987 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -141.38 -48.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.28 -34.73 7.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 106.08 -4.12 38.45 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 113.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.796 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 116' ' ' VAL . 10.2 t -76.76 119.41 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.726 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER -65.33 110.72 4.69 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.49 -20.8 71.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.383 2.056 . . . . 0.0 112.407 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -45.04 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.806 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.568 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -71.48 -52.41 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.543 ' CG2' HG12 ' A' ' 130' ' ' VAL . 14.6 mm -58.1 128.1 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.0 t -67.39 -56.32 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.453 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 138' ' ' TYR . 9.2 p -49.95 -30.84 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.352 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.06 -55.06 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.06 -25.08 19.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.272 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -134.2 51.04 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CZ3' ' CD ' ' A' ' 103' ' ' PRO . 57.0 t-105 -49.44 160.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.246 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 3.1 tt0 -140.62 177.16 8.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -77.32 -39.74 46.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 m -80.0 0.36 31.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.561 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.1 m-30 -72.78 149.66 43.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.962 0.411 . . . . 0.0 111.151 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -155.7 -176.45 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.36 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 31.7 mt -58.17 -37.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.721 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 6.5 ttpm? -62.04 -40.17 94.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 138' ' ' TYR . 22.0 t -67.88 -40.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.678 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 105' ' ' VAL . 32.2 t -61.13 -53.22 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.328 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 75' ' ' ILE . 27.0 mt -64.14 -44.8 91.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.847 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.31 -48.85 79.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.641 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 142' ' ' VAL . 1.5 tp10 -60.0 -53.26 59.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.6 pp -57.77 -41.0 81.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.814 0.34 . . . . 0.0 110.45 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.796 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.3 tmm_? -63.83 -33.09 74.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.168 0.509 . . . . 0.0 109.876 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -58.5 -44.85 89.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.101 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.8 mt -61.82 -41.97 98.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.887 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.418 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 14.7 mtt -56.44 -29.43 61.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 9.7 mtm -74.21 -22.69 59.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.3 t -65.96 158.09 29.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.054 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 6.2 mttt -65.41 -36.03 82.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.151 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.6 -44.33 97.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.008 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 20.4 m-20 -87.7 -20.8 25.74 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.472 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -88.74 23.43 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.81 -30.99 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.276 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.0 mt -54.71 145.5 40.4 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.83 124.69 10.87 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.263 1.976 . . . . 0.0 112.673 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 7.1 mm-40 -85.06 158.04 59.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.832 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 40.6 Cg_endo . . . . . 0 C--N 1.344 0.328 0 C-N-CA 122.333 2.022 . . . . 0.0 111.932 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 7.2 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.014 0.435 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.0 m -160.0 135.57 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CE1' ' HE2' ' A' ' 110' ' ' LYS . 24.6 m-85 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.422 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.676 HH11 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HG3' ' A' ' 36' ' ' ARG . 5.0 m120 -71.26 -44.85 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -58.16 -44.39 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 0.0 110.455 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -60.59 -40.48 91.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.365 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.676 HD11 HH11 ' A' ' 36' ' ' ARG . 80.4 mt -60.58 -53.65 54.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.888 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.55 -50.82 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.7 -43.98 97.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 89.6 mt-10 -71.71 -27.79 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.32 -46.01 91.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.84 0.352 . . . . 0.0 110.586 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 13.6 mt-10 -68.47 -44.06 75.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -27.72 43.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.484 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -88.13 -30.44 17.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -83.47 -43.7 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 10.0 mmtt -58.45 -62.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.898 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 174.71 45.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.737 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -153.04 -177.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.85 105.09 1.37 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.49 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 66.89 14.09 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.556 0.217 . . . . 0.0 111.33 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.737 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.05 41.33 29.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.875 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 p -71.43 -18.91 62.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 111.13 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' HG21 ' A' ' 51' ' ' VAL . 21.1 m -155.1 169.8 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 m -161.73 110.99 1.54 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.675 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.544 ' CH2' HG11 ' A' ' 51' ' ' VAL . 32.4 p90 -103.81 143.45 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -151.82 -136.09 2.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.039 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.945 HD11 HD23 ' A' ' 68' ' ' LEU . 10.6 mt -132.61 133.04 43.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.743 0.306 . . . . 0.0 110.905 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.038 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.945 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.782 0.325 . . . . 0.0 110.98 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 94' ' ' CYS . 2.9 m -97.78 -61.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.2 93.62 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.675 ' CE3' HD13 ' A' ' 140' ' ' ILE . 40.5 m95 -90.06 152.63 21.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.01 152.08 21.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.724 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -143.71 102.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.629 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.4 mtp -94.17 147.06 23.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 147' ' ' LEU . 45.5 mt -151.78 138.06 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.74 0.305 . . . . 0.0 111.588 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mt -99.26 148.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.118 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 83' ' ' TYR . . . -78.69 117.97 4.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.266 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 Cg_endo -54.41 146.86 49.61 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.163 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 13.4 Cg_exo -69.3 173.64 10.26 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.635 2.224 . . . . 0.0 112.73 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 41.48 43.14 2.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.792 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 80' ' ' ARG . 19.9 p -161.3 158.17 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.42 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.517 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -44.32 -27.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 84' ' ' GLU . 53.6 m-85 -78.79 -24.56 44.54 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -22.01 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.21 65.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.753 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 9.4 mmt180 -152.87 102.9 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 88' ' ' TYR . 11.0 mt -67.56 168.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.208 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.587 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.9 m-85 -150.34 132.91 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 0.0 110.992 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 48.7 m -94.18 146.7 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.296 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.855 HD21 ' CE2' ' A' ' 107' ' ' PHE . 3.8 mp -151.7 159.89 43.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.96 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.624 ' HE3' HG21 ' A' ' 108' ' ' VAL . 28.1 mttt -144.54 117.91 9.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.519 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 105' ' ' VAL . 5.0 mp -106.2 123.65 61.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -93.82 108.67 20.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.794 ' O ' HG23 ' A' ' 69' ' ' THR . 57.4 m -113.54 152.55 30.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.65 -149.36 4.95 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.592 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.78 -48.63 18.54 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.665 2.243 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 77.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -101.79 -66.68 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 98' ' ' TYR . 55.2 Cg_endo -69.76 -0.94 7.63 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.346 1.364 . . . . 0.0 112.312 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.22 -4.69 16.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.986 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.61 144.22 8.01 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 120.836 0.351 . . . . 0.0 111.308 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.01 110.07 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.868 2.378 . . . . 0.0 112.042 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 41.6 Cg_endo -67.56 -176.17 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.444 2.096 . . . . 0.0 112.244 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -94.76 94.63 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 111.197 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.719 HG22 HG23 ' A' ' 92' ' ' ILE . 44.6 t -96.32 138.54 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.781 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' A' ' 123' ' ' VAL . 1.9 ptm180 -150.22 126.12 10.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.864 ' CD2' HG21 ' A' ' 111' ' ' ILE . 25.1 m-85 -68.1 126.78 30.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 91' ' ' LYS . 38.2 t -78.35 -41.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.262 0.553 . . . . 0.0 109.948 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.4 t -68.41 -175.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.828 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' A' ' 168' ' ' TYR . 11.9 mttt -98.83 68.02 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.512 . . . . 0.0 110.274 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.864 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.343 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.47 101.89 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.1 ttm -125.2 157.5 36.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -54.67 -52.86 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -89.19 -11.64 64.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.109 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 1.011 HG22 HG13 ' A' ' 123' ' ' VAL . 43.7 t -107.19 121.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.42 143.75 52.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.925 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -98.25 29.15 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 p -140.0 -43.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.628 ' HB3' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -102.23 -32.74 9.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 110.033 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -3.16 81.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.874 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 120' ' ' ASN . 46.3 t -58.96 110.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.011 HG13 HG22 ' A' ' 116' ' ' VAL . 3.4 t -77.69 107.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -63.77 109.99 3.25 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.849 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.401 ' CB ' HD23 ' A' ' 131' ' ' LEU . 39.1 Cg_exo -60.41 -23.28 74.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.323 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -41.33 66.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.532 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -74.65 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 123' ' ' VAL . 35.5 mm -75.46 133.25 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.734 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.5 -58.84 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.016 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 HG12 ' A' ' 142' ' ' VAL . 14.9 p -49.85 -33.91 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.795 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD1' HG13 ' A' ' 130' ' ' VAL . 7.4 mp -81.91 -41.85 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.84 69.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.86 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 47.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -48.03 157.22 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.28 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 179.28 7.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 9.0 p30 -78.71 -31.98 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -79.13 -12.77 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.226 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.541 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.2 m-30 -72.87 153.74 40.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -156.16 -176.39 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.675 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.9 mt -54.92 -35.14 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.497 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -67.39 -38.93 85.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.707 HG12 HG21 ' A' ' 130' ' ' VAL . 49.1 t -68.63 -37.67 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HA ' HG11 ' A' ' 130' ' ' VAL . 38.5 t -63.5 -52.9 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.551 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.672 HD22 HD11 ' A' ' 75' ' ' ILE . 42.6 mt -62.48 -43.68 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.956 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -61.96 -51.11 69.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.054 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.419 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -59.8 -53.36 58.82 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 75' ' ' ILE . 4.6 pp -56.08 -40.76 74.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.987 0.422 . . . . 0.0 110.134 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 ttt-85 -62.6 -34.16 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.73 -38.47 78.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.538 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.6 mt -64.08 -41.48 97.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 34.7 mtt -55.7 -32.36 63.24 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.283 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -19.82 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.949 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -65.12 159.83 22.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' MET . 4.6 mtpm? -65.21 -36.01 82.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.301 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.78 -35.86 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -89.57 -11.63 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 14.1 ptm -90.61 24.57 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 111.187 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.07 -37.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.823 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.7 mt -54.37 157.66 4.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.413 ' C ' ' HG2' ' A' ' 161' ' ' GLN . 44.0 Cg_endo -66.11 146.59 82.31 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.326 2.017 . . . . 0.0 112.116 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.517 ' HG3' HG23 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -146.26 103.04 4.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.586 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.374 2.049 . . . . 0.0 112.204 -179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.737 0.303 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 83.8 m -155.99 154.3 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.609 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 109' ' ' THR . 24.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.835 0.35 . . . . 0.0 110.873 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -65.02 -34.81 79.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -55.72 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.3 mmt180 -58.47 -39.26 79.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.812 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 84.1 mt -61.72 -40.31 94.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.16 -52.57 15.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.64 -43.18 99.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.921 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 72.7 mm-40 -68.63 -29.72 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.797 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 64.0 tp -62.85 -47.13 84.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.6 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -58.11 -41.63 83.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -66.45 -62.81 4.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.586 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -52.28 -39.7 60.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.987 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -72.74 -27.48 62.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.57 170.01 22.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.515 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.497 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -113.04 -177.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.9 -76.72 0.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' HG23 ' A' ' 55' ' ' THR . 0.5 OUTLIER -73.95 -14.27 61.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.222 . . . . 0.0 111.288 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 68.6 28.65 73.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.44 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 53' ' ' ASP . 13.9 p -71.88 -12.32 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.585 0.231 . . . . 0.0 111.426 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.847 HG12 HG12 ' A' ' 75' ' ' ILE . 3.9 m -154.21 161.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.776 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.01 124.83 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.795 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ3' HG23 ' A' ' 56' ' ' VAL . 4.4 p90 -114.87 -179.12 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.28 44.12 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.057 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD23 ' A' ' 68' ' ' LEU . 4.7 mt -99.46 120.79 40.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.981 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 m -75.01 -68.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.31 142.68 50.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.752 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.812 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 92.0 m95 -135.17 144.16 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.293 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 159.9 14.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 156.81 26.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.885 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 24.5 mtp -145.48 147.25 31.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.712 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.847 HG12 HG12 ' A' ' 56' ' ' VAL . 41.3 mt -150.57 120.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.823 0.344 . . . . 0.0 111.759 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mt -86.66 149.21 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.429 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -74.69 134.0 16.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.844 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 84.1 Cg_endo -78.39 127.61 8.32 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.192 . . . . 0.0 111.737 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.8 Cg_endo -50.04 141.21 30.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.628 2.219 . . . . 0.0 112.727 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 75.4 44.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.235 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 17.6 p -159.4 154.55 25.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.442 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.11 -38.51 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.989 0.424 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 42.3 m-85 -80.35 -20.62 43.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.026 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.4 pt-20 -41.85 133.06 2.93 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 66.99 41.38 2.7 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.553 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 84' ' ' GLU . 2.4 mpt_? -149.59 115.7 5.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.718 0.294 . . . . 0.0 111.362 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 88' ' ' TYR . 37.1 mt -65.57 168.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.021 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 22.5 m-85 -153.32 119.53 5.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.586 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.8 m -88.77 153.17 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.632 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.0 mp -153.75 160.28 42.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.369 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -137.87 114.16 10.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.452 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.003 HG23 HG22 ' A' ' 105' ' ' VAL . 4.4 mp -106.19 121.45 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.494 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 40.4 mt-10 -94.25 127.6 40.21 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.787 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 83.8 m -132.19 121.46 23.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.69 -153.02 25.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.423 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 76.7 Cg_exo -49.94 -36.34 43.51 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.644 2.229 . . . . 0.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 118.21 32.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.531 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.6 t80 -135.93 -67.35 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.22 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.6 Cg_endo -69.37 0.92 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.439 1.426 . . . . 0.0 112.5 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -107.41 -20.59 13.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.313 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.25 161.03 28.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 0.0 111.469 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.58 119.17 6.21 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.659 2.239 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -86.49 -123.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.873 2.382 . . . . 0.0 111.675 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.419 ' H ' ' HB2' ' A' ' 103' ' ' PRO . 12.4 t80 -145.93 129.49 16.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.677 0.275 . . . . 0.0 110.693 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 92' ' ' ILE . 24.2 t -135.36 140.55 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.631 ' HA ' HG23 ' A' ' 123' ' ' VAL . 32.1 ptt85 -150.3 122.51 8.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.167 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.912 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.2 m-85 -60.03 141.21 56.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.446 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 90' ' ' LEU . 38.9 t -96.27 -44.05 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 110.327 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 88' ' ' TYR . 7.2 t -68.22 -175.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -91.25 86.97 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.977 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.912 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -119.46 151.47 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.481 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -126.07 102.33 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.649 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 147' ' ' LEU . 27.9 ttm -124.45 143.97 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.36 -25.75 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -111.58 15.3 27.04 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HG13 ' A' ' 123' ' ' VAL . 86.9 t -137.74 127.69 36.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.797 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.7 165.89 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.055 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' CZ ' ' A' ' 168' ' ' TYR . 15.6 m -106.22 -16.86 14.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.198 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.1 m -77.39 -61.45 1.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.62 -38.04 6.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 107.7 21.18 8.01 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.56 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.09 111.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 116' ' ' VAL . 3.3 t -77.49 100.91 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.3 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -64.74 119.75 60.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.421 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.3 Cg_exo -62.01 -14.99 40.59 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.505 2.137 . . . . 0.0 112.638 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -28.83 63.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.684 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -95.38 -28.22 15.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.256 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 123' ' ' VAL . 34.9 mm -77.18 128.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -67.52 -60.03 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.356 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 146' ' ' GLU . 16.9 m -49.98 -32.53 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.553 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.421 HD23 ' CB ' ' A' ' 125' ' ' PRO . 1.1 tp -83.67 -43.01 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.617 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.18 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 54.79 1.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -47.85 158.09 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.545 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -142.64 178.12 7.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.37 -30.57 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.017 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.8 p -79.31 -9.82 59.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.395 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -73.3 155.15 39.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.6 m -156.17 -176.52 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.3 mt -58.5 -41.57 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 pttt -62.36 -36.62 82.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 0.0 110.273 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.47 -37.94 78.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.436 0.636 . . . . 0.0 109.59 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.65 -53.34 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.941 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.492 HD12 ' CE3' ' A' ' 58' ' ' TRP . 21.9 mt -61.5 -46.02 91.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.689 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.02 -30.04 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.071 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 130' ' ' VAL . 16.6 tp10 -72.83 -48.54 36.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.01 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.9 mt -54.74 -45.94 74.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.69 -38.88 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.819 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 5.7 ttm180 -61.62 -43.99 97.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.051 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -62.02 -41.88 98.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.417 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 12.0 mtm -62.04 -27.66 69.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.2 mtm -75.95 -16.9 59.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.95 154.52 37.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -60.53 -43.25 97.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.12 -32.9 73.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.909 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 44.6 m-80 -86.76 -36.66 18.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 6.9 ptm -78.92 48.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 110.987 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -146.6 -39.57 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.316 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.9 mt -52.3 148.16 12.37 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.497 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.95 121.95 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.258 1.972 . . . . 0.0 112.659 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' A' ' 82' ' ' ILE . 87.4 mm-40 -87.54 122.59 70.48 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.046 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.221 1.947 . . . . 0.0 111.864 179.732 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.829 0.347 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 35.5 m -75.81 -179.36 4.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.524 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 4.6 m120 -66.54 -41.92 87.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 41' ' ' LEU . 11.1 m-85 -60.11 -44.57 94.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 13.2 mmm-85 -58.57 -43.41 89.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 41.3 mt -61.29 -39.38 90.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.986 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.593 HD23 HD21 ' A' ' 68' ' ' LEU . 6.6 mt -72.11 -52.66 15.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -42.19 99.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.919 0.39 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 9.3 mm-40 -69.02 -29.4 67.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.491 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 55.7 tp -61.77 -47.24 86.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.981 0.419 . . . . 0.0 110.36 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.27 -41.42 99.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.59 -48.82 78.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -63.93 -50.86 58.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.12 -47.97 81.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -62.55 -26.54 68.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.794 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.41 163.41 24.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.403 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.74 -177.19 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.12 -68.98 1.35 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.047 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -84.52 -3.91 58.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 53.21 35.53 50.01 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.373 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 p -71.37 -15.66 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.648 0.261 . . . . 0.0 111.603 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 HG12 ' A' ' 75' ' ' ILE . 33.9 m -154.13 175.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.386 . . . . 0.0 111.115 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -161.38 110.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.538 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.45 ' HB2' HG21 ' A' ' 140' ' ' ILE . 27.6 p90 -98.96 132.12 44.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.692 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.82 175.31 19.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.122 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 68' ' ' LEU . 1.1 mt -85.39 14.41 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.217 -0.491 . . . . 0.0 112.03 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.081 179.897 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.784 0.326 . . . . 0.0 111.145 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -81.47 -57.09 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 135.9 45.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 75.0 m95 -135.31 171.72 14.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 0.0 111.354 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -137.6 165.71 25.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.346 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -157.39 110.41 0.44 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.074 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtp -90.09 153.09 20.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 144' ' ' LEU . 29.8 mt -151.71 139.22 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.1 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.5 mt -114.35 149.13 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.29 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.75 138.79 14.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.955 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.29 146.88 25.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 112.12 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 13.2 Cg_endo -56.22 147.62 65.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.833 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 77.35 44.75 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.481 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 80' ' ' ARG . 76.7 p -161.87 152.94 18.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -52.71 -37.02 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.572 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 82.0 m-85 -81.84 -14.04 56.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.042 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -46.85 140.3 4.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.208 0.528 . . . . 0.0 112.191 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m120 45.96 42.2 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.012 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.7 mmt-85 -139.72 86.17 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.1 mp -47.25 164.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.569 ' N ' HG22 ' A' ' 87' ' ' ILE . 43.5 m-85 -154.34 128.02 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 111.242 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 m -92.87 154.66 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.467 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -152.38 160.63 43.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -136.65 116.03 12.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.73 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.6 149.01 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.684 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.7 134.83 39.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 110.904 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 98' ' ' TYR . 1.4 p -120.23 -178.33 3.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.175 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.39 -157.71 8.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.51 -25.29 14.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.618 2.212 . . . . 0.0 112.604 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 95.63 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.861 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 2.3 t80 -97.19 -65.11 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.59 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 42.8 Cg_endo -67.44 -1.68 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.655 1.57 . . . . 0.0 112.651 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -109.51 -6.06 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.363 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.03 157.95 33.98 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.69 125.98 20.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.678 2.252 . . . . 0.0 112.074 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 90.9 Cg_endo -81.55 163.69 18.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.553 2.169 . . . . 0.0 112.708 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -95.22 90.26 5.8 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.554 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG21 ' CG1' ' A' ' 143' ' ' VAL . 24.8 t -93.85 138.71 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.246 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -150.2 125.21 9.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 1.111 ' CD2' HG21 ' A' ' 111' ' ' ILE . 3.4 m-85 -70.52 153.66 42.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.19 -40.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.28 0.562 . . . . 0.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 89' ' ' SER . 6.5 t -68.31 -176.39 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 50.5 mmtt -87.68 94.62 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.779 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.111 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.2 tt -130.68 145.69 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.865 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -126.37 102.32 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.89 157.39 36.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.009 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -54.5 -58.89 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.238 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -79.77 -16.7 76.8 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 123' ' ' VAL . 62.8 t -94.92 136.61 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.925 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.91 179.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.8 m -133.09 34.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.986 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -152.57 -47.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 122' ' ' VAL . 7.5 p30 -105.39 -37.25 6.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.125 0.488 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.31 2.36 41.29 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.011 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 120' ' ' ASN . 30.8 t -58.89 110.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 116' ' ' VAL . 3.7 t -76.94 112.77 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.408 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -64.19 110.91 4.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB3' HD23 ' A' ' 131' ' ' LEU . 32.4 Cg_exo -58.25 -18.53 37.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.496 2.131 . . . . 0.0 112.403 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -47.82 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.7 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.604 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -67.91 -42.7 80.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.479 ' CG2' HG12 ' A' ' 130' ' ' VAL . 44.1 mm -69.01 123.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.5 t -66.06 -55.86 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.457 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 128' ' ' ILE . 8.6 p -49.97 -32.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.479 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -84.49 -49.51 8.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.52 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.306 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -134.81 43.87 2.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.912 0.387 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -49.55 148.64 2.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 138' ' ' TYR . 1.5 mt-30 -130.54 -171.93 2.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 37.8 t30 -104.25 58.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -160.52 -27.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.716 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.468 ' CD1' HG11 ' A' ' 142' ' ' VAL . 22.6 m-85 -70.78 172.03 9.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.465 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.2 m -156.07 -176.42 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.368 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.597 HD13 ' CE3' ' A' ' 71' ' ' TRP . 33.4 mt -53.87 -44.43 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.247 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 21.8 pttt -58.57 -37.48 75.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 138' ' ' TYR . 41.3 t -68.36 -39.23 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 109.627 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 105' ' ' VAL . 18.1 t -61.82 -53.39 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.835 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 75' ' ' ILE . 20.9 mt -61.4 -43.78 98.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.64 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.89 -40.21 79.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -53.04 62.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.65 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.9 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 16.2 mt -50.56 -46.21 57.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 110.658 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -62.15 -34.4 76.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.941 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -61.44 -43.04 99.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.958 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.6 mt -63.56 -44.75 93.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.437 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 15.1 mtt -58.32 -29.77 66.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.928 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.6 mtm -76.9 -15.95 59.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.3 m -64.94 141.23 58.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 10.8 tptt -51.28 -53.24 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.07 -23.1 65.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.747 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.12 -25.91 23.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.722 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 14.5 ptm -86.64 19.23 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.089 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.86 -30.72 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.282 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.8 mt -54.72 144.23 46.39 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.554 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.38 150.3 68.56 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.238 1.958 . . . . 0.0 112.04 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.53 ' HG3' HG23 ' A' ' 82' ' ' ILE . 25.0 mm-40 -146.49 116.59 4.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 110' ' ' LYS . 80.9 Cg_exo . . . . . 0 C--N 1.346 0.419 0 C-N-CA 122.509 2.139 . . . . 0.0 112.141 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 28.2 pt20 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.865 0.364 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 51.8 m -77.39 176.27 9.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.674 0.273 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.412 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 1.7 t30 -60.57 -32.78 71.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.744 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -54.58 41.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 6.0 mmt180 -57.68 -38.73 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.083 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 98' ' ' TYR . 69.9 mt -61.86 -52.26 64.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.23 -50.49 70.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -61.67 -46.36 90.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.4 mt-10 -70.56 -29.33 65.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.399 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 54.5 tp -62.12 -35.21 78.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.358 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 -34.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.2 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.17 -34.28 70.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.511 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.493 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -85.02 -34.39 15.09 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.41 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -51.98 -43.77 63.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.872 0.368 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -62.47 -29.45 70.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.505 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . 87.77 35.13 9.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.613 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER 40.41 -170.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.13 -83.35 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.734 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.96 -23.84 48.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 73.73 32.35 59.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -72.52 -13.31 61.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 75' ' ' ILE . 25.0 m -154.77 171.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.747 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -161.76 111.02 1.53 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 34.7 p90 -103.86 130.08 51.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -142.35 -139.05 3.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.066 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.733 HD11 HD23 ' A' ' 68' ' ' LEU . 7.7 mt -125.17 145.68 49.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.905 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.733 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.89 0.376 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -91.88 -66.5 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 98.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.791 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.596 ' CE3' HD13 ' A' ' 140' ' ' ILE . 62.0 m95 -88.78 152.09 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 147.39 26.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -140.31 99.53 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.996 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -92.45 149.29 21.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.6 mt -150.85 144.99 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 111.607 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -120.11 149.23 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.4 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.14 123.26 7.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.023 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 20.6 Cg_exo -65.47 142.28 71.18 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.488 2.125 . . . . 0.0 111.996 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 42.6 Cg_exo -57.07 146.14 82.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.699 2.266 . . . . 0.0 112.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 81' ' ' THR . 7.3 mtt180 81.61 42.46 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.825 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' ARG . 15.7 p -162.52 155.83 20.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.863 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -51.23 -40.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.937 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 67.2 m-85 -79.43 -18.0 53.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.841 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.6 pt-20 -41.28 143.87 0.39 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.279 0.561 . . . . 0.0 112.474 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.5 t30 45.65 54.35 7.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.822 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 4.8 mmt85 -152.72 107.27 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.492 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.1 mp -67.16 165.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.481 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HG22 ' A' ' 87' ' ' ILE . 27.5 m-85 -150.75 130.72 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.983 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 28.2 t -93.12 148.28 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.141 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.907 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.1 mp -152.27 160.02 43.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.046 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.8 mtmt -143.56 117.23 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.774 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.28 127.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.99 117.14 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' O ' HG23 ' A' ' 69' ' ' THR . 15.7 m -126.3 159.46 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.63 -126.53 0.82 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.02 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.378 2.052 . . . . 0.0 112.401 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 69.46 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.2 t80 -90.26 -64.5 0.18 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.042 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 72.9 Cg_endo -74.98 3.99 5.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.391 1.394 . . . . 0.0 112.307 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -113.13 -11.02 13.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.757 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.53 146.81 18.0 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.4 110.17 0.57 Allowed 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 122.825 2.35 . . . . 0.0 112.188 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 45.7 Cg_endo -67.89 -176.2 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 46.1 t80 -94.93 95.37 8.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 92' ' ' ILE . 48.1 t -95.42 138.15 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.645 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' VAL . 3.2 ptt-85 -150.2 138.31 20.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.984 ' CD2' HG21 ' A' ' 111' ' ' ILE . 14.3 m-85 -83.85 137.98 33.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.879 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 167' ' ' CYS . 19.0 t -93.63 -39.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.224 0.535 . . . . 0.0 109.867 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.0 t -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.924 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -94.11 82.8 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.984 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -112.57 149.09 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.53 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -126.23 102.95 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.525 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.9 ttm -124.37 155.39 38.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.953 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -54.54 -52.88 60.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.18 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.715 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -86.21 -14.47 66.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.037 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 123' ' ' VAL . 48.6 t -98.95 132.21 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.15 167.84 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.7 m -123.68 31.05 6.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.2 p -142.69 -47.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -104.69 -37.16 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.131 0.491 . . . . 0.0 110.119 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.32 43.61 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.998 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 21.5 t -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 116' ' ' VAL . 8.8 t -77.21 111.93 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.685 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.79 125.2 89.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 -15.85 24.62 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.421 2.08 . . . . 0.0 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -72.43 -42.46 65.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.938 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.715 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -77.6 -46.73 21.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.406 ' CG2' ' CG2' ' A' ' 130' ' ' VAL . 21.3 mm -62.46 132.29 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.3 p -67.36 -56.0 11.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.408 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 146' ' ' GLU . 3.2 m -49.93 -36.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.618 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 130' ' ' VAL . 6.6 mp -80.71 -43.71 19.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.652 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.74 62.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -139.08 55.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 61.9 t-105 -49.67 157.87 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HG3' ' CE1' ' A' ' 138' ' ' TYR . 9.0 mm100 -131.32 -166.65 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.34 -40.42 9.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 t -79.3 -3.89 48.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.394 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.46 ' HA ' HG21 ' A' ' 142' ' ' VAL . 5.2 m-30 -72.46 151.8 42.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.845 0.355 . . . . 0.0 111.045 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 p -156.34 -176.5 6.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.596 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mp -53.12 -29.96 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.28 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 8.6 pttt -71.04 -40.27 71.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 138' ' ' TYR . 66.4 t -68.88 -35.53 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.503 0.668 . . . . 0.0 109.453 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 105' ' ' VAL . 40.4 t -67.85 -52.81 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 75' ' ' ILE . 22.4 mt -62.72 -47.75 82.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.916 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -60.32 -48.86 79.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.529 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.585 ' HG2' HG13 ' A' ' 130' ' ' VAL . 7.3 tp10 -59.98 -53.23 60.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.826 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.837 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -60.63 -41.05 94.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.952 0.405 . . . . 0.0 110.301 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.68 -31.63 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.061 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -59.37 -44.6 92.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -63.37 -46.81 84.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.228 179.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 11.7 mtp -48.67 -39.11 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttp -77.33 -27.68 52.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -65.8 147.97 52.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 1.7 mmmp? -51.16 -25.58 5.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.58 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -54.86 36.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.012 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 12.8 m-80 -88.2 -30.96 19.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 81' ' ' THR . 2.7 ptm -72.91 52.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.112 0.482 . . . . 0.0 111.297 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.15 -42.68 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.024 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt -53.79 150.55 13.66 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.595 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.93 126.0 14.55 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.373 2.049 . . . . 0.0 112.43 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 35.8 mm-40 -84.38 120.4 74.33 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.224 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 161' ' ' GLN . 19.9 Cg_exo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 122.259 1.973 . . . . 0.0 111.896 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.5 m -77.3 -167.48 0.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 109' ' ' THR . 1.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 9.7 p-10 -65.77 -36.4 83.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -55.32 -53.86 50.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.716 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 8.1 tpp180 -57.51 -42.89 83.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 73.5 mt -59.44 -40.81 88.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.982 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 90.1 mt -72.22 -52.72 15.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.641 0.258 . . . . 0.0 111.366 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.76 -36.87 82.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 32.4 mt-10 -76.56 -28.91 56.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.0 tp -62.29 -35.08 77.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.137 0.494 . . . . 0.0 110.033 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -41.8 45.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.371 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -38.39 76.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.918 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.66 -58.29 5.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.693 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -58.0 -36.02 72.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -76.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.68 168.21 39.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.617 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.43 -176.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 111.166 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.05 97.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.682 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.61 22.18 12.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.718 0.294 . . . . 0.0 111.274 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 50.4 46.95 44.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.698 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.676 0.274 . . . . 0.0 111.297 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 75' ' ' ILE . 34.1 m -154.41 175.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.955 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.91 110.65 1.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.463 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.617 ' CH2' HG11 ' A' ' 51' ' ' VAL . 28.6 p90 -100.12 87.45 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -143.49 12.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.767 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.655 HD11 ' CD2' ' A' ' 68' ' ' LEU . 6.0 mt -120.4 140.65 51.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.775 0.322 . . . . 0.0 111.024 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.655 ' CD2' HD11 ' A' ' 60' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.909 0.385 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -51.86 12.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -78.86 95.97 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.713 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 40.8 m95 -89.06 165.36 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -127.08 118.5 24.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.617 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -114.64 119.12 4.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.662 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mtp -93.73 154.39 17.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.824 HD13 HD11 ' A' ' 147' ' ' LEU . 30.4 mt -152.27 138.06 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.846 0.355 . . . . 0.0 111.761 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -116.79 149.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.415 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.83 146.8 18.34 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.11 141.18 11.56 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.827 2.351 . . . . 0.0 112.25 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 58.0 Cg_exo -51.81 141.77 43.99 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.546 2.164 . . . . 0.0 112.798 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER 79.06 41.18 0.09 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.529 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.4 p -159.68 152.42 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -47.77 -39.14 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 111.316 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' CE ' ' A' ' 151' ' ' MET . 89.9 m-85 -78.8 -22.61 46.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.909 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -41.52 135.25 2.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 56.22 20.48 4.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.925 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.13 105.45 11.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.797 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 88' ' ' TYR . 47.1 mt -70.65 165.05 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 35.6 m-85 -150.25 130.22 13.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.02 0.438 . . . . 0.0 111.197 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 30.9 t -93.76 151.29 19.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.4 mp -151.29 160.31 43.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.0 ttmt -139.01 114.51 9.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.557 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.42 120.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.355 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 18.9 mt-10 -94.25 122.23 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.801 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.72 -169.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.98 -153.42 15.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.01 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.304 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -96.65 74.22 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.587 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.7 t80 -96.71 -52.8 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 2.3 Cg_endo -80.25 3.95 7.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.776 1.651 . . . . 0.0 112.224 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -114.5 -18.57 11.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.14 73.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HB3' HD13 ' A' ' 131' ' ' LEU . 48.2 Cg_exo -55.88 124.43 16.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.578 2.185 . . . . 0.0 112.325 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 89.0 Cg_endo -77.91 167.83 23.09 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.64 2.227 . . . . 0.0 112.223 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 87.3 t80 -96.45 89.23 4.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.239 0.543 . . . . 0.0 110.351 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.622 HG21 HG11 ' A' ' 143' ' ' VAL . 38.3 t -93.56 141.15 15.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.051 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -150.25 128.84 12.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.091 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 1.067 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.4 m-85 -75.23 123.15 24.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.492 HG22 ' HE3' ' A' ' 91' ' ' LYS . 20.7 t -75.72 -40.74 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.337 0.589 . . . . 0.0 109.499 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.415 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 7.4 t -69.75 -177.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.864 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 14.0 mttt -97.99 97.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.756 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.067 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -126.55 151.14 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.835 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.427 ' N ' HD13 ' A' ' 111' ' ' ILE . 21.4 t-20 -126.21 102.77 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 31.3 ttm -124.42 153.08 42.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -52.53 -26.16 12.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -123.15 22.49 7.11 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.041 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 123' ' ' VAL . 57.6 t -136.09 126.54 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.661 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 138.01 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 t -101.89 54.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.2 p -176.79 -39.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -102.81 -34.47 8.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 109.974 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.96 64.75 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.983 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.77 115.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 116' ' ' VAL . 15.0 t -77.51 115.18 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.8 OUTLIER -65.13 113.2 10.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.531 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.403 ' CB ' ' HB3' ' A' ' 131' ' ' LEU . 36.6 Cg_endo -65.21 -12.3 34.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.52 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.23 -49.95 31.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -69.97 -51.71 30.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 31.7 mm -57.81 132.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -60.33 2.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.202 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 146' ' ' GLU . 10.4 m -49.99 -30.15 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.717 0.294 . . . . 0.0 111.739 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.541 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 mm? -83.85 -47.63 10.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.6 -31.65 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.474 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -135.83 42.46 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -50.55 117.46 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.226 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -99.9 -176.79 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 3.9 m-20 -92.03 56.07 2.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.9 p -159.45 -18.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.2 m-85 -71.85 169.84 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.08 0.467 . . . . 0.0 111.416 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.74 -176.38 5.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.475 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.511 HD13 ' CE3' ' A' ' 71' ' ' TRP . 66.8 mt -56.22 -47.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 111.32 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.466 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 11.5 ptpt -60.69 -34.86 74.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.768 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 138' ' ' TYR . 21.4 t -68.54 -37.62 77.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.452 0.644 . . . . 0.0 109.392 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 105' ' ' VAL . 36.6 t -63.58 -52.88 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.843 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.56 HD22 HD11 ' A' ' 75' ' ' ILE . 21.1 mt -62.55 -48.75 78.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.698 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -60.36 -46.08 91.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.565 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HG2' HG22 ' A' ' 130' ' ' VAL . 9.1 tp10 -61.09 -53.47 56.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.735 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.824 HD11 HD13 ' A' ' 75' ' ' ILE . 3.5 pp -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 147' ' ' LEU . 73.4 ttt-85 -65.13 -33.42 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.741 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -43.68 90.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.961 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.1 mt -66.3 -38.19 87.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.106 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.453 ' CE ' ' CE1' ' A' ' 83' ' ' TYR . 8.7 mtt -54.97 -35.57 64.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.729 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 53.2 mtm -75.74 -12.55 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.226 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.85 26.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.6 mtpp -59.13 -44.07 92.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.19 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.38 -33.25 73.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.757 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 0.8 OUTLIER -87.81 -39.2 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.547 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -72.44 1.5 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 111.574 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -111.91 -32.42 6.61 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 110.154 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.81 147.19 43.57 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.13 141.13 75.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.383 2.055 . . . . 0.0 111.811 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -146.57 117.66 4.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo . . . . . 0 C--N 1.346 0.44 0 C-N-CA 122.464 2.109 . . . . 0.0 112.249 179.878 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.3 m -160.74 148.2 15.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.679 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 109' ' ' THR . 23.1 m-85 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.896 0.379 . . . . 0.0 111.034 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.473 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 34.7 m120 -68.27 -36.97 80.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.27 -57.62 11.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.013 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -57.6 -43.29 84.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.555 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.715 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 53.7 mt -62.8 -38.3 90.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 12.8 mt -72.13 -52.72 15.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.24 -43.25 98.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 98.2 mt-10 -68.01 -32.1 72.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 59.1 tp -61.44 -42.64 99.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.311 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.34 -50.78 68.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.799 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.95 -40.45 80.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -69.26 -58.55 6.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.66 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.76 -39.86 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 111.111 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -58.12 -72.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.36 158.02 9.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.576 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.404 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -130.24 -175.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.93 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.36 104.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.471 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.94 20.25 11.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.834 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.81 47.97 30.51 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.805 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 56' ' ' VAL . 27.9 p -71.73 -18.04 62.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 111.254 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG12 HG12 ' A' ' 75' ' ' ILE . 19.7 m -156.85 169.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.735 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -160.93 111.18 1.73 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.571 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.51 ' HB2' HG21 ' A' ' 140' ' ' ILE . 30.7 p90 -102.21 96.42 6.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -109.83 -144.4 10.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.912 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.015 HD11 HD23 ' A' ' 68' ' ' LEU . 7.1 mt -121.17 131.96 54.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.255 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.015 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.8 0.333 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -89.36 -55.34 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -77.99 97.07 5.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.715 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 27.2 m95 -91.79 152.02 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.804 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 1.9 m -102.23 144.95 30.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -136.06 103.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.73 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtp -92.59 151.66 20.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 147' ' ' LEU . 30.8 mt -151.82 142.72 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.765 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.23 149.42 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.323 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.29 148.92 17.75 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.004 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HG3' ' HG2' ' A' ' 152' ' ' MET . 92.0 Cg_endo -79.77 132.36 9.69 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.909 2.406 . . . . 0.0 111.975 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 15.8 Cg_endo -56.86 83.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.709 2.273 . . . . 0.0 112.583 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 81' ' ' THR . 5.2 ptt180 161.32 30.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.715 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 74.9 p -162.08 163.65 28.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.93 -37.97 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 97.0 m-85 -79.44 -11.61 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.153 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 5.1 pt-20 -51.71 146.41 7.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 t30 44.62 29.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.611 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 1.6 mmt180 -131.29 99.64 4.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -62.7 166.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.796 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 33.8 m-85 -150.82 130.21 12.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.032 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 40.5 m -92.97 151.19 20.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.187 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.41 160.17 43.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.7 OUTLIER -141.15 114.37 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.83 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 105' ' ' VAL . 4.8 mp -106.35 120.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.481 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 130.04 40.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.428 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 69' ' ' THR . 4.0 p -127.88 -179.03 4.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.18 -149.0 5.75 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.077 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.07 -78.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.466 2.11 . . . . 0.0 111.819 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.76 77.32 9.52 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.674 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -91.26 -52.37 0.29 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 3.4 Cg_exo -79.31 5.0 6.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.984 1.789 . . . . 0.0 112.516 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -8.14 9.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.343 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . . . -139.92 150.46 62.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.667 0.27 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 101' ' ' ALA . 31.3 Cg_exo -59.28 122.37 11.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.6 Cg_endo -82.29 175.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.721 2.28 . . . . 0.0 112.432 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -97.54 90.19 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 143' ' ' VAL . 41.8 t -91.88 138.9 18.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.058 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.19 130.18 13.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.026 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 1.061 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.6 m-85 -76.01 126.7 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.1 t -78.95 -39.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.354 0.597 . . . . 0.0 109.634 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.7 t -69.07 -176.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.067 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 30.1 mttt -99.14 87.52 3.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.061 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -116.87 153.52 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.95 -178.34 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.49 ' N ' HD13 ' A' ' 111' ' ' ILE . 10.6 t-20 -126.35 102.78 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.736 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.437 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 1.9 tpp -123.98 156.48 36.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.227 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -53.61 -43.37 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.164 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -109.05 28.41 11.17 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.944 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.968 HG22 HG13 ' A' ' 123' ' ' VAL . 76.9 t -135.4 130.17 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.824 0.345 . . . . 0.0 110.689 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.55 158.26 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -118.67 26.71 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.48 -51.42 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.5 -34.13 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.007 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.65 0.63 34.59 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.919 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.86 113.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 116' ' ' VAL . 13.1 t -76.67 115.17 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.471 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 110.14 3.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.918 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.38 -15.76 47.22 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.446 2.097 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -46.72 58.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -70.5 -42.65 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.699 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 131' ' ' LEU . 32.8 mm -70.03 103.78 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.647 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -53.96 -55.64 25.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 142' ' ' VAL . 7.2 p -49.97 -31.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' H ' HG22 ' A' ' 128' ' ' ILE . 1.3 tp -84.15 -48.69 9.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.11 69.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.09 34.44 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.427 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 54.8 t-105 -49.37 132.22 20.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -121.26 -178.34 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -86.11 61.06 6.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.9 m -160.85 -28.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.816 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.3 m-85 -70.96 168.16 17.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.425 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.09 -176.43 5.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.246 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.664 HD13 ' CE3' ' A' ' 71' ' ' TRP . 10.7 mt -55.94 -51.34 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.282 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 ptpt -53.16 -35.06 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.816 HG11 ' CD1' ' A' ' 138' ' ' TYR . 40.9 t -69.04 -41.19 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.47 0.652 . . . . 0.0 109.547 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 105' ' ' VAL . 40.5 t -62.61 -53.13 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.342 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.707 HD22 HD11 ' A' ' 75' ' ' ILE . 28.5 mt -63.09 -48.54 78.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.741 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.86 -46.53 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -60.0 -53.16 61.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.568 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 148' ' ' ARG . 4.4 pp -62.0 -38.39 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.838 ' N ' HD12 ' A' ' 147' ' ' LEU . 5.7 ttt-85 -69.59 -30.71 68.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.803 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -43.68 90.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.837 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.756 HD12 ' HA ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -65.33 -42.43 92.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.848 178.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 21.3 mtt -50.97 -35.26 32.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.81 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . 0.424 ' HG2' ' HG3' ' A' ' 78' ' ' PRO . 69.8 mtm -74.44 -22.21 59.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.94 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.6 m -65.79 158.3 28.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 28.7 mttp -65.19 -32.19 73.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -46.94 85.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.128 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -87.15 -21.76 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.48 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -82.56 13.64 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -116.52 -30.38 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.194 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.7 mt -55.41 148.85 30.93 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.829 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.63 149.57 89.61 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.156 . . . . 0.0 112.047 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 82' ' ' ILE . 20.0 mm-40 -146.31 133.71 10.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 C--N 1.345 0.391 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.87 0.367 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.6 p -80.3 -170.69 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.977 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 110' ' ' LYS . 10.7 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.99 131.2 20.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.603 2.202 . . . . 0.0 112.299 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -163.87 -146.91 4.9 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -152.77 30.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.627 HG22 ' HE2' ' A' ' 9' ' ' TYR . 28.4 t -127.71 136.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -49.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.3 -66.24 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.173 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -179.34 3.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.977 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.627 ' HE2' HG22 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -171.13 -167.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.837 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pp -176.51 152.47 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 mttm 60.09 104.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.23 106.98 0.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -103.43 -59.59 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.0 p -95.73 113.66 25.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -105.63 30.69 5.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.1 mp -141.7 -48.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 t -69.71 157.71 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.89 -53.74 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 68.6 -67.91 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.964 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.99 95.69 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 -135.53 138.4 43.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.6 tt -142.18 83.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.36 140.0 45.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.13 105.84 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.522 2.148 . . . . 0.0 112.304 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.62 153.02 45.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.937 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -164.12 -65.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.935 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.55 163.39 14.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -143.59 31.43 1.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.3 p -157.33 139.11 14.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -92.92 165.49 12.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.0 99.92 1.25 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.528 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.6 134.5 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.076 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.05 158.82 1.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.942 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.457 ' CG2' ' HD2' ' A' ' 35' ' ' PRO . 14.1 p -80.22 141.01 53.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.816 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 73.9 Cg_exo -49.54 142.38 23.92 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.362 2.042 . . . . 0.0 112.344 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -74.58 -59.64 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.747 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 14.8 m-80 -52.53 -35.63 53.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.491 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HB2' ' HB2' ' A' ' 35' ' ' PRO . 8.0 t80 -55.37 -53.54 54.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.288 . . . . 0.0 111.045 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 22.4 tpp180 -57.53 -40.16 78.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.42 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 78.8 mt -60.67 -51.46 69.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 64.3 mt -62.05 -52.75 62.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.447 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -61.43 -43.13 99.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.381 . . . . 0.0 110.764 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 80.6 mm-40 -72.41 -28.47 63.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.706 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 44.7 tp -61.35 -42.49 98.79 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.917 0.389 . . . . 0.0 110.496 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.53 -49.26 56.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.791 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.27 78.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.216 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -71.27 -51.31 18.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.649 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -59.18 -44.28 92.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 111.123 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -58.4 -56.21 25.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.977 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 147.19 170.01 15.12 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.677 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -138.95 -177.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 111.076 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.61 108.95 1.36 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.663 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.89 16.08 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.578 0.228 . . . . 0.0 111.272 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 47.42 50.72 17.39 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.981 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -70.52 -23.34 62.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 110.949 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.612 HG12 HG12 ' A' ' 75' ' ' ILE . 22.7 m -155.01 173.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.556 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -160.86 112.0 1.82 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.977 0.418 . . . . 0.0 110.562 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.485 ' HH2' HG11 ' A' ' 51' ' ' VAL . 25.2 p90 -101.14 81.66 2.26 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.84 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.77 179.01 35.39 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.995 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.843 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -90.38 144.58 25.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.977 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -76.93 -56.63 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.797 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.05 106.4 14.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.674 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 3.6 m-20 -68.17 46.38 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.146 0.425 . . . . 0.0 112.146 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 63' ' ' ASP . 39.0 mp0 -157.38 27.03 0.29 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.45 -169.81 2.22 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.353 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.8 mmt -130.6 -60.49 0.99 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.582 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.743 ' C ' HD12 ' A' ' 68' ' ' LEU . 4.4 t -86.68 -8.28 57.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.416 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.843 HD23 HD11 ' A' ' 60' ' ' LEU . 0.4 OUTLIER 55.94 81.99 0.11 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.828 0.347 . . . . 0.0 110.694 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.0 m -97.72 -66.8 0.88 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.353 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.38 93.7 0.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.245 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.588 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 81.6 m95 -90.87 169.27 11.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.958 0.409 . . . . 0.0 111.056 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -135.22 124.69 24.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.616 ' CA ' HD11 ' A' ' 144' ' ' LEU . . . -120.64 115.95 3.07 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.804 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -91.1 157.17 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.785 ' CD1' HD11 ' A' ' 147' ' ' LEU . 25.6 mt -152.86 141.32 14.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.819 0.342 . . . . 0.0 111.748 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.9 mt -113.47 149.2 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.731 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -79.43 139.57 21.83 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.865 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 72.0 Cg_endo -87.69 127.42 2.3 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.973 2.449 . . . . 0.0 112.109 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.61 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 81.7 Cg_exo -47.52 139.9 16.98 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.552 2.168 . . . . 0.0 112.99 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 mtt85 79.7 40.47 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.437 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 31.0 p -159.09 151.75 21.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.956 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.78 -39.63 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.018 0.437 . . . . 0.0 111.102 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.474 ' CZ ' ' HG2' ' A' ' 151' ' ' MET . 49.8 m-85 -80.27 -21.57 42.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.114 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.2 pt-20 -38.36 138.01 0.51 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 55.03 45.94 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.711 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -143.69 112.76 6.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.4 mp -70.45 160.39 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.425 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' N ' HG22 ' A' ' 87' ' ' ILE . 15.3 m-85 -151.9 126.76 9.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.96 0.41 . . . . 0.0 111.208 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.469 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 1.2 t -94.94 151.83 18.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.456 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -150.96 160.37 43.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.14 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.63 114.81 10.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.744 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.36 120.75 57.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.214 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -93.95 120.54 34.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.1 m -128.63 105.19 8.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -115.53 -110.64 2.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.387 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.1 118.28 5.48 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.153 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.401 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 4.8 mtpp 61.81 87.94 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.701 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -105.27 -66.82 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.896 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 55.4 Cg_endo -69.63 2.91 3.04 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.439 1.426 . . . . 0.0 112.952 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 97' ' ' LYS . 16.4 pt-20 -112.06 -9.34 13.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.663 0.268 . . . . 0.0 111.041 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' HD2' ' A' ' 102' ' ' PRO . . . -151.62 164.56 19.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 101' ' ' ALA . 45.7 Cg_exo -57.01 123.29 13.49 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.694 2.263 . . . . 0.0 112.382 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HB3' ' CD1' ' A' ' 98' ' ' TYR . 93.2 Cg_endo -80.07 167.81 19.52 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.726 2.284 . . . . 0.0 112.317 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.19 89.11 5.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.272 0.558 . . . . 0.0 110.212 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 92' ' ' ILE . 40.5 t -94.24 142.09 13.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.126 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 129.71 12.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.953 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.934 ' CD2' HG21 ' A' ' 111' ' ' ILE . 11.5 m-85 -75.2 130.93 39.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 t -85.31 -45.13 17.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.301 0.572 . . . . 0.0 109.647 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 9.9 t -69.0 -179.38 1.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.689 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 8.5 mmtt -88.95 105.23 17.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.934 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -132.25 153.15 37.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.771 -178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 111' ' ' ILE . 4.3 m-20 -125.98 102.6 7.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.565 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.665 ' HE1' ' HB2' ' A' ' 147' ' ' LEU . 18.4 ttm -124.3 144.71 49.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.022 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -53.17 -32.71 49.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.288 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.691 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -101.78 -10.65 39.87 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.09 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.856 HG22 HG13 ' A' ' 123' ' ' VAL . 46.1 t -111.75 126.36 69.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.399 . . . . 0.0 111.191 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -60.18 165.64 3.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -111.77 30.25 7.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.66 -58.16 1.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.808 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' A' ' 122' ' ' VAL . 2.5 m-20 -104.9 -34.16 8.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.08 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.18 11.3 32.14 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.598 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.7 t -58.89 110.58 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.852 0.358 . . . . 0.0 110.986 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.856 HG13 HG22 ' A' ' 116' ' ' VAL . 2.8 t -76.81 104.74 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.356 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -64.83 123.34 83.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.863 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.704 ' HB3' HD23 ' A' ' 131' ' ' LEU . 57.6 Cg_endo -70.92 -13.15 31.55 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.386 2.057 . . . . 0.0 112.491 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -72.31 -35.11 68.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.795 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.691 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -85.4 -46.56 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.887 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD13 ' A' ' 131' ' ' LEU . 22.8 mm -65.9 129.91 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.74 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 88.5 p -67.48 -59.16 3.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.595 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.595 HG13 ' HG2' ' A' ' 146' ' ' GLU . 4.5 m -49.79 -30.93 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.864 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -83.18 -43.66 15.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.731 0.3 . . . . 0.0 110.644 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.84 -54.86 36.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.817 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -105.92 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -48.5 139.86 8.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.345 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.458 ' HG2' ' CG ' ' A' ' 138' ' ' TYR . 14.8 pt20 -127.37 -170.71 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -86.39 -25.58 25.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.397 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.33 -12.17 59.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.424 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 135' ' ' GLN . 12.3 m-30 -73.92 155.43 38.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.002 0.43 . . . . 0.0 111.302 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.2 p -155.9 -176.4 5.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.454 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.4 mt -57.95 -44.45 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.085 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . 1.3 pttt -61.03 -34.88 75.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 110.657 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.3 t -68.34 -40.62 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.477 0.656 . . . . 0.0 109.446 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 105' ' ' VAL . 37.4 t -61.22 -53.03 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.966 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.616 HD11 ' CA ' ' A' ' 73' ' ' GLY . 25.0 mt -62.9 -48.87 77.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.967 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.14 -42.57 95.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.028 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.595 ' HG2' HG13 ' A' ' 130' ' ' VAL . 3.0 tp10 -68.99 -53.09 22.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 148' ' ' ARG . 3.5 pp -57.17 -42.63 81.49 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.945 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.801 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -67.03 -33.3 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 0.0 110.078 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -59.16 -41.8 89.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.054 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.5 mt -66.7 -38.15 86.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.912 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 1.7 mtp -58.25 -30.56 66.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.516 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . 0.413 ' CE ' ' CZ ' ' A' ' 148' ' ' ARG . 2.4 mtt -76.84 -26.3 54.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.677 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 73.1 m -65.42 162.66 17.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 12.1 ttmm -63.58 -27.78 69.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.302 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.85 -53.73 51.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.923 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.414 ' CB ' ' HA ' ' A' ' 151' ' ' MET . 51.4 m-20 -91.4 -22.96 20.2 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.464 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -80.72 19.64 0.82 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 5.1 mmpt? -118.34 -31.87 4.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.85 0.357 . . . . 0.0 110.33 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.8 mt -55.47 150.54 23.83 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.478 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.66 125.9 11.56 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.282 1.988 . . . . 0.0 112.458 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -83.71 154.86 65.27 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.798 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 58.4 Cg_endo -71.9 160.51 47.57 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.473 2.115 . . . . 0.0 112.21 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 5.6 Cg_endo -87.32 34.93 0.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.144 2.563 . . . . 0.0 112.902 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 169.2 163.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.009 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.29 32.98 6.34 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.413 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.492 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 14.7 pt20 -69.59 158.62 34.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.297 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 18.6 m -76.9 -168.83 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.703 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -99.91 -31.35 11.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.41 155.25 24.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.945 179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.748 0.309 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.64 166.21 26.77 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.514 2.143 . . . . 0.0 112.338 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.77 -120.27 1.02 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.477 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.4 31.02 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.807 0.336 . . . . 0.0 110.889 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -78.18 140.25 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 60.56 82.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.29 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.027 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -98.48 108.84 21.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.37 162.95 12.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.943 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.8 mt -113.74 -178.34 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.6 -44.44 4.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.69 111.19 23.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -123.15 21.95 9.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.157 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m 59.97 64.93 1.18 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.894 0.378 . . . . 0.0 110.934 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.24 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -168.85 142.95 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.922 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.31 95.53 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.11 126.39 53.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -88.06 179.97 6.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.63 120.06 0.71 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.517 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -167.65 33.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.845 0.355 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.61 -31.8 6.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -59.27 126.61 82.45 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.83 133.08 16.42 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.499 2.133 . . . . 0.0 112.291 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.72 -37.42 4.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -73.4 106.35 5.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.58 -169.44 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.14 152.36 37.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.5 p -164.46 167.91 19.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -66.55 -75.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.08 178.66 43.16 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.58 -27.63 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 111.199 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm 62.87 122.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -80.06 144.7 59.49 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.79 148.68 44.71 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.498 2.132 . . . . 0.0 112.359 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -61.01 -38.47 86.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -60.94 -35.0 75.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.54 -54.02 49.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.787 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 10.2 mmt180 -57.94 -40.28 80.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.477 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 90.1 mt -61.29 -39.43 90.4 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.6 mt -72.11 -52.82 14.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -63.37 -42.08 98.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 6.9 mm-40 -69.62 -29.6 67.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.738 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.491 HD13 ' HG ' ' A' ' 60' ' ' LEU . 31.7 tp -63.35 -45.18 92.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.893 0.378 . . . . 0.0 110.667 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.69 -43.31 89.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.018 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.17 -52.81 63.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.217 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -65.26 -31.61 81.11 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.625 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.16 -41.82 33.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.031 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.79 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.878 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.57 173.58 43.84 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.576 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -154.49 -177.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.35 . . . . 0.0 111.231 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.02 103.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.625 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.36 19.29 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.602 0.239 . . . . 0.0 111.307 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.35 43.98 35.08 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.779 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -70.18 -19.51 63.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 75' ' ' ILE . 30.1 m -155.03 172.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.35 111.46 1.43 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.742 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.478 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 31.9 p90 -102.9 97.02 7.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.686 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.13 21.55 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 120.601 -0.809 . . . . 0.0 113.108 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.957 HD11 HD23 ' A' ' 68' ' ' LEU . 1.8 mt -105.64 143.69 33.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.788 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.38 -46.25 73.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.012 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -94.8 -49.97 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.695 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 9.9 t0 97.49 -6.54 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.541 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -155.68 28.49 0.38 Allowed 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.17 162.61 14.58 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.289 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 35.1 mtp -78.92 -54.0 6.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.428 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -86.99 88.73 7.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.359 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.957 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -81.15 56.56 2.87 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -82.95 -44.01 15.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.447 179.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' O ' HD23 ' A' ' 60' ' ' LEU . 69.6 mtt-85 -77.45 139.84 39.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.303 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.474 ' CD2' ' CD1' ' A' ' 140' ' ' ILE . 71.2 m95 -135.31 144.37 46.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -102.1 120.48 40.51 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.8 108.88 2.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.675 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -95.15 150.92 19.68 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.805 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.1 mt -152.25 138.97 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.917 0.389 . . . . 0.0 111.743 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.1 mt -109.31 149.28 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.169 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -91.64 120.34 6.0 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.114 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.24 141.15 95.24 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.547 2.165 . . . . 0.0 111.925 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.674 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 21.1 Cg_endo -60.37 145.81 97.91 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.877 2.385 . . . . 0.0 113.278 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 80.53 43.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.818 179.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 80' ' ' ARG . 4.4 p -162.75 158.72 23.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.06 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.402 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -52.53 -40.2 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.043 0.449 . . . . 0.0 110.95 179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 30.1 m-85 -79.69 -18.69 50.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.913 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.8 pt-20 -40.74 148.27 0.1 Allowed 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 41.4 57.08 3.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.298 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.5 mmt85 -155.86 111.38 3.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.661 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.2 mp -66.55 165.07 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.234 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.548 ' N ' HG22 ' A' ' 87' ' ' ILE . 13.4 m-85 -149.43 133.31 17.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.083 0.468 . . . . 0.0 111.439 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.489 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 68.0 m -94.96 148.0 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.933 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.3 mp -151.3 160.07 43.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.719 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 14.8 mtpp -142.22 113.26 7.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.116 0.484 . . . . 0.0 110.25 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.851 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.32 148.92 10.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.268 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 69' ' ' THR . 12.5 mt-10 -131.53 130.59 42.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.07 0.462 . . . . 0.0 111.332 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.5 p -108.74 -169.16 1.45 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 157.59 -133.2 3.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.427 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.07 113.12 2.26 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.452 2.101 . . . . 0.0 112.146 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? 60.05 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.646 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.3 t80 -83.23 -63.71 0.25 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.371 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 58.7 Cg_endo -70.91 1.83 4.8 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.666 1.578 . . . . 0.0 112.688 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -111.62 -13.77 13.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.674 0.273 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.22 156.83 61.07 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 111.312 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.49 122.43 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.614 2.209 . . . . 0.0 112.245 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.1 Cg_endo -82.37 175.24 9.16 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.744 2.296 . . . . 0.0 112.739 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 106' ' ' ARG . 17.3 t80 -94.84 121.41 36.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.802 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.851 HG22 HG23 ' A' ' 92' ' ' ILE . 38.9 t -135.04 138.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.239 0.543 . . . . 0.0 111.596 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -150.28 128.72 12.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.49 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.933 ' CE2' HD21 ' A' ' 90' ' ' LEU . 11.7 m-85 -71.55 131.93 43.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.168 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.97 -39.35 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.23 0.538 . . . . 0.0 109.634 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.514 HG21 ' CD2' ' A' ' 88' ' ' TYR . 5.0 t -68.59 -173.51 0.45 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.692 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 3.0 mmtt -99.51 69.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.439 . . . . 0.0 110.312 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.746 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 153.28 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.8 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -126.11 101.91 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.486 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.1 tpp -124.89 153.52 42.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -54.89 -44.06 73.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.328 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.652 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -99.13 -6.54 55.69 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.277 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.992 HG22 HG13 ' A' ' 123' ' ' VAL . 47.2 t -108.78 131.75 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -60.1 165.21 3.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.5 m -113.05 -12.57 13.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 t -109.33 -33.3 6.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.32 . . . . 0.0 111.001 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -104.43 -39.61 6.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.03 0.443 . . . . 0.0 110.427 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.55 -1.58 69.29 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.053 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.9 t -58.84 112.68 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.815 0.341 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.992 HG13 HG22 ' A' ' 116' ' ' VAL . 10.9 t -77.47 109.73 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.633 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -64.58 110.31 3.87 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.702 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.98 -19.24 62.0 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.547 2.164 . . . . 0.0 112.432 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.12 -49.77 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.976 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.652 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -68.59 -40.93 80.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.036 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.573 ' CG2' HG12 ' A' ' 130' ' ' VAL . 29.6 mm -67.71 129.22 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 68.2 m -67.56 -54.56 18.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.636 ' CG2' HG12 ' A' ' 142' ' ' VAL . 6.7 p -50.08 -36.61 12.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.496 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -83.03 -44.5 15.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.22 -52.8 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.824 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -105.88 45.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.66 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -48.83 136.89 13.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.368 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.68 -170.38 1.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.04 -36.85 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.12 -0.53 36.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.552 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.551 ' HA ' HG21 ' A' ' 142' ' ' VAL . 4.3 m-30 -72.56 154.49 40.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 111.099 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.0 p -156.07 -176.27 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.474 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 44.1 mt -54.7 -37.86 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.408 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 20.2 ttpp -61.44 -39.74 91.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.202 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.636 HG12 ' CG2' ' A' ' 130' ' ' VAL . 46.9 t -68.52 -33.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.932 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 105' ' ' VAL . 24.7 t -69.16 -53.43 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.674 HD22 HD11 ' A' ' 75' ' ' ILE . 26.8 mt -64.77 -48.32 74.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.066 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -59.45 -49.73 76.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.758 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 4.2 tp10 -60.15 -53.06 62.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.5 pp -58.33 -41.59 84.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 110.6 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.87 ' N ' HD12 ' A' ' 147' ' ' LEU . 8.4 tmm_? -62.61 -34.07 76.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.2 0.524 . . . . 0.0 109.648 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.28 86.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.826 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.0 mt -60.83 -48.1 83.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.871 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 30.0 mtt -51.58 -35.74 42.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.776 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.6 ttm -74.04 -14.59 61.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.71 164.44 14.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.875 0.369 . . . . 0.0 110.783 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.0 tttt -65.32 -48.85 71.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.25 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.06 -31.17 71.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.025 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -87.07 -25.16 24.31 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 24.4 ptm -88.1 42.77 1.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 0.0 110.815 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -141.19 -35.15 0.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.393 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.3 mt -52.88 151.11 8.88 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.317 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.77 122.58 8.98 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.144 1.896 . . . . 0.0 112.73 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.402 ' HG2' HG12 ' A' ' 82' ' ' ILE . 17.2 mm-40 -86.91 152.86 54.27 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.9 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.81 118.22 5.53 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.462 2.108 . . . . 0.0 111.972 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 164' ' ' GLU . 72.4 Cg_endo -76.91 72.94 5.59 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.464 2.11 . . . . 0.0 112.599 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 0.2 OUTLIER 165.97 -59.0 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.768 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.35 18.09 10.71 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.41 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -70.3 144.56 51.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.655 0.264 . . . . 0.0 111.025 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 3.0 m -79.7 175.82 10.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.647 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 109' ' ' THR . 14.9 m-85 -69.14 136.18 51.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.969 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.18 156.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.601 0.238 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.46 -44.48 0.4 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.455 2.104 . . . . 0.0 112.334 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.83 -161.18 24.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.561 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -132.48 141.92 49.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.723 0.297 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.6 p -80.62 60.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -97.61 97.18 8.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 59.27 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.297 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -87.73 -63.73 1.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.982 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -142.25 165.35 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mt -136.46 127.76 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.45 39.55 2.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -104.82 -51.58 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.102 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -94.36 -51.44 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.069 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t 61.71 167.23 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 127.43 17.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.59 125.93 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.0 t -136.12 106.1 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -108.25 31.44 5.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -155.18 76.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.66 83.1 0.35 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.548 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtm105 -67.41 152.65 45.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.808 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.69 170.96 8.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.37 149.94 97.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 149.46 21.36 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.613 2.209 . . . . 0.0 112.286 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -64.42 130.92 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -128.67 36.27 4.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -116.87 88.23 2.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.3 m170 -80.8 132.65 35.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 95.6 m -68.29 166.79 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.41 134.88 34.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -105.34 83.78 0.39 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.83 164.81 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 111.123 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -97.79 148.64 23.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.1 m -80.21 154.46 74.67 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.276 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.41 161.85 5.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.672 2.248 . . . . 0.0 112.066 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -54.13 -52.34 61.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.264 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -53.41 -36.91 62.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.069 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.55 -52.56 63.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -58.19 -39.08 78.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.68 HD22 ' HB2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -63.56 -53.88 44.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.765 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.5 mt -58.94 -51.48 69.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.884 0.373 . . . . 0.0 111.226 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.75 -49.79 73.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.028 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -67.15 -28.61 68.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.6 tp -62.31 -42.55 99.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.896 0.379 . . . . 0.0 110.61 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.68 -44.41 74.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -30.47 65.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -74.21 -64.77 2.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.64 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -53.62 -44.06 69.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -59.35 -25.92 64.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.92 161.82 26.7 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.68 -178.0 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.972 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.09 -63.63 5.08 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.818 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.58 -6.52 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.85 31.98 32.68 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.443 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 p -72.52 -17.01 61.77 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 144' ' ' LEU . 35.5 m -152.14 175.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.945 0.403 . . . . 0.0 111.161 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.05 110.78 1.67 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.335 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 28.5 p90 -100.0 105.36 17.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.59 148.47 18.07 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.9 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.0 HD11 HD23 ' A' ' 68' ' ' LEU . 1.7 mt -54.66 130.22 39.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.956 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -61.97 -62.07 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.148 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 5.2 t0 -76.44 -53.6 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 5.2 t70 96.04 -3.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.041 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -158.17 29.86 0.25 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -80.44 -164.77 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.432 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.28 118.84 37.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.384 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.556 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.1 p 62.95 12.74 6.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.856 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 46.41 63.3 1.93 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.748 0.309 . . . . 0.0 110.973 179.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.8 m -80.8 -27.47 36.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.754 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -99.64 147.79 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 111.168 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.576 ' CE2' HD11 ' A' ' 140' ' ' ILE . 70.4 m95 -134.84 160.99 36.48 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.249 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -130.4 118.09 20.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -113.36 118.41 4.51 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.244 -0.979 . . . . 0.0 114.178 -178.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mtp -92.9 150.3 20.68 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 90' ' ' LEU . 47.5 mt -150.02 138.0 14.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.899 0.38 . . . . 0.0 111.759 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.7 mt -95.34 148.87 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.357 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.45 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -73.21 116.01 5.35 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 8.4 Cg_endo -50.68 128.33 23.64 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.463 2.108 . . . . 0.0 111.873 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 33.0 Cg_exo -61.16 172.85 2.84 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.376 2.051 . . . . 0.0 112.598 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.55 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 3.9 mpp_? 44.42 41.78 4.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.737 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.528 HG22 ' CB ' ' A' ' 157' ' ' MET . 0.6 OUTLIER -162.14 161.66 28.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.688 179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.44 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.4 OUTLIER -43.91 -29.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.02 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' O ' ' C ' ' A' ' 84' ' ' GLU . 68.2 m-85 -80.03 -21.01 44.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -23.9 124.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 t30 49.21 69.92 0.53 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.904 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.1 mmt180 -154.24 106.26 2.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 88' ' ' TYR . 50.3 mt -69.69 165.37 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.347 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.908 ' CE2' HD12 ' A' ' 111' ' ' ILE . 29.9 m-85 -153.2 128.19 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.033 0.444 . . . . 0.0 111.441 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.543 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 33.3 t -94.01 149.29 21.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.83 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -151.56 160.63 43.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.916 0.388 . . . . 0.0 111.323 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 108' ' ' VAL . 26.2 mttt -136.21 115.34 12.42 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' TRP . 5.3 mp -107.05 126.47 63.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.348 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 51.3 mt-10 -95.38 126.13 40.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.87 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.4 p -114.29 -178.32 3.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -157.98 -164.16 13.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.4 -40.58 62.14 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.661 2.241 . . . . 0.0 112.457 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.45 73.04 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.462 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 1.3 t80 -76.52 -58.48 1.15 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.432 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 59.6 Cg_endo -71.09 0.42 6.65 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 121.882 1.722 . . . . 0.0 112.836 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -120.09 9.72 11.23 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.448 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.64 20.61 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 111.551 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -57.0 119.78 7.27 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 0.0 112.361 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 50.9 Cg_endo -84.07 164.26 13.38 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.869 2.379 . . . . 0.0 112.531 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 28.7 t80 -97.94 98.58 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.491 . . . . 0.0 110.28 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.8 t -95.12 138.51 20.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.024 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.89 120.46 7.47 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.687 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 1.087 ' CD2' HG21 ' A' ' 111' ' ' ILE . 4.1 m-85 -65.87 155.53 36.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.743 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.487 HG21 ' HE3' ' A' ' 91' ' ' LYS . 25.0 t -110.04 -51.47 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.105 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.414 HG21 ' HA ' ' A' ' 88' ' ' TYR . 6.7 t -67.35 -175.81 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.942 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 11.1 mmtm -88.57 110.76 21.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.924 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.087 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.4 tt -138.79 150.35 23.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.715 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -126.02 102.43 7.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.463 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.46 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.8 tpp -124.56 152.9 42.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -34.97 62.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.602 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -118.2 25.12 8.42 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.126 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.967 HG22 HG13 ' A' ' 123' ' ' VAL . 48.5 t -130.83 126.0 59.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.797 0.332 . . . . 0.0 110.839 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -59.89 151.69 25.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 p -112.78 28.37 8.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.979 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -131.08 -55.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -105.25 -34.31 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 108.18 1.0 33.52 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.956 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.2 t -58.95 111.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.894 0.378 . . . . 0.0 110.876 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.967 HG13 HG22 ' A' ' 116' ' ' VAL . 5.2 t -77.34 117.69 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.682 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.86 112.92 9.12 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.519 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.452 ' HB3' HD23 ' A' ' 131' ' ' LEU . 36.4 Cg_endo -65.43 -17.23 57.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.311 2.007 . . . . 0.0 112.333 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -37.92 68.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.346 . . . . 0.0 110.756 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.602 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -80.76 -38.29 28.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.509 ' CG2' HG12 ' A' ' 130' ' ' VAL . 48.8 mm -76.41 121.75 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.836 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.8 p -67.23 -55.2 15.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.372 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.651 HG23 ' CD2' ' A' ' 138' ' ' TYR . 14.8 p -49.97 -32.45 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 125' ' ' PRO . 1.4 mp -83.57 -50.51 8.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.899 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.71 32.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -105.16 52.27 0.74 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.474 ' CD2' ' HD3' ' A' ' 103' ' ' PRO . 63.2 t-105 -49.92 140.11 12.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.292 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 138' ' ' TYR . 2.1 mm100 -117.67 -172.22 2.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.827 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -90.75 -32.81 15.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.2 m -78.97 -12.22 60.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.255 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.651 ' CD2' HG23 ' A' ' 130' ' ' VAL . 10.9 m-30 -72.75 152.17 41.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 111.032 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.0 t -155.98 -176.36 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.514 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.576 HD11 ' CE2' ' A' ' 71' ' ' TRP . 50.1 mt -53.96 -40.08 43.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 2.0 ptpt -60.59 -39.75 89.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 110.13 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 138' ' ' TYR . 34.7 t -69.27 -38.39 77.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.922 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.404 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 20.7 t -62.53 -53.85 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.055 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 75' ' ' ILE . 22.7 mt -63.86 -43.7 95.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.535 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -57.66 -39.95 78.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.66 -51.49 69.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.579 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.972 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 11.6 mt -49.5 -46.07 47.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.961 0.41 . . . . 0.0 110.588 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -34.4 77.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.746 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -61.13 -42.76 99.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -64.64 -48.21 75.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.081 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.442 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 35.7 mtt -54.56 -27.62 40.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.089 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 25.7 mtm -76.27 -19.95 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 45.3 t -65.07 157.32 28.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -65.15 -46.14 82.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.012 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -61.35 -28.77 69.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -87.77 -27.71 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.528 ' CB ' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -88.94 22.92 2.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -124.31 -33.46 3.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.464 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.65 145.07 41.93 Favored Pre-proline 0 C--N 1.333 -0.137 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.533 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.8 125.02 13.54 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.26 1.973 . . . . 0.0 112.215 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.412 ' HG2' HG12 ' A' ' 82' ' ' ILE . 30.2 mm-40 -84.07 124.67 74.11 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.973 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.25 118.16 4.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.175 1.917 . . . . 0.0 111.999 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.75 87.55 1.54 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.0 112.467 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 167.91 -35.31 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 57.62 21.86 44.15 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.351 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.513 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.2 pt20 -70.67 158.23 36.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.4 p -78.15 145.31 35.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.148 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 2.9 m-85 -58.64 112.63 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.8 t -111.11 100.57 9.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.846 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.925 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mmm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.666 0.27 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.04 178.27 5.55 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.585 2.19 . . . . 0.0 112.346 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 123.04 139.8 5.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -108.81 165.63 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.82 127.32 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -129.31 -47.03 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.76 -46.94 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -160.44 -46.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -75.38 173.54 10.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.7 mt -114.0 70.33 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.73 109.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.09 108.78 17.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.816 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -23.2 62.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.26 148.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.836 0.35 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -64.37 162.47 14.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 110.87 11.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.11 100.1 1.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -114.15 99.14 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.76 165.86 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.44 22.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.523 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -90.46 129.5 36.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.745 0.307 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HA ' HD13 ' A' ' 22' ' ' LEU . 3.4 mm? -114.75 117.87 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -67.22 151.39 97.19 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.5 -64.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.467 2.111 . . . . 0.0 112.261 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.3 -80.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.989 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.52 -70.93 0.11 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.055 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 49.28 94.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -85.25 167.86 15.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -140.08 92.05 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.32 107.97 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -122.09 -118.18 2.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.409 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -68.12 148.35 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.001 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.4 -46.06 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 34' ' ' VAL . 12.9 p -80.58 126.75 77.64 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.0 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.7 161.67 2.01 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.381 2.054 . . . . 0.0 112.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? -76.45 -41.81 46.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.6 p30 -66.09 -29.01 69.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.901 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -50.24 70.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.196 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 7.6 mmt85 -66.41 -36.74 83.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 43.4 mt -60.01 -41.18 91.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.2 mt -72.13 -52.73 15.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 0.0 111.537 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -41.34 98.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.978 0.418 . . . . 0.0 110.695 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 74.4 mm-40 -70.51 -29.3 65.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.75 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 51.1 tp -61.89 -46.82 87.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.968 0.413 . . . . 0.0 110.258 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.52 -49.65 74.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.876 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.93 -29.72 63.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 58' ' ' TRP . . . -78.45 -44.14 11.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.724 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -76.8 -43.75 35.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.671 0.272 . . . . 0.0 111.097 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -52.86 -28.12 21.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.99 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.91 179.08 18.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.845 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -141.11 -177.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.83 -86.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.608 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -73.59 -16.42 61.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.569 0.224 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.845 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 71.35 31.43 65.95 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.2 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 56' ' ' VAL . 30.4 p -73.0 -9.52 58.82 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 75' ' ' ILE . 20.4 m -156.19 165.22 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.998 0.428 . . . . 0.0 111.172 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -162.0 111.04 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.406 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.486 ' CD1' ' HA3' ' A' ' 47' ' ' GLY . 27.2 p90 -101.57 130.82 47.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -136.36 -160.16 8.66 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.576 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' A' ' 68' ' ' LEU . 5.7 mt -116.54 127.67 54.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.821 0.343 . . . . 0.0 110.951 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -51.65 -64.56 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.277 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -79.64 -64.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.961 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 3.1 t70 96.1 2.23 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.148 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -157.22 29.54 0.29 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.69 -165.34 1.21 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.278 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.9 mtm -59.84 -40.42 88.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.834 ' OG1' HD12 ' A' ' 68' ' ' LEU . 1.5 t -154.6 -117.61 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.561 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD12 ' OG1' ' A' ' 67' ' ' THR . 0.0 OUTLIER -153.88 58.61 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.904 0.383 . . . . 0.0 110.661 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 -63.66 1.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.026 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -72.24 98.31 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.702 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.508 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 50.9 m95 -90.2 158.52 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.78 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.57 148.58 25.37 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -141.62 102.13 0.3 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 119.761 -1.209 . . . . 0.0 113.754 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 mtp -93.96 146.15 24.13 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.827 HD13 HD11 ' A' ' 147' ' ' LEU . 52.7 mt -150.74 126.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.883 0.373 . . . . 0.0 111.771 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.2 mt -102.74 149.19 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.126 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -90.49 140.81 15.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.952 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.4 Cg_endo -83.97 136.38 6.98 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.792 2.328 . . . . 0.0 112.093 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 77.0 Cg_exo -48.65 144.49 14.31 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.641 2.228 . . . . 0.0 113.127 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 75.45 43.72 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.795 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 80' ' ' ARG . 49.8 p -161.16 147.01 14.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.378 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -46.61 -36.06 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 111.052 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.469 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 49.1 m-85 -80.91 -22.36 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.963 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -39.41 148.41 0.06 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 84' ' ' GLU . 26.0 p30 41.08 47.8 2.81 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.418 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 6.4 mmt85 -148.39 109.86 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.692 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.57 HG22 ' N ' ' A' ' 88' ' ' TYR . 43.1 mt -68.52 166.15 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.525 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.57 ' N ' HG22 ' A' ' 87' ' ' ILE . 28.0 m-85 -150.25 132.33 15.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.531 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 46.8 t -93.46 147.4 23.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.955 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.58 160.15 43.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.102 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 4.1 mtpp -143.44 115.56 8.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.863 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.924 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.43 120.68 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.608 -178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 103' ' ' PRO . 51.0 mt-10 -94.17 124.05 37.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.374 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.1 p -113.02 -169.5 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.081 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 156.27 -136.97 5.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.556 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.69 130.49 26.47 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.594 2.196 . . . . 0.0 112.124 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.48 59.61 3.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.995 0.426 . . . . 0.0 110.596 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.606 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.9 t80 -84.63 -55.51 0.44 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.635 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.0 Cg_endo -78.13 5.6 5.27 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.961 1.774 . . . . 0.0 112.568 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -123.74 -4.48 8.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.23 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.32 18.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.986 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.543 ' HB3' HD23 ' A' ' 131' ' ' LEU . 6.0 Cg_exo -77.26 110.97 3.11 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.723 2.282 . . . . 0.0 112.009 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 97.8 Cg_endo -76.78 -99.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.358 2.038 . . . . 0.0 112.12 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -149.9 131.45 14.84 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.731 0.3 . . . . 0.0 111.49 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 92' ' ' ILE . 44.2 t -135.54 139.51 46.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.332 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.595 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.3 ptt180 -150.25 141.66 23.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.512 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.955 ' CE2' HD21 ' A' ' 90' ' ' LEU . 22.8 m-85 -83.97 139.92 32.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.837 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 167' ' ' CYS . 19.1 t -93.66 -40.69 11.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.234 0.54 . . . . 0.0 110.088 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.443 HG21 ' CD2' ' A' ' 88' ' ' TYR . 4.9 t -68.52 -173.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.879 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 5.4 mmtt -97.23 76.77 2.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 110.166 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.927 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -103.76 149.55 7.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.476 -179.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -126.09 102.32 7.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.743 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.428 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -124.74 150.37 46.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.123 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.27 -26.73 30.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.705 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -116.8 16.24 13.79 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.09 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HG13 ' A' ' 123' ' ' VAL . 76.6 t -137.61 122.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.936 0.398 . . . . 0.0 110.77 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.71 165.84 2.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 96.4 p -117.01 21.75 13.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -51.5 1.55 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.899 0.381 . . . . 0.0 110.586 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.536 ' CG ' HG23 ' A' ' 122' ' ' VAL . 11.6 p30 -103.11 -32.17 9.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.937 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 106' ' ' ARG . . . 94.29 5.92 61.75 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.049 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.536 HG23 ' CG ' ' A' ' 120' ' ' ASN . 39.7 t -58.84 112.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.815 0.341 . . . . 0.0 110.964 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.765 HG13 HG22 ' A' ' 116' ' ' VAL . 11.9 t -78.16 106.66 9.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' GLY . 8.6 t0 -65.86 116.56 33.47 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.575 ' HB3' HD22 ' A' ' 131' ' ' LEU . 41.1 Cg_endo -66.74 -14.89 45.65 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.403 2.069 . . . . 0.0 112.388 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -72.39 -36.11 68.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.782 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.705 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -84.91 -36.54 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 19.9 mm -74.42 128.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.775 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 t -67.77 -54.74 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.736 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.587 HG12 HG22 ' A' ' 128' ' ' ILE . 12.6 p -49.9 -33.01 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 125' ' ' PRO . 0.4 OUTLIER -85.25 -45.59 11.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 110.664 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -55.0 -28.86 55.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -135.53 42.59 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CE3' HG22 ' A' ' 130' ' ' VAL . 73.3 t-105 -49.42 125.2 10.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.327 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 138' ' ' TYR . 2.9 tt0 -81.93 175.83 10.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -96.45 31.45 2.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.08 9.6 0.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.812 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 135' ' ' GLN . 10.2 m-30 -75.09 177.56 6.32 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.767 0.317 . . . . 0.0 110.734 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.8 m -156.85 -176.56 6.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.776 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 62.4 mt -57.91 -37.03 58.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.864 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 24.7 ttpt -62.83 -37.03 85.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.085 0.469 . . . . 0.0 110.219 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.551 HG12 HG21 ' A' ' 130' ' ' VAL . 42.7 t -68.83 -34.8 66.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.005 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.43 -53.24 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.435 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 75' ' ' ILE . 24.5 mt -63.06 -47.32 83.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.998 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -60.31 -44.82 95.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.418 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 2.6 tp10 -61.95 -53.3 57.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.867 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.89 ' HA ' HD12 ' A' ' 150' ' ' LEU . 4.3 pp -60.61 -37.97 83.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.399 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 ttp-105 -64.44 -36.2 83.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.064 0.459 . . . . 0.0 109.932 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 146' ' ' GLU . 45.1 mtt-85 -59.04 -40.5 85.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.701 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' A' ' 147' ' ' LEU . 5.9 mt -62.13 -41.14 97.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.778 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.76 ' HE3' HD13 ' A' ' 147' ' ' LEU . 60.7 mtt -55.9 -34.98 66.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.469 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . 0.426 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 10.8 mtm -75.57 -14.21 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.21 154.22 38.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 3.0 mttt -62.24 -50.79 70.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.106 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.99 -35.41 76.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.396 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -86.78 -20.74 27.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.813 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -92.7 24.45 3.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.827 0.346 . . . . 0.0 111.227 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.3 mmtt -117.75 -32.02 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.501 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.3 mt -54.72 138.52 62.2 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.471 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.36 121.54 8.51 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.224 1.95 . . . . 0.0 112.729 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -87.67 113.68 55.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.762 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.33 117.8 3.77 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.133 1.889 . . . . 0.0 112.055 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.69 105.12 1.94 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.712 2.275 . . . . 0.0 112.336 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 167.33 -40.79 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.89 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 74.35 11.99 82.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 16.0 pt20 -70.31 158.56 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 0.0 111.031 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.625 ' HB2' HG12 ' A' ' 108' ' ' VAL . 31.9 p -76.39 -170.26 1.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.606 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 6.3 m-85 -90.77 -43.91 9.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.978 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 10.8 p -172.66 81.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.903 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.632 0.253 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.82 -43.05 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.451 2.101 . . . . 0.0 112.304 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.52 112.71 0.36 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.417 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.77 159.41 42.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.5 p -80.61 114.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.86 92.97 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.775 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' O ' ' CD2' ' A' ' 9' ' ' TYR . . . -110.07 -26.22 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.224 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 m -58.83 99.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 11.3 p90 -176.92 143.86 0.43 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.8 mt 60.96 92.29 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 -75.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -145.96 -47.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.77 -44.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m 62.42 168.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 171.08 10.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.07 -179.02 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.962 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 92.7 p -83.83 75.53 10.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -100.5 31.54 3.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.14 87.6 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 139.44 14.42 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.497 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.11 114.66 26.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.825 0.345 . . . . 0.0 110.892 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.5 mt -108.12 -63.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.926 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.66 130.24 22.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.43 169.64 22.04 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.478 2.119 . . . . 0.0 112.325 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.1 mtm105 -102.52 36.82 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -87.28 -41.31 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 60.94 -175.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -86.23 115.26 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -134.83 31.46 3.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -88.64 -48.74 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.84 -178.55 17.4 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.2 p -164.7 -44.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.362 . . . . 0.0 111.173 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' N ' HG13 ' A' ' 32' ' ' VAL . 12.1 mttt 59.61 174.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 m -150.61 135.23 9.66 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.16 144.11 48.86 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.353 2.035 . . . . 0.0 112.17 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.1 -38.56 79.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -67.74 -35.38 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.92 26.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.717 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 15.5 tpp180 -57.61 -41.68 81.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.468 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.788 HD13 ' HB2' ' A' ' 68' ' ' LEU . 22.5 mt -62.71 -36.07 81.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.5 mt -72.03 -52.68 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 111.209 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -65.02 -47.44 77.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 73.1 mm-40 -63.33 -32.88 74.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.025 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 57.8 tp -63.01 -45.46 92.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -60.13 -47.57 85.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.716 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -32.67 67.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.442 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -84.03 -40.64 8.54 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.688 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -69.52 -47.98 62.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.999 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -61.65 -28.6 69.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.717 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.4 174.62 15.77 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.593 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' ' HA3' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -127.48 138.58 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.082 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.61 -70.6 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.535 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -110.53 11.27 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' A' ' 51' ' ' VAL . . . -75.32 110.1 2.96 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.631 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -72.66 -17.42 61.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.755 0.312 . . . . 0.0 111.246 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.666 HG12 HG12 ' A' ' 75' ' ' ILE . 33.1 m -93.72 176.45 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.065 0.459 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.36 112.79 2.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.344 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.505 ' CZ3' HG23 ' A' ' 56' ' ' VAL . 32.7 p90 -105.47 102.27 11.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.72 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.63 147.82 16.88 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.0 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.608 HD11 HD23 ' A' ' 68' ' ' LEU . 4.6 mt -55.18 155.51 4.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.851 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -31.28 42.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.849 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.92 102.94 3.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -68.25 42.71 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -159.74 31.69 0.19 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.36 -173.66 2.39 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.61 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.2 mtm -122.6 1.05 9.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.213 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 t -154.21 118.64 4.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.817 0.342 . . . . 0.0 110.538 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.788 ' HB2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.66 61.47 4.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 94' ' ' CYS . 6.9 m -93.88 -60.72 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.583 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -69.99 91.07 0.66 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.421 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.634 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 88.2 m95 -89.11 160.29 17.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.713 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.65 123.39 22.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.691 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 144' ' ' LEU . . . -113.17 171.06 13.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.789 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.4 mtp -142.58 151.15 41.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.211 -0.495 . . . . 0.0 109.815 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.666 HG12 HG12 ' A' ' 56' ' ' VAL . 48.2 mt -150.27 120.91 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.886 0.374 . . . . 0.0 111.847 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.0 mt -93.37 149.1 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.253 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -88.67 143.13 17.53 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -85.65 130.36 3.75 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.984 2.456 . . . . 0.0 112.097 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.636 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 74.3 Cg_exo -48.47 141.05 20.26 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.526 2.15 . . . . 0.0 113.039 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.421 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.1 OUTLIER 80.46 40.67 0.07 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.512 179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 51.7 p -160.64 150.28 17.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.743 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -47.81 -37.53 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.964 0.411 . . . . 0.0 111.157 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 25.3 m-85 -79.85 -22.85 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.841 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -38.52 145.65 0.08 Allowed 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.0 t30 43.18 54.72 4.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.123 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 64.8 mmt-85 -154.18 107.21 2.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.734 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 87' ' ' ILE . 3.9 mp -66.2 167.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 20.7 m-85 -150.26 128.3 11.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.926 0.393 . . . . 0.0 111.018 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.578 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 17.0 t -90.05 149.7 22.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.332 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.843 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.0 mp -152.52 160.34 43.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.035 -178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.0 OUTLIER -142.9 116.65 9.26 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 92' ' ' ILE . 5.0 mp -106.6 124.11 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.441 -178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -93.98 105.77 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG23 ' A' ' 69' ' ' THR . 81.6 m -105.5 120.97 42.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.875 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -122.59 -145.29 6.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.524 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.89 116.55 2.46 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.548 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 62.32 76.71 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.183 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.598 ' CD2' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -81.66 -62.72 0.33 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.945 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 47.8 Cg_endo -68.53 -1.64 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.651 1.567 . . . . 0.0 112.5 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -114.67 8.88 16.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.036 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.48 143.38 3.42 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.767 0.317 . . . . 0.0 111.289 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.32 118.37 5.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.763 2.309 . . . . 0.0 112.239 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 91.5 Cg_endo -80.8 -179.61 5.27 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.558 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 61.3 t80 -97.04 100.09 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.788 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 92' ' ' ILE . 25.6 t -94.51 137.78 22.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HA ' HG23 ' A' ' 123' ' ' VAL . 2.7 ptm180 -150.28 118.58 6.4 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.249 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.909 ' CD2' HG21 ' A' ' 111' ' ' ILE . 15.8 m-85 -62.31 149.27 42.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.507 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.59 -42.41 7.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.144 0.497 . . . . 0.0 110.122 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.5 t -68.62 -176.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.009 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -92.79 76.52 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.865 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.909 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -104.99 150.1 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.868 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -125.99 102.68 7.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.879 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.449 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 10.5 ttm -124.45 153.97 41.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.837 0.351 . . . . 0.0 111.235 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -38.22 66.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -110.74 23.96 18.32 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.925 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.904 HG22 HG13 ' A' ' 123' ' ' VAL . 58.7 t -132.72 128.33 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.886 0.374 . . . . 0.0 110.683 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -59.67 157.38 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -116.88 28.47 8.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.5 t -135.05 -52.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -105.35 -33.07 8.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.083 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.13 0.82 44.74 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.988 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.558 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 54.8 t -58.91 110.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.84 0.352 . . . . 0.0 110.743 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.904 HG13 HG22 ' A' ' 116' ' ' VAL . 19.5 t -77.06 115.11 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.685 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.19 115.06 17.98 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.602 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.15 -12.15 34.93 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.305 2.004 . . . . 0.0 112.605 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -33.71 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.639 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -89.02 -33.86 17.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.517 ' CG2' HG12 ' A' ' 130' ' ' VAL . 38.0 mm -73.99 122.15 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.133 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -67.49 -54.55 19.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.364 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.659 HG23 ' CE2' ' A' ' 138' ' ' TYR . 11.4 p -49.94 -32.39 8.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.532 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.94 -51.76 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.28 -34.21 60.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.202 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -123.11 51.12 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -49.02 155.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.245 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 138' ' ' TYR . 0.4 OUTLIER -132.81 179.6 6.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.8 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.32 -37.64 18.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 t -79.81 -1.51 39.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.444 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.659 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.4 m-30 -73.11 160.56 31.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.969 0.414 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 20.1 m -156.52 -176.55 6.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.551 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 71' ' ' TRP . 72.6 mt -59.36 -38.84 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -64.68 -34.56 78.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.37 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 138' ' ' TYR . 47.2 t -67.76 -37.1 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.464 0.65 . . . . 0.0 109.409 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 25.2 t -66.94 -53.1 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.942 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.422 HD11 ' HA3' ' A' ' 73' ' ' GLY . 20.7 mt -61.64 -44.29 97.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.976 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -57.54 -41.94 81.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.093 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -60.11 -48.65 80.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 150' ' ' LEU . 12.7 mt -52.41 -45.99 66.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.931 0.396 . . . . 0.0 110.768 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -42.44 86.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.215 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -61.96 -46.84 87.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.438 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.1 mt -61.01 -32.27 71.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.437 ' HA ' ' HB3' ' A' ' 156' ' ' ASN . 3.4 mtt -73.97 -25.63 60.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.059 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.4 mtp -76.42 -12.7 60.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.425 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.2 m -65.22 154.59 37.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.895 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 0.0 OUTLIER -58.58 -51.08 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -28.78 69.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.375 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 2.7 m-80 -88.16 -28.76 21.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.674 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 82' ' ' ILE . 4.0 ppp? -88.78 22.38 2.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 111.224 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -121.76 -30.37 4.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 160' ' ' PRO . 45.5 mt -54.85 143.17 52.5 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.532 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 159' ' ' LEU . 16.6 Cg_exo -68.73 125.81 13.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.452 2.102 . . . . 0.0 112.779 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 24.9 mm-40 -84.97 157.47 59.97 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.324 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 6.7 Cg_endo -50.0 164.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.453 2.102 . . . . 0.0 112.055 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.79 24.72 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.842 2.361 . . . . 0.0 113.578 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 169.59 -33.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.03 24.3 4.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 158.38 34.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.83 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 41.8 m -77.53 -176.23 4.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.404 ' CE2' ' O ' ' A' ' 109' ' ' THR . 11.4 m-85 -76.84 167.45 21.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.795 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 t -175.94 -40.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 1' ' ' MET . 94.1 Cg_endo -82.15 -39.23 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.52 2.147 . . . . 0.0 112.407 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 62.05 88.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.37 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.95 101.09 10.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.874 0.369 . . . . 0.0 110.992 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 7' ' ' ALA . 11.1 p -108.98 127.73 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -55.72 -35.91 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.933 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.514 ' H ' HG22 ' A' ' 5' ' ' VAL . . . 52.22 22.64 2.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.481 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.8 t -174.45 106.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -132.04 -62.66 0.84 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.2 mt 54.84 -174.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.193 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -104.65 125.47 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.774 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -75.89 138.79 41.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.72 -43.89 2.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -87.79 159.31 18.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -131.8 155.0 48.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 17' ' ' SER . 1.2 tt -121.08 142.15 50.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.58 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -129.27 -61.79 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' HD21 ' A' ' 16' ' ' LEU . 1.1 t70 -90.4 148.93 22.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -139.89 -54.79 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.64 -145.42 7.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.422 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -158.84 168.13 27.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.777 0.322 . . . . 0.0 110.832 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.92 173.58 11.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -142.83 118.02 6.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.42 143.59 58.35 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.431 2.088 . . . . 0.0 112.223 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.19 -178.84 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.955 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -160.76 -45.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.815 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -152.32 177.77 10.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -106.37 -42.25 5.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.946 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m 60.77 -174.2 0.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 60.54 108.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.49 179.05 5.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.409 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 33' ' ' LYS . 11.0 p -140.9 -45.55 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.746 0.308 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 32' ' ' VAL . 11.9 mttm -163.41 159.96 22.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.612 ' O ' HG23 ' A' ' 34' ' ' VAL . 22.7 m -150.53 94.15 3.69 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.5 155.53 46.87 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.558 2.172 . . . . 0.0 112.325 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 3.4 ppt_? -55.32 -40.37 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.049 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.411 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 26.3 m120 -59.38 -34.82 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.637 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.57 -52.52 63.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.733 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -60.83 -34.16 74.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.524 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 79.8 mt -63.14 -48.87 76.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.805 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.0 mt -69.64 -46.28 66.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.762 0.315 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -62.71 -50.34 71.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.602 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -64.99 -28.5 69.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.774 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 60.9 tp -61.99 -44.27 97.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 110.503 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -65.67 -44.05 87.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.93 -59.51 5.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.439 ' HA3' ' CE2' ' A' ' 58' ' ' TRP . . . -59.35 -47.25 91.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.706 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -57.0 -47.26 81.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.768 0.318 . . . . 0.0 111.067 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -53.96 44.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.993 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.19 -176.25 40.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.631 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.673 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -155.67 -178.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 0.0 111.149 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.06 106.64 1.65 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.468 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.67 13.65 9.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.56 0.219 . . . . 0.0 111.318 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 47.65 43.85 22.36 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.876 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.4 p -71.39 -16.95 62.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 111.189 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 75' ' ' ILE . 25.5 m -155.74 172.13 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.511 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.25 113.31 1.59 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.901 0.381 . . . . 0.0 111.197 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.469 ' HB2' HG21 ' A' ' 140' ' ' ILE . 35.9 p90 -108.11 114.85 29.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.202 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.08 -158.38 10.0 Favored Glycine 0 CA--C 1.509 -0.305 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.971 HD11 HD23 ' A' ' 68' ' ' LEU . 5.2 mt -114.26 144.87 42.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.38 -0.41 . . . . 0.0 111.004 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -70.64 -47.01 62.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER -92.55 -46.34 7.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 17.4 m-20 93.46 -2.24 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.285 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -158.05 30.23 0.25 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.301 0.572 . . . . 0.0 109.556 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -163.64 0.77 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.257 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.534 ' C ' HG23 ' A' ' 67' ' ' THR . 9.4 mtt -123.8 131.62 53.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.988 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.534 HG23 ' C ' ' A' ' 66' ' ' MET . 1.5 p 75.9 -11.25 1.15 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.971 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.971 HD23 HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 46.26 57.41 5.33 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.809 0.337 . . . . 0.0 111.248 179.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -65.87 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.071 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 99.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.518 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 49.3 m95 -90.13 155.39 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.642 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 m -102.04 158.65 16.0 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.18 153.3 24.82 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.565 -1.303 . . . . 0.0 114.203 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 31.6 mtp -145.66 147.62 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.764 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 88' ' ' TYR . 50.3 mt -151.38 120.77 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 111.796 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mt -93.77 149.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.392 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.57 140.43 16.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.825 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 93.0 Cg_endo -78.62 136.74 13.94 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.681 2.254 . . . . 0.0 112.062 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.628 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.5 Cg_endo -53.52 142.6 58.95 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.749 2.3 . . . . 0.0 112.829 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.42 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.61 42.75 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.535 179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.43 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 68.9 p -160.4 154.5 23.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.846 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.443 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.59 -37.65 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.049 0.452 . . . . 0.0 111.141 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CE1' ' OE1' ' A' ' 161' ' ' GLN . 51.4 m-85 -80.09 -22.28 42.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.907 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -40.37 136.44 1.27 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.173 0.511 . . . . 0.0 112.362 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 56.58 49.14 15.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.467 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -148.71 108.21 3.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.038 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 4.5 mp -69.08 165.4 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.604 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 23.5 m-85 -152.2 121.22 6.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.583 ' C ' HD12 ' A' ' 90' ' ' LEU . 43.0 m -88.91 151.24 22.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.721 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.9 mp -153.99 160.29 41.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.106 0.479 . . . . 0.0 111.511 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 2.9 mmtp -137.75 116.23 12.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.257 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.506 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.59 120.71 58.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.861 -0.608 . . . . 0.0 112.492 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 58.2 mt-10 -94.08 117.64 30.39 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.722 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.3 p -109.64 -169.14 1.42 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.767 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.21 -147.76 8.47 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -58.08 -70.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.546 2.164 . . . . 0.0 112.378 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -89.85 68.36 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.894 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.554 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -87.94 -61.36 0.24 Allowed Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.589 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 60.8 Cg_endo -71.97 2.25 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.619 1.546 . . . . 0.0 112.764 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -119.66 7.64 11.1 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.659 0.266 . . . . 0.0 111.079 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.52 151.35 12.57 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.133 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -52.11 123.1 11.8 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.25 167.0 22.06 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.604 2.203 . . . . 0.0 112.267 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 54.0 t80 -95.55 89.44 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.294 0.568 . . . . 0.0 110.445 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 92' ' ' ILE . 22.3 t -92.32 143.39 11.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.043 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' HA ' HG23 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -149.97 118.72 6.59 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.035 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.896 ' CE1' HD13 ' A' ' 147' ' ' LEU . 7.9 m-85 -65.15 127.95 33.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.708 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 90' ' ' LEU . 27.1 t -84.44 -46.39 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.251 0.548 . . . . 0.0 110.182 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 88' ' ' TYR . 8.2 t -69.21 -175.76 0.82 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.004 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 162' ' ' PRO . 5.9 mmtt -90.52 102.79 15.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.813 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.874 HG21 ' CG ' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -129.7 146.41 34.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.783 0.325 . . . . 0.0 111.63 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -125.94 102.26 7.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.656 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 3.6 ttm -125.1 159.05 32.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.203 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -55.84 -27.91 53.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.159 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.766 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -126.64 30.01 4.32 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.265 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.065 HG22 HG13 ' A' ' 123' ' ' VAL . 59.9 t -137.86 127.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.902 0.382 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -59.43 151.23 24.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.271 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.0 25.92 10.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.787 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.49 -46.3 0.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.74 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.505 ' HB3' HG23 ' A' ' 122' ' ' VAL . 2.1 t30 -102.36 -34.77 9.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.132 0.492 . . . . 0.0 109.815 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 99.16 -1.76 57.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.595 -0.729 . . . . 0.0 113.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 120' ' ' ASN . 37.5 t -58.83 110.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.065 HG13 HG22 ' A' ' 116' ' ' VAL . 4.7 t -76.17 110.8 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.428 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.75 113.27 10.24 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.944 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 131' ' ' LEU . 39.3 Cg_endo -66.49 -15.7 48.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.381 2.054 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -36.16 67.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.763 0.316 . . . . 0.0 111.119 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.766 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -88.1 -28.63 21.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.297 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.587 HG22 HG12 ' A' ' 130' ' ' VAL . 44.8 mm -80.44 132.18 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.54 -55.34 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.534 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.67 HG13 HD12 ' A' ' 131' ' ' LEU . 7.2 p -49.88 -37.43 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.67 HD12 HG13 ' A' ' 130' ' ' VAL . 1.0 OUTLIER -86.11 -46.61 10.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.11 -29.37 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -135.44 48.29 2.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.011 0.434 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -49.59 132.11 21.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.242 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -165.69 1.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.728 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -96.68 -39.01 9.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.003 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.9 t -80.76 2.51 25.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.688 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG23 ' A' ' 130' ' ' VAL . 5.0 m-30 -72.8 156.79 38.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.919 0.39 . . . . 0.0 111.158 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 -176.37 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.62 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 71' ' ' TRP . 74.0 mt -55.25 -44.97 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.064 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -56.72 -37.85 71.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.034 0.445 . . . . 0.0 110.114 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 138' ' ' TYR . 40.4 t -69.04 -35.95 71.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.996 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.405 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 18.5 t -65.71 -53.84 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.533 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.441 HD22 HD11 ' A' ' 75' ' ' ILE . 24.7 mt -64.37 -45.88 85.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.888 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -57.34 -31.35 65.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -71.22 -52.24 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.952 ' HA ' HD12 ' A' ' 150' ' ' LEU . 9.6 mt -49.61 -46.08 48.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.504 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.0 OUTLIER -64.26 -37.92 89.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.984 179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.504 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 20.2 mtt180 -63.01 -44.28 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.991 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.952 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.4 mt -65.43 -32.68 74.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.341 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 32.0 mtt -68.41 -29.11 67.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.681 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 30.2 mtm -76.23 -10.96 59.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.324 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.1 t -64.88 151.36 45.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.1 OUTLIER -52.93 -54.8 29.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.185 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -61.19 -24.78 66.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.47 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -86.88 -34.31 19.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.411 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 27.1 ptm -87.08 43.01 1.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.043 0.449 . . . . 0.0 110.84 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -144.23 -39.04 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.375 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.7 mt -52.97 145.67 22.16 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.29 124.95 14.72 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.197 1.932 . . . . 0.0 112.067 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.443 ' HG2' HG12 ' A' ' 82' ' ' ILE . 74.0 mm-40 -85.26 119.08 72.01 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.549 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HB2' ' HB2' ' A' ' 110' ' ' LYS . 56.6 Cg_exo -51.99 165.89 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.622 2.215 . . . . 0.0 112.03 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 165' ' ' GLY . 89.6 Cg_exo -43.09 175.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.03 2.487 . . . . 0.0 113.011 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 165' ' ' GLY . 4.4 mp0 -44.44 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.309 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 163' ' ' PRO . . . 20.86 50.75 0.01 OUTLIER Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.795 -0.639 . . . . 0.0 114.537 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.436 ' CG ' ' CG ' ' A' ' 110' ' ' LYS . 29.6 pt20 -71.19 158.35 36.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.556 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 65.1 m -77.24 174.02 11.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.524 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -89.46 86.67 6.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.802 179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 m -144.71 38.18 1.21 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.987 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 t30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.905 179.892 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.609 0.242 . . . . 0.0 111.46 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 59.8 Cg_endo -72.38 -27.78 15.69 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.398 2.066 . . . . 0.0 112.32 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 63.99 -174.31 12.43 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.508 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -109.86 134.32 52.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.97 -44.77 28.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.082 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 63.0 145.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.981 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.64 -50.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 p -90.81 110.45 21.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.836 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -155.54 -170.53 3.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 49.6 mt -52.54 -51.3 60.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.21 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.2 tttt 67.79 27.42 7.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 55.27 -177.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -127.72 21.95 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.021 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.9 t 57.8 -177.71 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.948 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -157.38 146.36 19.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.52 175.18 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 122.91 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.2 77.65 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -176.47 170.83 2.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.85 89.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.23 48.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.424 . . . . 0.0 110.903 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.58 -48.5 8.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -138.63 151.18 68.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.97 -167.69 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.525 2.15 . . . . 0.0 112.323 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.86 164.21 14.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.44 39.96 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -132.1 34.31 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.03 37.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.936 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 90.26 4.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.03 98.88 10.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.53 88.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -109.01 143.22 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.361 . . . . 0.0 111.12 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.54 110.09 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.5 m -150.61 130.79 6.89 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.121 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 38' ' ' PHE . 51.1 Cg_exo -53.7 161.87 4.07 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.436 2.091 . . . . 0.0 112.233 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.11 -38.21 76.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -67.02 -40.4 87.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.423 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -55.59 -50.8 69.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.826 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.3 OUTLIER -57.86 -45.36 86.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.606 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 97.3 mt -63.87 -34.11 77.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.756 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.678 HD23 HD21 ' A' ' 68' ' ' LEU . 50.3 mt -72.12 -52.89 14.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.76 0.314 . . . . 0.0 110.976 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.51 -49.64 68.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.6 mt-10 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.716 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.594 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.3 tp -63.44 -49.17 74.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.907 0.385 . . . . 0.0 110.588 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -54.98 -56.63 17.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.15 -25.69 59.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -72.36 -55.42 6.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.722 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -69.19 -47.87 63.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.733 0.301 . . . . 0.0 111.333 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -39.67 68.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.884 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 133.44 170.84 12.5 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.594 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.779 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -122.23 -177.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.77 -93.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.68 -23.12 66.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.831 0.348 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.779 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 83.49 27.75 38.26 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.395 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -72.24 -10.32 59.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.637 HG12 HG12 ' A' ' 75' ' ' ILE . 35.1 m -154.24 171.71 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 111.484 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.69 111.69 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.759 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.474 ' NE1' ' HA3' ' A' ' 47' ' ' GLY . 35.3 p90 -103.48 157.5 16.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.547 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -150.83 174.0 30.23 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.308 -0.948 . . . . 0.0 113.323 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.693 HD21 ' HA ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -86.83 11.99 12.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.403 -0.399 . . . . 0.0 112.024 -179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 66.88 -68.47 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 111.037 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' LEU . 4.0 m-20 -130.3 121.91 26.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.787 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.43 46.41 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.91 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -159.24 28.13 0.2 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -88.8 -172.75 3.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.361 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 6.0 mtt -131.26 130.21 42.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.047 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.627 ' C ' HD12 ' A' ' 68' ' ' LEU . 4.5 p 59.12 18.79 6.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.693 ' HA ' HD21 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 47.03 65.77 1.16 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.81 0.338 . . . . 0.0 111.239 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.77 -55.72 3.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.57 138.84 40.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.536 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 77.3 m95 -135.36 164.73 27.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.89 -179.84 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.285 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 58' ' ' TRP . . . -164.53 159.08 31.98 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.402 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 20.9 mtp -144.88 148.68 34.2 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.947 ' CD1' HD11 ' A' ' 147' ' ' LEU . 56.6 mt -152.3 121.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.8 mt -95.76 149.2 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.013 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -98.95 148.01 18.68 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.131 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 90.6 Cg_endo -82.24 144.22 13.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.783 2.322 . . . . 0.0 112.112 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 10.1 Cg_endo -53.17 142.35 55.81 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.74 2.293 . . . . 0.0 112.673 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.4 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.9 OUTLIER 78.82 41.28 0.1 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.52 179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.44 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.7 p -159.93 150.0 18.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.783 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.578 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -47.22 -37.02 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 111.192 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.51 ' CD1' HG22 ' A' ' 82' ' ' ILE . 65.9 m-85 -79.95 -21.66 43.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.72 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.7 pt-20 -42.33 137.7 1.94 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.252 0.549 . . . . 0.0 112.165 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 48.5 42.06 18.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.645 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 79.1 mmt-85 -144.61 107.06 4.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.865 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.6 mp -67.39 167.34 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.184 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.623 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 26.7 m-85 -147.98 125.96 12.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.824 0.345 . . . . 0.0 110.654 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.583 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 38.1 t -88.84 148.7 23.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.434 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.728 HD21 ' CE2' ' A' ' 107' ' ' PHE . 2.9 mp -151.4 160.16 43.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.183 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -142.77 114.78 8.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.518 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.7 mp -106.34 149.16 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.858 -178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -133.31 125.69 29.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.568 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.35 -179.18 3.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.307 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.8 -144.57 8.18 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.168 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -51.64 113.57 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.0 112.121 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.14 70.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.938 0.399 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.549 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.1 t80 -83.51 -60.12 0.35 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.547 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 61.0 Cg_endo -72.31 3.35 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 121.869 1.712 . . . . 0.0 112.993 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.41 -6.23 10.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 111.228 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.49 151.84 44.28 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.37 123.25 12.82 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.65 2.234 . . . . 0.0 112.339 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.497 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 96.6 Cg_endo -80.53 173.16 12.61 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.689 2.259 . . . . 0.0 112.438 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -94.89 89.13 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.202 0.525 . . . . 0.0 110.455 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.545 HG21 HG11 ' A' ' 143' ' ' VAL . 50.1 t -95.77 138.74 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.153 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -150.15 126.52 10.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.884 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 1.045 ' CD2' HG21 ' A' ' 111' ' ' ILE . 9.9 m-85 -73.77 135.66 43.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.894 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.14 -41.59 14.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -69.24 -178.51 1.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.082 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 40.6 mttt -93.43 91.02 6.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.744 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -121.48 144.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 -178.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -122.7 102.99 8.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.931 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.0 ttm -124.34 157.35 35.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.018 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -54.22 -38.67 65.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.178 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.663 ' CA ' ' HB3' ' A' ' 127' ' ' ALA . . . -112.36 25.98 11.7 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.958 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.907 HG22 HG13 ' A' ' 123' ' ' VAL . 81.1 t -137.72 126.62 33.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -59.81 149.32 31.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.07 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 m -110.9 28.43 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.792 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.64 -46.45 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.838 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' HB2' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -103.79 -33.68 8.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.147 0.499 . . . . 0.0 110.027 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.7 -4.45 56.41 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.753 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 120' ' ' ASN . 38.3 t -58.83 115.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.828 0.347 . . . . 0.0 110.837 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.907 HG13 HG22 ' A' ' 116' ' ' VAL . 11.8 t -76.74 108.13 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.619 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 115' ' ' GLY . 3.5 t0 -64.95 110.73 4.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 131' ' ' LEU . 43.2 Cg_endo -67.61 -13.12 37.92 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.287 1.992 . . . . 0.0 112.433 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -30.51 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.769 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.663 ' HB3' ' CA ' ' A' ' 115' ' ' GLY . . . -93.09 -48.08 6.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.654 ' CG2' HG12 ' A' ' 130' ' ' VAL . 24.5 mm -61.02 131.51 26.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.806 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 56.7 p -67.49 -54.47 19.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.454 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.654 HG12 ' CG2' ' A' ' 128' ' ' ILE . 7.2 p -49.87 -32.79 8.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.552 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 125' ' ' PRO . 61.9 mt -84.24 -53.03 5.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.722 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.45 -24.06 18.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.512 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -136.73 45.12 2.31 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.905 0.383 . . . . 0.0 111.016 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 70.5 t-105 -50.38 138.5 16.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.053 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -108.36 -170.3 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.925 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.57 -40.52 12.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.46 1.92 27.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.552 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.618 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 m-30 -72.75 151.76 41.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 90.3 p -155.43 -176.33 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.805 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.491 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 65.6 mt -51.19 -48.08 32.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.26 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -55.37 -39.48 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.659 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 45.7 t -69.03 -37.61 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.289 0.566 . . . . 0.0 110.017 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.545 HG11 HG21 ' A' ' 105' ' ' VAL . 22.4 t -63.38 -53.77 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.093 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 75' ' ' ILE . 25.7 mt -64.98 -45.06 87.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.878 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -61.34 -51.08 70.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.075 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.5 OUTLIER -59.76 -53.47 57.6 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.947 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -57.59 -37.7 73.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.926 0.394 . . . . 0.0 110.056 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.741 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.6 tmt_? -64.49 -33.8 76.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.695 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.35 89.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.899 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.819 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.7 mt -62.63 -40.45 97.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.451 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 22.9 mtt -55.22 -34.7 64.16 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.615 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 17.3 mtm -75.43 -13.96 60.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.103 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.2 t -65.56 158.31 27.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.817 0.341 . . . . 0.0 111.01 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 15.7 mttm -65.41 -49.87 67.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -61.14 -30.07 70.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.321 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' LEU . 0.8 OUTLIER -86.91 -26.17 24.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.653 -179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.422 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -89.74 46.66 1.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -143.17 -39.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.256 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.35 155.62 9.37 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.589 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -67.11 142.16 60.28 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.288 1.992 . . . . 0.0 111.8 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 82' ' ' ILE . 6.3 mm-40 -146.63 98.67 4.17 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.47 149.09 18.5 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.477 2.118 . . . . 0.0 112.199 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.84 158.68 55.19 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.565 2.177 . . . . 0.0 112.458 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.4 ' OE1' HD12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -48.64 174.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.34 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.4 -66.84 1.72 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -69.72 158.48 35.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 110.931 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 86.4 m -157.64 169.72 24.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.505 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 110' ' ' LYS . 16.2 m-85 -74.39 84.15 1.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.2 m -120.09 166.12 13.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.865 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.741 0.305 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.87 -28.27 24.95 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.582 2.188 . . . . 0.0 112.317 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.87 -156.14 20.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.409 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -80.48 76.48 7.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.73 118.59 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.026 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 66.34 -76.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 8' ' ' SER . . . -145.7 -50.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 7' ' ' ALA . 1.8 p 84.13 -19.56 0.36 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.685 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.2 t80 66.89 -70.77 0.1 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.75 0.31 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.25 148.44 30.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -159.84 174.87 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 60.62 -179.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.03 -71.92 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.3 p -120.69 29.98 7.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.961 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt 62.52 123.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.003 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 16' ' ' LEU . 1.3 pp -152.83 100.81 2.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -138.99 121.55 16.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.62 -34.55 5.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 61.31 -178.94 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.96 134.5 4.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.81 76.12 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 mt -160.96 127.25 3.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -112.13 126.59 28.17 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.827 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.37 -62.47 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.405 2.07 . . . . 0.0 112.295 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.0 mmm-85 -84.38 178.35 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -151.99 -57.43 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.82 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -109.96 178.2 4.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -151.32 -178.29 6.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -91.86 96.15 10.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -104.16 105.58 15.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 32' ' ' VAL . . . 93.29 -107.31 3.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.428 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 32' ' ' VAL . 12.6 p 43.67 36.25 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.649 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.71 155.94 34.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.14 114.38 46.29 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' A' ' 38' ' ' PHE . 36.9 Cg_endo -65.88 161.95 37.13 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.423 2.082 . . . . 0.0 112.229 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.69 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.1 tmm_? -55.8 -51.31 67.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.032 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.428 ' HA ' HD12 ' A' ' 40' ' ' LEU . 3.0 m120 -54.96 -35.61 64.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CD1' ' HG2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -55.36 -51.91 65.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.664 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 12.9 mmt-85 -57.95 -40.32 80.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.309 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.811 HD21 ' CD2' ' A' ' 98' ' ' TYR . 90.5 mt -61.82 -50.67 71.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.636 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 79.8 mt -62.81 -51.59 66.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.453 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.97 -47.97 82.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.097 0.475 . . . . 0.0 110.303 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 51.0 mt-10 -67.93 -26.66 66.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.464 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 43.1 tp -60.7 -45.35 94.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.048 0.451 . . . . 0.0 110.391 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.12 -37.08 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.637 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.43 -42.59 78.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.476 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -77.01 -40.64 24.63 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.676 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -66.1 -40.58 90.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 111.02 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -59.28 -76.16 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.956 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.12 165.68 36.36 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.452 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -148.51 -177.74 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.365 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.12 104.35 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.933 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 56.53 22.28 6.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.595 0.236 . . . . 0.0 111.497 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.472 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 51.07 46.35 50.66 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.794 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.6 p -71.4 -22.5 61.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.674 0.273 . . . . 0.0 111.206 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG12 HG12 ' A' ' 75' ' ' ILE . 28.1 m -154.93 173.78 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.78 110.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.341 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.49 ' CH2' HG11 ' A' ' 51' ' ' VAL . 26.5 p90 -99.92 96.26 7.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.149 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -105.66 -152.95 20.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.585 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 60' ' ' LEU . 4.9 mt -121.81 147.61 45.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 111.148 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -58.69 -41.64 86.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.954 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 5.7 t0 -110.23 -49.75 3.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 11.0 t0 95.61 -2.68 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.278 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -157.93 30.03 0.26 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.55 166.29 16.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.276 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 8.1 mtm -83.37 1.36 41.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.2 p -154.55 103.1 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.854 0.359 . . . . 0.0 111.151 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD12 HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -82.99 58.46 4.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.723 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.85 -56.28 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.59 105.35 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.431 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 30.4 m95 -89.5 150.86 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.669 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -101.99 113.29 26.39 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -110.75 106.54 2.08 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.913 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.9 mtp -90.63 147.32 23.38 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 90' ' ' LEU . 56.8 mt -149.61 150.14 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.872 0.368 . . . . 0.0 111.447 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.8 mt -105.89 148.83 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.231 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' HA2' ' HD2' ' A' ' 78' ' ' PRO . . . -76.09 117.22 5.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.256 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD2' ' HA2' ' A' ' 77' ' ' GLY . 5.9 Cg_endo -48.8 142.56 18.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.425 2.083 . . . . 0.0 112.0 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 61.0 Cg_endo -73.01 175.97 9.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.418 2.079 . . . . 0.0 112.753 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 40.92 41.8 1.33 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.592 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 80' ' ' ARG . 6.8 p -162.0 160.97 28.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -43.65 -28.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.883 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 84' ' ' GLU . 72.0 m-85 -79.58 -22.09 44.2 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 1.7 tt0 -24.16 125.76 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 45.55 72.9 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.137 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 22.5 mmt180 -157.43 104.66 2.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.587 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -66.02 167.64 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.302 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' N ' HG22 ' A' ' 87' ' ' ILE . 60.1 m-85 -153.4 128.67 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.015 0.436 . . . . 0.0 111.546 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -93.17 145.87 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.82 179.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.657 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.5 mp -149.43 160.44 43.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.282 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.9 OUTLIER -138.61 111.49 7.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.188 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.0 HG23 HG22 ' A' ' 105' ' ' VAL . 4.1 mp -106.33 120.15 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.479 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -93.85 133.16 37.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.739 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 98' ' ' TYR . 21.5 p -115.35 -169.3 1.54 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.14 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.85 -147.04 15.23 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.234 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.6 119.03 4.2 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.478 2.119 . . . . 0.0 111.999 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp 59.46 75.19 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.852 0.358 . . . . 0.0 110.064 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.811 ' CD2' HD21 ' A' ' 40' ' ' LEU . 6.1 t80 -86.52 -54.49 0.39 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.84 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 95.6 Cg_endo -82.57 8.76 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.991 1.794 . . . . 0.0 112.236 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.92 3.87 7.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.81 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -167.21 143.34 3.57 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.952 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.61 110.95 2.48 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.847 2.365 . . . . 0.0 112.632 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 73.0 Cg_endo -76.9 -96.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.505 2.137 . . . . 0.0 112.416 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.773 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 59.8 t80 -148.17 136.02 20.94 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.894 0.378 . . . . 0.0 111.651 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.0 HG22 HG23 ' A' ' 92' ' ' ILE . 38.6 t -135.75 140.28 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.395 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HA ' HG23 ' A' ' 123' ' ' VAL . 8.4 ptt180 -150.5 139.43 20.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.965 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 1.065 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.8 m-85 -77.44 114.83 16.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.868 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.65 -46.68 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.164 0.507 . . . . 0.0 110.273 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 88' ' ' TYR . 9.5 t -68.6 -179.83 1.5 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.06 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.409 ' HB3' ' HG3' ' A' ' 162' ' ' PRO . 27.3 mttt -88.68 120.22 29.87 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.065 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -157.84 153.57 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -178.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.506 ' N ' HD13 ' A' ' 111' ' ' ILE . 52.5 m-20 -125.94 102.03 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.43 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.498 ' SD ' HD13 ' A' ' 150' ' ' LEU . 7.6 ttm -125.24 143.49 50.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.231 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 113' ' ' MET . 2.4 m-80 -58.03 79.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.008 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 113' ' ' MET . . . 145.94 -35.38 1.39 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.284 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.921 HG22 HG13 ' A' ' 123' ' ' VAL . 58.5 t -89.16 139.3 17.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -59.71 138.45 57.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.078 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.0 p -96.14 48.88 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.781 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.0 p -178.07 -38.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.802 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.464 ' HB3' HG23 ' A' ' 122' ' ' VAL . 1.5 t30 -102.45 -37.73 7.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.095 0.474 . . . . 0.0 109.991 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.16 -5.58 61.24 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.126 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.773 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 24.4 t -58.54 111.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 117.089 0.444 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.921 HG13 HG22 ' A' ' 116' ' ' VAL . 7.4 t -77.08 110.07 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.477 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -64.59 110.28 3.84 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.836 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.0 Cg_exo -62.2 -17.71 58.3 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.353 2.035 . . . . 0.0 112.326 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -72.43 -43.79 63.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -73.69 -31.6 63.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.79 HG23 ' OE1' ' A' ' 146' ' ' GLU . 44.4 mm -81.91 130.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.57 -59.88 3.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.59 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 146' ' ' GLU . 12.5 m -49.7 -30.82 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.662 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 1.8 mp -84.39 -45.22 12.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.21 -63.38 1.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.052 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 58.89 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -49.15 164.56 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -152.98 173.92 14.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.977 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.49 -27.24 63.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.194 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.52 -24.76 41.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.907 ' CD1' HG11 ' A' ' 142' ' ' VAL . 14.8 m-85 -73.56 144.72 45.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 111.256 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.81 -176.32 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.364 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 58' ' ' TRP . 62.5 mt -50.09 -39.39 15.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.715 0.293 . . . . 0.0 111.108 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HG3' ' CZ3' ' A' ' 58' ' ' TRP . 14.6 ttpp -61.7 -45.73 92.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.0 110.328 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.907 HG11 ' CD1' ' A' ' 138' ' ' TYR . 19.4 t -67.45 -35.6 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.287 0.565 . . . . 0.0 109.884 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.9 t -62.99 -53.81 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.917 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.433 HD22 HD11 ' A' ' 75' ' ' ILE . 21.6 mt -64.36 -44.6 90.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.556 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -57.66 -40.62 79.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.985 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.889 ' OE1' HD11 ' A' ' 150' ' ' LEU . 2.7 tm-20 -59.97 -53.03 62.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.766 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.91 HD13 ' CE1' ' A' ' 107' ' ' PHE . 7.5 mt -50.25 -45.9 54.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.767 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.3 ttp85 -62.94 -38.15 89.88 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.755 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -46.52 88.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.206 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.889 HD11 ' OE1' ' A' ' 146' ' ' GLU . 1.6 mt -59.43 -46.28 89.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.34 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.426 ' HB3' ' CD1' ' A' ' 83' ' ' TYR . 2.5 mtt -61.13 -25.41 66.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.784 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' PRO . 0.2 OUTLIER -75.76 -20.4 58.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.026 179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.9 t -65.26 154.57 37.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 11.6 mttm -65.13 -45.79 83.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.06 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -27.38 68.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.41 -27.67 22.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.348 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 0.1 OUTLIER -89.72 45.98 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.098 0.475 . . . . 0.0 110.698 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -138.82 -38.56 0.51 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.1 mt -53.18 147.3 18.22 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.461 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.83 125.89 12.05 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.285 1.99 . . . . 0.0 112.535 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -83.7 157.39 64.07 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 110' ' ' LYS . 36.8 Cg_exo -56.88 165.19 5.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.555 2.17 . . . . 0.0 112.207 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.52 19.86 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.806 2.337 . . . . 0.0 112.967 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 168.44 -174.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.848 0.356 . . . . 0.0 110.594 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -94.62 21.99 40.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.62 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.12 158.12 36.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 29.4 p -78.74 -168.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 109' ' ' THR . 2.2 m-85 -85.11 155.79 21.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.47 32.92 22.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.745 0.307 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.78 -46.42 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.598 2.199 . . . . 0.0 112.295 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.81 -90.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 60.32 74.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 110.796 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.11 -48.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.132 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 43.74 68.49 0.52 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.463 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.71 -44.1 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.8 m 61.62 159.94 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 1.2 p90 -157.48 161.1 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.763 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 9' ' ' TYR . 8.2 mt 74.0 -59.56 0.55 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.049 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 75.58 79.68 0.1 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.839 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m -158.35 133.95 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.838 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.55 -60.79 2.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -171.41 -56.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.38 109.44 3.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.67 113.47 26.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 p -160.74 176.95 10.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -128.04 -44.22 1.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 69.0 -67.69 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.84 -106.76 0.55 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.562 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 174.44 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.648 HD12 ' HB2' ' A' ' 23' ' ' GLU . 3.2 pp -103.81 -38.13 7.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' HB2' HD12 ' A' ' 22' ' ' LEU . 22.8 mt-10 -158.19 102.24 1.72 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.66 58.54 6.45 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.599 2.199 . . . . 0.0 112.373 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -69.78 -69.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.91 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.69 102.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -132.28 101.63 5.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.04 83.48 2.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.72 91.84 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.06 29.0 0.52 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.483 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 32' ' ' VAL . 23.4 m -62.49 102.78 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.062 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 -159.81 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.3 m -78.58 142.05 61.38 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.644 0.259 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.5 151.86 22.73 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.651 2.234 . . . . 0.0 112.358 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.675 ' HD3' HD11 ' A' ' 40' ' ' LEU . 1.5 tmm_? -56.0 -48.95 74.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.072 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -32.9 51.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.965 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -54.93 37.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.62 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.3 mmt-85 -57.52 -37.74 73.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.054 0.454 . . . . 0.0 110.196 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.675 HD11 ' HD3' ' A' ' 36' ' ' ARG . 91.9 mt -61.87 -38.35 87.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.626 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.1 mt -72.25 -52.74 15.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.396 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -63.51 -50.02 71.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 110.545 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 91.5 mt-10 -60.34 -32.34 71.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.336 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.551 HD13 ' HG ' ' A' ' 60' ' ' LEU . 25.8 tp -62.66 -43.7 98.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.941 0.401 . . . . 0.0 110.38 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.73 -56.13 26.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.041 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.25 -45.02 84.37 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -65.08 -44.31 94.41 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.768 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -67.8 -48.04 67.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.721 0.296 . . . . 0.0 111.185 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -22.84 64.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.817 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.83 167.18 27.21 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.265 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -115.62 -176.96 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 0.0 111.163 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -47.14 -86.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.195 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.91 -14.42 61.05 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 72.92 37.73 56.54 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.26 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.2 p -72.35 -17.1 61.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.59 0.233 . . . . 0.0 111.53 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 75' ' ' ILE . 31.8 m -154.26 174.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.942 0.401 . . . . 0.0 111.336 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.78 111.07 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.272 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.495 ' HB2' HG21 ' A' ' 140' ' ' ILE . 34.8 p90 -103.01 73.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.042 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.41 -170.29 46.36 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.773 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.048 HD11 HD23 ' A' ' 68' ' ' LEU . 2.5 mt -104.72 141.7 36.0 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.845 0.355 . . . . 0.0 111.035 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.6 -32.64 73.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.796 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 64' ' ' GLU . 1.6 t70 -169.4 129.98 1.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.64 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.76 33.38 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 62' ' ' ASP . 34.5 mm-40 -158.81 29.33 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.62 1.94 47.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.824 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.58 113.01 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.011 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.401 ' C ' HD12 ' A' ' 68' ' ' LEU . 2.8 p 62.35 15.56 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.601 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.048 HD23 HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER 44.71 47.15 8.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.016 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -58.17 -65.55 0.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.361 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.48 146.28 52.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.06 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.553 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 63.8 m95 -134.9 146.68 49.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.254 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -102.04 121.44 42.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.486 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -118.44 109.8 1.83 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.679 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mtp -94.33 152.47 18.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.849 ' CD1' HD11 ' A' ' 147' ' ' LEU . 37.4 mt -152.31 129.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 111.697 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.8 mt -102.85 149.26 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.275 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -85.09 143.42 20.38 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.02 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HG3' ' CG ' ' A' ' 152' ' ' MET . 83.2 Cg_endo -84.2 134.02 5.8 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.826 2.351 . . . . 0.0 111.942 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.593 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 71.0 Cg_exo -48.79 143.22 17.4 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.502 2.135 . . . . 0.0 112.987 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.1 OUTLIER 74.17 43.97 0.27 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.504 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 30.7 p -160.06 149.45 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.623 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -46.91 -36.82 3.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.994 0.426 . . . . 0.0 111.065 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.511 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 94.4 m-85 -80.27 -22.27 41.83 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.949 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.1 pt-20 -42.54 133.09 3.47 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 64.79 11.91 7.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.622 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -115.28 104.17 11.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.797 0.332 . . . . 0.0 110.943 179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.607 HG22 ' N ' ' A' ' 88' ' ' TYR . 40.5 mt -61.79 169.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.282 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.607 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.4 m-85 -152.42 129.73 11.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.987 0.422 . . . . 0.0 111.389 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.6 m -93.84 146.41 23.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.83 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -151.06 160.19 44.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.5 mtpt -141.68 114.53 8.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.72 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 105' ' ' VAL . 4.5 mp -106.13 120.79 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.182 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.08 126.78 40.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.696 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.8 p -113.53 -172.02 1.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 150.19 -140.08 7.77 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.589 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.72 120.46 5.94 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.607 2.205 . . . . 0.0 112.514 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.2 mttt 51.44 70.3 0.56 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.062 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.581 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 2.3 t80 -88.58 -63.0 0.21 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 70.5 Cg_endo -73.47 3.7 4.55 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.605 1.536 . . . . 0.0 112.478 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.54 -4.43 12.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.785 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.33 161.26 29.81 Favored Pre-proline 0 N--CA 1.455 -0.189 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.59 123.88 14.26 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.655 2.237 . . . . 0.0 112.474 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 85.6 Cg_endo -79.17 171.76 15.77 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.641 2.228 . . . . 0.0 112.31 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -96.39 89.37 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.093 0.473 . . . . 0.0 110.473 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 92' ' ' ILE . 25.6 t -93.71 139.3 18.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.221 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.455 HH12 HG22 ' A' ' 108' ' ' VAL . 2.9 ptm180 -150.42 120.22 7.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.822 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.935 ' CD2' HG21 ' A' ' 111' ' ' ILE . 20.5 m-85 -65.56 139.44 58.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG22 HH12 ' A' ' 106' ' ' ARG . 21.0 t -91.45 -42.97 14.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.865 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.409 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 9.5 t -69.05 -178.63 1.3 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.803 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' HB3' ' A' ' 166' ' ' GLN . 0.3 OUTLIER -93.36 76.44 4.51 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.265 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.935 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -99.6 152.0 4.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.475 -179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.73 102.48 7.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.676 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.477 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 12.4 ttm -124.69 148.01 48.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.236 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -55.02 -28.36 51.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.185 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.568 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -120.07 28.01 6.52 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.012 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.018 HG22 HG13 ' A' ' 123' ' ' VAL . 94.1 t -136.25 131.99 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.89 0.376 . . . . 0.0 110.726 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -59.49 132.34 53.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.993 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 m -97.81 31.98 2.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.987 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t -141.38 -48.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.744 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -105.28 -34.73 7.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.031 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 107' ' ' PHE . . . 106.08 -4.12 38.45 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.78 113.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.886 0.374 . . . . 0.0 110.796 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 116' ' ' VAL . 10.2 t -76.76 119.41 25.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.726 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.4 OUTLIER -65.33 110.72 4.69 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.65 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.49 -20.8 71.65 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.383 2.056 . . . . 0.0 112.407 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -45.04 61.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.806 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.568 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -71.48 -52.41 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.985 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.543 ' CG2' HG12 ' A' ' 130' ' ' VAL . 14.6 mm -58.1 128.1 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.0 t -67.39 -56.32 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.453 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 138' ' ' TYR . 9.2 p -49.95 -30.84 6.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.352 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.537 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.3 OUTLIER -86.06 -55.06 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.806 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.06 -25.08 19.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.272 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -134.2 51.04 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 0.0 110.746 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.45 ' CZ3' ' CD ' ' A' ' 103' ' ' PRO . 57.0 t-105 -49.44 160.97 0.22 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.246 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 138' ' ' TYR . 3.1 tt0 -140.62 177.16 8.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -77.32 -39.74 46.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.97 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 17.4 m -80.0 0.36 31.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.488 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.561 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.1 m-30 -72.78 149.66 43.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.962 0.411 . . . . 0.0 111.151 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -155.7 -176.45 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.36 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.507 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 31.7 mt -58.17 -37.59 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.721 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.451 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 6.5 ttpm? -62.04 -40.17 94.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.034 0.445 . . . . 0.0 109.998 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 138' ' ' TYR . 22.0 t -67.88 -40.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.678 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.457 HG11 HG21 ' A' ' 105' ' ' VAL . 32.2 t -61.13 -53.22 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.328 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 75' ' ' ILE . 27.0 mt -64.14 -44.8 91.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.847 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.31 -48.85 79.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.641 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 142' ' ' VAL . 1.5 tp10 -60.0 -53.26 59.93 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.849 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.6 pp -57.77 -41.0 81.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.814 0.34 . . . . 0.0 110.45 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.796 ' N ' HD12 ' A' ' 147' ' ' LEU . 3.3 tmm_? -63.83 -33.09 74.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.168 0.509 . . . . 0.0 109.876 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -58.5 -44.85 89.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.101 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.8 mt -61.82 -41.97 98.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.887 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.418 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 14.7 mtt -56.44 -29.43 61.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.606 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . 0.437 ' CG ' ' HG3' ' A' ' 78' ' ' PRO . 9.7 mtm -74.21 -22.69 59.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.848 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.3 t -65.96 158.09 29.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.054 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.472 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 6.2 mttt -65.41 -36.03 82.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.151 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.6 -44.33 97.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.008 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 20.4 m-20 -87.7 -20.8 25.74 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.472 ' CG ' ' HA ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -88.74 23.43 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.881 0.372 . . . . 0.0 111.255 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.81 -30.99 4.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.276 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.0 mt -54.71 145.5 40.4 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.413 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.83 124.69 10.87 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.263 1.976 . . . . 0.0 112.673 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.452 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 7.1 mm-40 -85.06 158.04 59.03 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.832 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 161' ' ' GLN . 40.6 Cg_endo -66.76 118.25 5.4 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.333 2.022 . . . . 0.0 111.932 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 12.0 Cg_exo -70.99 55.79 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.768 2.312 . . . . 0.0 112.882 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 165.12 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.823 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -93.9 45.67 2.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.131 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' HB3' ' HG3' ' A' ' 110' ' ' LYS . 7.2 mm-40 -69.72 159.06 34.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.014 0.435 . . . . 0.0 111.436 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 10.0 m -160.0 135.57 8.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.389 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CE1' ' HE2' ' A' ' 110' ' ' LYS . 24.6 m-85 -46.61 146.81 1.4 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.422 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.3 84.58 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.825 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.666 0.27 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.4 141.13 34.63 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.522 2.148 . . . . 0.0 112.271 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.04 -73.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.587 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.28 92.18 3.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.818 0.342 . . . . 0.0 110.847 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 5' ' ' VAL . 9.4 p -101.49 53.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 127.4 32.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.38 22.55 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.297 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m 62.04 108.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.865 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -69.9 147.51 50.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 18.4 mt 60.0 161.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -160.56 170.94 19.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.857 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -121.22 179.53 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -132.26 -50.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.887 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 p -168.73 153.9 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -82.8 -32.1 27.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -171.25 125.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 m -156.47 86.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -69.39 87.83 0.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -165.68 110.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.18 93.78 1.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.54 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.61 30.79 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.799 0.333 . . . . 0.0 110.954 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -171.42 105.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.73 142.57 25.24 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.59 59.71 6.32 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 112.337 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.89 88.53 2.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -165.56 -44.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.968 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.78 95.68 7.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.78 150.77 20.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.9 m -77.07 -80.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.6 mttp 53.33 94.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.027 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.36 93.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.577 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 32' ' ' VAL . 15.3 t -136.76 32.39 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.827 0.346 . . . . 0.0 110.977 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.17 -176.99 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.667 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 34' ' ' VAL . 17.7 m -79.47 112.62 30.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.19 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.415 ' O ' ' HG3' ' A' ' 36' ' ' ARG . 22.5 Cg_exo -64.81 137.53 54.02 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 112.477 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.676 HH11 HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER 82.24 -48.97 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.755 179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' N ' ' HG3' ' A' ' 36' ' ' ARG . 5.0 m120 -71.26 -44.85 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -58.16 -44.39 87.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.941 0.4 . . . . 0.0 110.455 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -60.59 -40.48 91.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.365 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.676 HD11 HH11 ' A' ' 36' ' ' ARG . 80.4 mt -60.58 -53.65 54.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.888 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.7 mt -62.55 -50.82 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.7 -43.98 97.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 89.6 mt-10 -71.71 -27.79 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.553 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -60.32 -46.01 91.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.84 0.352 . . . . 0.0 110.586 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 13.6 mt-10 -68.47 -44.06 75.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.422 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.74 -27.72 43.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.059 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.484 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -88.13 -30.44 17.04 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -83.47 -43.7 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' GLU . 10.0 mmtt -58.45 -62.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.898 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.65 174.71 45.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.813 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.737 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -153.04 -177.11 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.85 105.09 1.37 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.49 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 66.89 14.09 9.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.556 0.217 . . . . 0.0 111.33 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.737 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 49.05 41.33 29.46 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.875 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 p -71.43 -18.91 62.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 0.0 111.13 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.631 ' O ' HG21 ' A' ' 51' ' ' VAL . 21.1 m -155.1 169.8 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.824 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 m -161.73 110.99 1.54 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.675 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' CH2' HG11 ' A' ' 51' ' ' VAL . 32.4 p90 -103.81 143.45 32.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.576 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -151.82 -136.09 2.38 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.039 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.945 HD11 HD23 ' A' ' 68' ' ' LEU . 10.6 mt -132.61 133.04 43.15 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.743 0.306 . . . . 0.0 110.905 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -57.14 -53.56 56.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.038 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 9.0 t70 -110.05 -48.62 3.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.969 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.743 ' HA ' HD13 ' A' ' 60' ' ' LEU . 2.5 t70 95.96 21.91 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.968 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -157.17 29.53 0.3 Allowed 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.04 -166.03 1.42 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.205 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.52 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -84.97 109.71 18.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 66' ' ' MET . 15.0 t 46.7 35.6 3.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.945 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 55.52 80.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.98 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 94' ' ' CYS . 2.9 m -97.78 -61.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.2 93.62 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.209 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.675 ' CE3' HD13 ' A' ' 140' ' ' ILE . 40.5 m95 -90.06 152.63 21.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.01 152.08 21.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.724 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -143.71 102.36 0.28 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.629 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.4 mtp -94.17 147.06 23.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.881 HD13 HD11 ' A' ' 147' ' ' LEU . 45.5 mt -151.78 138.06 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.74 0.305 . . . . 0.0 111.588 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mt -99.26 148.85 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.118 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' CA ' ' HB3' ' A' ' 83' ' ' TYR . . . -78.69 117.97 4.73 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.266 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 10.7 Cg_endo -54.41 146.86 49.61 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.392 2.061 . . . . 0.0 112.163 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 13.4 Cg_exo -69.3 173.64 10.26 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.635 2.224 . . . . 0.0 112.73 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' HG23 ' A' ' 81' ' ' THR . 0.0 OUTLIER 41.48 43.14 2.14 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.792 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 80' ' ' ARG . 19.9 p -161.3 158.17 26.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.42 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.517 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -44.32 -27.8 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.47 ' O ' ' C ' ' A' ' 84' ' ' GLU . 53.6 m-85 -78.79 -24.56 44.54 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.604 ' HG3' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -22.01 122.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 46.21 65.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.753 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 9.4 mmt180 -152.87 102.9 2.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 88' ' ' TYR . 11.0 mt -67.56 168.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.208 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.587 ' N ' HG22 ' A' ' 87' ' ' ILE . 25.9 m-85 -150.34 132.91 15.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 0.0 110.992 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 48.7 m -94.18 146.7 23.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.296 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.855 HD21 ' CE2' ' A' ' 107' ' ' PHE . 3.8 mp -151.7 159.89 43.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.96 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.624 ' HE3' HG21 ' A' ' 108' ' ' VAL . 28.1 mttt -144.54 117.91 9.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.519 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.719 HG23 HG22 ' A' ' 105' ' ' VAL . 5.0 mp -106.2 123.65 61.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -93.82 108.67 20.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.816 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.794 ' O ' HG23 ' A' ' 69' ' ' THR . 57.4 m -113.54 152.55 30.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.65 -149.36 4.95 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.592 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.78 -48.63 18.54 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.665 2.243 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 77.76 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.939 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' CB ' ' CD ' ' A' ' 99' ' ' PRO . 1.0 OUTLIER -101.79 -66.68 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.346 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 98' ' ' TYR . 55.2 Cg_endo -69.76 -0.94 7.63 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 121.346 1.364 . . . . 0.0 112.312 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -109.22 -4.69 16.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.986 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -162.61 144.22 8.01 Favored Pre-proline 0 N--CA 1.455 -0.191 0 CA-C-O 120.836 0.351 . . . . 0.0 111.308 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.01 110.07 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.868 2.378 . . . . 0.0 112.042 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.424 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 41.6 Cg_endo -67.56 -176.17 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.444 2.096 . . . . 0.0 112.244 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -94.76 94.63 8.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.067 0.46 . . . . 0.0 111.197 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.719 HG22 HG23 ' A' ' 92' ' ' ILE . 44.6 t -96.32 138.54 21.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.781 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HA ' HG23 ' A' ' 123' ' ' VAL . 1.9 ptm180 -150.22 126.12 10.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.031 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.864 ' CD2' HG21 ' A' ' 111' ' ' ILE . 25.1 m-85 -68.1 126.78 30.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.948 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.624 HG21 ' HE3' ' A' ' 91' ' ' LYS . 38.2 t -78.35 -41.48 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.262 0.553 . . . . 0.0 109.948 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.405 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 6.4 t -68.41 -175.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.828 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' CE1' ' A' ' 168' ' ' TYR . 11.9 mttt -98.83 68.02 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.174 0.512 . . . . 0.0 110.274 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.864 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -90.51 152.15 3.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.343 -179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.47 101.89 7.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 110.618 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.422 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.1 ttm -125.2 157.5 36.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -54.67 -52.86 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -89.19 -11.64 64.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.109 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 1.011 HG22 HG13 ' A' ' 123' ' ' VAL . 43.7 t -107.19 121.01 59.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.08 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.42 143.75 52.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.925 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 p -98.25 29.15 3.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 p -140.0 -43.62 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.628 ' HB3' HG23 ' A' ' 122' ' ' VAL . 1.5 m-20 -102.23 -32.74 9.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 110.033 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -3.16 81.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.874 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 120' ' ' ASN . 46.3 t -58.96 110.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.011 HG13 HG22 ' A' ' 116' ' ' VAL . 3.4 t -77.69 107.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.243 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -63.77 109.99 3.25 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.849 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.401 ' CB ' HD23 ' A' ' 131' ' ' LEU . 39.1 Cg_exo -60.41 -23.28 74.37 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.323 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.43 -41.33 66.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.907 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.532 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -74.65 -35.99 62.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.476 HG13 HG12 ' A' ' 123' ' ' VAL . 35.5 mm -75.46 133.25 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.734 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.5 -58.84 4.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.016 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.707 HG21 HG12 ' A' ' 142' ' ' VAL . 14.9 p -49.85 -33.91 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.795 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD1' HG13 ' A' ' 130' ' ' VAL . 7.4 mp -81.91 -41.85 20.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.84 69.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.86 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 47.01 0.96 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -48.03 157.22 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.28 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 179.28 7.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.906 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 9.0 p30 -78.71 -31.98 46.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.3 m -79.13 -12.77 60.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.226 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.541 ' CE2' HG23 ' A' ' 130' ' ' VAL . 5.2 m-30 -72.87 153.74 40.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 110.938 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 t -156.16 -176.39 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.675 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.9 mt -54.92 -35.14 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.497 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -67.39 -38.93 85.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.8 0.333 . . . . 0.0 110.496 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.707 HG12 HG21 ' A' ' 130' ' ' VAL . 49.1 t -68.63 -37.67 77.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HA ' HG11 ' A' ' 130' ' ' VAL . 38.5 t -63.5 -52.9 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.551 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.672 HD22 HD11 ' A' ' 75' ' ' ILE . 42.6 mt -62.48 -43.68 98.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.956 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -61.96 -51.11 69.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.054 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.419 ' CG ' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -59.8 -53.36 58.82 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -178.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.881 HD11 HD13 ' A' ' 75' ' ' ILE . 4.6 pp -56.08 -40.76 74.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.987 0.422 . . . . 0.0 110.134 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.809 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 ttt-85 -62.6 -34.16 76.45 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -58.73 -38.47 78.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.538 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 147' ' ' LEU . 6.6 mt -64.08 -41.48 97.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.492 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 34.7 mtt -55.7 -32.36 63.24 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.283 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -19.82 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.949 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 t -65.12 159.83 22.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 157' ' ' MET . 4.6 mtpm? -65.21 -36.01 82.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.301 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.78 -35.86 81.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.472 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -89.57 -11.63 42.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 154' ' ' LYS . 14.1 ptm -90.61 24.57 2.61 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 111.187 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.07 -37.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.823 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.7 mt -54.37 157.66 4.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.684 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.413 ' C ' ' HG2' ' A' ' 161' ' ' GLN . 44.0 Cg_endo -66.11 146.59 82.31 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.326 2.017 . . . . 0.0 112.116 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.517 ' HG3' HG23 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -146.26 103.04 4.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.586 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 52.2 Cg_exo -55.74 117.96 4.66 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.374 2.049 . . . . 0.0 112.204 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 2.2 Cg_endo -81.49 90.4 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.813 2.342 . . . . 0.0 112.321 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 167.54 -173.74 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.876 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.27 30.62 8.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.369 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.09 158.63 34.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.737 0.303 . . . . 0.0 110.979 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 83.8 m -155.99 154.3 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.609 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 109' ' ' THR . 24.7 m-85 -54.64 111.08 0.73 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.1 m -142.37 30.58 1.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.917 179.958 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.653 0.263 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.17 128.51 22.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.547 2.164 . . . . 0.0 112.355 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.03 -110.39 3.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.438 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.34 167.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 5' ' ' VAL . 14.3 p -98.21 42.99 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.999 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.85 90.74 0.81 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.56 -37.32 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 m -85.66 125.72 33.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -86.97 158.66 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mt 60.31 176.52 0.09 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.2 tttt 68.25 -69.08 0.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.056 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m 63.14 130.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.952 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -130.17 -72.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 p 55.72 -171.27 0.07 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.45 120.05 6.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.19 138.2 31.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.01 -169.61 1.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.79 37.67 0.58 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.07 56.13 3.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -152.04 17.26 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.533 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 64.52 -78.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.7 139.97 47.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.64 127.06 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.22 -168.17 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.5 2.133 . . . . 0.0 112.232 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -126.52 36.44 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt 65.07 -78.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.1 87.06 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -171.48 115.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.2 m -76.41 112.97 13.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.982 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.57 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.043 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.46 8.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 m -133.21 141.98 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -117.71 -66.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.8 p -80.03 128.03 75.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.53 152.09 17.04 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.35 2.033 . . . . 0.0 112.218 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' A' ' 96' ' ' PRO . 0.0 OUTLIER -66.07 -40.94 91.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.873 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -65.02 -34.81 79.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.45 -55.72 28.45 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 4.3 mmt180 -58.47 -39.26 79.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.386 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.812 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 84.1 mt -61.72 -40.31 94.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.16 -52.57 15.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.375 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.64 -43.18 99.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.921 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 72.7 mm-40 -68.63 -29.72 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.797 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD13 ' CZ3' ' A' ' 71' ' ' TRP . 64.0 tp -62.85 -47.13 84.71 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.6 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.24 -48.32 80.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.723 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -58.11 -41.63 83.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -66.45 -62.81 4.32 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.586 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -52.28 -39.7 60.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.907 0.384 . . . . 0.0 110.987 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -72.74 -27.48 62.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.77 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.57 170.01 22.75 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.515 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.497 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -113.04 -177.0 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.357 . . . . 0.0 110.983 179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.9 -76.72 0.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' HG23 ' A' ' 55' ' ' THR . 0.5 OUTLIER -73.95 -14.27 61.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.222 . . . . 0.0 111.288 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 68.6 28.65 73.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.44 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 53' ' ' ASP . 13.9 p -71.88 -12.32 61.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.585 0.231 . . . . 0.0 111.426 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.847 HG12 HG12 ' A' ' 75' ' ' ILE . 3.9 m -154.21 161.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.776 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.01 124.83 3.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.795 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.544 ' HZ3' HG23 ' A' ' 56' ' ' VAL . 4.4 p90 -114.87 -179.12 3.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.456 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.14 -171.28 44.12 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.057 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.58 HD11 HD23 ' A' ' 68' ' ' LEU . 4.7 mt -99.46 120.79 40.19 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.981 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -57.41 -34.77 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -101.05 -53.89 2.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 9.6 t0 94.91 1.55 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -158.63 30.03 0.23 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 121.333 0.587 . . . . 0.0 109.598 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.62 -165.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.306 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mtt -111.74 122.14 46.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.519 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.4 p 61.1 17.18 7.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.522 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' A' ' 40' ' ' LEU . 0.5 OUTLIER 47.35 70.74 0.38 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.239 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.0 m -75.01 -68.8 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.017 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.31 142.68 50.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.752 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.812 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 92.0 m95 -135.17 144.16 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.293 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 159.9 14.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.705 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 156.81 26.9 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.885 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 24.5 mtp -145.48 147.25 31.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.712 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.847 HG12 HG12 ' A' ' 56' ' ' VAL . 41.3 mt -150.57 120.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.823 0.344 . . . . 0.0 111.759 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mt -86.66 149.21 4.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.429 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -74.69 134.0 16.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.844 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 84.1 Cg_endo -78.39 127.61 8.32 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.192 . . . . 0.0 111.737 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.612 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 7.8 Cg_endo -50.04 141.21 30.43 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.628 2.219 . . . . 0.0 112.727 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.2 OUTLIER 75.4 44.03 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.235 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 17.6 p -159.4 154.55 25.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.732 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.442 HG12 ' HG2' ' A' ' 161' ' ' GLN . 0.3 OUTLIER -50.11 -38.51 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.989 0.424 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.461 ' O ' ' HA3' ' A' ' 77' ' ' GLY . 42.3 m-85 -80.35 -20.62 43.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.026 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 1.4 pt-20 -41.85 133.06 2.93 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 66.99 41.38 2.7 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.553 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 84' ' ' GLU . 2.4 mpt_? -149.59 115.7 5.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.718 0.294 . . . . 0.0 111.362 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 88' ' ' TYR . 37.1 mt -65.57 168.04 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.021 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.663 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 22.5 m-85 -153.32 119.53 5.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.78 0.324 . . . . 0.0 110.773 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.586 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 4.8 m -88.77 153.17 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.632 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 107' ' ' PHE . 4.0 mp -153.75 160.28 42.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.369 -178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -137.87 114.16 10.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.452 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.003 HG23 HG22 ' A' ' 105' ' ' VAL . 4.4 mp -106.19 121.45 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.494 -178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 40.4 mt-10 -94.25 127.6 40.21 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.787 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 83.8 m -132.19 121.46 23.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -101.69 -153.02 25.48 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.535 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.423 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . 76.7 Cg_exo -49.94 -36.34 43.51 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.644 2.229 . . . . 0.0 112.381 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 118.21 32.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.531 ' HB3' ' CD ' ' A' ' 99' ' ' PRO . 1.6 t80 -135.93 -67.35 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.22 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 55.6 Cg_endo -69.37 0.92 4.66 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.439 1.426 . . . . 0.0 112.5 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -107.41 -20.59 13.21 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.313 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.25 161.03 28.35 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.838 0.351 . . . . 0.0 111.469 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.58 119.17 6.21 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.659 2.239 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.488 ' HG3' ' CD1' ' A' ' 98' ' ' TYR . 31.9 Cg_endo -86.49 -123.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.873 2.382 . . . . 0.0 111.675 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.419 ' H ' ' HB2' ' A' ' 103' ' ' PRO . 12.4 t80 -145.93 129.49 16.99 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.677 0.275 . . . . 0.0 110.693 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 92' ' ' ILE . 24.2 t -135.36 140.55 44.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.631 ' HA ' HG23 ' A' ' 123' ' ' VAL . 32.1 ptt85 -150.3 122.51 8.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.167 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.912 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.2 m-85 -60.03 141.21 56.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.446 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 90' ' ' LEU . 38.9 t -96.27 -44.05 12.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.087 0.47 . . . . 0.0 110.327 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 88' ' ' TYR . 7.2 t -68.22 -175.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.074 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -91.25 86.97 6.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.977 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.912 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -119.46 151.47 21.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.481 -178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -126.07 102.33 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.649 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 147' ' ' LEU . 27.9 ttm -124.45 143.97 50.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.022 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.36 -25.75 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -111.58 15.3 27.04 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HG13 ' A' ' 123' ' ' VAL . 86.9 t -137.74 127.69 36.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.886 0.374 . . . . 0.0 110.797 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -59.7 165.89 2.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.055 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.42 ' O ' ' CZ ' ' A' ' 168' ' ' TYR . 15.6 m -106.22 -16.86 14.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.198 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.1 m -77.39 -61.45 1.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.62 -38.04 6.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.0 110.0 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 116' ' ' VAL . . . 107.7 21.18 8.01 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.56 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.09 111.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 116' ' ' VAL . 3.3 t -77.49 100.91 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.3 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 0.9 OUTLIER -64.74 119.75 60.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.143 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.421 ' CB ' HD23 ' A' ' 131' ' ' LEU . 27.3 Cg_exo -62.01 -14.99 40.59 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.505 2.137 . . . . 0.0 112.638 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.8 -28.83 63.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.742 0.306 . . . . 0.0 111.204 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.684 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -95.38 -28.22 15.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.256 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 123' ' ' VAL . 34.9 mm -77.18 128.28 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.154 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.4 m -67.52 -60.03 2.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.356 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 146' ' ' GLU . 16.9 m -49.98 -32.53 8.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.553 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.421 HD23 ' CB ' ' A' ' 125' ' ' PRO . 1.1 tp -83.67 -43.01 16.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.617 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.9 -31.18 59.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.5 54.79 1.9 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.515 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -47.85 158.09 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.545 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -142.64 178.12 7.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.37 -30.57 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.017 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.8 p -79.31 -9.82 59.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.395 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -73.3 155.15 39.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.907 0.384 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.6 m -156.17 -176.52 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.575 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.482 ' CD1' ' CD2' ' A' ' 71' ' ' TRP . 61.3 mt -58.5 -41.57 82.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 pttt -62.36 -36.62 82.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 0.0 110.273 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.47 -37.94 78.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.436 0.636 . . . . 0.0 109.59 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.65 -53.34 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.941 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.492 HD12 ' CE3' ' A' ' 58' ' ' TRP . 21.9 mt -61.5 -46.02 91.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.689 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -58.02 -30.04 65.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.071 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.613 ' HG2' HG22 ' A' ' 130' ' ' VAL . 16.6 tp10 -72.83 -48.54 36.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.01 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.898 ' HA ' HD12 ' A' ' 150' ' ' LEU . 8.9 mt -54.74 -45.94 74.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.804 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 149' ' ' ARG . 0.4 OUTLIER -62.69 -38.88 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.819 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.416 ' N ' ' HG3' ' A' ' 148' ' ' ARG . 5.7 ttm180 -61.62 -43.99 97.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.051 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 147' ' ' LEU . 2.3 mt -62.02 -41.88 98.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.171 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.417 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 12.0 mtm -62.04 -27.66 69.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.771 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 5.2 mtm -75.95 -16.9 59.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.075 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.95 154.52 37.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.852 0.358 . . . . 0.0 110.853 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 0.0 OUTLIER -60.53 -43.25 97.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.166 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.12 -32.9 73.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.909 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 44.6 m-80 -86.76 -36.66 18.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 6.9 ptm -78.92 48.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.005 0.431 . . . . 0.0 110.987 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -146.6 -39.57 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.316 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 16.9 mt -52.3 148.16 12.37 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.497 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.95 121.95 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.258 1.972 . . . . 0.0 112.659 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' A' ' 82' ' ' ILE . 87.4 mm-40 -87.54 122.59 70.48 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.046 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.48 136.42 63.7 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.221 1.947 . . . . 0.0 111.864 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.623 ' O ' ' CB ' ' A' ' 164' ' ' GLU . 55.7 Cg_endo -70.09 97.28 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.42 2.08 . . . . 0.0 112.666 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.623 ' CB ' ' O ' ' A' ' 163' ' ' PRO . 8.7 tt0 114.99 155.41 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.714 0.806 . . . . 0.0 110.889 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.04 35.12 4.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.304 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -69.33 158.48 34.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.956 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 35.5 m -75.81 -179.36 4.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.524 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.421 ' CE2' ' O ' ' A' ' 109' ' ' THR . 0.4 OUTLIER -90.4 131.54 36.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.868 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 3.6 t 60.19 77.59 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.865 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.576 0.227 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.39 126.94 11.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.447 2.098 . . . . 0.0 112.308 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 90.13 93.65 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.586 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 62.05 114.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.92 -15.44 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.51 104.98 0.05 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.43 -28.24 9.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.185 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t 68.16 -70.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -177.51 -61.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.6 pp -89.08 178.33 6.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -134.13 174.58 10.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.97 92.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.191 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' CB ' ' A' ' 14' ' ' SER . 1.1 pt20 -119.22 -3.01 10.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.39 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER 85.44 -25.6 0.11 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.643 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.97 108.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.13 91.75 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.7 m -158.57 175.19 13.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.898 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.27 138.5 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -128.98 126.49 39.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.87 -68.14 0.16 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -147.83 110.05 4.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.1 mt -130.31 177.14 7.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.816 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -148.17 101.02 3.6 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.45 -168.16 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.525 2.15 . . . . 0.0 112.268 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.09 116.06 28.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 tttm -167.14 -48.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -83.75 122.83 29.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.54 -169.15 3.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 94.7 m -108.77 163.59 13.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -91.22 -65.8 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 76.73 132.14 0.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.574 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.42 -23.57 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp 65.24 93.62 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.949 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 38' ' ' PHE . 21.6 t -150.59 131.13 7.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.77 159.67 8.69 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.471 2.114 . . . . 0.0 112.381 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -62.97 -37.98 89.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 4.6 m120 -66.54 -41.92 87.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.613 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 41' ' ' LEU . 11.1 m-85 -60.11 -44.57 94.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.716 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 13.2 mmm-85 -58.57 -43.41 89.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.765 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 41.3 mt -61.29 -39.38 90.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.986 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.593 HD23 HD21 ' A' ' 68' ' ' LEU . 6.6 mt -72.11 -52.66 15.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -42.19 99.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.919 0.39 . . . . 0.0 110.513 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 39' ' ' ARG . 9.3 mm-40 -69.02 -29.4 67.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.491 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 55.7 tp -61.77 -47.24 86.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.981 0.419 . . . . 0.0 110.36 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -63.27 -41.42 99.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.59 -48.82 78.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' HA3' ' NE1' ' A' ' 58' ' ' TRP . . . -63.93 -50.86 58.02 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.338 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -58.12 -47.97 81.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.794 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -62.55 -26.54 68.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.794 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.41 163.41 24.49 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.403 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 ' HA2' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -112.74 -177.19 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.12 -68.98 1.35 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.047 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -84.52 -3.91 58.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 53.21 35.53 50.01 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.373 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.0 p -71.37 -15.66 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.648 0.261 . . . . 0.0 111.603 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 HG12 ' A' ' 75' ' ' ILE . 33.9 m -154.13 175.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.386 . . . . 0.0 111.115 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 m -161.38 110.41 1.57 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.538 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.45 ' HB2' HG21 ' A' ' 140' ' ' ILE . 27.6 p90 -98.96 132.12 44.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.692 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -130.82 175.31 19.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.122 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 68' ' ' LEU . 1.1 mt -85.39 14.41 5.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.217 -0.491 . . . . 0.0 112.03 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 66.97 -68.55 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.754 0.311 . . . . 0.0 111.081 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.481 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 3.2 t0 -101.66 -47.22 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.981 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 14.8 m-20 93.03 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.911 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.33 30.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.301 0.572 . . . . 0.0 109.495 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.68 -164.44 0.97 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.307 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mtt -116.03 124.41 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.001 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 p 57.88 21.85 8.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER 51.28 59.73 4.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.145 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -81.47 -57.09 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.98 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.94 135.9 45.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.782 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.736 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 75.0 m95 -135.31 171.72 14.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 0.0 111.354 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -137.6 165.71 25.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.346 179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -157.39 110.41 0.44 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.503 -1.332 . . . . 0.0 114.074 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 mtp -90.09 153.09 20.81 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.502 HD11 HD22 ' A' ' 144' ' ' LEU . 29.8 mt -151.71 139.22 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.574 -0.451 . . . . 0.0 112.1 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.5 mt -114.35 149.13 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.29 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.75 138.79 14.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.955 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.29 146.88 25.38 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.599 2.199 . . . . 0.0 112.12 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 13.2 Cg_endo -56.22 147.62 65.03 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.833 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 79' ' ' PRO . 0.0 OUTLIER 77.35 44.75 0.09 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.481 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 80' ' ' ARG . 76.7 p -161.87 152.94 18.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.315 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 161' ' ' GLN . 0.1 OUTLIER -52.71 -37.02 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.083 0.468 . . . . 0.0 110.572 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 82.0 m-85 -81.84 -14.04 56.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.042 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.649 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.4 pt-20 -46.85 140.3 4.79 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.208 0.528 . . . . 0.0 112.191 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.1 m120 45.96 42.2 9.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.012 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 13.7 mmt-85 -139.72 86.17 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.773 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 88' ' ' TYR . 4.1 mp -47.25 164.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.569 ' N ' HG22 ' A' ' 87' ' ' ILE . 43.5 m-85 -154.34 128.02 8.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.938 0.399 . . . . 0.0 111.242 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 m -92.87 154.66 18.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.467 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 75' ' ' ILE . 4.1 mp -152.38 160.63 43.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 72' ' ' THR . 0.0 OUTLIER -136.65 116.03 12.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.73 -179.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mp -106.6 149.01 10.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.684 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.7 134.83 39.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 110.904 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 98' ' ' TYR . 1.4 p -120.23 -178.33 3.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.175 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.39 -157.71 8.21 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.337 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.51 -25.29 14.07 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.618 2.212 . . . . 0.0 112.604 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.56 95.63 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.861 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 2.3 t80 -97.19 -65.11 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.59 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 98' ' ' TYR . 42.8 Cg_endo -67.44 -1.68 6.95 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.655 1.57 . . . . 0.0 112.651 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -109.51 -6.06 15.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.363 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.03 157.95 33.98 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.884 0.373 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.69 125.98 20.85 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.678 2.252 . . . . 0.0 112.074 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 90.9 Cg_endo -81.55 163.69 18.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.553 2.169 . . . . 0.0 112.708 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -95.22 90.26 5.8 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.554 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG21 ' CG1' ' A' ' 143' ' ' VAL . 24.8 t -93.85 138.71 19.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.246 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -150.2 125.21 9.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.894 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 1.111 ' CD2' HG21 ' A' ' 111' ' ' ILE . 3.4 m-85 -70.52 153.66 42.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.5 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.19 -40.63 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.28 0.562 . . . . 0.0 110.049 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 89' ' ' SER . 6.5 t -68.31 -176.39 0.74 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.216 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 166' ' ' GLN . 50.5 mmtt -87.68 94.62 9.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.779 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.111 HG21 ' CD2' ' A' ' 107' ' ' PHE . 1.2 tt -130.68 145.69 35.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.865 -178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -126.37 102.32 7.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.89 157.39 36.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.009 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -54.5 -58.89 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.238 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -79.77 -16.7 76.8 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.155 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.782 HG22 HG13 ' A' ' 123' ' ' VAL . 62.8 t -94.92 136.61 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.925 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.91 179.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.8 m -133.09 34.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.986 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -152.57 -47.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' CG ' HG23 ' A' ' 122' ' ' VAL . 7.5 p30 -105.39 -37.25 6.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.125 0.488 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.31 2.36 41.29 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.011 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.462 HG23 ' CG ' ' A' ' 120' ' ' ASN . 30.8 t -58.89 110.94 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.782 HG13 HG22 ' A' ' 116' ' ' VAL . 3.7 t -76.94 112.77 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.408 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -64.19 110.91 4.45 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.489 ' HB3' HD23 ' A' ' 131' ' ' LEU . 32.4 Cg_exo -58.25 -18.53 37.97 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.496 2.131 . . . . 0.0 112.403 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -47.82 52.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.7 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.604 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -67.91 -42.7 80.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.479 ' CG2' HG12 ' A' ' 130' ' ' VAL . 44.1 mm -69.01 123.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.706 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.5 t -66.06 -55.86 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.457 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG12 ' CG2' ' A' ' 128' ' ' ILE . 8.6 p -49.97 -32.71 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.479 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.489 HD23 ' HB3' ' A' ' 125' ' ' PRO . 2.2 mp -84.49 -49.51 8.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.769 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.19 -24.52 18.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.306 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -134.81 43.87 2.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.912 0.387 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -49.55 148.64 2.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.132 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 138' ' ' TYR . 1.5 mt-30 -130.54 -171.93 2.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 37.8 t30 -104.25 58.0 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.645 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 11.9 t -160.52 -27.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.716 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.468 ' CD1' HG11 ' A' ' 142' ' ' VAL . 22.6 m-85 -70.78 172.03 9.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.465 . . . . 0.0 111.404 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.2 m -156.07 -176.42 5.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.368 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.597 HD13 ' CE3' ' A' ' 71' ' ' TRP . 33.4 mt -53.87 -44.43 60.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.247 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB3' ' CH2' ' A' ' 58' ' ' TRP . 21.8 pttt -58.57 -37.48 75.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.848 0.356 . . . . 0.0 110.445 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 138' ' ' TYR . 41.3 t -68.36 -39.23 80.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.339 0.59 . . . . 0.0 109.627 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.482 ' CG1' HG21 ' A' ' 105' ' ' VAL . 18.1 t -61.82 -53.39 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.835 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 75' ' ' ILE . 20.9 mt -61.4 -43.78 98.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.64 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -57.89 -40.21 79.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.749 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -53.04 62.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.65 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.9 HD13 ' CZ ' ' A' ' 107' ' ' PHE . 16.2 mt -50.56 -46.21 57.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.119 0.485 . . . . 0.0 110.658 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp-105 -62.15 -34.4 76.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.941 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -61.44 -43.04 99.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.958 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.869 HD12 ' HA ' ' A' ' 147' ' ' LEU . 3.6 mt -63.56 -44.75 93.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.437 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 15.1 mtt -58.32 -29.77 66.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.928 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.6 mtm -76.9 -15.95 59.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 74.3 m -64.94 141.23 58.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.791 0.329 . . . . 0.0 110.804 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.452 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 10.8 tptt -51.28 -53.24 37.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.07 -23.1 65.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.747 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.12 -25.91 23.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.722 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.452 ' HG2' ' HA ' ' A' ' 154' ' ' LYS . 14.5 ptm -86.64 19.23 2.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 111.089 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.86 -30.72 3.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.282 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.8 mt -54.72 144.23 46.39 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.554 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.38 150.3 68.56 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.238 1.958 . . . . 0.0 112.04 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.53 ' HG3' HG23 ' A' ' 82' ' ' ILE . 25.0 mm-40 -146.49 116.59 4.65 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.763 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 80.9 Cg_exo -50.29 129.19 25.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.509 2.139 . . . . 0.0 112.141 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 23.9 Cg_exo -64.1 65.04 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.725 2.284 . . . . 0.0 112.812 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.0 OUTLIER 166.88 143.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.24 38.81 2.98 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.137 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 110' ' ' LYS . 28.2 pt20 -69.53 158.57 34.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 51.8 m -77.39 176.27 9.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.615 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -92.41 127.89 38.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -102.96 -45.52 4.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.986 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.719 0.295 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.23 142.46 45.94 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.655 2.237 . . . . 0.0 112.311 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.53 172.17 39.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.497 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -108.33 -175.08 2.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.892 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.39 82.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.17 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.2 OUTLIER -160.48 105.69 1.47 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.746 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 6' ' ' GLN . . . 84.04 -41.88 0.08 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.546 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.1 t 65.93 149.43 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -136.89 -178.37 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.98 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.27 31.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 118.9 34.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.987 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.55 -47.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.81 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -80.54 -61.21 2.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.3 m 68.3 -69.01 0.16 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 78.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -173.04 177.86 2.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.6 t -158.81 101.08 1.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -123.63 118.83 28.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 153.03 35.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.57 -102.71 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.503 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 60.66 165.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.826 0.346 . . . . 0.0 110.91 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.63 156.2 47.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -65.41 143.91 98.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.777 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.49 117.0 4.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.531 2.154 . . . . 0.0 112.384 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -140.73 -174.86 4.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.09 -44.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -69.18 132.82 47.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -141.88 -67.26 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.823 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.453 ' HB2' HG22 ' A' ' 32' ' ' VAL . 85.5 m -114.93 141.2 48.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.72 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -68.11 107.55 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' CA ' HG12 ' A' ' 34' ' ' VAL . . . 107.34 -92.02 0.74 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.666 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 29' ' ' CYS . 16.0 t 70.15 -65.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.731 0.3 . . . . 0.0 111.254 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.67 16.02 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.405 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG12 ' CA ' ' A' ' 31' ' ' GLY . 13.8 p -80.67 131.52 60.66 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.012 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -59.59 155.88 39.93 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.394 2.063 . . . . 0.0 112.046 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 37' ' ' ASN . 2.7 ppt_? -62.32 -41.95 98.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.237 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.412 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 1.7 t30 -60.57 -32.78 71.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.744 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' HG2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -55.41 -54.58 41.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 6.0 mmt180 -57.68 -38.73 75.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.019 0.438 . . . . 0.0 110.083 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 98' ' ' TYR . 69.9 mt -61.86 -52.26 64.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.666 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.23 -50.49 70.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -61.67 -46.36 90.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.968 0.413 . . . . 0.0 110.601 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 97.4 mt-10 -70.56 -29.33 65.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.399 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 54.5 tp -62.12 -35.21 78.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.358 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 -34.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.2 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.17 -34.28 70.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.511 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.493 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -85.02 -34.39 15.09 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.41 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -51.98 -43.77 63.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.872 0.368 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -62.47 -29.45 70.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.505 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 51' ' ' VAL . . . 87.77 35.13 9.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.613 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 50' ' ' GLY . 0.1 OUTLIER 40.41 -170.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 179.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.13 -83.35 0.25 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.734 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.96 -23.84 48.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.734 0.302 . . . . 0.0 111.306 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 73.73 32.35 59.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.479 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 p -72.52 -13.31 61.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 75' ' ' ILE . 25.0 m -154.77 171.26 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.747 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -161.76 111.02 1.53 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CE2' ' CA ' ' A' ' 47' ' ' GLY . 34.7 p90 -103.86 130.08 51.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.309 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -142.35 -139.05 3.55 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.066 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.733 HD11 HD23 ' A' ' 68' ' ' LEU . 7.7 mt -125.17 145.68 49.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -66.01 -31.68 72.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 2.0 t70 -105.95 -54.99 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 62' ' ' ASP . 4.0 t70 96.48 -1.17 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.31 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -158.02 29.61 0.26 Allowed 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.12 174.89 8.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.2 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.18 13.74 33.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.3 p -155.21 115.67 3.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.751 0.31 . . . . 0.0 110.788 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.733 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -83.24 58.86 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.748 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 94' ' ' CYS . 0.2 OUTLIER -91.88 -66.5 0.92 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.87 98.5 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.791 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.596 ' CE3' HD13 ' A' ' 140' ' ' ILE . 62.0 m95 -88.78 152.09 21.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.238 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 147.39 26.58 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -140.31 99.53 0.25 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.996 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtp -92.45 149.29 21.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' A' ' 147' ' ' LEU . 44.6 mt -150.85 144.99 16.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 111.607 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.5 mt -120.11 149.23 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.4 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.14 123.26 7.42 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.023 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 79' ' ' PRO . 20.6 Cg_exo -65.47 142.28 71.18 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.488 2.125 . . . . 0.0 111.996 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.691 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 42.6 Cg_exo -57.07 146.14 82.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.699 2.266 . . . . 0.0 112.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 81' ' ' THR . 7.3 mtt180 81.61 42.46 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.825 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 80' ' ' ARG . 15.7 p -162.52 155.83 20.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.863 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -51.23 -40.63 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.937 179.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 67.2 m-85 -79.43 -18.0 53.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.841 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 2.6 pt-20 -41.28 143.87 0.39 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.279 0.561 . . . . 0.0 112.474 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.5 t30 45.65 54.35 7.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.822 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 4.8 mmt85 -152.72 107.27 3.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.492 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.1 mp -67.16 165.38 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.481 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' N ' HG22 ' A' ' 87' ' ' ILE . 27.5 m-85 -150.75 130.72 13.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.983 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.526 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 28.2 t -93.12 148.28 22.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.141 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.907 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.1 mp -152.27 160.02 43.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.046 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 1.8 mtmt -143.56 117.23 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.774 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.28 127.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.192 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.99 117.14 29.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.617 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' O ' HG23 ' A' ' 69' ' ' THR . 15.7 m -126.3 159.46 33.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.848 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.63 -126.53 0.82 Allowed Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.544 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.02 -74.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.378 2.052 . . . . 0.0 112.401 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.91 69.46 10.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.892 0.377 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.562 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.2 t80 -90.26 -64.5 0.18 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.042 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 72.9 Cg_endo -74.98 3.99 5.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.391 1.394 . . . . 0.0 112.307 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -113.13 -11.02 13.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.757 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -153.53 146.81 18.0 Favored Pre-proline 0 N--CA 1.455 -0.179 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.4 110.17 0.57 Allowed 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 122.825 2.35 . . . . 0.0 112.188 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HG3' ' CE1' ' A' ' 98' ' ' TYR . 45.7 Cg_endo -67.89 -176.2 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.328 2.019 . . . . 0.0 112.055 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.433 ' CZ ' HG13 ' A' ' 122' ' ' VAL . 46.1 t80 -94.93 95.37 8.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.127 0.489 . . . . 0.0 111.082 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 92' ' ' ILE . 48.1 t -95.42 138.15 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.645 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' VAL . 3.2 ptt-85 -150.2 138.31 20.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.984 ' CD2' HG21 ' A' ' 111' ' ' ILE . 14.3 m-85 -83.85 137.98 33.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.879 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 167' ' ' CYS . 19.0 t -93.63 -39.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.224 0.535 . . . . 0.0 109.867 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.0 t -69.09 -176.36 0.88 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.924 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -94.11 82.8 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.984 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -112.57 149.09 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.53 -179.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -126.23 102.95 7.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.715 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.525 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 5.9 ttm -124.37 155.39 38.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.953 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -54.54 -52.88 60.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.18 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.715 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -86.21 -14.47 66.48 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.037 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 123' ' ' VAL . 48.6 t -98.95 132.21 44.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.93 0.395 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.15 167.84 2.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 72.7 m -123.68 31.05 6.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.2 p -142.69 -47.86 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -104.69 -37.16 7.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.131 0.491 . . . . 0.0 110.119 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.41 0.32 43.61 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.998 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 21.5 t -58.92 112.41 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.929 HG13 HG22 ' A' ' 116' ' ' VAL . 8.8 t -77.21 111.93 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.685 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -65.79 125.2 89.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 -15.85 24.62 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.421 2.08 . . . . 0.0 112.516 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -72.43 -42.46 65.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.938 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.715 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -77.6 -46.73 21.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.038 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.406 ' CG2' ' CG2' ' A' ' 130' ' ' VAL . 21.3 mm -62.46 132.29 28.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 89.3 p -67.36 -56.0 11.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.408 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 146' ' ' GLU . 3.2 m -49.93 -36.26 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.618 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 130' ' ' VAL . 6.6 mp -80.71 -43.71 19.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.652 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -56.28 -30.74 62.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.939 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -139.08 55.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 61.9 t-105 -49.67 157.87 0.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.293 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HG3' ' CE1' ' A' ' 138' ' ' TYR . 9.0 mm100 -131.32 -166.65 1.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.985 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.34 -40.42 9.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.8 t -79.3 -3.89 48.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.394 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.46 ' HA ' HG21 ' A' ' 142' ' ' VAL . 5.2 m-30 -72.46 151.8 42.33 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.845 0.355 . . . . 0.0 111.045 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.5 p -156.34 -176.5 6.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.617 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.596 HD13 ' CE3' ' A' ' 71' ' ' TRP . 2.7 mp -53.12 -29.96 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.28 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 58' ' ' TRP . 8.6 pttt -71.04 -40.27 71.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.846 0.355 . . . . 0.0 110.493 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 138' ' ' TYR . 66.4 t -68.88 -35.53 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.503 0.668 . . . . 0.0 109.453 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.518 HG11 HG21 ' A' ' 105' ' ' VAL . 40.4 t -67.85 -52.81 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.002 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.636 HD22 HD11 ' A' ' 75' ' ' ILE . 22.4 mt -62.72 -47.75 82.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.916 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -60.32 -48.86 79.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.529 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.585 ' HG2' HG13 ' A' ' 130' ' ' VAL . 7.3 tp10 -59.98 -53.23 60.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.826 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.837 HD11 ' CD1' ' A' ' 75' ' ' ILE . 4.3 pp -60.63 -41.05 94.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.952 0.405 . . . . 0.0 110.301 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.799 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -66.68 -31.63 72.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.061 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -59.37 -44.6 92.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.382 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.766 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -63.37 -46.81 84.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.228 179.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.425 ' HG2' ' CZ ' ' A' ' 83' ' ' TYR . 11.7 mtp -48.67 -39.11 23.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttp -77.33 -27.68 52.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.407 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 157' ' ' MET . 0.2 OUTLIER -65.8 147.97 52.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.894 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.499 ' HA ' ' CG ' ' A' ' 157' ' ' MET . 1.7 mmmp? -51.16 -25.58 5.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.58 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -54.86 36.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.012 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 12.8 m-80 -88.2 -30.96 19.34 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.503 ' SD ' HG22 ' A' ' 81' ' ' THR . 2.7 ptm -72.91 52.75 0.32 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.112 0.482 . . . . 0.0 111.297 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.15 -42.68 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.024 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 78.2 mt -53.79 150.55 13.66 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.595 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.93 126.0 14.55 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.373 2.049 . . . . 0.0 112.43 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 162' ' ' PRO . 35.8 mm-40 -84.38 120.4 74.33 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.224 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 161' ' ' GLN . 19.9 Cg_exo -64.65 164.85 22.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.259 1.973 . . . . 0.0 111.896 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.57 89.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.375 2.05 . . . . 0.0 112.019 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.62 151.65 0.55 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.367 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 111.05 -67.91 0.22 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.403 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -70.24 132.31 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.5 m -77.3 -167.48 0.92 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 109' ' ' THR . 1.2 m-85 -86.23 120.56 27.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.783 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -81.83 -59.24 2.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.864 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.598 0.237 . . . . 0.0 111.497 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 1' ' ' MET . 92.8 Cg_endo -81.34 -40.98 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.556 2.171 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 121.95 -67.85 0.45 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.381 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.58 141.94 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.876 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.5 p -109.32 59.18 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.02 -49.08 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 56.59 22.36 6.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.415 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -175.93 133.06 0.26 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 2.2 p90 -128.97 -54.25 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.8 mt -163.69 148.63 10.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.799 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -108.23 102.01 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.746 ' HB2' HD23 ' A' ' 16' ' ' LEU . 49.6 m -93.09 134.62 35.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.8 -22.96 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.2 t -105.1 91.47 3.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 0.0 111.04 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.18 160.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.045 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.58 123.28 11.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.447 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -151.46 170.47 19.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.96 99.56 3.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -125.35 153.64 43.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -165.98 -123.55 0.66 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -117.47 41.34 2.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.84 -54.53 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -110.34 98.36 35.61 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.926 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.55 -25.88 61.18 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.585 2.19 . . . . 0.0 112.341 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.53 147.36 22.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.973 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -146.57 -58.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.78 91.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -114.86 120.92 41.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.6 t -155.49 130.92 9.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -119.12 125.89 50.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -149.77 27.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.56 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.61 107.24 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -86.52 -38.38 17.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.3 p -80.22 139.48 52.52 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.457 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 52.1 Cg_exo -54.43 126.73 23.25 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.459 2.106 . . . . 0.0 112.199 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -38.67 84.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.409 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 9.7 p-10 -65.77 -36.4 83.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 35' ' ' PRO . 4.0 m-85 -55.32 -53.86 50.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.716 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 8.1 tpp180 -57.51 -42.89 83.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.09 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 73.5 mt -59.44 -40.81 88.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.982 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 90.1 mt -72.22 -52.72 15.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.641 0.258 . . . . 0.0 111.366 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -61.76 -36.87 82.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.013 0.435 . . . . 0.0 110.18 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 32.4 mt-10 -76.56 -28.91 56.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.219 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 56.0 tp -62.29 -35.08 77.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.137 0.494 . . . . 0.0 110.033 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -41.8 45.44 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.371 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -38.39 76.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.918 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -71.66 -58.29 5.45 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.693 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -58.0 -36.02 72.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.0 111.071 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -76.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.951 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -177.68 168.21 39.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.617 HG11 ' CH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -153.43 -176.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 111.166 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.05 97.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.682 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 61.61 22.18 12.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.718 0.294 . . . . 0.0 111.274 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' HG23 ' A' ' 51' ' ' VAL . . . 50.4 46.95 44.76 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.698 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.5 p -72.11 -19.8 61.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.676 0.274 . . . . 0.0 111.297 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 75' ' ' ILE . 34.1 m -154.41 175.76 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 110.955 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.91 110.65 1.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.463 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.617 ' CH2' HG11 ' A' ' 51' ' ' VAL . 28.6 p90 -100.12 87.45 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -103.39 -143.49 12.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.767 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.655 HD11 ' CD2' ' A' ' 68' ' ' LEU . 6.0 mt -120.4 140.65 51.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.775 0.322 . . . . 0.0 111.024 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -63.88 -56.39 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -93.59 -114.43 0.1 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.656 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -176.19 20.49 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.659 0.266 . . . . 0.0 111.543 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -157.35 -49.86 0.07 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 42.82 -166.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.772 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.3 mtm -115.04 -34.73 4.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.0 p -154.49 26.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.989 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.655 ' CD2' HD11 ' A' ' 60' ' ' LEU . 1.0 OUTLIER 53.13 40.82 31.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -51.86 12.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.808 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -78.86 95.97 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.713 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.575 ' O ' ' HA ' ' A' ' 91' ' ' LYS . 40.8 m95 -89.06 165.36 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.29 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 m -127.08 118.5 24.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.617 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -114.64 119.12 4.57 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.662 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 mtp -93.73 154.39 17.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.824 HD13 HD11 ' A' ' 147' ' ' LEU . 30.4 mt -152.27 138.06 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.846 0.355 . . . . 0.0 111.761 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 17.9 mt -116.79 149.16 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.415 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 83' ' ' TYR . . . -94.83 146.8 18.34 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.771 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.11 141.18 11.56 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.827 2.351 . . . . 0.0 112.25 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.592 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 58.0 Cg_exo -51.81 141.77 43.99 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.546 2.164 . . . . 0.0 112.798 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' O ' ' CG2' ' A' ' 81' ' ' THR . 0.0 OUTLIER 79.06 41.18 0.09 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.529 179.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.428 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 43.4 p -159.68 152.42 21.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -47.77 -39.14 7.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.971 0.415 . . . . 0.0 111.316 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE1' ' CE ' ' A' ' 151' ' ' MET . 89.9 m-85 -78.8 -22.61 46.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.909 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 0.9 OUTLIER -41.52 135.25 2.15 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.116 0.484 . . . . 0.0 112.168 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 56.22 20.48 4.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.925 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -120.13 105.45 11.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.797 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 88' ' ' TYR . 47.1 mt -70.65 165.05 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.604 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 35.6 m-85 -150.25 130.22 13.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.02 0.438 . . . . 0.0 111.197 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 30.9 t -93.76 151.29 19.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.021 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.4 mp -151.29 160.31 43.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.361 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 9.0 ttmt -139.01 114.51 9.77 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.281 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.557 HG23 HG22 ' A' ' 105' ' ' VAL . 4.6 mp -106.42 120.5 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.355 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 104' ' ' PHE . 18.9 mt-10 -94.25 122.23 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.801 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.72 -169.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.006 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.98 -153.42 15.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.01 -63.92 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.594 2.196 . . . . 0.0 112.304 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -96.65 74.22 2.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.587 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.66 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.7 t80 -96.71 -52.8 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.526 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 2.3 Cg_endo -80.25 3.95 7.22 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.776 1.651 . . . . 0.0 112.224 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -114.5 -18.57 11.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.14 73.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HB3' HD13 ' A' ' 131' ' ' LEU . 48.2 Cg_exo -55.88 124.43 16.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.578 2.185 . . . . 0.0 112.325 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 89.0 Cg_endo -77.91 167.83 23.09 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.64 2.227 . . . . 0.0 112.223 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' HB3' ' HB2' ' A' ' 93' ' ' GLU . 87.3 t80 -96.45 89.23 4.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.239 0.543 . . . . 0.0 110.351 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.622 HG21 HG11 ' A' ' 143' ' ' VAL . 38.3 t -93.56 141.15 15.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.051 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -150.25 128.84 12.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.091 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 1.067 ' CD2' HG21 ' A' ' 111' ' ' ILE . 8.4 m-85 -75.23 123.15 24.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.492 HG22 ' HE3' ' A' ' 91' ' ' LYS . 20.7 t -75.72 -40.74 40.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.337 0.589 . . . . 0.0 109.499 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.415 ' O ' ' CE2' ' A' ' 168' ' ' TYR . 7.4 t -69.75 -177.13 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.864 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 168' ' ' TYR . 14.0 mttt -97.99 97.16 8.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.756 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.067 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -126.55 151.14 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.835 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.427 ' N ' HD13 ' A' ' 111' ' ' ILE . 21.4 t-20 -126.21 102.77 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.629 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.541 ' HE1' ' O ' ' A' ' 147' ' ' LEU . 31.3 ttm -124.42 153.08 42.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.957 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -52.53 -26.16 12.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.243 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -123.15 22.49 7.11 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.041 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 123' ' ' VAL . 57.6 t -136.09 126.54 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 110.661 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 138.01 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.049 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.4 t -101.89 54.39 0.81 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.76 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.2 p -176.79 -39.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -102.81 -34.47 8.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.12 0.486 . . . . 0.0 109.974 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.96 64.75 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.983 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 36.3 t -58.77 115.22 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.877 0.37 . . . . 0.0 110.745 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 116' ' ' VAL . 15.0 t -77.51 115.18 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.753 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.8 OUTLIER -65.13 113.2 10.3 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.531 179.289 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.403 ' CB ' ' HB3' ' A' ' 131' ' ' LEU . 36.6 Cg_endo -65.21 -12.3 34.15 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.369 2.046 . . . . 0.0 112.52 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.23 -49.95 31.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -69.97 -51.71 30.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 131' ' ' LEU . 31.7 mm -57.81 132.23 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.795 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -60.33 2.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.202 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 146' ' ' GLU . 10.4 m -49.99 -30.15 6.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.717 0.294 . . . . 0.0 111.739 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.541 ' CD2' HG23 ' A' ' 130' ' ' VAL . 4.0 mm? -83.85 -47.63 10.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.938 0.399 . . . . 0.0 110.805 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -54.6 -31.65 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.474 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -135.83 42.46 2.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -50.55 117.46 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 111.226 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.446 ' NE2' ' CZ ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -99.9 -176.79 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 3.9 m-20 -92.03 56.07 2.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.9 p -159.45 -18.09 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.792 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.2 m-85 -71.85 169.84 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.08 0.467 . . . . 0.0 111.416 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.74 -176.38 5.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.475 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.511 HD13 ' CE3' ' A' ' 71' ' ' TRP . 66.8 mt -56.22 -47.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 111.32 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.466 ' CB ' ' CH2' ' A' ' 58' ' ' TRP . 11.5 ptpt -60.69 -34.86 74.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.768 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.792 HG11 ' CD1' ' A' ' 138' ' ' TYR . 21.4 t -68.54 -37.62 77.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.452 0.644 . . . . 0.0 109.392 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 105' ' ' VAL . 36.6 t -63.58 -52.88 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.843 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.56 HD22 HD11 ' A' ' 75' ' ' ILE . 21.1 mt -62.55 -48.75 78.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.698 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -60.36 -46.08 91.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.565 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HG2' HG22 ' A' ' 130' ' ' VAL . 9.1 tp10 -61.09 -53.47 56.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.735 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.824 HD11 HD13 ' A' ' 75' ' ' ILE . 3.5 pp -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 110.108 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 147' ' ' LEU . 73.4 ttt-85 -65.13 -33.42 75.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.741 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -43.68 90.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.961 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 147' ' ' LEU . 1.1 mt -66.3 -38.19 87.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.106 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.453 ' CE ' ' CE1' ' A' ' 83' ' ' TYR . 8.7 mtt -54.97 -35.57 64.44 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.729 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 53.2 mtm -75.74 -12.55 60.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.226 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.7 158.85 26.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.839 0.352 . . . . 0.0 111.051 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 2.6 mtpp -59.13 -44.07 92.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.19 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -61.38 -33.25 73.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.757 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 151' ' ' MET . 0.8 OUTLIER -87.81 -39.2 15.07 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.547 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -72.44 1.5 7.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 111.574 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -111.91 -32.42 6.61 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.941 0.401 . . . . 0.0 110.154 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 22.5 mt -55.81 147.19 43.57 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.839 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.13 141.13 75.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.383 2.055 . . . . 0.0 111.811 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -146.57 117.66 4.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.862 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.59 164.46 4.26 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.464 2.109 . . . . 0.0 112.249 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.29 134.1 26.1 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.573 2.182 . . . . 0.0 112.255 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -47.04 162.37 0.05 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.307 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 111.08 -55.63 0.49 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.475 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -69.75 158.51 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.3 m -160.74 148.2 15.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.679 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 109' ' ' THR . 23.1 m-85 -57.62 109.14 0.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.912 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 7.0 p 62.89 142.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.927 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.79 0.328 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.78 -46.0 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.558 2.172 . . . . 0.0 112.299 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.43 89.36 0.16 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 159.93 41.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 6' ' ' GLN . 21.5 t -149.65 156.49 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.44 ' N ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 61.59 116.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.942 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -112.95 -71.6 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.032 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.4 p -138.46 17.47 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.214 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.61 -71.89 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.123 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.19 175.8 10.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.037 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 160.25 12.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.72 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 -74.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -65.86 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.7 t 62.44 49.85 3.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm 60.8 68.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.6 -34.22 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.4 p -62.26 154.32 27.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.947 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.15 123.08 49.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.0 110.3 6.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.853 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.81 62.54 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.65 142.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.4 tp -110.78 -67.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.06 148.27 18.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.64 117.2 3.58 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.307 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -82.89 112.94 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 ttmm -134.17 33.5 3.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -150.94 80.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -137.04 84.17 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -166.04 178.51 6.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -138.4 98.12 3.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.33 154.22 25.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.572 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.53 165.97 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 111.143 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -111.05 101.01 9.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.818 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 34' ' ' VAL . 8.6 m -150.65 105.2 3.07 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.03 161.71 43.09 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.416 2.077 . . . . 0.0 112.409 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.473 ' HD3' ' N ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -54.48 -34.47 61.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.034 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.473 ' N ' ' HD3' ' A' ' 36' ' ' ARG . 34.7 m120 -68.27 -36.97 80.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.27 -57.62 11.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.013 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -57.6 -43.29 84.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.555 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.715 HD22 ' CZ2' ' A' ' 71' ' ' TRP . 53.7 mt -62.8 -38.3 90.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.131 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 37' ' ' ASN . 12.8 mt -72.13 -52.72 15.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.744 0.307 . . . . 0.0 111.165 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -63.24 -43.25 98.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 98.2 mt-10 -68.01 -32.1 72.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.712 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 59.1 tp -61.44 -42.64 99.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.311 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.34 -50.78 68.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.799 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.95 -40.45 80.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' CA ' ' CE2' ' A' ' 58' ' ' TRP . . . -69.26 -58.55 6.51 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.66 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -56.76 -39.86 74.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 111.111 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -58.12 -72.44 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.97 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 164.36 158.02 9.91 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.576 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.404 HG11 ' HH2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -130.24 -175.33 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.93 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.36 104.72 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.471 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 61.94 20.25 11.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.728 0.299 . . . . 0.0 110.834 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 48.81 47.97 30.51 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.805 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 ' O ' HG13 ' A' ' 56' ' ' VAL . 27.9 p -71.73 -18.04 62.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.746 0.308 . . . . 0.0 111.254 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG12 HG12 ' A' ' 75' ' ' ILE . 19.7 m -156.85 169.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.735 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -160.93 111.18 1.73 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.571 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.51 ' HB2' HG21 ' A' ' 140' ' ' ILE . 30.7 p90 -102.21 96.42 6.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.76 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' O ' ' CE3' ' A' ' 71' ' ' TRP . . . -109.83 -144.4 10.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.912 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.015 HD11 HD23 ' A' ' 68' ' ' LEU . 7.1 mt -121.17 131.96 54.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.531 -0.334 . . . . 0.0 111.255 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -66.57 -33.59 76.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -135.77 101.43 4.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -67.95 49.01 0.05 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -157.69 27.03 0.28 Allowed 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.75 -167.77 1.86 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.286 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -123.08 -67.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.655 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.749 ' O ' HD12 ' A' ' 68' ' ' LEU . 29.3 p -86.46 -8.77 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.317 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.015 HD23 HD11 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 63.4 72.64 0.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.8 0.333 . . . . 0.0 110.671 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 94' ' ' CYS . 0.0 OUTLIER -89.36 -55.34 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.173 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -77.99 97.07 5.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.865 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.715 ' CZ2' HD22 ' A' ' 40' ' ' LEU . 27.2 m95 -91.79 152.02 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.804 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 58' ' ' TRP . 1.9 m -102.23 144.95 30.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -136.06 103.67 0.46 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 119.962 -1.113 . . . . 0.0 113.73 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.0 mtp -92.59 151.66 20.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.788 ' CD1' HD11 ' A' ' 147' ' ' LEU . 30.8 mt -151.82 142.72 15.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.883 0.373 . . . . 0.0 111.765 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.23 149.42 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.323 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.29 148.92 17.75 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.004 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HG3' ' HG2' ' A' ' 152' ' ' MET . 92.0 Cg_endo -79.77 132.36 9.69 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.909 2.406 . . . . 0.0 111.975 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.617 ' HA ' ' HB2' ' A' ' 84' ' ' GLU . 15.8 Cg_endo -56.86 83.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.709 2.273 . . . . 0.0 112.583 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 81' ' ' THR . 5.2 ptt180 161.32 30.58 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.715 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HB3' ' A' ' 84' ' ' GLU . 74.9 p -162.08 163.65 28.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.546 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 157' ' ' MET . 0.2 OUTLIER -53.93 -37.97 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 151' ' ' MET . 97.0 m-85 -79.44 -11.61 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.153 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 79' ' ' PRO . 5.1 pt-20 -51.71 146.41 7.95 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.267 0.556 . . . . 0.0 112.154 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.0 t30 44.62 29.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.611 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 1.6 mmt180 -131.29 99.64 4.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 87' ' ' ILE . 5.0 mp -62.7 166.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.796 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 87' ' ' ILE . 33.8 m-85 -150.82 130.21 12.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.03 0.443 . . . . 0.0 111.032 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.514 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 40.5 m -92.97 151.19 20.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.187 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' A' ' 107' ' ' PHE . 4.2 mp -152.41 160.17 43.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.074 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 71' ' ' TRP . 0.7 OUTLIER -141.15 114.37 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.83 -179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 105' ' ' VAL . 4.8 mp -106.35 120.5 57.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.481 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.19 130.04 40.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.428 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 69' ' ' THR . 4.0 p -127.88 -179.03 4.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.025 0.44 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -166.18 -149.0 5.75 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.077 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -51.07 -78.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.466 2.11 . . . . 0.0 111.819 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.76 77.32 9.52 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.674 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 1.9 t80 -91.26 -52.37 0.29 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 98' ' ' TYR . 3.4 Cg_exo -79.31 5.0 6.11 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.984 1.789 . . . . 0.0 112.516 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.2 -8.14 9.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.343 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . . . -139.92 150.46 62.48 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.667 0.27 . . . . 0.0 111.252 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 101' ' ' ALA . 31.3 Cg_exo -59.28 122.37 11.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.678 2.252 . . . . 0.0 112.372 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 67.6 Cg_endo -82.29 175.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.721 2.28 . . . . 0.0 112.432 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -97.54 90.19 4.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.171 0.51 . . . . 0.0 110.374 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.547 HG21 HG11 ' A' ' 143' ' ' VAL . 41.8 t -91.88 138.9 18.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.058 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.19 130.18 13.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.026 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 1.061 ' CD2' HG21 ' A' ' 111' ' ' ILE . 10.6 m-85 -76.01 126.7 31.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.1 t -78.95 -39.77 22.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.354 0.597 . . . . 0.0 109.634 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 6.7 t -69.07 -176.38 0.88 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.067 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 166' ' ' GLN . 30.1 mttt -99.14 87.52 3.7 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.061 HG21 ' CD2' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -116.87 153.52 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.95 -178.34 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.49 ' N ' HD13 ' A' ' 111' ' ' ILE . 10.6 t-20 -126.35 102.78 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.736 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.437 ' HB2' ' CD1' ' A' ' 111' ' ' ILE . 1.9 tpp -123.98 156.48 36.34 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 111.227 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -53.61 -43.37 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.164 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' ' 127' ' ' ALA . . . -109.05 28.41 11.17 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.944 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.968 HG22 HG13 ' A' ' 123' ' ' VAL . 76.9 t -135.4 130.17 50.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.824 0.345 . . . . 0.0 110.689 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -59.55 158.26 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.084 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -118.67 26.71 9.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.48 -51.42 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.679 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.5 -34.13 7.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.007 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.65 0.63 34.59 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.919 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.86 113.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 111.041 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 116' ' ' VAL . 13.1 t -76.67 115.17 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.471 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.62 110.14 3.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.918 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.38 -15.76 47.22 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.446 2.097 . . . . 0.0 112.323 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.61 -46.72 58.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.658 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -70.5 -42.65 71.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.699 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 131' ' ' LEU . 32.8 mm -70.03 103.78 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.647 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -53.96 -55.64 25.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.37 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.441 HG21 HG12 ' A' ' 142' ' ' VAL . 7.2 p -49.97 -31.73 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' H ' HG22 ' A' ' 128' ' ' ILE . 1.3 tp -84.15 -48.69 9.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.825 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -53.7 -48.11 69.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.09 34.44 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.862 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.427 ' CH2' ' HB3' ' A' ' 138' ' ' TYR . 54.8 t-105 -49.37 132.22 20.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -121.26 -178.34 3.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -86.11 61.06 6.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.757 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.9 m -160.85 -28.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.693 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.816 ' CD1' HG11 ' A' ' 142' ' ' VAL . 19.3 m-85 -70.96 168.16 17.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.425 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.09 -176.43 5.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.246 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.664 HD13 ' CE3' ' A' ' 71' ' ' TRP . 10.7 mt -55.94 -51.34 62.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.282 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 58' ' ' TRP . 4.3 ptpt -53.16 -35.06 59.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.816 HG11 ' CD1' ' A' ' 138' ' ' TYR . 40.9 t -69.04 -41.19 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.47 0.652 . . . . 0.0 109.547 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 105' ' ' VAL . 40.5 t -62.61 -53.13 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.342 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.707 HD22 HD11 ' A' ' 75' ' ' ILE . 28.5 mt -63.09 -48.54 78.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.741 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -59.86 -46.53 89.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -60.0 -53.16 61.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.568 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.838 HD12 ' N ' ' A' ' 148' ' ' ARG . 4.4 pp -62.0 -38.39 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.944 0.402 . . . . 0.0 110.109 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.838 ' N ' HD12 ' A' ' 147' ' ' LEU . 5.7 ttt-85 -69.59 -30.71 68.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.803 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -43.68 90.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.837 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.756 HD12 ' HA ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -65.33 -42.43 92.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.848 178.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 83' ' ' TYR . 21.3 mtt -50.97 -35.26 32.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.81 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . 0.424 ' HG2' ' HG3' ' A' ' 78' ' ' PRO . 69.8 mtm -74.44 -22.21 59.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.94 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.6 m -65.79 158.3 28.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.856 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' HA ' ' HG2' ' A' ' 157' ' ' MET . 28.7 mttp -65.19 -32.19 73.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.083 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -46.94 85.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.128 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -87.15 -21.76 25.75 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.48 ' O ' ' HB ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -82.56 13.64 3.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.778 0.323 . . . . 0.0 111.447 179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -116.52 -30.38 5.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.194 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.7 mt -55.41 148.85 30.93 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.829 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.63 149.57 89.61 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.156 . . . . 0.0 112.047 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.44 ' HG3' HG23 ' A' ' 82' ' ' ILE . 20.0 mm-40 -146.31 133.71 10.25 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.795 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 37.0 Cg_endo -65.85 126.31 15.73 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.553 2.168 . . . . 0.0 112.228 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 162' ' ' PRO . 28.5 Cg_exo -61.94 75.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.365 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 162' ' ' PRO . 0.1 OUTLIER 166.96 -168.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.715 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -135.67 21.96 3.53 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.656 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -69.63 158.56 35.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 111.171 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 31.6 p -80.3 -170.69 2.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.977 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 110' ' ' LYS . 10.7 m-85 -91.24 83.15 5.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 42.4 m -101.55 125.54 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.936 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.54 179.956 . . . . . . . . 0 0 . 1 stop_ save_